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GENERAL INTRODUCTION 
Among the different fields of organic chemistry, Heterocyclic Chemistry is one 
of the most developed both in terms of methods and applications. Indeed, many 
textbooks are now nicely giving a detailed overlook of the various general methods 
available for the building up of heterocycles, and their further functionalizations. Yet, 
if the preparation of the heterocycles is following well established strategies, the 
preparation of their precursors can be somehow a little bit tedious. This aspect is one 
of the major topics described in this manuscript. Indeed, we have been investigating 
short, efficient, in other words user friendly approaches to precursors of small 
heterocycles, especially pyrazoles and isoxazoles, as well as their downstream 
transformations. Such precursors are cyclic 2-Azahetaryl-3-enaminonitriles of 
general formula A. 
 
Figure GI.1. General structure of cyclic 2-Azahetaryl-3-enaminonitriles 
investigated in this PhD work. 
 
Cyclic 2-Azahetaryl-3-enaminonitriles have been shown to exhibit different 
configuration around the double bond depending on their substitution. We have 
thoroughly investigated their behavior in order to assess the potential relationship 
between their configuration and their reactivities.  
These compounds proved not only useful for azoles syntheses, but we found that 
they could undergo a further clean functionalization at the not highly reactive 
position 3 of the pyrrolidine ring under very specific circumstances. 
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Finally, we also explored the potential coordination properties of these 
derivatives toward boron and metals. This allowed us to characterize a wide range of 
new derivatives and investigate their photophysical properties. 
 
Figure GI.2. Fate of cyclic 2-Azahetaryl-3-enaminonitriles within this manuscript. 
 
Thus, this manuscript describes all the experiments carried out in these different 
directions. 
In a first chapter there is a general survey of the literature related to 2-(1-R-
pyrrolidine-2-ylidene)acetonitriles and their benzo-fused analogues. Details are 
provided on the various synthetic approaches to these compounds. Their various 
reactivities depending on their cyclic or acyclic nature and substitutions are then 
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covered with a range of nucleophiles and with dimethylformamide acetals. A final 
part of this chapter describes the complexation of boron and metals by 2-(pyrrolidin-
2-ylidene)acetonitrile and the applications of the complexes isolated are 
characterized. 
A second chapter describes in details the synthesis and characterization of all 
the 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitrile and 2-azahetaryl-2-(3-
oxoindolin-2-ylidene)acetonitrile obtained in the course of our studies. Thorough 
investigation of the configuration by different analytical methods, such as X-Ray 
diffraction, NMR including variable temperature experiments as well as computation 
is then described. 
Within the third chapter we describe the reactivity of 2-azahetaryl-2-(1-R-
pyrrolidin-2-ylidene)acetonitrile as 1,3-dielectrophiles toward binucleophilic 
compounds, and the synthesis of differently substituted pyrazoles and isoxazoles. The 
downstream transformations on pyrazoles are thoroughly described and showed 
excellent region- and chemoselectivities.  
Alternate paths observed upon modification of the hetaryl substituent are also 
reported highlighting the control of the reactions path in spite of the different reactive 
sites. 
After developing the electrophilic nature of 2-azahetaryl-2-(1-R-pyrrolidin-2-
ylidene)acetonitrile, we demonstrate in chapter 4 that these adducts can also behave 
as nucleophile in the presence of electrophiles such as dimethylformamide acetals. A 
detailed investigation of the reaction outcome allowed us to propose a mechanistic 
rational for the very specific reactivity. Further transformation of the “formylated” 
adducts are then reported. This chapter is concluded by the description of the 
photophysical properties of a pyrrolopyridinimine obtained from these previous 
transformations, and more precisely its ability to react with traces amounts of water 
in dry organic solvents providing a simple fluorometric way to assess solvent 
dryness. 
Finally the fifth chapter is devoted to the formation of (i) boron-difluoride 
complexes of 2-azahetaryl-2-(1H-pyrrolidin-2-ylidene)acetonitrile and the 
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photophysical properties of a range of isolated adducts; (ii) d-metal (Cu, Zn, Co, Ni) 
complexes, their isolation and full characterization as well as their implementation in 
devices to study their potent applications in solar cells and for detection of the Zn an 
Cu in biological fluids. 
After a general conclusion, the last part of this manuscript provides the 
experimental details of all the products synthesized and the experiments carried out.
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ABBREVIATIONS 
Ас acyl 
Alk  alkyl 
Ar aryl 
Bn  benzyl 
Boc tert-butyloxycarbonyl 
Bu  butyl 
BODIPY boron-dipyrromethene 
CHA cyclohexane 
cat.  catalyst, catalytic 
1,2-DCE 1,2-dichloroethane 
DFT density functional theory 
DMAc dimethylacetamide 
DMF DMA N,N-dimethylformamide diethyl acetal 
DMF DEA N,N-dimethylformamide dimethyl acetal 
DMF  dimethylformamide 
DMS dimethyl sulfate 
DMSO  dimethyl sulfoxide 
Е electrophile 
equiv  equivalent 
Et ethyl 
ex vivo out of the living 
HRMS high resolution mass spectrometry  
IR infrared 
in situ  without isolation 
in vitro  in laboratory 
in vivo  in living organism 
J  coupling constant, Hz 
Ме  methyl 
mp. melting point 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
Nu  nucleophile 
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one-pot without isolation of intermediates 
Ph  phenyl 
PI polarity index 
ppm parts per million 
Pr  propyl 
Pyr pyrazole 
rt room temperature 
TFA  trifluoroacetic acid 
THF tetrahydrofuran 
TLC thin layer chromatography 
UV  ultraviolet 
VTP experiment variable temperature experiment 
XRD  X-Ray diffraction 
δ  chemical shift, ppm (NMR spectroscopy) 
∆ reflux 
Ф quantum yield 
∆ʋ, cm-1 Stokes shift 
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СHAPTER 1. SYNTHESIS, REACTIONS AND APPLICATION OF 2-(1-R-
PYRROLIDIN-2-YLIDENE)ACETONITRILES AND THEIR BENZO 
ANALOGUES (literature review) 
This chapter is devoted to a comprehensive description of the access to 2-(1-R-
pyrrolidin-2-ylidene)acetonitriles (section 1.1) and their benzo analogues (section 
1.2) as well as their transformations upon treatment with 1,2-binucleophiles (section 
1.3) and N,N-dimethylformamide dialkyl acetals (section 1.4). These transformations 
provide a fast access to range of heterocyclic scaffolds due to the rich synthetic 
potential of starting material A featuring two electrophilic sites (the nitrile carbon 
atom and sp2-hybridized C-2 carbon atom of the pyrrolidine moiety) and two 
nucleophilic sites (N-1 nitrogen atom in the case of R = H and the pyrrolidine C-3 
atom) as illustrated in Figure I.1. 
 
 
 
 
Figure I.1. Graphical representation of the literature review. 
 
Moreover, when 2-(1-R-pyrrolidin-2-ylidene)acetonitriles feature extra electron 
donating atom (X = O, N) they are used for complexation (section 1.5).  Upon 
complexation with boron difluoride the bright fluorescence arises allowing consider 
the BF2-comlexes as BODIPY-dyes analogues (subsection 1.5.1). Coordination with 
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3d-metals is discussed in subsection 1.5.2. The complexes structure exploration along 
with their catalytic properties in enantioselective and polymerization reactions are 
presented.  
 
1.1. Synthesis of 2-R1-2-(1-R-pyrrolidin-2-ylidene)acetonitriles  
One of the most general methods for the preparation of compounds 
with general formula 1.1 is the condensation of 5-methoxy-3,4-dihydro-
2H-pyrrole 1.2a or 5-(methylthio)-3,4-dihydro-2H-pyrrole 1.2b with 
compounds bearing the activated methylene group (Scheme 1.1).1-4 The 
reaction to 1.3 proceeds smoothly from room temperature (rt) to reflux; the selection 
of reaction conditions depends on the electronegativity of the substituents connected 
to the methylene moiety. No additional basic catalysts are required for these 
reactions.  
  
Scheme 1.1. Synthesis of 2-R1, R2-pyrrolidin-2-ylidenes 1.3. 
 
The starting material, namely methoxybutyrolactam 1.2a, was obtained by the 
reaction of pyrrolide-2-one with dimethyl sulfate (Me2SO4, DMS) or via utilization  
of triethyloxonium tetrafluoroborate (Meerwein's salt).5-6 S-methylthiobutyrolactam 
was prepared in two steps, starting with the reaction of pyrrolide-2-one and 2,4-bis(4-
methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide (Lawesson's reagent, LR) 
followed by methylation with DMS.7  
The structurally related pyrazolone 1.4 was synthesized via heating in 
dimethylformamide (DMF) as illustrated in Scheme 1.2.1   
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Scheme 1.2. The cyclization of 1.3а into the corresponding pyrazolone 1.4. 
 
The reaction of O-methoxybutyrolactam 1.2a with N-unsubstituted 2-
cyanoacetohydrazides upon heating in DMF led to the corresponding pyrazolones 1.4 
(DMF, reflux); alternatively, amidrazones 1.5 were formed under milder conditions 
(DMF, 40 °C.). The conversion from the open-chain form 1.5 to the cyclic one 1.4 
occurs via the amidine-enamine rearrangement through the transition state A (Scheme 
1.3).8  
Scheme 1.3. The reaction of О-methoxybutyrolactame 1.2a with N-unsubstituted 2-
cyanoacetohydrazides 
 
According to the scope of literature methods, only a few β-enaminonitriles 1.6 
bearing a heterocyclic substituent are known. They were prepared by the 
condensation reaction of lactim ether 1.2a or thioester 1.2b and hetaryl acetonitriles 
(Scheme 1.4).8-10  
 
Scheme 1.4. Synthesis of enaminonitriles 1.6 bearing heterocyclic substituents. 
15 
 
 
SMe is better nucleofuge, than ОMe; the condensation reaction of thioester proceeds 
without addition of basic agents.  
2-(3,4-Dihydro-2H-pyrrol-5-yl)-2-(pyrrolidin-2-ylidene)acetenonitrile 1.7 
featuring a stereogenic centre in the position 5 of the pyrrolidine core was obtained 
by condensation of substituted O-ethoxybutyrolactame 1.2c and enaminonitrile 1.6 
under strongly acidic conditions, i.e. by using TFA (trifluoroacetic acid) (Scheme 
1.5). 11-12 This approach was used for the synthesis of semicorrins1 1.7. 
 
 
2-(1-Alkylpyrrolidin-2-ylidene)acetonitriles were also synthesized by alkylation 
of their unsubstituted analogues with alkyl halides. Several examples of alkylation of 
β,β-pyrrolidienamalononitrile were illustrated,13-16 in particular, with 1.3b 
bromoacetic acid ester, methyl phenacyl bromide and chloroacetanilide 1.8  (Scheme 
1.6).  
 
Scheme 1.6. Synthesis of 2-(1-alkylpyrrolidin-2-ylidene)acetonitriles and their 
further modifications into the potentially biologically active compounds. 
 
The purpose of these transformations was obtaining fused systems: pyrrolizines 1.10 
(Thorpe-Ziegler condensation) and pyrrolopyrimidines 1.11, that exhibit a range of 
biological activities, in particular, antitumor, anti-inflammatory, antiviral. In some 
experiments, compound 1.9 served as an intermediate and used without isolation, but 
                                                        
1
 Semicorrins - nitrogen-containing ligands for enantioselective catalysis (details on their using are in section 1.5.2). 
Scheme 1.5. Synthesis of chiral 5-(cyano(5-pyrrolidin-2-ylidene)methyl)-3,4-dihydro-
2H-pyrroles 1.7. 
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immediately transformed to the corresponding pyrrolizines 1.10. Biological in vitro 
and in vivo studies were also provided. 
Alkylation proceeds smoothly, when the pyrrolidine's NH proton is only loosely 
bound. If a hydrogen bond acceptor, e.g. a carbonyl group, is located close to the NH 
moiety, then the proton become less acidic and deprotonation becomes harder 
preventing subsequent alkylation (Scheme 1.7, route 1).16  
    
Scheme 1.7. Approaches to the synthesis of 2-(1-alkylpyrrolidin-2-
ylidene)acetonitriles. 
 
An alternative approach to the synthesis of 2-(1-alkylpyrolidine-2-
ylidene)acetonitriles is the condensation of 1-alkylpyrrolidin-2-one dialkyl acetal 
1.14a with a malonate equivalent (Scheme 1.7, route 2).  
1-Methylpyrrolidin-2-one diethyl acetal 1.14b is in equilibrium with the 
corresponding ambident cation 1.15 , formed by dissociation of one ethoxy from 
1.14b (Scheme 1.8).17  
 
Scheme 1.8. Diethyl acetal exists as an equilibrium mixture of three forms. 
 
At the same time, 2-ethoxyenamine 1.16 exists in equilibrium with the ambident 
cation 1.15. This occurs due to the existence of a complete positive charge in 
compound 1.15, which increases the proton mobility in the third position. Acetals are 
more reactive electrophiles than O-alkoxybutyrolactam 1.2a, thus they react even 
with nitromethane and with other acidic CH upon milder conditions. The 
disadvantage of acetals is their instability and degradation with time to the starting 
pyrrolidin-2-one; such process accelerates upon heating. 
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Another method for the preparation of 2-(1-alkylpyrrolidin-2-
ylidene)acetonitriles 1.17 is the condensation reaction of 1-methylpyrrolidin-2-thione 
and the corresponding substituted acetonitrile in the presence of Ag2CO3.18 The silver 
salt has two significant features: first of all, it is thiophilic; secondly, it acts as a base 
allowing  the reaction to proceed under mild conditions such as at rt (Scheme 1.9).  
  
 
Scheme 1.9. Synthesis of bifunctionalized enamines 1.17 at room temperature with 
addition of Ag2CO3. 
 
The reaction occurs with nucleophiles bearing two electron withdrawing groups, 
and at least one of them should be nitrile moiety. It was observed that no reaction 
occurs if the nitrile group was replaced with ethyl acetoacetate or dimethyl malonate, 
which have similar electron withdrawing properties. Also, the reaction does not take 
place with 1H-pyrrolidin-2-thione; this statement confirms the passivity of neutral 
silver complexes in this transformation.  Solvents with coordination ability were used 
in above-mentioned transformations, i.e. acetonitrile, tetrahydrofuran. 
Substituted α-alkylidene 1.19, can be obtained by a [3+2] cycloaddition 
reaction between activated alkenes and N-(silylmethyl)-substituted ketene N,S-
dithioacetals 1.18, which serve as synthetic equivalents of alkyliden azamethine 
ylides (Scheme 1.10).19 The reaction takes place by 1,3-elimination of 
(methylthio)trimethylsilane with subsequent formation of a dipole A, which reacts 
stereo- and regiospecifically with activated alkenes to form α-alkylidene pyrrolidines 
1.19. The reaction requires 72 h at rt. The starting N,S-dithioacetals are not 
commercially available and must be synthesized in 2 steps starting with ketene 
dithioacetals 1.20 and ((trimethylsilyl)methyl)amines 1.21.  
18 
 
 
Scheme 1.10. Synthesis of α-alkylidene-substituted [3+2] cycloadducts 1.19.  
 
Moreover, analogues of pyrrolidinacetonitriles, e.g. (1-arylpyrrolidin-2-
ylidene)acetates 1.23 were synthesized by alkylation of N-arylthiolactam with α-
haloacetates, followed by Sulfur atom elimination and subsequent C–C bond 
formation (Scheme 1.11).20 In the first step of the reaction, salts 1.22 were formed. 
Due to the conjugation of nitrogen lone pair with an aromatic ring and decreasing of 
the nucleophilicity of the sulfur moiety, the reaction takes place over several hours 
(max. 189 h for R = C6H4OMe), from rt to 50 °C, in the absence of a solvent (neat). 
The produced salts 1.22 without isolation were subjected to the next step. Yields of 
the target products 1.23 were low (5-65%) due to the formation of by-products such 
as the starting 1-arylacetate and 3-alkylthiolactam 1.24.  
Scheme 1.11. One-pot synthesis of (1-arylpyrrolidin-2-ylidene)acetates 1.23 by 
alkylation of thiolactams followed by Sulfur displacement. 
 
For the first time, the method for the C–C bond construction via Sulfur 
displacement was studied by Knott in his work dedicated to sulfur-containing 
chromophores.21-22 In attempts to carry out the dihydrobromination reaction of 
(phenacylthio)benzothiazolium bromide 1.25 using triethylamine, the corresponding 
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unsaturated ketone 1.27 was formed instead of the expected sulfide 1.26. The 
reaction passes through the episulfide intermediate A followed by sulfur extrusion 
(Scheme 1.12). 
 
 
The authors of the above-described method for the synthesis of (1-
arylpyrrolidin-2-ylidene)acetates 1.23 also have reported a more efficient method 
providing higher yields (41-80%); it consists in the condensation of 6-chlorohexanoic 
acid ethyl ester with aniline at 65 оC in the presence of catalytic amounts of iodine, a 
drying agent (Na2SO4) and a base (Na2HPO4) used to trap hydrogen chloride (Scheme 
1.13).20 
 
 
This method was unfruitful only with p-nitrophenyl substituents (0% yield). 
However, due to the known literature procedures, condensation of nitroanilines with 
ethyl acetate in the presence of iodine does not occur in the desired direction.23 The 
disadvantage of the method is the formation of acyclic vinylogues of urethanes, as 
well as condensation products of the parent ester, which significantly complicates the 
purification of the final product of the reaction. 
 
Scheme 1.12. The first application of the C–C bond forming reaction via the Sulfur 
displacement (1955).21 
Scheme 1.13. Synthesis of (1-arylpyrrolidin-2-ylidene)acetates 1.23 by condensation 
of 6-chlorohexanoic acid ester with aniline. 
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1.2. Synthesis of  2-R1-2-(indolin/3-oxoindolin-2-ylidene)acetonitriles  
Synthesis of 2-R1-(indolin/3-oxoindolin-2-
ylidene)acetonitriles with general formula 1.28 is not a 
common problem and there are exiguous ways to solve it. 
Application of the alkylation method for cyclic amide by 
utilizing DMS or Meerwein's salt followed by 
condensation with acidic CH (the approach used for the 
synthesis of pyrrolidin-2-ylidenacetonitrile 1.3) in this 
case is not fruitful. Thus, isatins are mainly alkylated at 
the nitrogen atom; when the indolin-2-one 1.29 is alkylated with Meerwein's salt, an 
equilibrium mixture of 2-alkoxy-1H-indole 1.30a and 2-alkoxy-3H-indole 1.30b was 
obtained, which is passive in reactions with most of the C-nucleophiles.24  
In the resulting tautomeric system, the equilibrium is shifted to a more 
thermodynamically stable isomer 1.30b with 10π electronic aromatic system, 
comparing to the non-conjugated lactam ester 1.30a (Scheme 1.14). According to 1H 
NMR data, the ratio of  tautomers 1.30a:1.30b in the equilibrium system was 1:10.24. 
In addition, it was observed that the 2-alkoxy-3H-indole 1.30b is unstable due to 
subsequent oxidation to the correspoding indirubin under air.25  
 Scheme 1.14. Synthesis of 2-(indolin-2-ylidene)malononitrile 1.31 by alkylation of 
indolin-2-one 1.29. 
 
For the formation of systems with general formula 1.28a via condensation with 
acidic CH, it is necessary that the equilibrium is shifted towards the lactam ether 
1.30a. For this purpose, the methylene moiety of the nucleophile must be sufficiently 
activated to promote the shift of equilibrium and, consequently, the reaction.26 The 
target product 1.31 can only be prepared using malononitrile, which methylene group 
is located between two strong acceptors, i.e. nitrile groups (Scheme 1.14). The 
 
1.28a – indolin-2-
ylidene 
1.28b – 3- oxoindolin -
2- ylidene 
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reaction did not occur without the isolation of desired product while involving to the 
reaction other acidic CH, e.g. nitromethane, ethylcyanoacetate, ethylnitroacetate.26 
Bearing in mind the complexity of this synthetic route, its use in the synthesis of 
2-functionalized indoles is limited to one publication.26 In section 1.4, the reactions of 
enaminonitrile 1.31 with C-electrophiles will be reviewed. 
Another approach to the synthesis of compounds with general formula 1.28a 
was published by German scientists (Scheme 1.15, route 1),27 and subsequently 
improved by Swiss ones (Scheme 1.15, route 2);28 those strategies were related to the 
reduction of  β-diketones 1.33. 
Scheme 1.15. Synthesis of 2-R-(indolin-2-ylidene)ketones / esters 1.34 by the 
reduction of β-diketone derivatives 1.33. 
 
 Compounds 1.33 were synthesized by the condensation of 2-(2-
nitrophenyl)acetyl chloride 1.32 with methylene active compounds 1.35 (Scheme 
1.15, route 1),27 or with methoxy-magnesium derivative of dimethylmalonate 1.36.28 
An efficient one-pot method for the synthesis of 2-vinylindole derivatives 1.37 
was developed by the S. Blechert group.29 The starting compounds were aldehyde, 
phenylhydroxylamine and cyanoallen. The reaction intermediates N-phenylnitrons 
were converted to 2-vinylindole derivatives by means of tandem reactions: 1,3-
dipolar cycloaddition, Cope rearrangement, retro-Michael addition, and indolization 
(Scheme 1.16). The reaction proceeds at 20-60 °C in ethanol. According to the 
structure simplicity of the starting materials, as well as the number of steps, the 
reaction yield can be seen as satisfactory (36-77%). 
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Scheme 1.16. Synthesis of 2-vinylindoles 1.37 by the tandem reactions. 
 
This method was applied for the synthesis of 2-vinylindoles with various 
substituents, i.e. heterocyclic and aromatic, as well as aliphatic ones. The only 
limitation in scope for this procedure is the availability of nitrones A; some of them 
are formed very slowly and are unstable. However, this method does not require the 
stage of nitrons isolation and purification; they are immediately involved into the 
next step with cyanoallenes, which made this approach successful. 
The resulting 2-vinylindoles 1.37 proved to be a powerful source for the 
construction of linear carbazole cores, which are the key intermediates in the 
synthesis of some indole alkaloids (ellypticine, olivacine).30 The cycloaddition 
reaction (Diels-Alder) with electron deficient alkenes in dichloromethane takes place 
at rt in the presence of TFA and ends with the formation of tetrahydrocarbazols 1.38. 
The reaction proceeds with high stereo- and regioselectivity and results in the 
formation of endo-adducts. Tetrahydrocarbazols 1.38 can be further oxidized to 
carbazole 1.39 using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (Scheme 
1.17). 
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Scheme 1.17. Synthesis of tetrahydrocarbazols 1.38 with 2-vinylindoles 1.37 by the 
Diels-Alder reaction. Oxidation of saturated compounds 1.38 into the corresponding 
carbazoles 1.39. 
 
As it was mentioned above, isatins are mainly alkylated at the nitrogen atom; 
thus, no examples of the application of their 2-alkoxy derivatives in the construction 
of 2-C–C bond are reported to date. 
 In general, the C-2 position of isatin is passive in reactions with nucleophiles 
(without  addition of catalysts for this process, as discussed below) in contrast to C-3, 
which could be functionalized by widely reported various methods. 
The only purposeful approach to the synthesis of 1.28b of 2-R1-(3-oxoindolin-2-
ylidene)acetonitrile with general formula 1.28b, in particular, 2-(6-R1-3-oxoindolin-
2-ylidene)-2-arylacetonitrile 1.42, is the condensation of 1-acetylindoxyl 1.40 and 
aldehydes followed by a substitution reaction of the vinyl hydrogen atom with a 
cyano group. (Scheme 1.18).31-32 
The reaction occurring in the first step of the synthesis is accompanied by 
hydrolysis of the amide bond (NAc) and the formation of the non-substituted 
indogenide 1.41. In order to avoid hydrolysis, Buzas et al.33 have developed the 
method for carrying the reaction in the presence of a less strong base, i.e. piperidine, 
upon boiling in an inert solvent (benzene/toluene) 
In the reaction with potassium cyanide, N(1)-substituted analogues of 
indogenide 1.41 were found to be better substrates; thus, the modification was carried 
out by the introduction of an alkyl group in the third step of the synthesis, after the 
incorporation of nitrile moiety.  
Cyanoindogenenes 1.42 and 1.43 were modified in order to obtain new potent 
antituberculous drugs – analogues of pyridazoindole. It is known that hydrazine 
derivatives exhibit activity against different strains of bacteria, in particular 
24 
 
M. tuberculosis H37Rv and M. Fortuitum, and also inhibit monoamine oxidase, an 
enzyme involved in the pathogen metabolism. Tricyclic pyridazoindoles 1.44 were 
prepared by the reaction with hydrazine hydrate; their primary amino group were 
modified by diazotisation-hydrolysis reactions to form pyridazinone 1.45, 
formylation, which gave pyridazoamide 1.46 and subsequent acylation led to 
diacylaminopyridazine 1.47.32 
 
 
 
Analogues of 2-R1-(3-oxoindolin-2-ylidene)acetonitriles, which nitrile group 
was substituted by another electron-withdrawing group 1.48 were obtained by the 
sequence illustrated in Scheme 1.18 (synthesis of compound 1.41); they were acting 
as a dienophile in the synthesis of model cores of Aristotelía alkaloids  (Scheme 
1.19).34 
Scheme 1.18. Synthesis of 2-R1-(3-oxoindolin-2-ylidene)acetonitrile and their 
modification in order to obtain potential anti-tuberculosis drugs. 
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Scheme 1.19. Synthesis of model cores of Aristotelía alkaloids. 
 
An interesting alternative approach to the synthesis of 2-R1-(3-oxoindolin-2-
ylidene)acetatoacetates 1.51 was recently published and consists in simultaneous 
construction of the C–C and C=O bonds using cross-coupling reaction between the 
indole 1.50 and β-ketoesters with oxygen as a mild oxidant (Scheme 1.20).35-36 The 
reaction is tolerant to a wide range of substituents connected to the indole core and 
takes place both with the electron-withdrawing and the electron-donating groups. 
Also, the reaction is not sensitive to air humidity. 
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Scheme 1.20. Oxidative cross-coupling of indoles 1.50 with β-ketoesters. 
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The oxidative cross-coupling takes place regioselective with good yields of the 
product only with β-ketoesters, since the activity of the catalyst that is formed in situ 
[(1,3-diketonato)2Co(II)] strongly depends on the electronic effect of 1,3-diketones. 36 
The possible reaction mechanism involves the formation of the β-ketoester A 
radical, which adds to the 2-position of the indole to form a stabilized radical B, 
which, in turn, reacts with the air oxygen and turns into the corresponding peroxide 
C. The latter is converted to the intermediate D, which transforms into the final 
compound during oxidative dehydrogenation 1.51. 
Another example of the cross-coupling reaction for the synthesis of 2-R1-(3-
oxoindolin-2-ylidene)acetoacetates 1.51 is the reaction between isatin 1.52 and 
alkanoates 1.53 (Scheme 1.21).37  
 Scheme 1.21. The coupling reaction of isatin and alkynoates, which is accompanied 
by the migration of oxygen atom. 
 
The proposed catalytic cycle starts with the palladiation of the C-2 carbonyl group of 
isatin 1.52 to form intermediate A, followed by the syn-addition to the alkyn, which 
ends with the formation of the vinyl-palladium complex B, subsequently rearranged 
to C. The catalytic cycle is completed by the release of the intermediate D, which 
oxocyclobutane undergo acid catalysed rearrangement to 1.51. The presence of an 
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unsubstituted N(1)-isatin is compulsory to start the catalytic cycle, namely the 
formation of the intermediate A. No reaction is observed with N-alkyl substituted 
isatins. 
The reaction of isatin with nucleophiles can also occur by activating the C-2 
position by introducing a halogen atom. For the first time such approach was used in 
the Bayer's works devoted to the synthesis of indigo in 1878-1879 years.38 He made 
the statement that the reaction of isatin with phosphorus pentachloride upon boiling 
in benzene led to 2-chloro-3H-indole-3-one 1.54 (Figure 1.1a), which was isolated 
and characterized (by methods available at that time: elemental analysis, melting 
point with a decomposition at 180 °C). This compound is unstable under air and 
hydrolyzes to the starting isatin. In 1996, the "2-chloroisatin approach" was used in 
37 articles and 4 patents published by 26 scientific groups. In 1996, Sir John 
Cornforth published an article in which he provided evidence, that upon the synthesis 
conditions proposed by Bayer, no 2-chloroisatin was formed, as it was thougt to be 
for more than a century, but its dimer, namely 2-2-2-dichloro-2,3-dihydro-3-
oxoindol-1-yl)3H-indole-3-one 1.55 (Figure 1.1 b).38 The structure of the compound 
was confirmed by X-ray diffraction analysis. 
 
 
Figure 1.1. а). 2-Chloro-3Н-
indole-3-on – phantom. 
Figure 1.1. b) 2-(2,2-Dichloro-2,3-dihydro-3-
oxoindol-1-yl)3H-indole-3-one - a confirmed 
structure. 
 
Using his own assumptions, Sir John Cornforth explained the strange features 
observed in the reactions of "2-chloroisatin" with nucleophiles, such as the 
competitive condensation at the C-3 position, which is less active than C-2, according 
to the proposed structure 1.54. Prior to this, the results of these reactions were mainly 
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explained by the instability of 2-chloroisatin and its degradation to the starting isatin, 
which is an active component of the reaction.39 
 On the example of the reaction with aromatic amines, Sir John Cornforth 
explained why the structure of the formed products may depend on the amount of the 
starting amine.  
Imidochloride 1.55 predominantly exists in the non-dissociated form 1.55a. The 
transition to form 1.55b may be caused by a polar solvent. Apparently, The С-3 
position of isatin is more active in the form 1.55a (Figure 1.1b); thus it undergoes 
nucleophilic attack by amino group 1.56 (Scheme 1.22). Two equivalents of water 
released during condensation induce the dissociation of the C-Cl bond 1.57 and 
subsequent attack by the second amine molecule at the C-2 position of 1.58. In the 
case of stoichiometric quantities of reagents, the only product of the reaction was 3-
(arylimino)indolin-2-one 1.59; the water produced during the condensation attacks at 
the C-2 position of imidoylchloride 1.57.  
Scheme 1.22. Reaction of 1.55a imidocloride with aromatic amines. 
 
This activation approach for the C-2 position of isatin was used to synthesize 2-
R1-(3-oxoindolin-2-ylidene)acetatoacetates 1.51 (Scheme 1.23).40-42In the first step, 
isatin reactes with phosphorus pentachloride. The formed imidochloride 1.55a2  is 
filtered under nitrogen and dissolved in a more polar solvent – dioxane. To the 
solution is added malonate salt and after a brief stirring at room temperature, C-2-
functionalized isatins 1.51 were obtained in 30-50% yield . 
                                                        
2
 authors have not described the structure of the intermediate product and depict it in the form of imidoyl chloride 1.54 
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During the course of the condensation of the latter compounds with hydrazines,  
pyridazino[4,3-b]indole esters 1.59 were prepared; they have shown activity as 
benzodiazepine receptor ligands. A series of works by Italian scientists is devoted to 
synthesis and structural modifications of compounds 1.59 (alkylation with the 
formation of N-Alk 1.60 and O-Alk 1.61 derivatives, etc.) to pursue studies related to 
the structure of benzodiazepine receptors and affinity of ligands.40-43  
 
1.3. Reactions of β-enaminonitriles with 1,2-binucleophiles for the synthesis of 
pyrazoles (isoxazoles) 
Pyrazole is a common moiety found in many medicinal and agrochemical 
products (derivatives of 1-arylpyrazole are inhibitors of cyclooxygenase-2 and 
protein kinase, antifungal drugs, 1,5-diarylpyrazoles inhibitors of HIV-1 reverse 
transcriptase, etc.).44-45 Pyrazole derivatives are also used in food and polymer 
chemistry (catalysts of polymerization reactions).44 Considering the wide array of 
applications for pyrazoles usage, the interest in their synthesis does not fade over 
time. Several works of interest have recently been published on combinatorial 
synthesis of pyrazoles,46 as well as cross-coupling reactions for the post-
functionalization of pyrazoles47 and modified syntheses of 4-trifluoromethyl 
Scheme 1.23. Functionalization of the C-2 position of isatins via the formation of 
imidochloride 1.55a. 
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substituted pyrazoles.48 Chemistry of pyrazoles,44 their catalytic properties,49 and 
therapeutic use45 have been extensively reviewed. 
There are several approaches to access the pyrazole ring. The most common is 
condensation between 1,3-dielectrophilic synthons and hydrazines. In this section, we 
focus on the synthesis of pyrazoles with the participation of cyclic or acyclic 
enaminonitrile having two electrophilic centres: the carbon atom of the nitrile group 
and the β-atom of the acrylonitrile fragment; therefore, these compounds may act as a 
1,3-dielectrophilic agent (Figure 1.2). 
 
 
Figure 1.2. Electrophilic sites of cyclic and acyclicenaminonitriles. 
 
A search in the SciFinder database revealed about 720 publications devoted to 
the reactions of acyclic β-enaminonitrile with 1,2-binucleophiles. Focusing on the 
nearest analogues of the systems, to which our work is devoted, namely on α-hetaryl-
β-enaminonitrile, the range was managed to narrow down to about 20 publications, 
which will be discussed in subsection 1.3.1. The use of cyclic β-enaminonitrile 
derivatives in the synthesis of azoles, which will be discussed in subsection 1.3.2, has 
been studied scarcely and described in only 6 publications, whereas cyclic α-hetaryl-
β-enaminonitrile has been used only once. 
1.3.1. Reactions of acyclic α-hetaryl-β-enaminonitrile with 1,2-binucleophiles 
A series of works devoted to the synthesis of 4-hetaryl-5-aminopyrazoles from 
acyclic α-hetaryl-β-enaminonitriles has been reported (Figure 1.3).50-57 
 
Figure 1.3.  A schematic representation of the synthesis of  
4-hetaryl-5-aminopyrazoles from acyclic α-hetaryl-β-enaminonitriles.  
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Synthesis started with the functionalization of the methylene group of 
hetarylacetonitrile 1.62. The necessary precursors, i.e. α-hetaryl-β-enaminonitriles,  
can be synthesized in three ways: 1) the reaction with dimethylformamide 
dimethylacetal (DMF DMA) leading at 2-hetaryl-3-(dimethylamino)acrylonitrile 1.63 
(Scheme 1.24, route 1); 2) the reaction with carbon disulfide followed by alkylation 
and the substitution of one methylthiol group by arylamine (Scheme 1.24, route 2); or 
3) reaction with isothiocyanate followed by alkylation (Scheme 1.24, route 3) for the 
preparation of 2-hetaryl-3-(methylthio)-3-(phenylamino) acrylonitrile 1.65. The 
subsequent cyclization with hydrazines (hydroxylamine) results in 4-hetaryl-5-
amino-pyrazoles (isoxazoles) 1.66. 
 Scheme 1.24. Strategies for the preparation of 4-hetaryl-5-aminoazoles 1.66. 
 
The obtained azoles have functional groups, that can be converted into various 
heterocyclic frames by reactions with the appropriate reagents; thereby, this method 
opens a range of new ways for creating potentially biologically active compounds. 
Thus, in the above-mentioned works were described transformations involving the 
aromatic exo-amino group and the pyrazole nitrogen. The authors state that in the 
first step aromatic amino group was involved into the reaction, and secondly, the 
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cyclization occurs at the pyrazole nitrogen atom. More transformations are presented 
on Scheme 1.26.  
 
 Scheme 1.26. Modifications of pyrazoles 1.66. 
 
5-NH2-Group of pyrazole 1.66 adds to the activated double bond by the Michael 
reaction to form the pyrazolo[1,5-a]pyrimidine 1.67. Alternatively, the latter can be 
obtained in two steps through the preparation of Schiff base 1.68, followed by its 
reaction with malononitrile. Pyrazolo[1,5-a]pyrimidines 1.69a,b can be prepared by 
reaction of pyrazoles 1.66 with β-diketones or β-ketoesters. When using the latter 
compound, the nucleophilic attack of the amino group occurs on the ester carbon 
atom. Diazonium chloride 1.70 formed by the reaction of the diazonation of the 
amino group, reacts with methylene active compounds to form the pyrazolo[5,1-
c][1,2,4]triazines 1,71, 1.72. In this case, the diazo group such as electrophile, 
meanwhile β-diketone or β-ketosester acts as the nucleophile. 
In 2009 report has appeared opening a way to the synthesis of combinatorial 
libraries of 5-(1H-4-pyrazolyl)-[1,2,4]oxidiazole  (Scheme 1.27).46 The authors of the 
33 
 
article synthesized more than 1000 compounds using the parallel liquid phase 
synthesis. 
 
Scheme 1.27. Parallel liquid-phase synthesis of combinatorial libraries of 5-(1H-4-
pyrazolyl)-[1,2,4]oxidiazoles.3 
 
Using route 2 (Scheme 1.24) precursors of pyrazoles 3-(methylthio)-3-
(arylamino)-2-(thiazol-2-yl)acrylonitrile 1.65 were obtained in a reaction of 
oxadiazolylacetonitrile 1.62 with CS2 followed by methylation and substitution of 
one methylthiol group by the amino moiety. Using this approach, it is possible to 
synthesize pyrazoles with a large variety of 3-NR1R2 substituents in the core and to 
avoid the use of toxic isothiocyanate. The authors note, that using the excess of 
hydrazine hydrate in the cyclization reaction leads to the formation of a by-product 
1.66a' (in the case of  R1 = SMe) which cannot be obtained by the reaction of 
pyrazole 1.66a with hydrazine. Consequently, a side reaction occurs at the stage of 
addition of two molecules of hydrazine to acyclic (bis(methylthio)vinyl)hetaryl 1.64, 
preceding the cyclization step. 
                                                        
3
 The decryption of the substituents R2-R3, Ar1 is not given, since the article is devoted to combinatorial synthesis with 
large number of variants. For more information, please refer to the article 46  
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The first step of the combinatorial synthesis was a regioselective alkylation by 
the pyrazole N-1 position with 2-chloroacetamides, which terminates with the 
formation of acetamides 1.73. The next acylation takes place on the aromatic amino 
group and leads to the formation of monoacyl derivative 1.74 in the case of using 
acyl chlorides. If anhydrides were used, no double acylation is occuring. Reaction 
with acetoacetates is carried out under standard conditions via boiling in acetic acid 
media, which led to the pyrazolo[1,5-a]pyrimidines 1.75. 
α-Hetaryl-β-enaminonitriles have also becоme precursors in the synthesis of 
new oxazolidinone compounds that are candidates for the treatment of diseases 
caused by resistant gram-positive bacteria, such as methicillin-resistant 
Staphylococcus aureus, penicillin-resistant Pneumococcus (Streptococcus 
pneumonia) and vancomycin-resistant Enterococcus faecalis.58-59 
Among the synthesized compounds, the highest activity was shown by (S)-N - 
((3-(3-fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxo-oxazolidine-5-yl) 
methyl)acetamide 1.76;58 for this compound, an industrial 7-stage synthetic method 
was developed, providing a 27.6% total yield; in this sequence, the key intermediate 
was 3-(dimethylamino)-2-(pyridin-2-yl)acrylonitrile 1.63а (Scheme 1.28).  
 
Scheme 1.28. 3-(Dimethylamino)-2-(pyridin-2-yl)acrylonitrile 1.63a the key 
intermediate in an industrial method for a synthesis of an antibiotic 1.76. 
 
Thus, acyclic 2-hetaryl-3-enaminonitrile were starting compounds to prepare 4-
hetaryl-5-aminopyrazoles. Well-studied cyclizations, involving the exo-amino group 
and the pyrazole nitrogen atom, were used to obtain the compounds with potential 
biological activity.  
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1.3.2. Reactions of cyclic β-enaminonitrile with 1,2-binucleophiles 
If an acyclic enaminonitrile is used, then methylthiol or dimethylamine acts as 
the leaving group in the course of the synthesis of pyrazoles; alternatively, in the case 
of cyclic analogues, the nucleofuge is ω-aminoalkyl (Figure 1.4).  
 
Figure 1.4. Schematic representation of the synthesis of 3-ω-aminoalkyl-5-
aminopyrazoles from cyclic β-enaminonitriles. 
 
The first article, which describes the reactions of cyclic β-enaminonitrile with 
nucleophiles, was published by M. Patzel et al. in 1991.60 According to the authors, 
the cyclic β-enaminonitriles are more stable than their acyclic analogues. Thus their 
reaction with hydrazine hydrate does not occur upon heating in alcohol, DMF, acetic 
acid. In all cases, the starting 2-(1-R-pyrrolidin-2-ylidene)malononitrile was isolated. 
Only refluxing in a 10-12-fold excess hydrazine hydrate provided 5-amino-3-(3-(R-
aminopropyl)-1H-pyrazole-4-carbonitrile 1.78 (Scheme 1.29). It is also stated on that 
the reaction cannot be carried out either with arylhydrazines or with derivatives of 
1.77, in which one of the cyano groups is substituted by the ester moiety. It was also 
shown that 2-(dihydrofuran-2(3H)-ylidene)malononitriles undergo the same 
recyclization in milder conditions. 
The reaction mechanism involves the nucleophilic attack of nitrogen atom of the 
enamine C-2 atom of pyrrolidine A in the first step, followed by an intramolecular 
attack of the second nucleophilic atom, namely carbon of the nitrile group with 
subsequent formation of spiro-intrameditate B. The pyrrolidine ring-opening step 
causes the aromatisation of the pyrazole core and the formation of the ω-aminoalkyl 
chain. This reaction mechanism was named ANSARO (Addition of Nucleophile – 
Spiro Annulation – Ring opening) (Scheme 1.29).61-62  
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Scheme 1.29. The first synthesis of pyrazoles from cyclic β-enaminonitrile. The 
mechanism of reaction (ANSARO).  
 
To facilitate the ring opening of cyclic β-enaminonitrile reactions under the 
action of binucleophiles, K. Shvydenko et al. proposed the introduction of electron-
withdrawing group to pyrrolidine nitrogen atom, which was envisaged to increase the 
electrophilicity of the neighbour carbon atom.63 Indeed, the N-benzoyl derivative of 
pyrrolidine 1.79 was obtained by the reaction of 2-(pyrrolidin-2-
ylidene)malononitrile 1.77 with benzoyl chloride; this compound was involved in the 
reaction with arylhydrazines in boiling pyridine media, which gave the ω-
benzoylaminoalkyl pyrazoles in satisfactory yields 1.80 (Scheme 1.30).  
 
Scheme 1.30. Activation of β-enaminonitrile 1.77 by introducing an electron-
withdrawing substituent into the N-1 position.  
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An interesting method for obtaining pyrazoles from a mixture of cyclic and 
acyclic β-enaminonitrile was  presented in the work by the same authors, which 
consists in an in situ activation of the C-2 position.10  
The reaction of thioimidate 1.2b with benzo[d]thiazol-2-ylacetonitrile in the 
presence of 2 equiv of acetic anhydride led to the mixture of products, which are 
directly ending in the subsequent reaction with hydrazine (Scheme 1.31). The first 
nucleophile attack occurs at the vinyl carbon atom and is accompanied either by the 
substitution of the methylthio group (in the case of 1.81a) or by the pyrrolidine ring 
opening (in the case of 1.81b) to form a common intermediate with the same 
structure 1.82. When the latter was boiling in ethanol in the presence of 
triethylamine, N-(3-(5-amino-4-(benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-
yl)propylacetamide was obtained 1.83. 
 
Scheme 1.31. Formation of pyrazole ring 1.83 from a mixture of cyclic and acyclic β-
enaminonitriles 1.81. 
 
For the preparation of pyrazoles with the branched ω-aminoalkyl chain, which 
are potent glutamate receptor antagonists (Figure 1.5) D. Young et al.64 also used 
recyclization method for the cyclic β-enaminonitrile bearing stereogenic centres in 
the 3d and 5th position of the pyrrolidine ring (Scheme 1.32). 
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Figure 1.5. а) Biologically active 
substances of glutamate receptors. 
Figure 1.5. b) Potential glutamate 
receptor antagonists. 
 
 
Scheme 1.32. Synthesis of pyrazoles with branched ω-aminoalkyl chain 1.84. 
 
In the case of 3-substituted pyrrolidines, an epimerization occurred during the 
reaction with hydrazine, thus, compound 1.84 was obtained as a mixture of epimers.  
Compared to the mechanism shown in Scheme 1.29, another sequence of 
nucleophile attacks is observed for β-enaminones with general formula 1.87 which 
are analogues of β-enaminonitriles. First, the reaction of a 1,2-nucleophile with a 
carbonyl carbon atom takes place with the formation of an intermediate A, followed 
by the Michael addition of a second nucleophile atom (Scheme 1.33).62, 65Cyclic β-
enaminones have been repeatedly used in the synthesis of 3-(ω-aminoalkyl/phenyl 
alkyl)azoles.61, 66-67 
 
Scheme 1.33. The mechanism of the reaction of β-enaminones 1.87 with 1,2-
binucleophiles. 
 
Thus, 5-acetyl-3,4-dihydropyridine 1.88 reacts with variously substituted 
hydrazines: aromatic, aliphatic, heterocyclic with the formation of 4-ω-
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aminoalkylpyrazoles 1.90 (Scheme 1.34).66 Cyclization occurs under harsh 
conditions, i.e. in ethylene glycol at 140 °C. By performing the reaction in ethanol at 
78 °C, it is possible to isolate an intermediate hydrazone 1.89. According to the 
authors, the reaction occurred regioselectively, due to  N-ethoxycarbonyl protection 
of the amino group of the substrate 1.88. Successful removal of the protective group 
and the formation of pyrazoles 1.91 occurred at the last step of the reaction with 92-
97% yield upon heating in concentrated hydrochloric acid. 
  
Scheme 1.34. The regioselective transformation of β-enaminones 1.88 into 4-ω-
aminoalkyl pyrazoles 1.90. 
 
The benzo analogues of 1-aryl-2-(1,3,3-trimethyl-indolin-2-ylidene)ethanones 
1.92 are converted to the corresponding dihydroisoxazole 1.93 via the reaction with 
hydroxylamine. Further treatment with concentrated hydrochloric acid, gives the 
products of the ring opening 1.94 with 75-90% yield (Scheme 1.35).67  
 
Scheme 1.35. Synthesis of aminophenylalkyl isoxazoles 1.94. 
 
Consequently, the reactions of cyclic 3-enaminonitriles with 1,2-binucleophiles 
lead to the formation of ω-aminoalkylpyrazoles. In the absence of C-2 activation, the 
reaction takes place under harsh conditions (an excess of 1,2-binucleophile, at high 
temperatures). Reactions of cyclic 2-hetaryl-3-enaminonitriles are presented in only 
one publication, where they were subjected to the reactions with 1,2-binucleophiles 
in  the presence of their acyclic analogues in the mixture. 
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1.4. Reactions of 2-(1-R-pyrrolidin/indolin-2-ylidene)acetonitriles with C-
electrophiles in the synthesis of fused heterocyclic systems 
The C-3 position of the pyrrolidine ring exhibit 
electron-deficient character as a result of the acceptor 
effect of the 2-acrylonitrile fragment and can react 
with electrophiles via base catalysed  process. 2-(1-R-
Indolin-2-ylidene)acetonitriles 1.28a are more active 
compared to 2-(1-R-pyrrolidin-2-ylidene)acetonitriles 
1.1. In addition to the two electron withdrawing groups in the side chain of 
compounds 1.28a, they also contain a benzene ring, which additionally makes the C-
3 position more acidic.68 
The reactions of 2-(1-R-pyrrolidin/indolin-2-ylidene)acetonitriles (1.1, 1.28a) 
with dimethylformamide dialkylacetal and orthoesters have been studied. They result 
in the formation of pyrrolidines containing masked aldehyde group in the 3rd position 
of the cycle or in the side chain. Such systems were found to be precursors of 
pyrrolo[3,2-c]pyridines 1.97, 1.100, which are modified analogues of purine bases 
and pyrrolo-pyrimidine bases that are involved in the nucleic acid metabolism.69  
2-(Pyrrolidin-2-ylidene)malononitrile 1.95 reacts with dimethylformamide 
diethylacetal (DMF DEA) to form 2-(3 -((dimethylamino)methylene)pyrrolidin-2-
ylidene)malononitrile 1.96, which upon aminolysis in the autoclave formes 
pyrrolo[3,2-c]pyridines 1.97 in 34% total yield (Scheme 1.36).70 During the process, 
the dimethylamino group is eliminated. 
 
Scheme 1.36. Synthesis of pyrrolo[3,2-c]pyridines 1.97 via the formation of a 
derivative with the masked aldehyde group 1.96. 
 
 
1.1 –  pyrrolidin-2-ylidene 
1.28a –  indolin-2-ylidene 
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In the case of enaminoamides 1.98, the reaction with DMF DEA or with 
tetramethylurea diethylacetal is taking place at the amide group of the side chain to 
form diene diamines 1.99 (Scheme 1.37).1, 69, 71-72  
 
Scheme 1.37. Reaction routes of enaminoamide 1.98 and C-electrophiles depending 
on the substituents at the pyrrolidine nitrogen. 
 
The subsequent heating contributes to the intramolecular condensation between 
the amidine carbon atom with the partial positive charge increased by the conjugation 
with the adjacent acetyl group, and activated methylene moiety of pyrrolidines. As a 
result of the reaction, derivatives of pyrrolo[3,2-c]pyridine-6-one 1.100  were 
obtained (Scheme 1.37, route 1). In the case of unsubstituted pyrrolidines 1.98 
(R = H), the reaction with acetal proceeds in a different manner. Thus, the closure of 
the pyrimidine cycle happened in the first step by heating with DMF DEA followed 
by the nucleophilic attack of the pyrrolidine NH group at the amide carbon atom; the 
second equivalent of DMF DEA  reacts with the CH2 group at position 3.72 In this 
case, the only reaction product was 5-((dimethyamino) methylene)-3-oxo-3,5,6,7-
tetrahydropyrolo [1,2-c] pyrimidine-4-carbonitrile 1.101 obtained in 74% yield 
(Scheme 1.37, route 2).  
Interestingly, in an attempt to synthesize pyrrolo[3,2-c] pyridine-6-one 1.100 by 
an alternative route starting with ethyl 2-cyano-2-(pyrrolidin-2-ylidene)acetate 1.102, 
the only product obtained was 1-ethylpyrrolidine 1.103 (Scheme 1.38).1 Neither the 
temperature rise nor the increase of DMF DEA concentration result in the formation 
of condensation product at the third position of the pyrrolidine ring. Attempts to 
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introduce the acetyl protection at NH group (by reaction with acetic anhydride, acetyl 
chloride, methylisocyanate) resulted only in the isolation of starting enaminonitrile 
1.102.  
 
Scheme 1.38. The reaction of 2-cyano-2-(pyrrolidin-2-ylidene)acetate 1.102 with 
DMF DEA 
 
The reaction of DMF DEA with 1.104 occurs similarly to the reaction depicted 
in Scheme 1.36, namely through condensation by C-3 position of pyrrolidine to form 
diene diamine 1.105, which was transformed by the condensation reaction to 5-
benzyl-6-oxo-2,3,5,6-tetrahydro-1H-pyrrolo[3,2-c]pyridine-7-carbonitrile after 
prolonged heating. 1.100 (Scheme 1.39).73  
 
 
Scheme 1.39. Carbamide 1.104 in the reaction with  DMF DEA. 
 
Pyrrolo[3,2-c]pyridin-6-ones 1.100 react with phosphorus oxychloride in order 
to prepare 2-chloropyridines 1.106, which subsequently react with O- and N-
nucleophiles.1, 74 Nitrile group of 1-benzyl-6 methoxy-2,3-dihydro-1H-pyrrolo[3,2-
c]pyridine-7-carbonitrile 1.107  was hydrolized only by prolonged boiling (119 h) in 
a 7% NaOH solution to the correspoding amide derivative 1.108 in 22% yield. The 
N-debenzylation reaction and decyanation were carried out by boiling in concentrated 
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hydrobromic acid to form 6-bromopyrolo[3,2-c]pyridine 1.110 and pyrrolo[3,2-
c]pyrid-6-one 1.111 (Scheme 1.40). 
 
Scheme 1.40. Modifications of pyrrolo[3,2-c]pyridine-6-one 1.100. 
 
Reactions of benzo analogues of pyrrolidine acetonitriles with C-nucleophiles 
are described only for 2-(indolin-2-ylidene)malononitrile 1.31 in the Granik et al. 
publication.26 By the reaction of the latter compound with the DMF DEA, the crude 
product 1.112 was obtained in 90% yield; but the amount of isolated product after 
thorough purification is dramatically decreased to 34% yield.  
  
Scheme 1.41. Reactions 2-(indolin-2-ylidene)malononitrile 1.31 with C-
nucleophiles. 
 
Due to the low yield of the target product an AlCl3 catalysis was used75, notably, the 
reaction took place in a different way. In particular the formation of 3-
ethoxymethylene 1.113 (26% yield) instead of 3-dimethylaminomethylene 1.112 was 
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observed. The same product 1.113 was obtained by condensation reaction 1.31 with 
triethylorthoformiate (87% yield); Scheme 1.41. 
It is assumed that in this case, AlCl3 catalyses the cleavage of the dimethylamino 
group from DMF DEA, in contrast to the previously described catalytic sequence 
(Scheme 1.42).75  
 
Scheme 1.42. The mechanism of AlCl3 catalysis. 
 
According to the known literature procedures,76 ethoxymethylene derivatives are 
more active in the reactions with nucleophiles, than enamines. Thus, 
ethoxymethylene nitrile 1.113 reacts with primary and secondary amines in mild 
conditions with good yields (62-79%) providing compounds 1.114, while 
dimethylmethylene derivatives are reacting only with privary amines (52%). Upon 
heating in acetic acid, cyclization of 1.112 led to 4-cyano-2,3-dihydropyrido[4,3-
b]indole-3-one 1.115.  
  
Scheme 1.43. Modifications of 2-(3-ethoxymethylene) 1.113 / 2-(3 - 
((dimethylamino)methylene)indolin-2-ylidene)malononitrile 1.112. 
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The reaction of 1.113 with the alcoholic ammonia solution gave 3-amino-4-
cyanopyrido[4,3-b]indole 1.116, which primary amino group is located in the α-
position to the nitrile group in the pyridine ring; this makes possible to carry out 
cyclization reactions, that provides tetracyclic amides 1.117 (Scheme 1.43). 
To conclude, the reactions with C-electrophiles takes place 1) at the third 
position of the pyrrolidine ring, followed by cyclization on the nitrile or carbonyl 
moiety, or 2) at the amide side chain group, followed by the cyclization at C-3 or 1-
NH position of pyrrolidine. The resulting pyrolopyridines and pyrolopyrimidines can 
be subjected to various modifications of their functional groups allowing various 
decorations to pursue SAR studies. 
 
1.5. Complexes based on 2-(pyrrolidin-2-ylidene)acetonitrile and their benzo 
analogues 
2-(Pyrolidine-2-ylidene)acetonitriles can act as bidentate ligand due to the close 
spatial arrangement of two donor nitrogen atoms connected by a bridge of three 
сarbon atoms. Such a feature is used to create BF2-rigidified complexes that are 
similar to BODIPY dyes, as well as metal complexes for the asymmetric catalysis 
and copolymerization reactions. 
 
1.5.1. Synthesis and application of BF2-rigidified complexes 
Among heterocycles capable of forming boron-containing 
complexes, the dominant position is taken by dipiromethene 
derivatives. By the reaction with boron trifluoride diethyl 
etherate, the latter compounds form boron-dipiromethenes – 
BODIPY (Figure 1.5). This structural framework is based on the 
class of dyes, discovered by Treibs and Kreuzer in 1968.77  
The interest of the unique properties of BODIPY-dyes (high quantum yields, 
stability in physiological conditions, narrow absorption and emission bands (Figure 
 
Figure 1.5. 
BODIPY core 
 1.6) has grown over time; thus, up to 2018, 4995 articles have already been published 
on BODIPY4.  
 
Figure 1.6.
(λabs = 503 nm, 
 
The class of BODIPY dyes is used for biomolecules labelling and for studying 
their distribution in cells/tissues 
accuracy, since the fluorescence spectroscopy method has a high sensitivity (10
12 М) and high spatial resolution (1 
methods for in vivo studies is limited to the depth of penetration of the emitted light 
(≤ 1 cm). The resulting signal is blurred due to the partial scattering and absorption
light by body fluids, water and tissues.
1) the synthesis of dyes, which emit the light within the optical window in the 
                                                        
4 according to the Web of Science portal
5 http://www.lumiprobe.com 
Figure 1.7.  Schematic representation of 
the mechanism of positron emission 
tomography.
 Classic spectrum of BODIPY dye
λem = 509 nm, ε = 80000, Ф
90%)5 
in vitro and ex vivo. Such studies have high 
μm). On the other hand, the use of fluorescence 
78
 There are two ways to resolve the problem: 
infrared spectral region (650 
nm), or 2) use a method, not 
fluorescence based, that invol
the emission of photons of greater 
energy, which, accordingly, 
increases the depth of light 
penetration.  
A such method is the 
positron emission tomography 
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(PET) based on the radioactive decay of a positron-emitting nucleus (11C, 18F etc.). 
The positrons formed during decay annihilate with the electron of surrounding tissues 
and form two photons with 511keV energies directed at an angle of 180° to each 
other. High-energy particles are detected by a PET scanner (Figure 1.7). The method 
is characterized by unlimited depth of penetration, high sensitivity (10-11–10-12 М), 
but lower resolution – 1-2 mm, compared with fluorescence spectroscopy of 1 μm. 
The combination of PET and fluorescence spectroscopy methods offset the 
shortcomings of each other and is a basis for the creation of a bimodal probe. 
The presence in the structure of BODIPY BF2 group, which could be a site for 
introducing an isotope label – [18F], makes dyes attractive bimodal probe precursors. 
The idea of preparation of the bimodal probe based on BODIPY was first 
presented in 2011 by Gabbai et al.79 The authors proposed an introduction of [18F] 
into the compound 1.118 by exchanging the OH group connected to the boron atom 
with drained by azeotropic distillation tetrabutylammonium fluoride ([18F]-ТBAF) in 
the presence of a strong Lewis acid, namely trimethylsilyl trifluoromethanesulfonate 
(TMSOTf) (for binding water residues) in acetonitrile at 60 °C. The reaction was 
completed within 5 minutes with 61% yield of [18F]-BODIPY 1.119 (Scheme 1.44).  
 
 
 
Scheme 1.44. Radiofluorination of 
BODIPY dye. 
Figure 1.8. Еx vivo mouse organ 
visualization by fluorescence 
spectroscopy (left) and microPET 
(right). Injection of dye 1.128 – 4 h – 
photo. 
 
The authors used the synthesized radioactive dye 1.119 to investigate its ex vivo 
binding using fluorescence spectroscopy and PET methods; consequently, they have 
obtained satisfactory results on the stability and selectivity of binding, as well as a 
48 
 
high correlation between the results of fluorescence spectroscopy and PET analysis 
(Figure 1.8). 
Subsequently, novel methods have been developed, which allow the direct 
exchange of 19F-18F in BODIPY dyes in the presence of Lewis acids.80-82 Methods, 
which allow avoiding azeotropic drying of fluoride ion, are developing to date. For 
example, cartridges containing boranes with cationic structure – fluoride-ion adherent 
molecules.83 
At present, about 30 articles6 have been published in which BODIPY-dyes are 
used as bimodal probes. 
Despite the intense fluorescence of BODIPY-dyes in the solution, which allows 
them to be used for biological objects labelling, they almost do not fluoresce in solid 
state, which prevents their use in the field of organic electronics and photonics, 
including liquid crystal displays, OLEDs, solar collectors. Weak fluorescence is 
caused by self-absorption, which is the result of almost complete overlapping of 
absorption and fluorescence spectra of the dye (Stokes shift is on average 5-30 nm).84 
Small Stokes shifts can also be a problem for the correct interpretation of the signals 
obtained by labelling of biological objects. In vivo studies shows that light scattering 
may also occur with tissues in addition to the self-absorption; the reason is in a small 
difference in absorption and radiation maxima, thus, this light can be perceived as 
emitted one. In order to overcome this disadvantages it would be desirable to access 
Stokes shift over 80 nm.85 
There are two ways to increase the Stokes shift: 1) BODIPY dye binding with a 
molecule capable of emitting light. In this case, BODIPY serves as the antenna that 
receives the signal, then excited and transmitted the signal to another fluorophore 
(through space or by bonds), whose wavelength of emitted light is much different 
from that absorbed one. Such systems are usually efficient, but they have a complex 
structure that requires multistage synthesis. 2) Desimetrization of the bidentant ligand 
in the boron complex in order to increase the distinction between the electronic 
                                                        
6 according to the Web of Science portal 
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structure of the main and excited states. This approach is simpler in terms of 
synthesis.85 
There is a large number of publications devoted to the development of 
desimetrized dyes based on boroaza cycle (С3N2B).84 However, there are only several 
studies concerning the molecules containing a structural fragment of 2-
functionalized-2-(pyrrolidin-2-ylidene)acetonitrile – BODIPY analogue (Figure 1.9). 
a) 
b) 
Figure 1.9. Structural core of BODIPY (on the left) and its 
analogue - 2-functionalized-2-(pyrrolidin-2-
ylidene)acetonitrile (right). 
 
Desimetrized analogues of BODIPY dyes were studied, namely BF2 complexes 
with benzo[c,d]indole with N-heteroarenes, which are interconnected by = N– or 
=C(CN)– bridges 1.120, 1.121 (Figure 1.10).86 In this case, there was a large Stokes 
shift: about  2000 cm-1 for 1.129 and about 3000 cm-1 for 1.121, which is much larger 
than the Stokes shift in BODIPY dyes within 400 – 1000 cm-1.  
The authors note that absorption and 
emission maxima  of compounds bearing the 
electron-withdrawing nitrile group 1.120 is 
shifted by about 40-70 nm (for absorption) and 
10 nm (for emission) into the infrared region 
comparing to compounds 1.121. Based on the 
data obtained in electrochemical studies, the 
authors explain this shift by reducing the energy gap between HOMO–LUMO 1.120 
by about 0.2eV comparing to 1.121. 
One-pot synthesis of dyes 1.120 and 1.121 have been developed by 
condensation of commercially available benzo[c,d]indoles 1.131 and N-heteroarenes 
1.123 in the presence of Lewis acid (TiCl4) or POCl3, followed by the base and boron 
N
N
B
F
F
CN
1.120
 
 
Figure 1.10.  BF2 fixed compounds 
of benzo[c,d]indole of N-
heteroarenes. 
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trifluoride etherate treatment in the second step (26-47% yield) (Scheme 1.45). This 
approach opens the route to the rapid creation of a library of such dyes.  
 
Scheme 1.45. Synthesis of BODIPY-dyes analogues 1.120 and 1.121. 
 
The introduction of the electron-donating substituent in the 6 position of the 
pyridine ring of dyes 1.121 increases λmax  of absorbtion for 30-40 nm and emission 
for  ~ 10 nm. 
 XRD analysis of crystals showed that the molecules have a dense packing 
caused by intermolecular hydrogen bonds H···F and form aggregates with head-to-
tail placement (Figure 1.11). 
Apart from the fluorescence in the solution, the complexes also exhibit 
fluorescence in solid state (Figure 1.12), unlike the classic BODIPY. Moreover, in all 
cases there is a bathochromic shift in the emission spectrum ~ 40-70 nm. 
 
 
Figure 1.11. a) X-ray structural analysis 
of 1.120.  
b) Aggregates 1.120 with head-to-tail 
packing 
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Synthesized complexes exhibit high 
photostability and also show a bathochromic shift in 
nonpolar solvents. Both characteristics promote their 
use for biovisualization. Visualization of fat droplets 
was reported by using the 1.121 complex (X = N, Het: 
4-methylthiazole). This dye easily passes into the 
middle of the droplet due to the neutrality of the core and shows a bright green 
fluorescence. 
Also, the fragment of pyrrolidin-2-ylidene acetonitrile became a component of 
BODIPY-like dyes developed by a group of German scientists.87-89 Synthesized dyes 
emit light (690-805 nm) within the optical window, in the near infrared (NIR) region 
of the spectrum. As it was noted above, substances that have such characteristics can 
be used for biovizualization, since biological fluids and tissues of the body do not 
absorb light in this region, which increases the depth of light penetration. It should be 
noted, that the Stokes shift for these dyes is small (within 250-500 cm-1). 87-88 The 
authors attempted to increase the Stokes shift by synthesizing of the asymmetric 
dyes,89 but they failed to achieve a sufficient deviation from C2 symmetry and Stokes 
shift remained within 739-786 cm-1.  
Synthesis of symmetric BF2-pyrrolopyrrolocyanines (BF2-PPC) 1.126 has been 
achieved by the condensation of 3,6-bis(4-octyloxyphenyl)-2,5-dihydropyrolo[3,4-
c]pyrrole-1,4-dione 1.124 with hetaryl acetonitriles with excess POCl3 in toluene at 
boiling point. The next reaction of PPC 1.125 with boron trifluoride etherate led to 
complexes 1.126 (Scheme 1.46, route 1). In the synthesis of asymmetric pyrrolidines, 
monosubstitution was achieved by evaporation of the excess POCl3 in the first step of 
the process (Scheme 1.46, route 2). The resulting salt 1.127 reacted with 1 equiv of 
hetaryl acetonitrile and forms the mono-substituted product 1.128. The reaction with 
the second equivalent of hetarylacetonitrile resulted in the asymmetric PPC 1.129. 
Complex formation with BF3•Et2O gave the asymmetric complexes 1.126 in 60-86% 
yield. The authors note that mono-substituted PPC 1.128 can also form complexes 
 
1.121 (Х = N, Het: 
pyridine ) 
1.120 (Х = ССN, 
Het:  pyridine ) 
Figure 1.12.  Fluorescence 
in solid state. 
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with BF2; in this case Stokes shift reaches to 1320 cm-1 for 1.128c, 1130 cm-1 for 
1.128d, the maximum emission was about 670 nm. 
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Scheme 1.46. Synthesis of symmetric 1.126a and asymmetric 1.126b BF2-PCC. 
 
In order to show the possibility of using the synthesized complexes for 
biovizualization, HeLa cells were incubated with Arg9 peptide in which the terminal 
amino acid was covalently bound to BF2-PCC 1.130 (А = Het1 = h, B = Het2 = m). 
Cell nuclei are pre-painted with Hoechst 33342 fluorescent dye. A merged image of 
HeLa cells in which the blue fluorescence marks the nuclei stained with Hoechst 
33342, while the red fluorescence indicates the position of the Arg9 peptide is shown 
in Figure 1.13. The image shows that the aggregates Arg9-BF2-PCC 1.130 do not 
penetrate into the core, but remain outside of it. 
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To conclude, it should be noted that the structural fragment of pyrrolide-2-
ylidene acetonitriles are included to the BODIPY dyes analogues and exhibit larger 
Stokes shifts comparing to the classical dyes by means of the ligand 
desymmetrization. Other representatives emit the light in the near-infrared region of 
the spectrum, which allows them to be used for biovizualization (in vitro studies have 
been demonstrated). None of the articles discusses the possibility of radiofluorination 
of complexes with the indicated ligands for use as markers in PET, despite the fact 
that this opens the way for unimpeded visualization in vivo. Such literature data 
determine the relevance of research in this direction. 
 
1.5.2. Synthesis and application of metal complexes 
Many steps have already been done to create enantioselective catalysts; the 
necessity of developing new asymmetric catalysts is increasing with the enlargement 
in the number of new pharmaceutical, agro-pharmaceuticals, flavor and odor 
regulators, that are effective only in an enantiomerically pure form.  
Typically, asymmetric catalysts are 
molecules consisting of metal and chiral 
ligand. 
One class of ligands for asymmetric 
catalysis, well-studied in the 80s-90s is 
semicorrins (Figure 1.14). This name of 
compounds was proposed by Stevens in 
the 70s. The name is associated with the corrin (eng, "core" -  "base") - a natural 
 
 
Corrin - a macrocycle 
that is part of the 
structure of cobalamin 
(vitamin B12) 
Semicorrin -  Semicorrin - 
the name of the class of 
ligands, which was 
proposed by American 
scientist Stevens in the 70s 
Figure 1.14 
Figure 1.13 
20µм 
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macrocycle that is part of the cobalamin (vitamin B12). The systematic name of the 
ligand: 5-(cyano(5-pyrrolidin-2-ylidene)methyl)-3,4-dihydro-2H-pyrrole.11  
One of the advantages of semicorrins is their simple synthesis and modification 
of substituents at stereogenic centres. Enantiomerically pure ligands can be 
synthesized on multigram scale starting with commercially available L- or D-
pyroglutaminic acid 1.131 with 30–40% total yield (Scheme 1.47).11  
Scheme. 1.47. Semicorrins synthesis. 
 
The synthesis includes the following steps: the esterification of L-pyroglutamic 
acid 1.131, which is catalyzed by an ion-exchange resin, followed by alkylation with 
a Meerwein salt; condensation of 1.2c with tert-butyl 2-cyanoacetate, which gave the 
enamine 1.132; hydrolysis of tert-butyl ester and subsequent decarboxylation were 
applied for the preparation of cyanogenamine 1.6 as a mixture of Z/E-isomers. The 
last step was the hardest to implement, in particular, methods that worked on similar 
systems previously did not lead to the target product. Thus, an attempt to connect two 
monocyclic bilding blocks 1.2c and 1.6 by carboximidate-enamine condensation was 
unsuccessful. In neutral or weakly basic conditions, condensation did not occur at all. 
Strong basic conditions could not be applied due to the potential racemization of the 
product. Semicorrin 1.7 can by synthesized only in the presence of TFA in 70% 
yield. Catalysis by other acids (AcOH, TsOH, BF3•Et2O) gave a less satisfactory 
results. 
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Semicorrins ester groups can be easily modified by various methods (Scheme 
1.48).  
 
Scheme 1.48. Structural modifications of semicorrins.  
 
The reaction with an excess of Grignard's reagent gave diols 1.135. The 
reduction with sodium borohydride resulted in the formation of 
bis(hydroxymethyl)semicorrins 1.133. Hydroxy groups can be modified with silyl or 
triphenylmethyl groups 1.134.  
 
Figure 1.15. Crystal structure, numbering and stereoscopic view of the semicorrin 
complex with Cu(II). 11 
 
Semicorrins form stable complexes with a number of metal ions: Co(II), Rh(I), 
Ni(II), Pd(II), or Cu(II). Structures of some complexes were studied by X-ray 
diffraction analysis (Figure 1.15). It was observed that, depending on the metal ion, 
the structure of the ligand and the reaction conditions, mono- or bis(semicorrins) can 
be prepared. 
In metal complexes with semicorrins as ligands, two substituents at the 
stereogenic centres of pyrrolidine are close to the coordination centre. They surround 
the atom of metal from two opposite sides, which should noticeably induce a control 
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of the stereochemistry of the reaction occurring in the coordination sphere of the 
complex (Figure 1.16). 
 
 
Figure 1.16. Spatial view of the complex: 3D structure (left) and orthogonal 
projection (right).11 
 
Semicorrin complexes generated in situ or 
synthesized in advance with Cu(II) 1.136a and Co (II) 
1.136b (Figure 1.17) were used as catalysts for 
enantioselective cyclopropanation of olefins by diazo 
compounds90 and for reduction of α,β-unsaturated esters 
as well as amides (Scheme 1.49 and 1.50).12, 91-93 
 
 
 
Scheme 1.49. Asymmetric synthesis of cyclopropanes. 
 
The best enantiomeric excess (95-97%) was achieved in the case of R1 = Ph or 
CH2=CH2; R2 = D-menthyl; R = СMe2OH (Scheme 1.49). 
Reduction reactions with the Co(II) complex 1.136a were carried out in 
quantitative 90-99% yield with enantiomeric excess (up to 99.9%, in the case R1 = 
Ph(CH2)2, R2=CONHMe) (Scheme 1.48). The solvent plays the key role in the 
reaction. In particular, changing the reaction media from DMF/ethanol to the 
diglyme/ethanol solution dramatically increased the reaction rate. According to the 
authors, such effect is associated with better solubility of sodium borohydride in 
diglyme.91  
 
Figure 1.17. Semicorrin 
complex with Cu(ІІ) 
(1.136а) and Cо(ІІ) 
(1.136b). 
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Scheme 1.50. Reduction of α,β-unsaturated esters and amides. 
 
Notably, isolated double bond are inert in these conditions, a high 
chemoselectivity is achieved only with electrophilic C=C bonds conjugated with 
electron-withdrawing groups.  
Ni(II) complexes with pyrrolidin-2-ylidene 
acetonitriles have been used as polymerization catalysts 
to access polyketones (Figure 1.18), polymers with a 
unique combination of physico-chemical properties.94-96 
In 1996, polyketones were first synthesized on an 
industrial scale and named as «Carilon».96 The production was relied on the 
methodology involving palladium complex with a bidentant ligand (Ph2P(CH2)3PPh2) 
as a catalyst, which produces polyketone under mild conditions (90 °C, 45 bar) in 106 
grams yield of polymer per gram of catalyst.97-98  
The impetus for the study of complexes based on Ni(II) as cheaper Pd(II) 
analogue in the copolymerization of olefins and carbon monoxide (CO), was 
reducing the cost of the process, since catalysts can not be regenerated in the 
production process.96 
The starting (E/Z)-(pyrrolidin-2-ylidene)acetonitrile 1.6a was synthesized 
according to Scheme 1.45 and subsequently used for the synthesis of semicorrin.12 
Upon treatment with a weak base and acylating agent (anhydride or acyl chloride), 
the product of acylation of β-enamine carbon atom 1.137 was obtained. In the case of 
soft acylating agents featuring bulky substituents, the product of N-acylation was 
isolated 1.138 (Scheme 1.51).95 
 
Figure 1.18.  The 
general structure of 
polyketones. 
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Scheme 1.51. Synthesis of CO and olefins copolymerization catalysts 1.139.  
 
Ni(II) containing complexes 1.139 with N,O-chelating ligands 1.137 were 
obtained; these compounds were investigated in the copolymerization of ethylene and 
CO.94 The highest efficiency was demonstrated by complexes  1.139 with 
polyfluoroalkyl substituents (R = C3F7, C7F15) – 11 kg of polykethone per gram of 
nickel were prepared. The solvent in the polymerization reaction can be 
dichloromethane, THF, toluene or supercritical carbon dioxide (CO2) 
(environmentally friendly solvent). These complexes are the most effective of known 
nickel-containing catalysts. The reaction of copolymerization in their presence takes 
place under mild conditions: 60 °C, 40 bar, which emphasizes their promising utility 
 
From this  literature review  covering synthesis, subsequent transformation using 
various electrophilic and nucleophilic agents, complex formation and the practical 
application of cyclic β-enaminonitrile, it is easy to find out the directions that need to 
be deeper investigated. Thus, there is only few information about the reactions of 
cyclic β-enaminonitriles with 1,2-binucleophiles, although they can serve as a 
convenient access to polyfunctional pyrazoles, which are widely used for therapeutic 
applications and for catalysis.  
In general, syntheses and further transformations of cyclic α-hetaryl-β-
enaminonitriles are scarcely studied to date. However, it is known that the 
heterocyclic fragment influence on the synthetic path and its presence might provide 
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novel methods for the construction of heterocyclic compounds. Moreover, a wide 
diversity of the heterocyclic substituents of starting enaminonitrile allows different 
biological activities of the products. 
Another application of componds featuring 2-hetaryl-3-enaminonitrile moiety is 
the synthesis of BF2-complexes for biovisualization purposes. Pyrrolidin-2-
ylideneacetonitrile-containing structures  are described in only a few articles and are 
characterized by the simplicity of their synthesis, practically better Stokes shifts, 
compared to the classical BODIPY dyes, as well as their light emission in the near 
infrared spectral region. Additionally, it has been shown that the nitrile group 
contributes to the bathochromic shift of the absorption and emission maxima.  
Finally, metal complexes based on cyclic β-enaminonitrile are used as catalysts 
in the copolymerization of olefins and CO for the preparation of new materials, in 
particular, polyketones with unique combination of characteristics. Pyrolidine-2-
ylideneacetonitrile with stereogenic centres exhibit high regio- and stereoselectivity 
in the cyclopropanation reaction as well as in the alkene reduction. 
Therefore, the chemistry of cyclic 2-hetaryl-3-enaminonitrile is scarcely studied 
but is thought to be a promising topic for future developments. 
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CHAPTER 2. 2-AZAHETARYL-2-(1-R-PYRROLIDIN/3-OXOINDOLIN-2-
YLIDENE)ACETONITRILES: SYNTHESIS AND STRUCTURE 
EXPLORATION 
Given the promising use of derivatives of 
pyrrolidinylidene acetonitriles in the synthesis of functionalized 
azaheterocycles, our primary task was to synthesize their 
analogues with azaheterocyclic substituents in the position 2 of 
the enaminonitrile fragment (Figure 2.1). 
 
2.1. 2-Azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles 
2.1.1. Synthesis 
For the first time, the synthesis of 2-(pyrrolidin-2-ylidene)acetonitriles bearing 
heterocyclic substituents was described in 2000.9 The method consisted in the 
condensation of hetarylacetonitrile 2.2 (CH-acid) with O-methylbutyrolactam 2.3 in 
the presence of Et3N in boiling toluene. This method has been described for quinolin-
2-yl 2.1a and pyridin-2-yl 2.1i as heterocyclic substituents. 
The adjustment of the synthetic scheme allowed us to expand the number of 
heterocyclic substituent in 2-(pyrrolidin-2-ylidene)acetonitriles and obtain 8 new 
compounds 2.1b-h,j depicted on the Scheme 2.1, route 1.  
We have also developed a new method for the synthesis of enaminonitriles 2.1 
by using a three-component condensation of hetarylacetonitrile 2.2, phosphorus 
oxychloride, and pyrrolidin-2-one 2.4. In contrast to the previously described method 
(Scheme 2.1, route 1) which requires the initial preparation of 5-methoxy-3,4-
dihydro-2H-pyrroles 2.3 the proposed method is streamlined enabling in situ 
generation of 5-chloro-3,4-dihydro-2H-pyrrolinium cation 2.5 and preparation of the 
desired 2-hetaryl-2-(pyrrolidin-2-ylidene)acetonitrile 2.1 within 1 h (Scheme 2.1. 
route 2). Our method allowed us to obtain both the previously known (E)-2-
(pyrrolidin-2-ylidene)-2-(quinolin-2-yl)acetonitrile 2.1а9 and (Z)-2-(1,3-benzothiazol-
2-yl)-2-(pyrrolidin-2-ylidene)acetonitrile 2.1b,10 as well as good yields of new 
 
Figure 2.1. Target 
molecule. 
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compounds such as (Z)-2-(1,3-benzoxazol- 2-yl)-2-(pyrrolidin-2-ylidene)acetonitrile 
2.1с, (Z)-2-(4-methylthiazol-2-yl)-2-(pyrrolidin-2-ylidene)acetonitrile 2.1d. 
The yields of known enaminonitriles are comparable or higher to those 
described in the literature: 2.1а – 58% route 1, 67% route 2 and 73% according to the 
literature; 2.1j – 70% route 1, 57% according to the literature;9  2.1b – 85% route 1, 
86% route 2 and 56% according to the literature.10 
 
Scheme 2.1. The routes to the synthesis of 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles 2.1. 
 
2.1.2. Structure exploration: XRD, 1H NMR, DFT-calculations 
Theoretically, enaminonitriles 
2.1 can exist in three tautomeric 
forms A-C (Figure 2.1). It was 
previously mentioned that the only 
form for compounds 2.1a and 2.1i is 
the enamine C.9 This conclusion was 
made on the basis of IR spectra analysis, in which there is a stretching vibration in the 
region ~ 3100-3400 cm-1 corresponding to a NH bond and a broad signal in 1H NMR 
 
Figure 2.2. Tautomeric forms of 
enaminonitriles 2.1. 
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spectra in the 10-12 ppm range assigned to the chelated proton. There are also no 
multiplets that would appear for the spin-spin coupling of 1-H and 6-H protons for 
2.1i in tautomeric form B. 
Our results are in 
agreement with these 
statements. Thus we 
observe the same 
stretching vibrations in 
IR and broad signal of 
chelated proton in the 
1H NMR spectra for 
enaminonitriles 2.1.  
(Figure 2.3).  
Beside three 
tautomeric forms 
(Figure 2.1) compounds 2.1 can also exist as 2 diastereomers (E and Z). (Figure 2.4).  
The explorations carried out indicate the 
existence of compounds 2.1 as Z isomer both in 
solid state and in solution with the heterocyclic 
substituent and the NH group of pyrrolidine in the 
cis position. 
The XRD study of the compounds 2.1b and 
2.1d has shown that molecules exist exclusively as 
Z-isomers in a crystalline state (Figure 2.5). XRD seems to indicate that Н1 atom has 
a covalent bond with N1 atom of pyrrolidine (Н1–N1 0.86 Å) and form the hydrogen 
bond with N2 (H1···N2 2.13 Å, N1–H1···N2 127.6°). The enaminonitrile 2.1b 
framework is almost planar, (deviation of the pyrrolidine ring from the plane below 
0.096 Å, the angle between the planes of pyrrolidine and benzothiazole is 4.91°, 
which is indicative of the delocalization of the enamine moiety electron density both 
toward the nitrile and benzothiazole. The shift promotes N1−C10 bond shortening 
 
Figure 2.3. A fragment of the 1H NMR spectrum of 
compound 2.1b with the highlighted shift of NH proton 
(CDCl3, 400 MHz).   
 
Figure 2.4. Diastereomers of 
tautomer C. 
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(1.32 Å) and C10−C8 bond elongation 1.39 Å (as compared to standard bond length 
values99) and also the deviation of the С8–С9–N3 angle (177.8°) from sp 
hybridization.  
 
 
 
 
 
Figure 2.5. а) Molecular structure of 
2.1b according to X-ray diffraction. 
 
b) Orthogonal projection 2.1b. 
 
The low field shift of proton of NH group is observed in the 1H NMR spectra 
(table 2.1) due to its intramolecular hydrogen bond with the nitrogen atom of the 
heterocycle. This bond stabilizes the Z isomer in the solution.  
Table 2.1. The shift of NH proton in the 1H NMR spectra of enaminonitriles 2.1. 
 
Entry 1 2 3 4 5 6 7 8 9 10 
Compound 2.1a 2.1b 2.1c 2.1d 2.1e 2.1f 2.1g 2.1h 2.1i 2.1j 
Shift NH, 
ppm 
11.35 10.27 9.65 9.83 9.60 10.10 10.64 8.70 10.46 10.69 
Solvent CDCl3 CDCl3 CDCl3 CDCl3 CDCl3 dmso-
d6 
CDCl3 dmso-
d6 
CDCl3 dmso-
d6 
  
According to the literature data the shift of NH 
proton in 2-(pyrrolidin-2-ylidene)malononitrile 2.6a 
is 7.52 ppm (solvent СDCl3). In the latter one there is 
not possible to form the intramolecular hydrogen 
bond. By contrast the NH proton shift in 3-
(pyrrolidin-2-ylidene)pentan-2,4-dione 2.6b, where 
the intramolecular hydrogen bond exists (С=О…Н), 
is 11.45 ppm (solvent СDCl3).2  
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 The theoretical analysis of the ratio between Z/E isomers in the solution was 
carried out by quantum-chemical calculations using the density functional theory 
(DFT). 
The Gibbs free energy (ΔG) was calculated for 2 diastereomers7 of 2.1b in the 
solvents of different polarity and donor-acceptor properties. CHCl3 (Polarity index 
(PI) = 4.1); (СН3)2СО (PI = 5.1); CH3OH (PI = 5.1); (СН3)2SО (PI = 7.2). ΔG of Z 
isomer was found to be lower in all solvents than ΔG of E stating higher stability of Z 
form. Based on values found the ratio between isomers was calculated applying 
Maxwell-Boltzmann distribution (table 2.2).  
 
Table 2.2. The ratio between Z/E isomers of 2-benzo[d]thiazol-2-yl-2-(pyrrolidin-2-
ylidene)acetonitrile 2.1b. 
 
Maxwell-Boltzmann distribution: Ni/N = exp(- ΔGi/kT)/∑jexp(- ΔGj/kT)* 
Compound 2.1b 
Ratio  Z/E 1903 1667 1642 1630 
Solvent CНCl3 (СН3)2СО CH3OH (СН3)2SО 
 
* ΔG – Gibbs free energy, J; k – Boltzmann's constant, J/К; Т – temperature, К;  
N – the total number of particles in the system; Nі – the number of particles with the energy ΔGi 
 
Quantum-chemical calculations show that the amount of E isomer in a 
diastereomeric mixture does not exceed 0.1%, which is in agreement with the 
experimental data we have obtained: the sensitivity of the NMR spectrometer does 
not allow to register the signals of E isomer, therefore, only one set of signals 
corresponding to the energetically favorable Z isomer is obserbed. 
The theoretical data obtained by us are in agreement with the experimental 
observations presented in the work of Solovea et al.2 for analogues with compact 
acceptor groups 2.6c-f and reinforce the conclusions made by them. Soloveva et al. 
point out that nor prolonged heating of solutions 2.6c-f at 70 ° C neither change of 
solvent provoke the rise of signals of the E isomer. Also, in the 1H NMR spectra, 
recorded in the temperature range from -60 ° C to +60 ° C, the chemical shift of NH 
                                                        
7 only isomers with S in cis position to CN group were taken into account regarding the bigger size of sulfur as 
compared to nitrogen 
65 
 
proton remains almost unchanged, indicating the presence of a strong intramolecular 
hydrogen bond. The authors conclude that the presence of hydrogen bonding in 
secondary amines 2.6c-f accounts for the lower energy of the Z isomer and 
consequently the absence of E form. Indeed, the calculations we made for the model 
enaminonitrile 2.1b show that the Gibbs free energy is lower for the configuration Z: 
ΔG Z isomer = -4.6400118•10-15 J, ΔG E isomer = -4.6399794•10-15 J.8 
 
2.2. 2-Azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles 
2.2.1. Synthesis 
Theoretically, 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles can be 
obtained by alkylation of their N-unsubstituted analogues. Using the standard 
alkylation conditions (MeI/DMS, K2CO3, DMF) for model compound 2.1b, it was 
possible to obtain only a 35% yield of product 2.7a after 36 hours of heating (Scheme 
2.2).  
 
Scheme 2.2. Methylation reaction of enaminonitrile 2.1b. 
 
The present approach is not suitable for the regioselective functionalization of 
NH group of pyrrolidine, in the presence of several reactive NH groups in the starting 
material.  
Thus in the case of benzimidazol-2-yl-2-(1H-pyrrolidin-2-ylidene)acetonitrile 
2.1f, the only reaction product is the 1,3-dimethylbenzimidazole salt 2.8 (Scheme 
2.3). No intermediate alkylation products could be isolated.  
 
Scheme 2.3. Methylation reaction of enaminonitrile 2.1f. 
                                                        
8 The values are given for the gas phase 
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In the case of the quinozalinone derivative 2.1j, methylation takes place at 
oxygen and nitrogen atoms leading to -OMe 2.9 and -NMe 2.10 isomers, which were 
separated by column chromatography (Scheme 2.4). The yield of -OMe product 2.9 is 
higher that is probably related to aromatization associated with pyrimidine cycle 
formation.  
 
Scheme 2.4. Methylation reaction of enaminonitrile 2.1j. 
 
O. Khilya et al. pointed out that in the case of 2-azaheteryl-2- (dihydrofuran-2-
ylidene)acetonitriles under similar 
conditions, the reaction proceeds 
exclusively on a more rigid nucleophilic 
centre to give the -OMe derivative.100   
Structural analysis of the 
compounds was carried out using IR and  
NMR analysis including two-
dimensional (2D) NMR techniques 
(COSY, HMQC, HMBC) and X-Ray 
analysis for 2.10. In the IR spectrum of 
NMe-quinozalinone 2.10 there is a characteristic stretching vibration of С=О group at 
1664 cm-1, a vibration is absent in isomer 2.9. Bands of the nitrile group are present 
in both isomers in the region of 2180-2190 cm-1. The carbonyl group carbon has a 
chemical shift of 162.8 ppm. Noticeably, protons have different chemical shifts for 
the OMe and NMe groups in the 1H NMR spectrum. Thus, δOMe = 4.23 ppm, δNMe = 
3.86 ppm. According to X-Ray analysis, enaminonitrile 2.10 is in isomeric form Z in 
a crystalline state, stabilized by a hydrogen bond N1–H1···N3 (estimated bond length 
H1···N3 2.12 Å, N1–H1···N3 122.6 °) (Figure 2.6). 
 
 
 
Figure 2.6.  Molecular structure of 2.10 
according to X-ray diffraction. 
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The difficulties of alkylating such secondary enamines are consistent with those 
described by Mezentseva et al.16 for a simpler analogue 2.6g. Thus this authors 
mentioned that any attempts to alkylate of (Z)-3-oxo-3-phenyl-2-(pyrrolidin-2-
ylidene) propanonitrile 2.6g in the presence of K2CO3, NaOEt, Na, and other bases 
did not lead to the desired products. This might be attributed to the presence of a 
strong intramolecular bond between the NH group and the oxygen of the carbonyl 
group stabilizes the starting material to such an extent that the deprotonation of 2.6g 
is substantially hindered.  
To overcome the limits of the alkylation method of pyrrolidine presented above 
we have developed an alternative approach to the synthesis of 2-azhetaryl-2-(1-R-
pyrrolidin-2-ylidene)acetonitriles (Scheme 2.5, route 1).101, 9 Such derivatives can be 
accessed through the condensation of the anion of 2-azahetarylacetonitriles 2.2 
(obtained via deprotonation by NaH) and 5-methoxy-1-R-3,4-dihydro-2H-pyrrol-1-
ium salt 2.11 in DMF. The starting 1-R-pyrrolidin-2-ones 2.12 have been synthesized 
in two steps by reaction between chloroanhydride of chlorobutiric acid and 
corresponding amines, and further cyclization is promoted in the presence of 
potassium tert-butoxide.102 This approach allows us to obtain a large set of 
substituents on the nitrogen atom. We have managed to obtain derivatives featuring a 
benzyl 2.12b, cyclopropyl 2.12c, 1-phenylethyl 2.12d, furan-2-ylmethyl 2.12e, tert-
butyl 2.12f, phenyl 2.12g substituent.10   
                                                        
9 The acetal method used to synthesize simpler analogues17,  in this case, was inefficient. 
10 1-methylpyrrolidin-2-one is cheap and commercially available substance. 
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2.15: 3,4-dihydro-4-oxoquinazolin-2-yl
2.16: 4-methylthiazol-2-yl
2.17: 1-methyl-1H-benzimidazol-2-yl
2.18: benzoxazol-2-yl
Route 1:
2.7a: 91%; 2.7b: 80%; 2.7c: 74%
2.13a: 80%; 2.13b: 77%; 2.13c: 60%
2.14b: 67%; 2.15a: 75%; 2.16b: 72%;
2.17a: 57%; 2.18a: 88%; 2.18b: 79%
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O
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1) R-NH2
2) KOt-Bu
2.12: R = Me, Bn, cyclopropyl, CH(Me)Ph, CH2Fur, t-Bu, Ph
2.12
CNHet
2.2
Scheme 2.5. Synthesis of 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles 2.7, 
2.13-2.18. 
 
1-R-pyrrolidin-2-ones 2.12 were reacted with DMS. Reaction was followed up 
by 1H NMR spectroscopy through the disappearance of 1-R-pyrrolidin-2-one 2.12 
signals in the crude reaction mixture. Pyrrolium salts 2.11 were directly subjected 
into reaction with the model compound: benzothiazol-2-ylacetonitrile 2.2. Reactions 
with 1-methyl/benzyl/cyclopropylpyrrolidine-2-ones proceed with the best 
conversion and yield. 5-Methoxy-1-phenylethyl/tert-butyl-3,4-dihydro-2H-pyrrol-1-
ium salts 2.11 react with benzothiazol-2-ylacetonitrile 2.2 only with partial 
conversion to the desired product most probably as a  consequence of steric bulk at 
nitrogen. 1-Phenylpyrrolidin-2-one does not react with DMS even at elevated 
temperature and excess of the reagent. The reason could be a decrease of the oxygen 
nucleophilicity resulting from the delocalization of the nitrogen lone pair on the 
benzene ring. 1-Furan-2-ylmethylpyrrolidine-2-one only yielded a mixture of 
inseparable products. 
The alternative method for the synthesis illustrated on Scheme 2.5, route 2 is 
analogous to the method that was developed for the synthesis of unsubstituted 
enaminonitriles 2.1 (Scheme 2.1, route 2).  
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With these results in hands further 2-azahetaryl-2-(1-R-pyrrolidin-2-
ylidene)acetonitriles were obtained from methyl(benzyl, cyclopropyl)-substituted 
pyrrolidin-2-ones. The reaction proceeded immediately at room temperature (rt) 
leading to the desired compounds 2.7, 2.13-2.18 in good to excellent yields 
(67−91%).  
Pyrrolium salts 2.11а-с are viscous oils, which were used directly in the next 
step without further purification. They could be obtained as solids upon treatment 
with KPF6 in water. The model compound 2.11΄a forms after the anion metathesis as 
a white precipitate that can be isolated by filtration (Scheme 2.5). 
 
2.2.2. Structure exploration: XRD, 1Н NMR, DFT-calculations, VTP-experiment 
As compared to the unsubstituted enaminonitriles 2.1, which theoretically can 
exist in the form of three tautomers and two diastereomers (Figure 2.1), N-substituted 
analogues can only be in the form of Z/E isomers.  
Analogously to unsubstituted enaminonitriles 2.1, configuration and 
conformation of the molecules were examined using XRD, NMR and dynamic NMR, 
and also confirmed by the DFT.  
Single crystals suitable for XRD study were obtained by solvent diffusion. The 
structures in the solid state of enamininitriles 2.7, 2.13-2.16, 2.18 revealed, as 
illustrated in Figure 2.7 for 2.13b, that the diastereomer featuring lower steric strain 
(N-alkyl and CN in the cis position) is preferentially formed, as expected.  
In all compounds the crystalline state revealed an almost planar conformation of 
the pyrrolidine ring (deviation from the plane within 0.16 Å), which is coplanar with 
the heterocyclic substituent (dihedral angle below 9°). 
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The delocalization of the electron density of the enamine moiety toward the 
nitrile and heterocycle promotes a general trend toward N4−C10 bond shortening and 
C10−C8 bond elongation, in a similar fashion as for 2.1.  
 
Table 2.3. The bond lengths and C8−C9−N3 angles of selected compounds  
Entry Comp
ound 
Length of 
pyrrolidine 
C−N 
bond (Å) 
Length of 
enamine 
C=C 
bond (Å) 
C8-C9-N3 
angle (deg) 
Dihedral angle 
between 
heterocycle 
and 
pyrrolidine 
ring planes 
(deg) 
Deviation of 
pyrrolidine 
ring from 
plane (Å) 
1 2.7b 1.334 1.403 176.1 5.3 0.027 
2 2.7c 1.353 1.373 174.6 4.3 0.051 
3 2.13a 1.328 1.382 173.7 8.8 0.161 
4 2.13b 1.337 1.389 173.4 2.4 0.068 
5 2.14b 1.348 1.395 175.5 5.9 0.026 
6 2.15a 1.339 1.401 177.5 1.9 0.019 
7 2.16b 1.342 1.389 175.5 4.9 0.024 
8 2.18b 1.336 1.389 177.1 2.6 0.130 
 
A clear correlation between the C8−C9−N3 angle values and the electron-
withdrawing abilities of the heterocyclic substituent is observed, which implies that 
 
  
 
Figure 2.7. а)   Molecular structure 
of 2.13b according to X-ray 
diffraction (E isomer). 
b) π-Diastereomerism of 2.13b. 
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both the nitrile and the heterocycle are involved in electron delocalization. For 
example, in the row benzoxazole 2.18b – benzothiazole 2.7b – benzimidazole 2.13b, 
the angle C8–C9–N3 changes 177.1° –176.1° –173.4°, respectively, which reflects 
the decrease of the electron withdrawing abilities of the heterocyclic substituent and 
the displacement of the electron density toward the nitrile group (Table 2.3).  
In previous publications103-105  the rotation around C=C bond of such conjugated 
enamines was identified as a “low energy” process with the free energy for activation 
(ΔG*) 9-20 kcal/mol. It was also argued that energy barrier decreases as the ability of 
the substituents to delocalize the charge in the transition state increases.  
Since azahetarylacetonitrile is a strong electron withdrawing fragment it was 
assumed that interchange between E/Z isomers occurs via heteropolar transition state 
A with efficient negative charge delocalization (Figure 2.8). 
 
Figure 2.8.  Interchange between E and Z 
diastereomers 2.7, 2.13-2.18 via transition state A. 
  
Bond length obtained by XRD analysis provides insight into the ability of 
rotation around the enamine double bond in the 2.7, 2.13-2.18  and the literature data 
stated low activation energy barrier for the rotation around C=C bond in similar 
conjugated enamines. Taking into account the above mentioned data the presence of 
signals from both diastereomers E and Z was expected in the 1H NMR spectra.  
The 1H NMR spectrum for the model compound 2.7a recorded in CDCl3, where 
the latter was completely soluble, showed only one set of signals. Nevertheless, the 
signals of N-CH3 at 3.46 ppm and 3-CH2 at 3.54 ppm adjacent to enamine double 
bond were broadened, that could be due to the fast exchange between isomers in the 
solution (Figure 2.9).   
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In most of the 
1H NMR spectra of 2.13-
2.18 recorded in CDCl3 
only one set of peaks is 
observed with broadened 
signals of protons 
adjacent to С=С bond; in 
rare cases the peaks of 
minor isomer appeared.  
Minimized steric 
interaction in E, with N-
Alk cis to linear nitrile 
group, as compared to Z 
with cis orientation of N-Alk and heterocycle substituent leads to constant prevalence 
of E isomer over Z. This conclusion is also substantiated by multiplets position in 1H 
NMR spectra. Protons of N-Alk substituent in E isomer are deshielded by a 
neighbour-anisotropy effect of cis nitrile group and shifted to low field as compared 
to N-Alk protons of Z isomer that are located in the shielding area of heterocyclyc 
moiety (Δδ within 1 ppm).  
Finally, assignment of the peaks either to E or Z form was made using the 2D 
NOESY technique (Figure 2.10).  
The model compound 2.13a was taken in DMSO-d6 at 298 K. -CH3 (δ = 2.78, 
3.37 ppm) and -NH- (δ = 11.75, 12.24 ppm) protons resonance for E configuration 
gave a distinguishing positive cross peaks correlating them to the corresponding 
resonance of Z configuration. There was also a positive cross peak correlating the -
NH-protons of benzimidazole to the residual water in the DMSO-d6 solvent (δ = 3.33, 
11.75, 12.24 ppm). Finally, the negative cross-peaks observed in the spectrum due to 
NOE between 4-CH and 3-CH2 groups (δ = 7.40 and 3.34 ppm) belonging to isomer 
with higher integration value has confirmed predominance of E isomer (Figure 2.11).  
 
Figure 2.9.  A fragment of the 1H NMR spectrum of 
compound 2.7a with the highlighted shift of broadened 
signals of the protons of  NСH3  and 3-СН2 moieties 
(CDCl3, 300 MHz).   
73 
 
 
Figure 2.10. NOESY spectrum of 2.13а. Exchange processes marked with 
blue and NOE with red (DMSO-d6, 500 MHz; 298 K). 
 
 
Figure 2.11. Cross peak іn NOESY spectrum which reflects the correlation 
between the 4-H and 3-CH2 protons of the predominant isomer in 2.13a. 
 
74 
 
Consequently, the absence of steric hindrance in the E isomer makes it 
predominant in the diastereomeric mixture, regardless of the type of solvent and the 
substitution at 2-(pyrrolidin-2-ylidene)acetonitrile fragment. This experimental result 
is consistent with the data of the quantum-chemical calculations performed for 
compounds 2.7a and 2.13a, whereby the Gibbs free energy of the E isomer was 
smaller than the ΔG Z isomer in all the cases, indicating a greater stability of the E 
form. The relation between isomers is calculated according to the Maxwell-
Boltzmann distribution and is given in Table 2.4.  
 Table 2.4. Ratio between E/Z isomers of 2-benzo[d]thiazol-2-yl-2-(1-
methylpyrrolidin-2-ylidene)acetonitrile 2.7 a  and 2-benzo[d]imidazol-2-yl-2-(1-
methylpurrolidin-2-ylidene)acetonitrile 2.13а. 
 
Compound 2.7a 
 E/Z ratio 46 30 29 28 
Solvent CНCl3 (СН3)2СО CH3OH (СН3)2SО 
Compound 2.13а 
E/Z ratio 64 22 20 19 
Solvent CНCl3 (СН3)2СО CH3OH (СН3)2SО 
 
To study the dynamic behavior of those compounds in the solution VTP 
experiment has been conducted for compound 2.13a. Upon cooling the solution of 
2.13а in CDCl3 down to 213 K the peaks of Z isomer arise. (table 2.5).  
Two broad singlets of 3-CH2 (3.57 ppm) and N-CH3 (3.46 ppm) signals splitted 
into four independent peaks upon cooling: triplet (3.48 ppm, J = 7.7 Hz, 3-СН2) and 
singlet (3.45 ppm, N-CH3) corresponded to E isomer and triplet (3.08 ppm, J = 7.5 
Hz, 3-СН2') and singlet (2.97 ppm, N-CH3) corresponded to Z isomer (Figure 2.12). 
Base on the spectral data the free activation energy (ΔG≠) for exchange between 
diastereomeric species 2.13a E and 2.13a Z was calculated. The kinetic parameters 
for unequal populated isomers were identified from modified Bloch equation (1-3).103  
[(δ2τ2-2)/3]3 = (ΔP)2 δ2τ2 (1), τ-1 = τe-1 + τz-1 (2),  peτe-1 = pzτz-1 (3), 
where δ – maximum chemical shift separation in radians, ΔP = pe-pz, when pe and pz 
are the molar fractions of the two exchanging diastereomers, τe and τz are the life time 
of E and Z. Rate constants are ke = 1/τe,  kz = 1/τz.. Inserting the resulting rate constant 
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into Eyring activation function, taking transmission coefficient (t) as unity, provides 
the ΔG≠ values: ΔG≠ E→Z = 14.4 kcal/mol, ΔG≠ Z→E = 13.3 kcal/mol.  
 =



	

Тк  (4), 
where k – rate constant, t – transmission coefficient, kB – Boltzmann constant, h 
– Planck constant, Тc – coalescence temperature.  
Coalescence temperature (Tc) was found as the average value of two consecutive 
temperatures surrounding the splitting of the signal (Tc = 285 K). Found ΔG≠ values 
are in agreement with previous ones stated for such conjugated enamines103-105 and 
characterize the isomerization process as low-energy one.  
Table 2.5. Selected chemical shifts data and ratio of isomers at different temperature 
observed for 2.13a in 1H NMR spectra (Solvent: CDCl3) 
Entry Solvent Temp. 
(K) 
E/Z ratio  Chemical shift (ppm) 
N-CH3 3-CH2 NH N-CH3 3-CH2 NH 
1 CDCl3 298 mixture 3.46 3.57 - - - - 
2 
 
2.13a E 2.13a Z 
 CDCl3 213 7:1 3.45 3.48 9.89 3.08 2.97 10.88 
 
 
76 
 
 
Figure 2.12. Exploration of dynamic effects in enaminonitrile 2.13а under cooling 
its solution in CDCl3. Temperature imnterval 298÷213 K. 
 
In summary 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles were 
synthesized by one known method and new ones, which can be used for preparative 
purposes. Their structure analysis was carried out using XRD, NMR, dynamic NMR 
and quantum-chemical calculations using DFT. Applying these techniques allowed us 
to show that 2-azahetaryl-2-(1Н-pyrrolidin-2-ylidene)acetonitriles exist both in the 
solution and the solid state as Z isomers. This contrasts with 2-azahetaryl-2-(1-
alkylpyrrolidin-2-ylidene)acetonitriles that exists as Z isomers in the solid state and as 
a mixture of Z/E diastereomers in the solution. The structure of Z isomers is stabilized 
by the intramolecular hydrogen bond. According to DFT-calculations the amount of 
E form in these cases is below 0.1%.  
Due to the absence of steric hindrance the E isomer is predominant in N-
substituted enaminonitriles, but there are also the signals of Z isomer in the spectra. 
The free activation energy of rotation at C=C double bond was calculated: ΔG≠ E→Z 
= 14.4 kcal/mol, ΔG≠ Z→E = 13.3 kcal/mol. The values found characterize this 
process as a low-energy one. 
 
2.3. Synthesis of 2-(pyrrolidin-2-ylidene)acetonitriles substituted with 
quaternized benzazoles  
It is known63 that the introduction of an electron-withdrawing group at the 
nitrogen atom in the heterocycle increases the electrophilicity of the adjacent carbon 
atom, and resulting substrates have increased reactivity in the reactions with 
nucleophiles. 
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 We have also attempted to use the above mentioned 
method to increase the electrophilicity of C-2 position of 
pyrrolidines, but the substrates 2.1 proved unreactive in 
acylation reactions (Figure 2.13). 
Therefore we have chosen a different approach to 
activate the C-2 position, which consist in increasing the 
charges separation in the molecule by quaternization of 
the nitrogen of azaheterocycle substituent.  
Direct methylation of substrates 2.12 (Scheme 2.6, route 1) with methyliodide or 
DMS worked only in the case of benzimadazole 2.13a leading to desired 2-(cyano(1-
methylpyrrolidin-2-ylidene)methyl)-1,3-dimethyl-1H-benzo[d]imidazol-3-ium iodide 
2.8 (Scheme 2.6). The structure of the product was identical to the one obtained by 
the reaction of 2.1f with methyliodide (section 2.2). In the case of enamines 
substituted with benzoxazolyl 2.18а and benzothiazolyl 2.7а the starting material was 
quantitatively recovered under the same conditions. 
 Scheme 2.6. Synthesis of 2-(pyrrolidin-2-ylidene)acetonitriles substituted with 
quaternized benzazoles 2.8, 2.21, 2.22. 
 
Access to such charged hetarylenamines was achieved using the method 
described by A. Dobrydnev et al.,106 which consist in methylation of initial 
azahetarylacetonitriles.  Using this method we were able to synthesize the previously 
described 2-(3-methylbenzo[d]thiazol-2(3H)-ylidene)acetonitrile 2.20 106, as well as 
2-(3-methylbenzo[d]oxazol-2(3H)-ylidene)acetonitrile 2.19 (Scheme 2.6, route 2).  
 
 
Figure 2.13.  Inactvity 
of compounds 2.1 in 
acylation reactions 
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Intermediate 5-chloro-1-methyl-3,4-dihydro-2H-pyrrol-1-ium 2.5a formed in 
situ upon reaction between POCl3 and N-methylpyrrolidin-2-one undergoes addition 
to enamine double bond of N-methylhetarylacetonitriles 2.19 and 2.20 (Scheme 2.6). 
This method corresponds to the one we applied for the formation of enaminonitriles 
2.1 and 2.7. 
 Practically, the reaction proceeds through the formation of emulsion of salts 
that separates into two layers after the stirring is ceased. The bottom layer – 
compounds 2.19 and 2.20 were separated and solidified by anion metathesis from Cl- 
to PF6- . 
The 1H NMR spectra of 2.21 and 2.22 are 
indicative of a single diastereomer. Considering the 
structure analysis results obtained for N-substituted 
enaminonitriles 2.7, 2.13-2.18 (section 2.2) these 
signals are thought to correspond to the less steric 
hindered E isomer (all the multiplets are well resolved). 
Comprehensive assignment of signals of 2.21 was made 
by homonuclear (COSY) and hetereronuclear (HMQC, 
HMBC) and NOESY 2D NMR techniques. The negative cross-peaks observed in the 
spectrum due to NOE between CH3 and 3-CH2 groups (δ = 3.22, 4.05 ppm) again 
confirmed the E configuration (Figure 2.14).  
The similarity of the chemical shifts of the corresponding protons in the 1H 
NMR spectrum of benzoxazole derivative 2.22 also indicates E configuration.  
For such cationic structures the 
existence of two resonance forms with 
localization of a positive charge on the 
nitrogen of azaheterocycle A or on the 
nitrogen atom of pyrrolidine B can be 
envisaged (Figure 2.15). The signal of one of -CH3 groups is shifted to low field (δ = 
4.02 ppm vs 3.50 ppm for 2.21; δ = 4.05 ppm vs 3.27 ppm for 2.22) as a potential 
consequence of its positioning at the nitrogen bearing more positive charge. From the 
 
Figure 2.14. The most 
indicative correlations 
found in NOESY and 
HMBC spectra of 2.21. 
 
Figure 2.15. Resonance forms of 
enaminonitriles 2.8, 2.21, 2.22. 
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other hand there is only minor changes in the location of -CH3 group of pyrrolidine in 
cationic structure as compare to neutral one (δ = 3.38 ppm for 2.7a vs 3.27 ppm for 
2.22; δ = 3.52 ppm for 2.18a vs 3.50 ppm for 2.21). Moreover, HMBC correlations 
with C-2 and the node carbon of benzothiazole situated next to the nitrogen (Figure 
2.14) are providing further evidence that this CH3 group is placed at nitrogen of 
benzothiazole and the predominant resonance structure is A (Figure 2.15).  
In the case of 2.8, with 1,3-dimethyl-1H-benzo[d]imidazol-3-ium (Х = NMe) 
substituent, heterocycle is symmetric about C-2 axis and the signals of both CH3 
groups arise as one singlet (6H) in 1H NMR spectrum. It has a low field shift versus 
N-CH3 group of pyrrolidine (δ = 4.20 ppm vs 3.60 ppm), but there is also a significant 
low field shift of -CH3 group of pyrrolidine as compared to the neutral analogue (δ = 
2.42 ppm for 2.17a vs 3.60 ppm for 2.8). These evidences cannot be indicative for 
predominance of one resonance form over the other.  
PF6- is evidenced by a septet in the 31Р NMR spectra and doublet in 19F NMR 
spectra of compounds 2.21 and 2.22.  
As illustrated in table 2.6 the 13С NMR spectrum of compound 2.8, 2.21 and 
2.22 exhibit a low field shift of С-2 atom of enaminonitrile fragment in comparison 
with neutral analogues. This indicates the extra deshielding  related to the 
displacement of the electron density to the electron deficient nitrogen.  
 
Table 2.6. Comparison of the chemical shift of С-2 atom of enaminonitrile fragment 
in N-substituted uncharged enaminonitriles 2.13а, 2.7а,2.18а and their analogues 
with quaternized azaheterocycles 2.8, 2.21,2.22.  
 
Entry Compound Chemical shift of С-2 atom of 
enaminonitrile fragment, (ppm) 
Solvent 
1 2.13а 167.0 (CD3)2SO 
2 2.8 170.7 CDCl3 
3 2.7а 167.6 (CD3)2SO 
4 2.21 170.7 (CD3)2SO 
5 2.18а 168.0 CDCl3 
6 2.22 173.9 CD3CN 
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The 1H NMR spectra of compounds 2.8 (in which the azaheterocyclic 
substituent is 1,3-dimethyl-1H-benzo[d]imidazole-3-ium) is indicative of the 
presence of the 2 diastereomers, 2 sets of signals being observed . An analysis of their 
chemical shifts leads to conclusion that the compound exists as a mixture of E and Z 
isomers.11 Interestingly the diastereomeric ratio varies with the solvent indicating 
equilibrium (Table 2.7)  
 
Table 2.7. Chemical shifts of N-CH3 and 3-СН2 groups of compound 2.8, that 
indicate the belonging of the set of signals to E or Z isomer. 
 
In the crystalline structure of 2-(cyano(1-methylpyrrolidin-2-ylidene)methyl)-
1,3-dimethyl-1H-benzo[d]imidazol-3-ium iodide 2.8 the dihedral angle between N,N-
dimethylbenzimidazole and pyrrolidine planes is 53.0°. Nitrile group and pyrrolidine 
are almost coplanar (the deviation from the plane is under 0.20 Å). There is also a 
shortening of N4–C12 (1.33 Å) and an elongation of C12–C10 (1.39 Å) bonds that 
                                                        
11 Signals that are in the shielding area of heterocycle (N-CH3 Z isomer and 3-СН2 Е isomer) shifted to high field, 
and those which are deshielded by nitrile group (N-CH3 Е isomer and 3-СН2 Z isomer) to low field. More detailed 
explanation was described in section 2.2. 
Entry Solvent E/Z ratio Chemical shift (ppm) 
2.8 E 2.8 Z 
N-CH3  3-CH2 N-CH3  3-CH2 
1 CDCl3 1.4:1 3.60 2.94 2.76 3.36 
2 CD3CN 1:1.2 3.51 2.51 2.46 3.25 
 
 
 
а) 
b) 
  
Figure 2.16. а)  Molecular structure of 
2.8 according to X-ray diffraction .  
b) Orthogonal projection. 
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are indicative of the electron density distribution. Taking into consideration the value 
of dihedral angle it can be assumed that delocalization on azaheterocycle is limited by 
the lack of planarity with the enamine moiety. Thus delocalization toward the nitrile 
group is mainly occurring (Figure 2.16). 
DFT calculation of partial charges in molecule 2.8 which has a quaternized 
heterocyclic substituent and its neutral analog 2.13a indicate a partial positive charge 
on С-2 atom of pyrrolidine in 2.8 is equal to +0.435 whereas in 2.13а in the same 
position, the charge is + 0.372. This result is in agreement with the conclusion on the 
increased electron deficiency of the C-2 atom, made from experimental data (low 
field shift of the signal of C-2 atoms in the 13C NMR spectrum). 
To conclude, enaminonitrile with quaternized azateterocyclic substituents can be 
obtained in two ways, one of which involves the introduction of the alkyl group to the 
hetarylacetonitrile at the first stage of synthesis and appears more versatile. The 
positive charge of the organic part of the molecule contributes to the charge 
separation and, as a result, increases the electron deficiency of the C-2 atom of the 
enaminonitrile fragment. 
 
2.4. Synthesis of 2-azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles 
There is only one publication where the functionalization of the position 2 of 
oxindole occurs through alkylation and further condensation with CH acidic group.26  
(Scheme 2.7). 
 
Scheme 2.7. Functionalization of С-2 position of oxindole. 
 
The applicability of this method is hampered by the equilibrium shift in the 
intermediate product of synthesis from 2-methoxy-3H-indole to 2-methoxy-1H-
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indole,24 which reduces the electrophilicity of C-2 atom (detailed description in the 
section 1.2). 
The attempt made in this work to create the С–С bond between С-2 position of 
oxoindole and hetarylacetonitrile was unsucceful (Scheme 2.7).  
To overcome the equilibrium issue we have to prevent the formation of 2-
methoxy-1H-indole. One way to proceed is to substitute oxindole at C-3 position.  
The indolin-2,3-dione 2.23 is a suitable candidate as it has a carbonyl group in 
the position 3 of the cycle. It is known,38-40 that its functionalization by nucleophiles 
possible at the position 2 via formation of intermediate imidochloride. Usually, the 
later one is isolated and dissolved in a more polar to perform condensation reaction.  
Due to the low stability of imidochloride the yield of the reaction is always low. We 
have thus developed a new one pot approach that includes the formation of 
imidochloride in situ (~1 h, boiling in benzene) and its further condensation with 
hetarylacetonitrile (Scheme 2.8). 
  
Scheme 2.8. Synthesis of 2-azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles 
2.24-2.26. 
 
The total reaction time is around 1 h, the limiting step being the formation of 
imidochloride. The products are formed with high yields and purified by filtration 
through a plug of silica gel (eluent dichloromethane).  
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2-Azahetaryl-2-(5-R-3-oxoindoline-2-ylidene)acetonitriles are brightly colored 
compounds varying from red to violet. They exhibit low solubility in common 
organic solvents and water, as usually observed for the isatin’s derivatives.107-108 The 
compounds 2.24a-c, 2.25a give a long wave-length absorption band in the 515-
550 nm range (Figure 2.17, table 2.8).  
 
 
a) 
 
b) 
 
c) Absorption spectra of 2.24a-c, 2.25а in DMSO. С = 10 
µmol/l. 
Figure 2.17. Photo of  
2.24b (a) and 2.24с (b) 
in the solution 
(DMSO) and a solid 
state. 
 
Table 2.8. Spectrophotometric characteristics of compounds 2.24а-с, 2.25 solutions.  
 
Entry Compound λmax, nm ελmax, l·mol-1·cm-1, 
104 
1 2.24а 520 1,48±0,05 
2 2.24b 530 1,38±0,05 
3 2.24c 550 1,03±0,05 
4 2.25а 515 1,66±0,10 
 
There is a predictable dependence between the increased electron donating 
abilities of the substituent at the position 5 of 3-oxindole (Н→Me→OMe) and the 
bathochromic shift of λmax in the absorption spectra. This occurs because of a 
decreased HOMO–LUMO gap. 
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 There is the broadened signal of NH group proton (δ = 11.4–12.0 ppm) in 1H NMR 
spectra of 2.24-2.26 as it was observed for 2-(pyrrolidin-2-ylidene)acetonitrile 
derivatives 2.1. Such low field shift caused by intramolecular hydrogen bond between 
nitrogen of azaheterocycle and hydrogen of pyrrolidine (NH). According to XRD 
estimated length of H3А···N1 hydrogen bond is 2.15 Å, the angle N3–H3А···N1 
123.3° (Figure 2.18). The low field shift is 
additionally enhanced due to the 
deshielding effect of conjugated carbonyl 
group. The dihedral angle between the 3-
oxindole and benzothiazole planes in 
2.24b is equal to 8.8° (Figure 2.18, b)), 
which indicates an effective delocalization 
of charge in the molecule. 
The 2D NMR techniques (COSY, 
HMQC, HMBC) were used to provide a 
comprehensive attribution of the 1Н and 
13С NMR signals (Figure 2.19).  
 
 
 
 
 
 
 
 
 
Figure 2.18. а) Molecular structure of 
2.24b according to X-ray diffraction. 
b) Orthogonal projection. 
 
 
Figure 2.19. The chemical shifts of 
protons and carbons in 2.25а found by 
2D NMR spectroscopy.  
  In the case of 2-(3-methylbenzo
reaction product is the base 
obtained in the reaction with 
enamine equilibrium shift
azaheterocycle (Scheme 2.9
N
H
O
O
N
S
1) PCl5, benz
2)
2.23a
Scheme 2.9. The reaction of isatin
 
Conclusions regarding the structure of the synthesized molecule were made on 
the basis of IR spectrum
group, as well as 1H NMR spectr
The particularity of
when changing the acidity of the medium. Absorption of 
function of pH (from 3.8 
2.20) and DMSO:Н2О 3:2 
 
Figure 2.20. The absorption
2.24b in DMSO:Н2О (5:1) 
acidity of the medium.С2.24
[d]thiazolyl-2(3H)-ylidene
2.27а, but not the salt  А, which is analogue to the one 
N-methylpyrrolidin-2-ones (section 2.3)
 is promoted by the positive charge
) . 
CN
ene, ∆, 1 h N
S CN
HN
O
Cl
A2.19
 2.23a with N-methylbenzothiazolylacetonitrile 
2.19. 
, in which there is no characteristic 
a, in which the signal of NH group 
 2-functionalized-3-oxindoles 2.24-2.26
2.24
to 11.2) were studied in DMSO:Н2О 5:1 
for 2.25а (Figure 2.21).  
 
 spectra of 
at different 
b = 40 µmol/l 
Figure 2.21. The absorption
2.25a in DMSO:Н2О
acidity of the medium
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vibration of the NH 
proton is absent.  
 is their behavior 
b and 2.25а as a 
for 2.24b (Figure 
 
 spectra of 
 (3:2) at different 
. С2.25a = 40 µmol/l 
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While increasing the basicity of the medium the batochromic shift of absorption 
λmax is occurring, 150 nm for 2.24b (λabsmax = 680 nm) and 130 nm for 2.25а (λabsmax = 
665 nm). Visually it is the change from purple to blue color.  
The conditional dissociation constants (pKa) were calculated for 2.24b and 
2.25a on the basis of the obtained data: pKa2.24b = 10.09±0.05; pKa2.25a = 10.96±0.25. 
Considering the ease of 2-azahetaryl-2-(5-R-3-oxoindolin-2-
ylidene)acetonitriles deprotonation we have tried to alkylate them. As it was 
mentioned earlier in the text (section 2.1) 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles 2.1 require harsh reaction conditions and even in this case the 
alkylation proceed only partly. In contrast methylation of 2.24b proceed already at 
room temperature with stochiometric amount of K2CO3 (Scheme 2.10).   
 
Scheme 2.10. Alkylation of 2-benzo[d]thiazol-2-yl-2-(5-R-3-oxoindolin-2-
ylidene)acetonitrile 2.24b 
 
To conclude, the preparative methods of 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles and 2-azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles 
synthesis we have developed allowed to study the functionalization of their reactive 
centres. A thorough structure investigation gives the access to prediction of their 
behaviour in the reactions with nucleophiles and electrophiles. 
The closely spaced location of the donor nitrogen atoms in N-unsubstituted 
pyrrolidines and 3-oxoindolines enables them to coordinate atoms with vacant 
orbitals. The results of the corresponding studies are presented in chapter 5. 
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СHAPTER 3. 2-AZAHETARYL-2-(1-R-PYRROLIDIN-2-
YLIDENE)ACETONITRILES AS 1,3-DIELECTROPHILES. SYNTHESIS OF 
PYRAZOLES/ISOXAZOLES AND THEIR CHEMICAL MODIFICATION 
The delocalization of electron density of enamine moiety in 2-azahetaryl-2-
(pyrrolidin-2-ylidene)acetonitriles is driving their reactivities toward nucleophiles. 
We have seen in chapter 2 that both nitrile and heterocycle act as electron 
withdrawing groups. Such delocalization promotes a shift in the 
enamine-imminium equilibrium, enhancing the electrophilicity 
of the C-2 atom of enaminonitrile fragment and simultaneously lowering that of the 
nitrile group. These observations suggest that 1,3-dielectrophiles can be expected to 
react with binucleophiles in a very regioselective fashion. This could therefore allow 
an overall atom- and step-economical generation of 3-(ω-aminoalkyl)-4-hetaryl-5-
aminoazoles 3.1-3.7, that have only scarcely described10 (Figure 3.1).  
 
Figure  3.1. 2-Azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles as 1,3-dielectrophiles. 
 
In this chapter we report the reactions of various enaminonitriles, which exhibit 
different electron density distributions and the spatial structures (chapter 2) with 1,2-
binucleophiles, such as hydrazines and hydroxylamine. Our aim was to explore: 1) 
the influence of alkyl substituent at the nitrogen of pyrrolidine (section 3.1), and 2) 
the influence of the nature and the substitution extent of benzazoles (section 3.2) on 
the reaction’s path with 1,2-binucleophiles.  
Synthesized polyaminoazoles were subjected into reactions of regioselective 
derivatization, transformation into tetracyclic azaheterocycles, Suzuki-Miyaura cross-
coupling and reductive deamination with further C-H activation (subsection 3.1.1).   
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3.1. Reactions of 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles with 1,2-
binucleophiles involving С-2 atom of pyrrolidine and carbon of nitrile group  
There are very few references dealing with the reactions of 2-(pyrrolidin-2-
ylidene)acetonitriles with 1,2-binucleophiles. The reason for this is the lack of 
reactivity of the latter (subsection 1.3.2). Without activation of С-2 centre of 
pyrrolidine the transformation requires harsh conditions (the excess of 1,2-
binucleophile, elevated temperature). 
We have attempted to conduct the reaction of N-unsubstituted pyrrolidines 2.1 
with 1,2-binucleophiles. Neither the excess of binucleophile nor the high temperature 
lead to the expected product. The starting material remained unchanged or the 
product of degradation was observed (hetarylacetonitrile was isolated).   
 In contrast, N-alkylpyrrolidines 2.7, 2.13-2.15 that has no intramolecular 
hydrogen bond react with 1,2-binucleophiles successfully. The reaction proceeded 
smoothly in refluxing dioxane with 10−20 equiv excess of the binucleophile reagent 
and provided the pyrazoles and isoxazoles in moderate to good yields (scheme3.1).101, 
109
   
The nature of the alkyl substituent on the pyrrolidine nitrogen was shown to 
only moderately affect the efficiency of the reaction (3.1а-с). Moving from 
methylhydrazine to hydrazine hydrate was found to promote a decrease in reaction 
yields (3.1c vs. 3.2c), whereas no discernable effect was observed upon switching 
from methylhydrazine to hydroxylamine (3.4b vs. 3.5b). Finally, variations in the 
nature of the heterocyclic moiety did not significantly affect the overall efficiency, 
although benzothiazole substitution systematically provided better efficiencies, all 
things being otherwise equivalent. 
3-(ω-Aminoalkyl)-4-hetaryl-5-aminopyrazoles 3.1–3.4, 3.6 and isoxazoles 3.5, 
3.7 were isolated with good analytical quality after a simple solvent evaporation and 
trituration in acetone or acetonitrile, or column chromatography.  
.  
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 Scheme 3.1. Reactions of 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles 2.7, 
2.13–2.15 with 1,2-binucleophiles. 
 
 The involvement 
of the nitrile group, 
initially present in 2.7, 
2.13–2.15, in the 
reaction is highlighted 
by the disappearance 
of its characteristic 
stretching vibration 
absorptions in the 
2198−2178 cm−1 range 
of the IR spectra. 
 Thorough 
structural analysis of the compounds was carried out using 1H NMR, 13C MNR, 2D 
NMR techniques and IR. Particularly, in DMSO-d6, a characteristic singlet of NH2 in 
the 1H NMR spectrum is observed at 6.25−6.94 ppm. Interestingly, this signal is 
shifted up-field for isoxazoles, probably as a consequence of oxygen electronegativity 
 
Figure 3.2. 1Н NMR spectrum of pyrazole 3.1а (400 MHz, 
DMSO-d6). 
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(3.6a, 8.04 ppm; 3.5b, 8.20 ppm). In both cases, addition of D2O promotes the 
disappearance of these singlets, evidencing the exchangeable nature of the 
corresponding protons.  
The 13C NMR spectra of 3.1-3.7 show three signals corresponding to the carbons 
of the pyrazoles (isoxazoles). The first one, found at a chemical shift in the 
147.1−149.0 ppm range, was assigned to the C5 atom of the pyrazole ring, and again, 
this signal was shifted up-field for isoxazoles (at around 169.2−170.5 ppm). The 
signals within the range 90.3−100.8 and 148.6−161.3 ppm correspond to C4 
connected with a heterocyclic substituent and to C3 bonded with the ω-aminoalkyl 
chain, respectively.  
Pleasingly, 4-hetarylaminopyrazoles 3.1a, 3.1с and 3.2а formed crystals suitable 
for XRD study, allowing careful analysis of their structure. The benzothiazolyl 
substituent is almost coplanar with the pyrazole ring, with a dihedral angle of 6.48° 
and 1.16° for 3.1a and 3.1с, respectively, indicating a significant overlap of the π 
systems. The flattened orientation of the planar fragments is further stabilized by an 
intramolecular hydrogen bond between one of the protons of the amino group and the 
nitrogen of the benzothiazole. In the crystal lattice molecules of 3.2а aligned 
antiparallel to each other and are complementary paired. Such packing stabilized by 
intermolecular hydrogen bonds (estimated bond length H4А…N5 2.00 Å, N4-
H4A…N5 164.8°) (Figure 3.3). 
 
Figure 3.3. Molecular structure of compound 3.2а according to X-Ray diffraction. 
Hydrogen bonds formation in the complementary pair. 
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For 3.6а (Figure 3.4) featuring a quinazolinonyl substituent, distinct changes in 
conformation were observed. XRD data seem to indicate that 3.6a exists as a zwitter-
ion in the solid state. Indeed, the hydrogen located, initially, at N2 in 2.15а seems to 
be covalently bound with the secondary amino group in the aliphatic chain of 3.6а 
(N6−H6B 0.93 Å). The lone pair on N2 exhibits stronger conjugation with its 
adjacent carbonyl group, as shown by the shortened N2−C7 (1.340 Å) and elongated 
C7−O1 (1.273 Å) bond lengths, when compared to that of 2.15а (N2−C7, 1.378 Å; 
C7−O1, 1.230 Å). N2 forms an 
intramolecular hydrogen bond with 
H6B (estimated bond length N2···H6B, 
1.89 Å; N6−H6B···N2, 175.49°), 
whereas O1 forms an intermolecular 
hydrogen bond with H6A (estimated 
bond length O1···H6A, 1.78 Å; 
N6−H6A,···O1 170.96°) of an adjacent 
molecule. The positioning of the 
pyrazole and quinazolone planes 
(dihedral angle of 19.65°) in 3.6а  
allows the molecule to adopt an 
energetically favored conformation, 
placing both N2−H6B and N1−H3A in close proximity (estimated bond length 
H3A···N1, 2.24 Å; N3−H3A···N1, 127.29°). 
Considering the analytical and structural data obtained for the pyrrolidine 
precursors, as well as precedents from the literature,62, 65 a ring conversion from 
pyrrolidine to pyrazole (or isoxazole) is expected to proceed via nucleophilic attack 
of the unsaturated carbon of the pyrrolidine yielding B; spiro intermediates C would 
then form upon attack of the second atom of the binucleophile on the nitrile group in 
a favored 5-exo-dig fashion. Finally, ring opening of the pyrrolidine ring promotes 
the aromatization of the azole ring and provides the nitrogen-substituted aliphatic 
 
 
Figure 3.4.  Molecular structure of 
compound 3.6а according to X-Ray 
diffraction. 
N
N
N
N
N
O NH
H
HNH
1.
89
1.78
1.27
1.34
0.93
H
H
2.24
93 
 
chain. Such an addition of nucleophile-spiro annulation-ring opening (ANSARO) 
mechanism is thought to be operative in this transformation (Scheme 3.2). 
Scheme 3.2. Proposed mechanism for the ring conversion. 
 
 
3.1.1. Regioselective functionalization of  3-(ω-aminopropyl)-4-azahetaryl-5-
aminopyrazoles 
Having this straightforward access to densely functionalized pyrazoles in hand, 
we further explored their synthetic potential by assessing the ability to selectively 
introduce structural variations on their reactive centres, namely, the amino groups.  
The first approach was to illustrate the possibility of selectively functionalizing 
the amino groups substituting the pyrazole core. For that purpose, we confirmed that 
the secondary alkylamine is significantly more nucleophilic than the primary 
aromatic one. Indeed, alkylation of the secondary amino group could be achieved 
simply by stirring 3.1a with 1 equiv of the base and 2.2 equiv of alkylating reagent at 
room temperature, leaving the primary amino group unaffected (Scheme 3.3). The 
reaction produced a white precipitate, which structure was confirmed to be 3.8 by 
analysis of the filtrated solid by 1H, 13C, and 2D NMR as well as high resolution mass 
spectrometry (HRMS). Expectedly, the symmetry achieved through formation of the 
ammonium salt significantly lowers the quadrupolar coupling constant of nitrogen, 
allowing observation in the 13C NMR spectrum of the 14N−13C coupling for the 
methyl (JCN = 4 Hz)  and the methylene (JCN = 3 Hz) carbons of the ammonium.  
Extensive attempts to perform Hofmann elimination from 3.8 failed to provide 
the corresponding alkene 3.9, leading to ammonium recovery or degradation when 
reaction conditions were forced.  
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Scheme 3.3. Regioselective alkylation of amino groups from 3.1а. 
 
Consequently, the substitution of the primary aromatic amino group was found 
to require the protection of the secondary amine (Scheme 3.3). This could be achieved 
in 93% yield by simple treatment of 3.1a with a slight excess of di-tert-butyl 
dicarbonate (Boc2O) in trifluoroethanol110 for 10 min at room temperature followed 
by column chromatography.  
With this protection in place, we could perform a reductive amination of the 
primary amino group. It is known that for 5-aminopyrazoles such transformation does 
not require any acidic catalysis and proceed at 60 °С.111   
In contrast to the reference data, the primary amino group of 3.1а reacts with 
aldehyde only at elevated temperature, in the presence of an acid. The produced Shiff 
bases are unstable and easily degrade to the starting material. After intensive efforts 
we have found the appropriate reaction conditions involving the use of sealed vessel 
and inert atmosphere to access the Shiff base. Then following reduction with sodium 
borohydride proceeded quickly in a protic solvent.  
Compound 3.10 was isolated after column chromatography in 47% yield (44% 
over three steps from 3.1a). Unreacted starting material was fully recovered (Scheme 
3.3). 
The pendant amino group on the pyrazole and proximate NH of the 
benzimidazole allows condensation of 3.3а with electrophiles such as orthoesters. 
This approach could deliver pyrazolopyrimidine scaffolds of interest for medicinal 
chemistry purposes, as has been exemplified in the development of inhibitors of 
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glycogen synthase kinase 3, an enzyme involved in numerous diseases such as type II 
diabetes, Alzheimer’s disease, cancer, bipolar disorder, and inflammation.112   
Upon boiling a mixture of 3.3a and 1,1,1-triethoxyethane in the presence of 
acetic anhydride, we could achieve the synthesis of 3H-benzo[4,5]imidazo[1,2-
c]pyrazolo[4,3-e]pyrimidine 3.11 (Scheme 3.4, route 1); it is important to note that a 
dehydrating agent is required to bring the reaction to completion. This illustrates 
weak stability of the formed pyrimidine ring that only tends to hydrolyze back to the 
acylated starting material both under strongly acidic and basic conditions. 
 
Scheme 3.4. Straightforward access to fused tetracyclic structures 3.11, 3.12. 
 
Yet, under neutral conditions, 3.11 could be isolated and thoroughly 
characterized. The 1H NMR spectrum of 3.11 in CDCl3 shows two sets of peaks 
corresponding to two unequally populated rotamers. Moreover, the symmetry of the 
benzimidazole moiety initially found in 3.3a is disrupted through this transformation, 
promoting the split of the two aromatic signals of 3.3a into four signals for 3.11, 
namely, two doublets at 7.94 and 8.04 ppm and two doublets of doublets at 7.41 and 
7.53 ppm. 
A somehow similar tetracyclic aromatic compound was also accessed by simple 
treatment of 3.3a with an excess of tert-butyl nitrite in DMF (Scheme 3.4, route 2). 
Under these conditions, the diazonium intermediate could indeed be trapped by the 
imidazole nitrogen to generate the corresponding triazene 3.12, with concomitant 
protection of the secondary amine as a nitrosoamine. 3.12 was isolated in 85% yield 
after column chromatography and fully characterized. It exhibits a unique tetracyclic 
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structure that has never been previously described, and as such, expands the chemical 
space of heterocyclic chemistry.  
Scheme 3.5. Sandmeyer iodination of the aminopyrazole core. 
 
Finally, following this diazotization strategy, we investigated the lability of the 
5-amino group. At first, we explored the ability of these heterocyclic-substituted 
aminopyrazoles to undergo Sandmeyer-type reactions. After extensive investigation, 
we found that to avoid the formation of numerous byproducts, the reaction had to be 
carried out at 65 °C with excess tert-butyl nitrite (5 equiv) and I2 (4.3 equiv) in 
acetonitrile,113 furnishing iodopyrazole 3.13 in 38% yield (Scheme 3.5). As stated 
above for the formation of 3.12, the secondary amine was converted to its 
nitrosamine derivative. We found that this could be avoided by first adding TsOH to 
the reaction mixture; under these acidic conditions, the secondary amine is protected 
as a weakly acidic ammonium salt avoiding nitrosation. Thus, only the primary 
aromatic ammonium formed under these conditions appears acidic enough to undergo 
nitrosation and water elimination to form the transient diazonium salt, which finally 
generates the iodopyrazole 3.14a in 30% yield.  
Interestingly, under these acidic conditions, the reaction proceeds with the 
formation of the reductive deamination byproduct 3.14b (~1:1). 
The introduction of iodine is easily monitored by the 13C NMR spectrum of 
3.14a characterized by considerable shielding of C5 by the adjacent I atom (3.1a, 
147.1 ppm; 3.14a, 86.5 ppm).  
Further, Boc protection of the secondary amine could be achieved in 
trifluoroethanol yielding 3.15 in 70% yield. This two step iodination−protection 
proved only moderately efficient (21%) that is almost two times less than one pot 
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reaction of iodination-nitrosation – 38%. The efficiency of the latter approach 
highlighting the nitrosamine as a potentially useful alternate protecting group, 
although cancerogenic properties might be found. 
With these iodinated pyrazoles in hand, we explored potential C−C bond 
formation by way of Suzuki−Miyaura cross-coupling with a range of boronic acids 
(Scheme 3.6). A first attempt using 3.14a and 4-methoxyboronic acid under 
conventional conditions (5% Pd(PPh3)4, dioxane-H2O, Cs2CO3) provided the desired 
cross-coupling compound 3.16а in 71% yield. Yet the presence of the secondary 
amine made chromatographic analysis and purification tedious.  
 
Scheme 3.6. Suzuki−Miyaura cross coupling of iodinated pyrazoles 3.13-3.15. 
 
We therefore turned to 3.15 as the starting pyrazole and were pleased to achieve 
the cross-coupling to 3.16b isolated in quantitative yield. We could further exemplify 
this reactivity by isolating 3.17 and 3.18 quantitatively, and 3.19 in 72% yield. Yet, 
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moving to ortho-substituted 2-nitrophenylboronic acid and 2,6-bis-
(trifluoromethyl)phenylboronic acid fully inhibited the coupling reactivity due to the 
steric bulk around the reactive site of the iodopyrazole derivative.  
Considering the more efficient access to 3.13 (38% vs 21% for 3.14a), we 
envisaged the unprecedented use of nitrosamine as a protecting group during the 
Suzuki−Miyaura cross-coupling. This was found to be a successful approach because 
the cross-coupling leading to 3.16с occurred in quantitative fashion (Scheme 3.6).We 
could also access the heterocyclic compound 3.20 using N-Boc-indole 2-
trifluoroborate, albeit with a moderate yield and under harsher conditions (140 °C) 
that promoted the thermolysis of the Boc group. 
According to XRD study 
in 5-indol-2-ylpyrazole 3.20 
the indole and pyrazole planes 
are orthogonal to each other 
(89.7°); benzothiazole and 
pyrazole are almost coplanar, 
the dihedral angle is equal to 
3.9° (Figure 3.5). Such a 
relative position of fragments 
stabilize by intermolecular 
hydrogen bonds in 
complementary pair, that consist of molecules of 5-indole-2-ylpyrazole aligned 
antiparallel to each other (H2A…O1 2.02 Å, N2–H2A…O1 171.3°).  
Finally, considering the observation of reduced product 3.14b (∼1:1 relative to 
iodinated product 3.14a) during the Sandmeyer reaction (Scheme 3.4), we 
investigated the possibility of performing such a reduction more efficiently.  
On the basis of former reports,114 we could achieve radical deamination of 
benzothiazole substituted pyrazole 3.1a to 3.21 with tert-butyl nitrite in 
dimethylformamide (Scheme 3.7). Indeed, opposite to the reaction with 
benzimidazole 3.3а (Scheme 3.4), no intramolecular trapping to the triazene can be 
 
 
 
Figure 3.5.  Molecular structure of compound 3.20 
according to X-Ray diffraction. 
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achieved from 3.1a. Therefore, it is thought that the classical homolytic 
decomposition during diazotization allowed hydrogen abstraction from the solvent by 
the pyrazolyl radical to afford the desired reduced compound 3.21. The latter was 
isolated and fully characterized. Similarly to the transformations described above, the 
reaction proceeds with concomitant nitrosation of the secondary amine. 
 
Scheme 3.7. Reductive deamination of 4-benzothiazol-2-ylpyrazole 3.1а. 
 
From the mechanistic point of view, the nature of the hydrogen source is 
expected to be the methyl group of DMF. Indeed, it has been stated114 that acetonitrile 
could also act as donor of hydrogen yet better conversions are achieved with DMF. 
And as tetramethylurea appears almost as efficicent as DMF it is thought that 
reduction occurs primarily by hydrogen transfer from the N-methyl group. 
The 1H NMR spectrum of 3.21 shows two sets of peaks corresponding to two 
unequally populated rotamers, and the characteristic singlet of the newly introduced 
proton arises at 7.88 ppm (in CDCl3). 
Deprotection of the nitrosamine to the corresponding ammonium salt could be 
easily achieved by bubbling HCl gas in a methanol solution of 3.21. This two-step 
procedure gave 3-(4-(benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)-N-
methylpropan-1-aminium chloride 3.22 in 89% overall yield. The 1H NMR spectrum 
of 3.22 recorded in DMSO-d6 features a broad singlet for the two protons of the 
ammonium at 8.94 ppm that disappeared upon D2O addition. 
Although nitrosamines are considered as having limited value as protective 
groups (mainly as they are considered carcinogenic),115  we believe, through all our 
observations, that in this specific case, their facile generation and deprotection make 
them an attractive option, provided cautious experimental procedures are followed. 
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Moreover, nitrosamines are also known to promote the umpolung reaction of 
secondary amines through deprotonation, and as such, they represent an interesting 
functionalization of aminoalkyl chain.116 
Having this reduced adduct in hand, we explored the possibility of further 
functionalization through the C−H activation reaction, as previously reported on 
pyrazoles.117-118 We found that heating 3.13 at 70 °C in the presence of Pd(OAc)2, 4-
bromoanisole, and tetrabutylammonium acetate in dimethylacetamide (DMAc) for 
24 h provided straightforward access to 3.16c in quantitative yield (Scheme 3.8).  
 
Scheme 3.8. Functionalization of pyrazole through C−H Activation. 
 
Once again, this illustrates the excellent compatibility of nitrosamine protection 
with palladium-catalyzed cross-coupling reactions. Moreover, this reaction path 
provides a highly efficient approach to densely substituted pyrazoles featuring both 
aryl and hetaryl substituents at the 4 and 5 positions, as 3.16c is isolated in 71% 
overall yield from benzothiazolylacetonitrile 2.1b and avoids ineffective stage of 5-
iodopyrazole formation (21-38%). 
In summary, we have developed a two-step procedure for the synthesis of fully 
substituted 4-hetaryl-5-aminoazoles from readily available starting materials in a 
modified Knorr-type reaction. The reaction was found to be fully selective thanks to 
an evidenced marked difference between the two centres of the 1,3-dielectrophile. 
These highly functionalized azoles have been shown to represent entries to various 
polyheterocyclic compounds, providing a straightforward route to a wide chemical 
space. Indeed, further reactivity of the 4-hetaryl-5-aminopyrazoles obtained was 
investigated, providing highly regioselective transformations and giving access to 
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unknown derivatives with high nitrogen contents. Moreover, transformation of the 5-
amino substituent allowed the straightforward introduction of aryl and hetaryl 
moieties at this position providing a four-step route to densely functionalized 
pyrazoles. This also illustrates the efficient nitrogen protection as a nitrosamine 
during the Pd-catalyzed cross-coupling reaction. We consider that this approach 
opens new routes to enlarge the chemical space of pyrazole-containing 
pharmacophores as it introduces chemical complexity in an unprecedented swift 
fashion from simple starting materials. 
 
3.2. Reactions of 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles with 1,2-
binucleophiles involving С-2 atom of pyrrolidine and С-2 atom of azaheterocycle  
To widen the scope of this kind of transformations of cyclic 2-azahetaryl-3-
enaminonitriles, we turned our attention to benzoxazolyl substituted derivatives and 
to quaternized benzazoles substituted ones.  
The similarity of the selected objects is that the C-2 atom of azaheterocycle is 
located between two electron-acceptor groups: the oxygen and the nitrogen in the 
case of benzoxazole and the corresponding heteroatom (S, N, O) and the quaternized 
nitrogen atom in another, which, accordingly, increases electron deficiency of above 
mentioned C-2 atom. Consequently, it could be predicted that the presence of one 
more electron deficient centre has its impact on the reaction path with 1,2-
binucleophiles (Figure 3.6).  
 
Figure 3.6. Influence of increased electron deficiency of C-2 atom of azaheterocycle 
on regioselectivity of reactions with 1,2-binucleophiles. 
 
3.2.1. 2-Benzo[d]oxazol-2-yl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles in reactions 
with 1,2-binucleophiles   
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Regioselectivity in reactions of benzoxazol-2-yl substituted pyrrolidin-2-
ylidenes 2.18 with 1,2-binucleophiles was primarily explored.  
After proceeding the reaction with methyl hydrazine12 two sets of peaks with the 
same integral intensity were observed in 1H NMR of crude reaction mixture arising as 
one spot on TLC. After the appropriate elution system was found (CHCl3–CH3OH–
Et3N, 20:2:1) we have separated the products and thoroughly analyze them by 1H, 13C 
and 2D NMR techniques as well as HRMS. The characteristic range for benzazoles 
aromatic protons is 7.1–7.7 ppm. Arising of aromatic protons in the 6.6-7.0 ppm 
range of one of the products might be influenced by benzoxazole ring opening 
(Figure 3.7). M + H+ equal to 286.17 obtained by mass analysis is indicative for the 
presence of two isomers. Moreover, the stretching vibrations at 2218 cm-1 found by 
IR analysis unambiguously indicated that one of the isomers has still a nitrile group, 
thus no nucleophile attack was occurring on this centre. Considering these evidences 
we have suggested the structure of two isomers 3.23a and 3.24a and the mechanism 
of their formation (Scheme 3.9).  
 
Figure 3.7. A fragment of the 1H NMR spectrum of 3.23а and 3.24а (Solvent: 
DMSO-d6). 
 
                                                        
12 Reaction was performed under the same  conditions applied earlier toward the synthesis of 3-(ω-aminoalkyl)-
4-hetaryl-5-amino-pyrazole (or isoxazole) 3.1-3.7: refluxing in dioxane, 10-20 equiv of methylhydrazine  
3.23а 
3.24а 
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Scheme 3.9. The reaction of benzoxazol-2-yl-2-(1-R-pyrrolidin-2-
ylidene)acetonitriles 2.18 with methylhydrazine.  
 
Mechanism includes the NH attack at C2 atom of pyrrolidine ring leading to 
intermediate A in which YH is situated in the same proximity to both nitrile group 
and C2 atom of benzoxazole and attacks one or the other with a probability that 
depends directly on their electrophilicity. As stated above, the structural isomers 
3.23а and 3.24а form with the ratio 1:1 that  indicates a similar electrophilicity of C-2 
atom of azaheterocycle and carbon of nitrile group in the intermediate A.   
A similar observation was made for the reaction involving 2.18b that afforded 
two structural isomers 3.23b and 3.24b with 1 to 1 ratio. 
This 1 to 1 ratio can be explained as follow: the reaction of 2-benzoxazol-2-yl-
N-R-pyrrolidinacetonitrile requires a 101 °C temperature to proceed (boiling point of 
dioxane) making this step the rate limiting one. Cyclization then proceed with no 
selectivity at such temperature thus promoting this 1:1 ratio. Careful follow up by 
TLC indicated that both products form simultaneously as soon as starting material is 
consumed. Moreover the relative amount of each product remaining unchanged until 
complete conversion of reactants. 
In the 1H NMR spectrum the protons of amine group of pyrazoles 3.23а,b arise 
at 6.55 and 6.51 ppm correspondingly; the NH proton of aminophenol is more 
deshielded  due to the nitrogen lone pair conjugation with benzene and pyrazole rings 
and as well due to formation of  the hydrogen bond with Oxygen of adjacent OH; its 
arises at 8.09 ppm for  3.24а and 7.89 ppm for 3.24b (Figure 3.7). The proton of OH 
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group exchanged with deuterium and is too shrinked to observe clearly in 1H NMR 
spectrum. 
Moreover, the structure of 3-(3-(benzylamino)propyl)-5-((2-
hydroxyphenyl)amino)-1-methyl-1H-pyrazole-4-carbonitrile 3.24b was confirmed by 
XRD analysis (Figure 3.8). A dihedral angle between pyrazole and benzene rings in 
3.24b of 75.5° is observed. The angle C16-N5-C13 is indicative of the conjugation of 
N5 lone pair with a nitrile group and benzene ring (C16-N5-C13 120.9°). In the solid 
state molecules are aligned antiparallel to each other and are complementary paired. 
Such packing is stabilized by intermolecular hydrogen bonds (Figure 3.8). 
 
Scheme 3.10. Reaction of benzoxazol-2-yl-2-(1-benzylpyrrolidin-2-
ylidene)acetonitrile 2.18b with hydroxylamine. 
 
Figure 3.8.  Molecular structure of compound 3.24b according to X-Ray 
diffraction. Hydrogen bonds formation in the complementary pair. 
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Under refluxing of N-benzylpyrrolidin-2-yledeneacetonitrile 2.18b in dioxane 
with 20 equiv excess of 50% solution of NH2OH in water, we also obtained two 
products (Scheme 3.10).  
These products were separated by column chromatography and analyzed by 1Н, 
13C and 2D NMR, IR and HRMS techniques. It was established that one of the 
reaction products as it was expected based on previous results obtained for the 
reaction of 2.18b with methylhydrazine is 4-(benzo[d]oxazol-2-yl)-3-(3-
(benzylamino)propyl)izoxazol-5-amine 3.25b. Unexpectedly, IR analysis of the 
second product did not indicate any absorption band at 2180-2230 cm-1 corresponding 
to nitrile starching vibrations. Moreover, molecular ion peak was equal to 382.17 u 
and differed from mass of expected product on 33 u. Nevertheless, up-field shift of 
aromatic protons in 1H NMR spectra clearly indicated the opening of benzoxazolyl 
cycle. Relying on the mechanism of reaction proposed for the formation of isomers 
(Scheme 2.8), we assumed the the second atom of nucleophile attacks the C-2 centre 
of benzoxazole; the following attack of the second molecule of hydroxylamine (Mr of 
NH2OH is 33 u) is directed at nitrile group leading to 3.26b (Scheme 3.10). The 
proposed structure was confirmed by 2D NMR (Figure 3.9) and XRD (Figure 3.10). 
 
Figure 3.9. The most indicative 
correlations found in HMBC 
spectrum of 3.26b. 
Figure 3.10. Molecular structure of compound 
3.26b according to X-Ray diffraction. 
 
In 1H NMR spectrum the signal of Н-6 aromatic proton is shifted to low field (δ 
= 7.57 ppm). Such a shift occurred as a consequence of deshielding effect of neighbor 
oxygen. Indeed, according to XRD study of 3.26b the Н16 and О1 are spatially 
approximated (dihedral angle between benzene and isoxazole planes is 4.81°). The 4-
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carboximidamide fragment is planar within 0.016 Å and turned on 17.98° toward 
isoxazole ring. Such orientation might allow formation of another hydrogen bond 
between H5A…N4 atoms.  
 
3.2.2. Cyclic enaminonitriles substituted with quaternized benzazoles in reactions 
with 1,2-binucleophiles 
When benzoxazole derivatives reacted with 1,2-binucleophiles three active 
centres were involved in reaction and the mixture of structural isomers were formed. 
The presence of quaternized nitrogen increases the electrophilicity of C-2 atom of 
heterocycle substituent (details are described in section 2.3) and thus the equilibrium 
of reaction should be shifted toward formation of one regioisomer – the product of 
the opening of azole cycle.  
The stated assumption was checked by introducing the cyclic enaminonitriles 
substituted with quaternized azoles 2.8, 2.21, 2.22 in the reaction with 1,2-
binucleophiles (Scheme 3.11).  
 
Scheme 3.11. Reaction of cyclic enaminonitriles substituted with quaternized azoles 
2.8, 2.21, 2.22 with hydrazines. 
 
The reaction proceeds smoothly under milder conditions (refluxing ethanol, and 
has been finished within 2h (TLC control), most probably as a consequence of the 
increased reactivity associated with introducing of the positive charge. 
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In the case of benzimidazole 2.8 and benzoxazole 2.21 derivatives there is only 
one set of signals in 1H NMR spectrum indicating a full regioselectivity of the 
reaction. After purification (recrystallization for 3.27 and column chromatography for 
3.28) the compounds were analyzed by NMR and IR spectroscopy techniques. 
Indicative vibration band of nitrile group absorption was found at 2214 cm-1 for 3.27 
and at 2220 cm-1for 3.28 in IR spectra; in 1H NMR spectrum signals of aromatic part 
were shifted down field and were split into 4 signals in the case of 3.27 as a 
consequence of the benzimidazole moiety symmetry disruption. The combination of 
these facts suggests the opening of the imidazole and oxazole cycles. 
 
 
Figure 3.11. The most 
indicative correlations found in 
HMBC, COSY spectra of 3.27.  
Figure 3.12. Molecular 
structure of compound 3.27 
according to X-Ray diffraction. 
 
The generated molecules exist in the form of ammonium salts with the 
localization of the proton on the nitrogen atom of the ω-aminoalkyl chain. Such a 
conclusion is made on the basis of 1H NMR spectra, in which the singlet of NH2 
protons is observed at 8.39 ppm in the case of 3.27 and 8.31 ppm in the case of 3.28. 
An additional study was carried out using the 2D NMR method (the most indicative 
correlations are shown in Figure 3.11) and XRD (Figure 3.12).  
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An unexpected result was obtained in reaction of the benzothiazole derivative 
2.22 with methylhydrazine. Instead of the expected “simple” product of the thiazole 
ring opening (as observed with benzimidazolyl 2.8 and benzoxazolyl 2.21) in this 
case the azepine 3.30 was formed (Scheme 3.10). The product was obtained in 78% 
yield after column chromatography. 
The structure of the compound was established by IR and NMR spectroscopy. 
Thus there is no characteristic signal of nitrile group vibration band in IR spectrum 
indicating its transformation during the reaction.  
In the 1H NMR spectra of 3.30 (Figure 3.13) there is down field shift of 
aromatic protons (δ = 7.1–7.3 ppm) indicating the opening of the thiazole ring. 
Doublet at 2.74 ppm (J = 5.0 Hz) and quadruplet at 5.31 ppm (J = 5.1 Hz) matching 
to СН3NH protons of substituent at benzene ring. Two low field singlets at 8.97 and 
8.80 ppm belong to the protons of NH groups. The intensity of these signals 
diminishes upon addition of D2O. 31Р and 19F NMR spectra are indicative for the 
presence of PF6- counterion. The molecular ion of PF6- group was also found by 
HRMS (calculated 144.9642, found 144.9649).  
 
Figure 3.13. A fragment of 1Н NMR spectra of 3.30 (Solvent: DMSO-d6). 
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The formation of the azepine cycle is confirmed 
by correlations in the HMBC spectrum between the 
CH3 and CH2 protons of the aminoalkyl chain with the 
quaternary carbon of the C-S bond. The absence of the 
cross peak in HMBC spectrum for correlation between 
protons of CH3NH group (substituent at benzene ring) 
and С-4 atom of azepine seems to be indicative for 
connection between thioaminophenol and azepine 
fragments via sulfur atom.  For example, such 
correlation is seen in 3.27 where the connection 
between fragments occurred via NCH3 group 
(correlation between protons of СН3 group and С-1 
atom of benzene ring, Figure 3.11). The most indicative correlations found in 2D 
NMR spectra of 3.30 depicted on Figure 3.14. 
The formation of the azepine 3.30 probably occurs via intermediate 3.29, which 
is formed by the second nitrogen atom attack at the carbon of nitrile group (the 1st 
route product) with the following attack of nitrogen of ω-aminoalkyl chain at C-2 
position of benzothiazole (Scheme 3.11).  
An attempt to conduct a similar reaction with benzimidazole 2.8 and 
hydroxylamine (50% solution NH2OH in Н2О) only resulted in one product which 
was identified as the amide 3.31 (Scheme 3.12, route 1). The same product was 
obtained by hydrolysis of nitrile group under the basic conditions NaOH, EtOH-H2O, 
reflux (Scheme 3.12, route 2).  
 
Scheme 3.12. The reaction of benzimidazole derivative 2.8 with hydroxylamine. The 
counter synthesis of amide 3.31. 
 
  
 
Figure 3.14.  The most 
indicative correlations 
found in HMBC, COSY 
spectra of 3.30.  
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In summary, the reactions of cyclic 2-azaheteryl-3-enaminonitriles with 1,2-
binucleophiles allows the efficient formation of various pyrazoles (isoxazoles) when 
the nitrogen of pyrrolidine ring is substituted. The first atom attack is directed at C-2 
centre of pyrrolidine, the direction of the next attack depends on the structure of 
azaheterocyclic substituent. Thus, in the case of N-alkyl substituted pyrrolidines the 
attack is regioselective and directed at carbon of nitrile group.  In the case of 
benzoxazole derivatives the attack occurs both at nitrile group and with the same 
probability at the C-2 atom of azaheterocycle (structural isomers are formed in the 
ratio 1: 1). In the case of enaminonitriles substituted with quaternized benzazoles the 
disclosure of the azole cycle is occurring. The mechanism of transformation varies 
depending on the nature of azaheterocyclic substituent.  
The synthetic methods developed for the synthesis of 3-(ω-aminopropyl)-4-
azahetaryl-5-aminopyrazoles open new routes to enlarge the chemical space of 
pyrazole-containing pharmacophores as it introduces chemical complexity in an 
unprecedented swift fashion from simple starting materials. Tetracyclic compounds 
are obtained in 3 steps with the overall yield up to 45%, 5-aryl(styryl, indol-2-
yl)pyrazoles in 4 steps with the overall yield up to 71%.  
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CHAPTER 4. REACTIONS OF 2-AZAHETARYL-2-(1-R-PYRROLIDIN-2-
YLIDENE)ACETONITRILES WITH DMF DMA. PYRROLO[3,2-с]PYRIDIN-
6-IMINE: SYNTHESIS AND PROSPECTS FOR USE 
Cyclic enaminoamides derivatives are the key compounds in the synthesis of 
condensed pyridine systems. С–Н activation at С-3 centre of pyrrolidine,1, 69-70, 72, 74-75 
indoline,68, 119-120 1,2,3,4-tetrahydroquinoline and 2,3,4,5-tetrahydro-1H-
benzo[b]azepine,121 featuring electron withdrawing groups (cyanoacetamide, 
malononitrile, ethylcyanoacetate) at the C-2 position was allowed for the synthesis of 
5-azaindolines, condensed pyrimidinecarbolines (pyridoindoles), pyrido[4,3-
b]benzo[f]azepines (Figure 4.1). These scaffolds are found to be useful for the 
treatment of cancer, neurodegenerative diseases, as inhibitors of serotonin receptors, 
antihistaminics.119, 122-123  
 
The common intermediates on the route to condensed pyridine systems are the 
derivatives of 3-dimethylaminomethylidenes A, obtaining by formylation reaction of 
C-3 centre of pyrrolidine ring by acetals (Figure 4.1).70, 73, 75 
 
 
Figure 4.1. Straightforward access to condensed pyridine systems. 
 
Figure 4.2. The reactive centre (С-3) of 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles under reactions with DMF DMA 
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The acidity of protons at position 3 of pyrrolidine in 2-azahetaryl-3-
enaminonitriles 2.1, 2.7, 2.13–2.18 is enhanced by conjugation with 
hetarylacetonitrile fragment. Thus these compounds could also react with acetals as 
C-nucleophiles and provide access to functionalized azaheterocycles (Figure 4.2).  
 
4.1. 2-Azahetaryl-2-(1-R-pyrrolidin-2-yliden)acetonitriles under reactions with 
DMF DMA  
Alkylation and formylation13 are the main types of reactions of DMF DMA 4.1. 
They mainly proceed via formation of aza-oxo-stabilized Vilsmeier-Haack salt 
analogue 4.1А (Figure 4.3).124 
 
Figure 4.3. Aza-oxo-stabilized methylene iminium salt 4.1А – the reactive form of 
acetal.  
 
As alkylating agents, they have been used in the synthesis of esters from acids, 
ethers and thioethers from phenols and aromatic and heterocyclic thiols, and the 
alkylation of active methines. As formylating agents, formamide acetals are useful in 
the synthesis of enamines from active methylenes and amidines from amines and 
amides.124  
Taking into account the reactivity of DMF DMA 
two alternative routes can be envisaged for the 
reaction of N-unsubstituted pyrrolidines (the nature of 
the substituent is omitted) with DMF DMA, namely, 
alkylation at nitrogen of pyrrolidine (Figure 4.4, route 
1) and/or incorporation of dimethylaminomethylidene 
moiety at С-3 position of the ring (Figure 4.4, route 
2).  
                                                        
13 Hereafter  formylation by DMF DMA stands for incorporation of dimethylaminomethylidene moiety, formyl 
equivalent. 
 
Figure 4.4. Alternative 
routes to reactions of 2.1 
with DMF DMA. 
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In the reaction of 2-benzo[d]thiazol-2-yl-2-(pyrrolidin-2-ylidene)acetonitrile 
2.1b with DMF DMA the only product observed is 3-dimethylaminomethylidene 
4.2a, corresponding to a formylation product at position 3 of pyrrolidine (Scheme 
4.1).  
 
Scheme 4.1. Formylation reaction of enaminonitrile 2.1b with DMF DMA. 
 
The reaction proceeds by refluxing the reactants in toluene. The TLC reaction 
control and the 1H NMR analysis did not reveal any N-alkylation product in the 
reaction mixture (Figure 4.4, route 1).  
In the 1H NMR spectra of 4.2a there are signals of dimethylaminomethylidene 
moiety at 3.06 ppm (s, 6Н 2СН3) and 7.76 ppm (t, J = 1.5 Hz, 1Н, СН). The 
broadened singlet of NH proton of pyrrolidine is observed at 10.24 ppm (Solvent: 
DMSO-d6).  
According to XRD 
analysis the benzothiazole 
substituent is almost 
coplanar with pyrrolidine 
ring with the dihedral angle 
of 3.85°. The flattened 
orientation of the planar 
fragments is stabilized by an 
intramolecular hydrogen 
bond  (the estimated bond 
length H3А···N1 2.00 Å, 
N3–H3А···N1 135.3°). The 
 а)
 б) 
Figure 4.5. a) Molecular structure of 4.2a  
according to X-ray diffraction; b) Orthogonal 
projection . 
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charge delocalization occur toward the hetarylacetonitrile fragment that is 
accompanied by N4–C14 (1.34 Å) and N3–C10 (1.34 Å) bonds shortening and С14–
С11 (1.37 Å) and С10–С8 (1.42 Å) bonds elongation (Figure 4.5).  
The reaction path appeared to be highly dependent on the nature of the 
heterocycle of the 2-azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles 2.1 (Scheme 4.2).  
 
Scheme 4.2. The dependence of reaction route on the nature of azaheterocyclic 
substituent in 2.1. 
 
In the case of 2-benzoxazol-2-yl-2-(pyrrolidin-2-ylidene)acetonitrile 2.1с the 
reaction proceeds with the formation of formylated product 4.3, and methylated 
product 2.18a, that was identified by analyzing the characteristic chemical shifts in 
1H NMR spectrum (Solvent: CDCl3, mixture, ratio 2.18а:4.3 = 3:2; 2.18а: δ, ppm, 
2.03–2.15 (m, 2Н, 4-СН2), 3.53 (s, 3Н, СН3); 4.3: 3.12 (s, 6Н, 2СН3), 7.96 (s, 1H, 
CH)). The reaction with benzimidazole 2.1f and quinazolinone 2.1j derivatives 
occurred with formation of N- 2.1g and O-alkylated 2.9 products. The reaction does 
not occur in the case of N-methylbenzimidazole 2.1g, pyridine 2.1і and quinoline 
2.1а derivatives.  
N-methyl-substituted pyrrolidines, namely 2-benzothiazol-2-yl-2-(1-
methylpyrrolidin-2-ylidene)acetonitrile 2.7а and 2-benzoxazol-2-yl-2-(1-
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methylpyrrolidin-2-ylidene)acetonitrile 2.18а neither react with DMF DMA that is in 
agreement with  the results reported for ethyl 2-cyano-2-(1-ethyl(phenyl)pyrrolidin-2-
ylidene)acetates.1, 73 
The experimental data as well as precedents from the literature1, 73 prompted us 
to assume that the presence of easily accessible NH group is essential in formylation 
of the C-3 centre of pyrrolidine allowing to propose a mechanism for this uncommon 
reaction (Scheme 4.4). 
 
Scheme 4.4. Proposed mechanism for reaction of 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles 2.1 with DMF DMA. 
 
The incorporation of dimethylmethylidene moiety proceeds in a reversible 
fashion via nucleophilic attack of aza-oxo-stabilized ion 4.1А by nitrogen of 
pyrrolidine yielding the key intermediate B; the C-3 position of pyrrolidine in B 
activated by inductive effect (-I) of amidine group and enhanced mesomeric stability 
of the anion by the acrylonitrile moiety. Consequently deprotonation by methoxy 
anion and reaction with another molecule of DMF DMA can occur yielding C; the 
latter transformed into 2-azahetaryl-2-(3-(dimethylamino)methylene)pyrrolidin-2-
ylidene)acetonitrile 4.3 by reversion of the first step.    
The proposed mechanism not only explain failed attempts to formylate the 
derivatives of N-substituted pyrrolidines 2.7а, 2.18а and 1.103, but also inactivity of 
118 
 
NMe-benzimizazole 2.1g, pyridine 2.1і and quinoline 2.1а derivatives for which 
pyrrolidine NH is less accessible, and different results for the reaction with 
benzothiazole 2.1b and benzoxazole 2.1с derivatives . 
Deprotonation of the NH might indeed take place when the proton is not 
involved in strong H bonding. Such binding is directly related to the pKa of 
azaheterocycles (Figure 4.6). In the benzazoles’ row the smallest pKа has 
benzoxazole – 0.5, the biggest – benzimidazole 5.5, benzothiazole – рKа 1.8. 
Consequently, the deprotonation by a methoxy-anion is significantly restricted in the 
case of NMe-benzimizazole 2.1g derivative and the key intermediate B cannot be 
accessed. For benzoxazole derivative 2.1с deprotonation proceeds easily. Yet the 
hard nucleophile N- attacks both the hard centre – methyl of methoxy-group and the 
soft – carbenium cation of DMF DMA. For benzothiazol derivative 2.1b 
deprotonation is less favored but still achievable. In this case, a deprotonation – 
nucleophilic attack promotes a reaction only at the soft centre. рKа values of pyridine 
and quinoline are 5.2 and 4.9, respectively, H bonding in 2.1a,i is stable and prevents 
the deprotonation.    
 
Figure 4.6. рКа of conjugate acids of relevant azaheterocycles. 
 
One more evidence for amidinium ion formation in the course of reaction is the 
successful interaction between 2-(1H-benzo[d]imidazol-2-yl)-2-(1-methylpyrrolidin-
2-ylidene)acetonitrile 2.13а with DMF DMA in contrast to failed attempts with 
benzothiazole 2.7а and benzoxazole 2.18а derivatives. The presence of a nucleophilic 
nitrogen atom in the benzimidazole 2.13а promotes reaction with the carbenium ion 
yielding intermediate D. Like in the previous case (Scheme 4.4), С-3 position is 
deprotonated upon interaction with metoxy-anion and cyclization into 
benzo[4,5]imidazo[1,2-a]pyrrolo[2,3-d]pyridine 4.4 occurs followed by elimination 
of dimethylamine.  
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Scheme 4.4. Proposed mechanism for reaction of 2-(1H-benzo[d]imidazol-2-
yl)-2-(1-methylpyrrolidin-2-ylidene)acetonitrile 2.13а with DMF DMA. 
 
Similar tetracyclic compound  4.4 in the mixture with the methylation product 
2.1g forms in the reaction of 2-(1H-benzo[d]imidazol-2-yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 2.1f with DMF DMA in the presence of catalytic amount of 
piperidine (Scheme 4.6). Golovko et al.121 use this method for formylation of 3,4-
dihydroquinolin-2(1H)-one that is inert under usual reaction conditions (toluene, ∆). 
Authors notice that N,O-acetal 4.5, which is formed by interaction of DMA DMF 
with piperidine is much more reactive than the corresponding amide acetal 4.1, due to 
better stabilization of amidinium E as compared to iminium-ether A΄ (Scheme 4.5).  
 
Scheme 4.5. Catalytic role of piperidine.121  
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Scheme 4.6. Proposed mechanism for reaction of benzimidazole 2.1f derivative 
with DMF DMA in the presence of catalytic amount of piperidine (2.1g:4.4 ratio = 
4:6) 
 
The reaction proceeds by a competitive attack of the nitrogen of benzimidazole 
at methyl group (route 1, Scheme 4.6) and at the carbenium ion (route 2, Scheme 4.6). 
As a result, compound 2.1g is formed, which does not react with DMF DMA due to 
the significant stability of the chelate, as noted above, and the intermediate 
amidinium ion F. In route 2, the nitrogen lone pair participates in the positive charge 
distribution of amidine moiety, thus indirectly influencing on the intramolecular 
hydrogen bond between NH and nitrogen of benzimidazole weakening. As a 
consequence the deprotonation of pyrrolidine can occur. The weakening of hydrogen 
bond allows the isomerization of Z-diastereomer G into Е-diastereomer D to proceed. 
Following steps are the similar to those presented in Scheme 4.4 to yield 
imidazopyridine 4.4.  
The symmetry of the benzimidazole moiety initially found in 2.1f is disrupted 
through this transformation, promoting the split of the two aromatic signals of 2.1f  in 
1H NMR spectrum into four signals for 4.4, namely, two doublets at 7.58 and 7.89 
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ppm and two doublets of doublets (J1 = J2) at 7.18 and 7.30 ppm. The signal of 
methylidene proton is shifted to low field and arises at 8.51 ppm. The formation of 
the pyridine ring is also confirmed by NOE which occurs between methylidene and 
4-Н protons: when selective irradiation of the molecule at the absorption frequency of 
the first, the signal of the latter increases in intensity by 7%. The IR spectrum shows 
there is the characteristic vibration of CN group at 2198 cm-1. 
In summary, individual formylation products: the 3-dimethylaminomethylidene 
derivative 4.2a and benzo[4,5]imidazo[1,2-a]pyrrolo[2,3-d]pyridine 4.4, formed only 
upon treatment with DMF DMA of 2-(benzo[d]thiazol-2-yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 2.1b and (1H-benzo[d]imidazol-2-yl)-2-(1-methylpyrrolidin-2-
ylidene)acetonitrile 2.13a. Considering the result, compound 4.2a became a model 
for further investigations of their reactivity.   
 
4.2. Reactions of 2-(benzo[d]thiazol-2-yl)-2-((E)-3-
((dimethylamino)methylene)pyrrolidine-2-ylidene)acetonitrile with amines  
The benzothiazolyl 3-dimethylaminomethylidene derivative 4.2a reacts with 
amines releasing dimethylamine. Successful transamination is occured with 2- (3,4-
dimethoxyphenyl)ethanamine, benzylamine and pyrrolidine to form secondary 4.6, 
4.7 and tertiary amines 4.8 (Scheme 4.7). In the 1H NMR spectra of 4.6 and 4.7 AX 
spin system of protons of СНNH fragment with trans constant of J = 12–13 Hz, 
doublet of СН2 group (J = 5.6 Hz) and the singlet of NH proton of pyrrolidine are 
observed (Figure 4.7). Upon addition of D2O to the solution of 4.6 in DMSO-d6 the 
intensity The NH signals decreases, the doublets of methylidene (СН) and  benzyl 
protons arise as singlets.  
 
Scheme 4.7. Transamination reactions of 4.2a. 
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Figure 4.7. A fragment of 1H NMR spectrum of 4.6 (400 MHz, DMSO-d6-CCl4). 
 
According to XRD the 
dihedral angle between 
benzothiazole and pyrrolidine 
planes is 14.5°. The estimated 
length of hydrogen bond is 
N1···Н2 2.13 Å, angle N2–
H2···N1 129.7°. H14 and H4 
atoms are located in a trans 
conformation with the torsion angle of 169.8° (Figure 4.8). 
Compound 4.2a was also reacted with propylamine, 4-metoxyaniline and β-
aminoethylpropanoate but the formed amines were not stable in solution preventing 
their characterization. 
 
4.3. Synthesis of pyrrolo[3,2-c]pyridin-6-imine, physicochemical study and 
prospects for use   
Intramolecular rection between the nitrile and amino groups provides access to a 
wide range of nitrogen-containing heterocycles, namely, azines, azoles, quinolines, 
pyridines, pyrimidines, azepines.125 Such rection is carried out by treatment with 
acids, bases or thermally and usually proceeds irreversibly.  
 
Figure 4.8.  Molecular structure of 4.6 
according to X-ray diffraction. 
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Numerous reports from Granik V.G. are devoted to the synthesis of pyrimidines 
and pyridines from derivatives of pyrrolidinylidenes creating C–N bond formation 
with such methods.1, 68-73, 75, 119-121 
Following on these reports we were able to conduct intramolecular condensation 
of the derivative of 3-((benzylamino)methylene) pyrrolidine-2-ylidene)acetonitrile 
4.6 by action of sodium ethylate to access pyrrolo[3,2-c]pyrimidine (Scheme 4.8). 
The overall yield of three-steps synthesis of 4.9 starting from 2.1b is 59% (51%, 
starting from 2-(benzo[d]thiazol-2-yl)acetonitrile).  
 
 
Scheme 4.8. Synthesis of pyrrolo[3,2-c]pyrimidine 4.9.  
It is known,120, 126-127 that for the structures 
of 4.9 type the imine-enamine tautomerism is 
characteristic (Figure 4.9). Thus, in the 1Н NMR 
spectrum of 4.9 recorded in CDCl3 there is 
broadened NH protons signals in the region 5.69-
10.34 ppm, which may indicate a fast proton 
transfer on the NMR time scale. When changing the solvent to DMSO-d6, the 
transition between the tautomers is slowing down and signals are observed in the 
spectrum both for the imine 4.9A and the enamine 4.9B tautomeric forms (Figure 
4.10).  
 
Figure 4.9. Imine-enamine 
tautomerism of 4.9. 
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Figure 4.10. 1H NMR spectrum of 4.9 in DMSO-d6. 
 
Thorough structural analysis of 
4.9 was carried out using 2D NMR, 
namely, СOSY, HMQC, HMBC 
(Figure 4.11). The pyridine ring 
closure was confirmed by correlation 
in HMBC between protons of 
methylene group of benzyl substituent 
and quaternary carbon C-6 of 
pyrrolopyridine fragment (cross peak 
δ = 4.93, 154.5 ppm). Coupling is 
observed between vinyl СН proton and 3-СН2 protons of pyrrolidine ring (J3 = 1.6 
Hz) in 1Н NMR spectrum and is confirmed by cross peaks in COSY (Figure 4.11). 
Cross peaks are also seen between NH–2-CH2 and NCH2–2,6-HPh.  
The structure of 4.9 was also confirmed by XRD analysis (Figure 4.12, а). In 
contrast to the solution in the solid state there is only the imine form of the molecule 
4.9A. This form is stabilized by the intramolecular hydrogen bond between nitrogen 
of benzothiazole and hydrogen of pyrrolidine (estimated bond length N1···Н2 2.14 Å, 
angle N2–H2···N1 125.1°, dihedral angle between the benzothiazole and 
pyrrolopyridine planes is 6.3°). The bond length in the vinamidine systems of 4.9 are 
indicative of an open-chain push-pull conjugated π-system rather than of π-
 
Figure 4.11. The compound  4.9 structure 
according to 2D NMR (400 MHz, CDCl3) 
(the arbitrary tautomer is depicted). 
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delocalization (Figure 4.12, b).128-129 The electron density from donor to acceptors 
imino group and benzothiazole seems arising to a greater extent from the nitrogen of 
pyrrolidine rather than the nitrogen of pyridine. This evidenced by smaller bond 
length of N2–C19 1.32 Å in contrast to the bonds N3–C14 1.41 Å and N3–C13 
1.38 Å. 
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Figure 4.12. a) Molecular structure of 
4.9 according to X-ray diffraction. 
b) The bonds length in 
pyrrolopyrimidine 
fragment according to 
XRD. 
c) The bonds 
length in 
diazepine 
according to 
XRD.129 
 
These data correlate with ones given for diazepines (Figure 4.12, с). The small 
difference in the bond length of N2–C9 and C9–C8 from the corresponding bonds in 
diazepine N1–C2 and C2–C3 might it be due to the electron delocalization in 4.9 
toward benzothiazole substituent.  
When attempting to convert pyrrolopyridin-6-imine into pyrolopyrid-6-one by 
acid hydrolysis with a 30% solution of H2SO4 in a water-dioxane mixture, the only 
reaction product was the salt 4.10a (Scheme 4.9). The protonation promotes the 
aromatization to the pyridinium thus preventing hydrolysis.  
Compound 4.10b, which only differs by the nature of the conteranion, was 
accessed by HCl bubbling in the solution of 4.9 in dioxane. The 1H NMR spectra for 
both compounds were almost identical (supplementary information).   
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Scheme 4.9. The interaction of pyrrolo[3,2-с]pyridine derivative 4.9 with acids. 
 
In the 1H NMR spectrum of compounds 4.10, the singlets of amino groups 
protons are clearly distinguished. The 
NH proton of pyrrolidine comes out at 
8.57 ppm for 4.10a and at 8.61 ppm 
for 4.10b (s, 1Н) and signal of NH2 
protons at 8.68 and 8.76 ppm (s, 2H), 
respectively. The significant low field 
shift of СН2 protons of  benzyl 
substituent (∆δ ~ 0.4 ppm) and almost 
constant  position of 2-СН2 signal (∆δ 
= 0.02 ppm), as compare to initial 
pyrrolopyridine 4.9, are indicative of localization of a positive charge on the nitrogen 
of pyridine ring rather than on the nitrogen of pyrrolidine. These confirm the 
structure proposed for 4.10b as do further 2D-NMR: COSY, HMQC, HMBC (Figure 
4.13). 
Pyrrolo[3,2-с]pyridine-6-imine 4.9 alkylation with the excess of  МеІ and in the 
presence of K2CO3 leads to the permethylated product 4.11 (Scheme 4.10). It is 
known127, that the formation of permethylated derivatives for similar compounds – 2-
imino-β-carbolines occurs via formation of a dimethylated product at endo- and 
exocyclic nitrogen atoms.  Taking into account precedents from the literature we 
propose the mechanism for the formation of 4.11. The mechanism involves the 
deprotonation of 4.9 leading to intermediate А↔В, followed by its methylation 
leading to С. Finally the methylation at methylamino group occurs yielding 4.11.  
 
Figure 4.13.  The compound 4.10b 
structure according to 2D NMR (400 MHz, 
DMSO-d6).  
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Scheme 4.10. Permethylation of pyrrolo[3,2-с]pyridin-6-imine 4.9.  
 
The structure of trimethyl-derivative 4.11 was confirmed by 1Н NMR, 13С NMR 
and HRMS. In the 1H NMR spectrum the singlet of NMe2 arises at 2.34 ppm (6Н), 
the signals of another СН3 group has the same shift as the residual peak of DMSO-d6 
in 1H NMR spectrum but in 13С NMR spectrum arises separately at 35.4 ppm; peaks 
of NMe2 carbons located at 42.4 ppm (Solvent: DMSO-d6). The values found for the 
molecular mass correspond to the calculated values for the cation of compound 4.11 
– calculated 401.1800, found 401.1800 and iodide – calculated 126.9045, found 
126.9047.  
It was noted that in the presence of acid pyrrolo[3,2-c]pyridin-6-imine 4.9 is 
protonated at the imino group yielding the salt 4.10. The protonation process can be 
monitored by spectrophotometric titration of 1.5•10-6 М solution of 4.9 in acetonitrile 
by НСl solution. Under increase of acid concentration there is the hypochromic effect 
within the range of 370–440 nm, however, hyperchromic within the range of 310–
370 nm (Figure 4.14). After adding the equimolar amount (curves 10-11), further 
acid additives do not cause significant changes in the spectra (curves 12-13). From 
Figure 4.16 it is seen that the shape of absorption band of 4.10b in acetonitrile (curve 
7) is similar to those obtained by titration of 4.9 by HCl at stoichiometric point (curve 
6). 
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Similar trends are observed upon addition of water from 0.5 to 11.8% to the 
solution of 4.9 in acetonitrile (Figure 4.15).   
 
 
Figure 4.14. Evolution of the absorption 
spectra of 4.9 upon titration with НСl 
solution (starting solution of 4.9 (0) with 
HCl additives (1-13)). C4.9 = 1.5•10-5 
mol/l. CHCl = 1.4•10-6 –2.4•10-5 mol/l.  
φH2O = 2.5% (in total). 
Figure 4.15. Evolution of the absorption 
spectra of 4.9 upon titration with Н2O 
(starting solution of 4.9 (0) with Н2O 
additives (1-19)). C4.9 = 1.5•10-5 – 1.3 
•10-5 mol/l.  
φH2O = 11.8% (in total). 
 
 
Figure 4.16. Normalized absorption spectra of pyrrolo[3,2-c]pyridin-6-imine 4.9 in 
the solvents of different polarity and proton donating abilities. The absorption 
spectrum of 4.10b in CH3CN (7). 
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From Figure 4.16 it can be seen that the absorption spectrum of 4.9 in protic 
solvent – freshly distilled methanol (curve 4), is similar to the spectra in acetonitrile 
with acid and water additives (curves 5,6) and has a maxima around 340 nm while in 
the aprotic solvents of different polarity, namely, СН3СN, DMSO, toluene (curves 1 
– 3 respectively) there are maxima in the range of  310 – 440 nm.130  
Spectrophotometric characteristics of 4.9 is presented in the Table 4.1.  
 
Table 4.1. Spectrophotometric characteristics of 4.9.  
Solvent λmax of 
absorp
tion, 
nm 
εmax, 104 

 •   
Solvent λmax of 
absorp
tion, 
nm 
εmax, 104 

 •   
Solvent λmax of 
absorp
tion, 
nm 
εmax, 104 

 •   
DMSO 
324 0.46±0,02 
CH3CN 
323 1.05±0,01 
Toluene 
320 0.42±0,02 
339 0.54±0,02 335 1.31±0,02 335 0.56±0,02 
366 0.59±0,02 360 1.25±0,04 372 0.71±0,05 
390 0.72±0,09 384 1.46±0,19 391 1.15±0,07 
409 0.69±0,09 404 1.33±0,18 414 0.99±0,07 
СН3СN
:HCl 
СН3СN
:H2O 
325 2.15±0,07 
CH3OH 
326 0.92±0,07 
Ethanol
* 
328 1.35 
340 2.47±0,06 341 1.11±0,08 342 1.69 
357 1.95±0,02 358 0.90±0,06 359 1.41 
Propan
-2-ol* 
332 0.79 
tert-
Buthano
l* 
319 0.55 397 0.14 
342 0.79 332 0.70 * The molar absorption 
coefficient is calculated for the 
solution with C4.9=1.5•10-5 mol/l 
361 1.00 363 0.87 
379 1.00 382 1.08 
397 0.91 400 0.97 
 
With a decrease of рKа of the solvents131 and their ability to act as donors of 
hydrogen bond, characterized by alpha coefficient,132 moving from methanol to 
ethanol, propan-2-ol and tert-buthanol induced a significant decrease of the donor 
solvent effect and the spectra in tert-butanol and propan-2-ol being close to the ones 
in aprotic solvents (Figure 4.17).  
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α-scale 
0.990 – methanol 
0.850 – ethanol 
0.687 – propan-2-ol 
0.436 – tert-butanol  
 
pKa 
15.2 – methanol 
16.0 – ethanol  
16.5 – propan-2-ol 
17.0 – tert-butanol 
 
 
 
Figure 4.17. The absorbtion spectra of 
pyrrolo[3,2-c]pyridin-6-imine 4.9 in alcohols: 
methanol–ethanol–propan-2-ol–tert-buthanol; 
C4.9 = 15 µmol/l. 
 
 
Taking into account the experimental data and the calculated pKa4.9 value of 
10.9 leads to the conclusion that at concentration required for spectrophotometric 
measurements, in solvents such as water, methanol and ethanol most of the molecules 
are in protonated state (estimated value 99% in water and methanol and about 95% in 
ethanol). Thus, the UV-spectra of pyrrolopyridine in the mentioned solvents and the 
spectrum on the salt 4.10 are similar. 
According to 1H NMR spectra of 4.9 recorded in DMSO-d6 and СDСl3 
compound 4.9 exist as a mixture of imine 4.9А and enamine 4.9В forms in solution. 
Thus the spectra in aprotic solvents show a broad absorption band within the range of 
310–440 nm reflecting the absorption of a mixture of tautomers.  
Pyrrolo[3,2-с]pyridine 4.9 has an intense (quantum yield of 61% in СН3СN; 
standard – quinine sulfate) with λmax of emission 460 nm. The emission intensity 
increases with the increase of concentration up to 1 µmol/l, the effect of the internal 
filter in the spectra does not appear (Figure 4.18).  
  
Figure 4.18. а) The spectra of excitation and emission of 
9.3•10-8 -5.6•10-7 mol/l (λ
compound 4.9 solutions of different concentrations in DMSO under irradiation with 
Such sensitivity of pyrrolo[3,2
high fluorescence quantum yield could be useful to develop an unprecedented water 
detection test for aprotic solvents. 
We have demonstrated, that upon water adding to the solution of 
the fluorescence quenching is occurring (
is ∆Іmax = (-2±2) + (96.0±0.9)·
detection by 3S-criterion is 0.068 %.
The pyrrolo[3,2-c]pyridine
convenient alternative to Karl Fischer titration as it does not require any specific 
equipment and can be used wherever fluorometer is available. The limit of de
of 0.068 % is sufficient to determine the water content in DMSO. Standard of DMSO 
anhydrous is DMSO with less than 0.1 % H
prevents an increase of the water content in the sample associated with a contact with 
wet air. 
 
 
4.9
ex = 380 nm, λfl = 460 nm). b) Picture of fluorescence of 
a UV lamp (λex = 365 nm). 
 
-с]pyridin-6-imine 4.9 to protonation along with 
 
Figure 4.19). The calibration graph equation 
φ(H2O), %, R2 = 0.999, n =
 
-6-imine based procedure therefore represents a 
2O133 Moreover, the fast measurement 
а
) 
С 
131 
 in DMSO. С4.9 = 
4.9 in DMSO 
 13. Limit of water 
tection 
б
) 
132 
 
 
Figure 4.19. The spectra of excitation and emission of 4.9 in DMSO with and 
without water additives (φ). 
 
In summary, 2-azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles react with DMF 
DMA yielding both the methylated products 2.18а, 2.1g, 2.9 and formylated ones 
4.2a, 4.3, 4.4. Pyrrolidinacetonitriles, that does not feature a NH group with a labile 
proton do not react with DMF DMA 2.1а,i 2.7a, 2.18a.  These observations prompted 
us to assume that the presence of easily accessible NH group is essential in 
formylation of the C-3 centre of pyrrolidine allowing to propose a mechanism for this 
uncommon reaction.  
Formylation reaction of 2-(benzo[d]thiazol-2-yl)-2-(pyrrolidin-2-
ylidene)acetonitrile with DMF DMA, followed by further transamination and 
cyclization under basic conditions gave rise to pyrrolo[3,2-c]pyridine-6-imine 4.9, a 
compound that exhibits a high fluorescent quantum yield (Ф = 61%) and proved to be 
very sensitive to protonation. Both characteristics are expected to be useful to 
develop an unprecedented water detection test for aprotic solvents. We have 
demonstrated that such a fluorometric method for determining water content in 
DMSO presents a limit of detection of 0.068%. 
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CHAPTER 5. COMPLEXES ON THE BASE OF 2-AZHETARYL-2-
PYRROLIDIN/5-R-3-OXOINDOLIN-2-YLIDENE)ACETONITRILES 
We have so far demonstrated numerous synthetic transformations of cyclic 2-
azahetaryl-3-enaminonitriles. They also may be considered as bidentate ligands due 
to the presence of two proximate electron donating nitrogen atom allowed to consider 
their photophysical properties upon binding to boron and their coordination chemistry 
toward 3d-metals.  
 
5.1. BF2-rigidified complexes on the base of 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles  
 The BF2 complexes of 2-
azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles 5.1 feature 
structural analogues with BODIPY-
dyes, namely, the boroazacycle. 
This similarity allows us to 
consider newly synthesized complexes 5.1 as desimetrized analogues of BODIPY-
dyes (Figure 5.1).  
BF2 complexes 5.1 were obtained from 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles 2.1 (Scheme 5.1). As these compounds are easily accessible 
starting material (section 2.1) it can be expected that a large structural versatility of 
dyes might be accessed from these precursors. Indeed, complexes are obtained in 
excellent yields 73–93% by treatment of the mixture of enaminonitrile 2.1, 2.9, 2.10 
and N,N-diisopropylethylamine (DIPEA) with BF3•OEt2 in refluxing 
dichloromethane.
 
Complexes 5.1 are stable to hydrolysis in slightly acidic or basic 
media and could be purified by aqueous work up followed by column 
chromatography on silica gel.   
   
Figure 5.1. a) Central core of BODIPY-dyes 
b) Desimetrized analogues of BODIPY-dyes. 
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Scheme 5.1. Synthesis of BF2-rigidified complexes 5.1. 
 
Benzimidazole 2.1f and 4-oxo-3,4-dihydroquinazoline 2.1j derivatives did not 
provide the desired complexes 5.1. The presence of several acidic NH protons in 
these molecules most probably hamper a regioselectivity of complexation. An 
attempt to isolate individual products from the reaction mixture, according to TLC 
control, failed. Changing NH to N-CH3 group allowed the isolation of the complexes 
5.1d,g-h.  
The 1Н NMR spectra of complexes 5.1 exhibit the disappearance of the NH 
signal that was observed in starting material (δ = 8.5–11.5 ppm); the significant low 
field shift of aromatic (∆δ = 0.2–0.8 ppm) and 5-СН2 (∆δ = 0.2–0.25 ppm) protons, 
arising from the close proximity to fluorine and induced by magnetic anisotropy 
effect of B–F bond and electronegativity of F (Figure 5.2, Table 5.1). For quinoline 
5.1e and quinazoline 5.1g,h derivatives the low field shift is larger than for 
benzazoles; for pyridine 5.1f derivative the 6-Н proton is shielded and shifted up field 
by 0.05 ppm (Table 5.1). 
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Figure 5.2. 1H NMR spectra of ligand 2.1b (bottom) and complexe 5.1а (top). 
 
Table 5.1. 1H NMR chemical shifts of protons modified by complex formation and 
corresponding protons in initial hetarylenaminonitriles 2.1(Solvent: СDCl3). 
 
Com
poun
d 
δ of aromatic 
proton, ppm 
δ of 5-CH2-
protons, ppm 
Com
poun
d 
δ of 
corresponding 
aromatic proton, 
ppm 
δ corresponding 
CH2-protons   
5.1а 8.05 4.07 2.1b 7.81 3.85 
5.1b 7.71 4.06 2.1c 7.52 3.85 
5.1c 2.51 (CH3) 3.98 2.1d 2.37 (CH3) 3.76 
5.1d 7.82 4.03 2.1g 7.57 3.82 
5.1e 8.61 4.10 2.1a 7.84 3.85 
5.1f 8.31 3.98 2.1i 8.36 3.75 
5.1g 8.38 4.05 2.9 7.67 3.85 
5.1h 8.28 4.10 2.10 7.47 3.86 
The complexes formation could be also confirmed by 11В NMR and 19F NMR 
spectra where the triplet and quartet arise respectively due to spin-spin interaction 
between 11В (the spin is 3 2 ) and 19F (the spin is 1 2  ) nuclei (JBF =  29–33 Hz).  
The stability of the complexes was checked by 1H, 11B and 19F NMR in CDCl3, 
CD3CN and for 5.1a and 5.1c in CD3OD. The NMR spectra were recorded: directly 
after preparation the solutions, in 3h, in 1 day and in 1 week. None of the compounds 
5 
5 
4 
4 
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degraded under these conditions. Addition of a drop of water to the solutions in 
CD3CN and CD3OD and another set of NMR spectra was recorded immediately and 
after 1 day. No degradation of complexes occurred. The stability of complexes was 
also checked in electron donating solvents: deuterated pyridine and tetrahydrofuran 
for compounds 5.1a and 5.1c. The graduate formation of another set of signals was 
observed only in aliphatic region in pyridine solution for compound 5.1a. The 11B 
and 19F NMR spectra showed no variation with time. Such change could be due to 
competitive coordination of pyridine to boron atom. The compound 5.1c stayed 
unaffected in pyridine solution. Tetrahydrofuran does not influence anyhow on the 
structure of complexes.  
Crystals suitable for X-ray analysis were obtained by slow diffusion of hexane 
into their dichloromethane solutions at room temperature. XRD shows a dihedral 
angle between azaheterocycle and pyrrolidine is within the range of 2.5–13.9°. The 
boron atom has distorted tetrahedral geometry [N2F2] (angles around B vary from 
105.8° to 112.0°). The dyes are well ordered and packed densely due to С–H···F and 
π-π interactions. The same packing is observed for other BF2-carrying compounds 
[N2F2]86 and [NОF2]134 reported in the literature. The structure of complexes (Figure 
5.2а), orthogonal projection (Figure 5.2b) and packing (Figure 5.2c,d) for the 
representative complex 5.1d are shown at Figure 5.2.  
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Absorption spectra are represented at Figure 5.3.135  
In the near UV and visible 
range there are bands resulting 
from transitions within aromatic 
fragments that are conjugated 
with heteroatoms lone pairs 
(n→π*, π→π* transitions). 
Most absorption maxima are 
located within the range of 320 
– 400 nm (Table 5.2), except for 
quinoline derivative 5.1е, which 
exhibits a λmax = 420 nm, 
(Solvent: CH3CN); this is in 
agreement with the data reported in the literature for BF2-rigidified pyrrolopyrrole 
cyanines for which λmax increase in order benzoxazol-2-yl→pyridin-2-
yl→benzothiazol-2-yl→quinolin-2-yl (754 nm)87, and for BF2-benzo[c,d]indole N-
  
 
 
Figure 5.2. а) Molecular structure of 
compound 5.1d according to X-Ray 
diffraction. 
   
b) Orthogonal projection.  
 
c) Dimerization of the layers (H14···F2 2.42 
Å, С14–H14···F2 128.2°, H5···F1  2.52 Å, 
С5–H5···F1 143.4°). 
 
d)  Layered crystalline structure (the average 
distance between layers is 3.54 Å). 
 
Figure 5.3. Absorption spectra of complexes 
5.1a-h in СН3СN with concentration of 1.6 
µmol/l. 
3.42 Å 
3.66 Å 
139 
 
heteroarenes in order pyridin-2-yl→thiazol-2-yl→benzothiazol-2-yl→quinolin-2-yl 
(455 nm)86. 
The decrease of energy gap between HOMO–LUMO is reflected in 
bathochromic shift of the absorption maximum of complexes 5.1 (9–50 nm) as 
compared to 2.1 (Table 5.2).  
4-Metoxyquinazoline derivative 5.1g has a batochromic shift of long wavelength 
maximum (λabsmax) relative to its structural isomer, namely, the derivative of 3-
methyl-4-oxo-3,4-dihydroquinazoline 5.1h (СН3СN). This arise from the elongation 
of p,π-conjugation chain (Figure 5.3, Table 5.2). 
The absence of isosbestic points in the normalized absorption spectra (A/Amax) 
of the same complex at different concentrations indicates that there is no self-
association in the solution.  
When increasing the 
structure’s rigidity the amount 
of radiationless transition 
decreases. Consequently, all 
BF2-rigidified complexes 5.1 
have brighter fluorescence as 
compared to initial 
hetarylenaminonitriles 2.1, 
2.9, 2.10, which florescence 
intensity in the same 
conditions of spectra 
recording is within the range of 20 – 40 relative units. The fluorescence quantum 
yields (Ф) of 5.1 are varied from 6% (5.1h) to 90% (5.1а) in DMSO (Figure 5.4).  
Desimetrization of the ligand around boroazacycle increases the distinction 
between the electron distribution in the ground and excited states, thus increasing the 
Stokes shift of 5.1 (≈ 2000–9000 cm-1) as compared to classical BODIPY dyes (the 
average value of the Stokes shift is in the range of 400–1000 cm-1(86))  
 
Figure5.4. Diagram of distribution of complexes 
5.1 depending on quantum yield and λflmax. 
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Table 5.2. Photophysical characteristics of complexes 5.1а-h and the ligands 2.1a-
d,g,i; 2.9, 2.10 in various solvents.  
 
Compound Solvent λabs 
(nm) 
εabs
max
  
 (M-1•cm-1) 
λfl (nm) ∆ʋ,  
(cm-1) 
Ф, 
DMSO, 
% 
ε× Ф  
(M-
1
•cm-1) 
2.1b CHCl3 336 20 000     
5.1a 
DMSO 360 96 000 398 2652 90 86 400  
CH3CN 358 52 700 398 2807 
 
 
CHCl3 361 43 300 393 2256  
Толуен 364 42 100 392 1361  
Solid state   406, 423   
2.1с DMSO 323 43 000     
5.1b 
DMSO 322 84 800 450 8 834 83 70 400 
CH3CN 320 40 600 447 8 879 
 
 
CHCl3 323 31 900 406 6 329 
Toluene 325 31 300 382 4 591  
      
2.1d DMSO 327 33 900     
5.1с 
DMSO 349 28 000 400 3653 10 2 800 
CH3CN 349 30 900 430 5397 
 
 
CHCl3 349 13 900 395 3337  
Toluene 355 34 100 386 2262  
Solid state   434   
2.1g DMSO 325, 338 
26 900   
 
 
5.1d 
DMSO 339 46 000 370, 382 3321 17 7800 
CH3CN 337 63 800 431 6472 
 
 
CHCl3 339 14 900 453 7423  
Toluene 342 36 700 366 1917  
Solid state   376, 396   
2.1а DMSO 380 24 100     
5.1е 
DMSO 398, 
417 
38 100 
35 900 
462 3 481 87 33 100 
CH3CN 396, 
416 
35 000 
33 700 
459 3 466 
 
 
CHCl3 397, 
420 
22 400 
22 200 
   
Toluene 400, 
424 
19 200 
19 600 
441 9 092  
Solid state   496   
2.1і DMSO 295, 334 
18 600   
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5.1f 
DMSO 369 34 700 450 4 878 67 10 200 
CH3CN 367 15 300 447 4 877 
 
 
CHCl3 369 10 600 434 4 059  
Toluene 375 7 000 437 3 783  
Solid state   Fluorescence is in the 
range of 20 units 
 
2.9 DMSO 320 28 000     
5.1g 
DMSO 370 62 200 458 5 193 20 12 400 
CH3CN 367 12 500 455 5 270 
 
 
CHCl3 368 21 000 437 4 291  
Toluene 374 26 100 440 4 011  
Solid state      
2.10 DMSO 337 15 100     
5.1h 
DMSO 346 78 800 465 7 396 6 4 700 
CH3CN 345 23 000 431 5 784 
 
 
CHCl3 347 28 500 457 6 937  
Toluene 350 10 400 437 5 688  
Solid state      
 
Polar solvents exhibit a better solvation of the excited state compared to the 
ground state. This is reflected in the bathochromic shift of the maximum of excitation 
when switching from toluene to DMSO (∆λ up to 68 nm). Solvatochromism in 
absorption spectra is negligible, shift of absorption maxima upon changing the 
solvent polarity being within 7 nm. 
 
 
Figure 5.5. Normalized spectra of fluorescence of complexes substituted with azole 
5.1с and benzazoles 5.1а,b,d (left) and quinoline 5.1е, pyridine 5.1а and azines 
5.1g,h (right) (Solvent: CH3CN). 
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The optical properties of the compounds in solution remain constant for at least 
a month upon storage in unprotected from air and humidity conditions.  
In contrast to BODIPY dyes which are not usually fluorescent in the solid state 
due to small Stokes,84, 86 complexes 5.1 have a bright fluorescence in the solid state 
that could be even detected with a naked eye (Figure 5.6).  
 Solid-state luminescence usually arises from luminescent dyes carrying 
peripheral bulky groups that prevent close packing and subsequent aggregation-
induced fluorescence annihilation. On the other hand, aggregation-induced 
fluorescence is sometimes observed for dyes due to the restriction of intramolecular 
rotation in the solid state compared to solution.134, 136-137 This phemomenon called 
“aggregation-induced emission” is probably the case for complexes 5.1, which are 
characterized by numerous intermolecular С–H···F hydrogen bonds and strong 
packing, governed by π-π interactions with interlayer distances of 3.36–3.99 Å.  
 
In summary, BF2-rigidified complexes that are easily accessible by two-steps 
approach from azahetarylacetonitriles have advantageous over BODIPY dyes: 1) 
Stokes shift up to 9000 cm-1 due to the desimetrization of the ligand around 
boroazacycle; 2) emission at violet-blue range that is not covered by BODIPY-dyes; 
3) fluorescence both in solution (Ф up to 90%) and crystalline state.  
 
 
 
 
 
Figure 5.6.  Photographs of borate complexes as amorphous powders 5.1a,c,e; 
powders and solutions under bench UV lamp (irradiation λex=365 nm).  
5.1е 
5.1с 
5.1а 
5.1с 5.1е 5.1а 
5.1а 5.1с 5.1е 
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The brightness of these molecules, especially benzothiazole (86400 М-1•см-1) 
and benzoxazole (70400 М-1•см-1) derivatives, matches the brightness of BODIPY 
dyes (for example, BODIPY-FL14 86 000 М-1•см-1) and is one of the largest at violet-
blue range among the dyes that are used for biovizualization (quinine – 3000 М-1•см-
1
, Hoechst 33342 (the dye of dibenzimidazole group) – 17000 М-1•см-1, 7-hydroxy-4-
methylcumarin – 11000 М-1•см-1).138 The brightness of these dyes is sufficient for in 
vitro studies, but their emission (400 – 460 nm) is out of the optical window (650 – 
900 nm) required for in vivo studies. Nevertheless, the presence of BF2 group could 
be used for incorporation of radioactive label [18F] and would provide these probes a 
bimodal character.   
An important characteristic for biovizualization is neutrality of such probes 
allowing crossing through the cell membrane.   
 
5.2. Complexes of 2-azahetaryl-2-(pyrrolidin/5-R-3-oxoindolin-2-
ylidene)acetonitriles with 3d-metals: synthesis, structure and prospects for use  
One of the tasks of modern coordination chemistry is the search for new ligands 
that can form thermodynamically and kinetically stable metal complexes. Bidentate-
chelating ligands are one of the most studied types due to their ability to coordinate 
both d- and f-metals.139  
The use of complexes of chiral β-enaminonitriles with Co(II), Cu(II), Zn(II), 
Ni(II) as catalysts for asymmetric synthesis and copolymerization is reported 
(subsection 1.5.2). We have investigated the prospect for use of metal complexes on 
the base of β-enaminonitriles in the synthesis of films of polymeric composites (FPC) 
that exhibit photovoltaic effect (subsection 5.2.1) and optical probes for Zn(II) and 
Сu(II) determination (subsection 5.2.2). 
 
                                                        
14  
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5.2.1. Complexes on the base of 2-azahetaryl-(2-pyrrolidin-2-ylidene)acetonitriles 
On the base of new ligands of enaminonitrile type (HL) 2.1 the method to access 
complexes ML2 was established yielding 5.2 with 60–65%.139   
 
Scheme 5.2. Synthesis of transition metals coordination compounds with heterocyclic 
enaminonitriles 5.2. 
 
The IR spectra of 5.2 show no absorption band for NH group assessing the 
coordination of ligands. The absence of significant changes in the vibrations of CN 
and C=O (in the case of 5.2j) indicates that these groups do not participate in the 
coordination of metal ions.  
  
Figure 5.7. Molecular structure of compound 5.2b with Co(ІІ) (left) and 5.2g with 
Ni(II) (right) according to X-Ray diffraction. 
 
Coordination of ligands in deprotonated form is also confirmed by the absence 
of signals of NH group proton in 1H NMR spectra of complexes with Zn(II). For the 
remaining protons, there is a general tendency for an up field shift, which can be 
explained by the increase of the electron density on the ligand due to its 
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deprotonation. XRD shows that the central 3d-metal in 5.2 takes tetrahedral geometry 
with four coordinating nitrogen atoms (Figure 5.7). 
The photovoltaic and photoconductive properties of film composites of a 
copolymer of styrene with octyl methacrylate (COM) and additions of the complexes 
of 5.2d with Co(II), Cu(II), Ni(II) were investigated (Figure 5.8).140 In the samples 
with a free surface the photovoltaic effect was found. The value of electric potential 
of the surface (VPHmax) increases in a row CuL2 (80 mV), NiL2 (120 mV), CoL2 
(180 mV),
 
(concentrations of these additives in the SOM smaller than 50 wt.%).  It 
was established that these composites have hole-type photoconductivity and upon 
increase of the magnetic moment of the metal ions (Сu(II) 1.8, Ni(II) 3.3, Co(II) 5.4) 
the efficiency of photogeneration of free charge carriers increases, which 
consequently causes the increase of the photovoltaic effect. 
 
Figure 5.8.  Films composites of a 
copolymer of styrene with octyl 
methacrylate and additions of the 5.2d 
with Сo(II), Cu(II), Ni(II).  
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5.2.2. Complexes on the base of 2-azahetaryl-2-(5-R-3-oxoindolin-2-
ylidene)acetonitriles  
As indicated in Section 2.4, 2-azahetharyl-2-(5-R-3-oxoindolin-2-ylidene) 
acetonitriles 2.24a-c, 2.25a are compounds having a bright purple color. Their 
absorption spectra in DMSO are characterized by bands with λmax in the range of 
515 – 550 nm.  
Taking into account the λmax position in the visible range of the spectrum, as 
well as the tendency of compounds to form chelate complexes, we have studied their 
photophysical properties in the presence of 3d-metal ions.141  
Two model compounds that 
characterized by the highest extinction 
coefficient and λmax of absorption (section 
2.4) were selected, namely benzothiazole 
derivative 2.24b and benzoxazole derivative 
2.25a. A spectrophotometric study showed that with a gradual addition to the 
solutions of compounds 2.24b and 2.25a in DMSO:H2O Cu(II) and Zn(II) acetates in 
a buffer solution (Tris, pH = 7.2), a significant bathochromic shift of the absorption 
maxima occurs (Figure 5.8 , Table 5.3), which indicates the high visibility of these 
compounds as chromophore reagents (Δλ ≥ 70 nm). 
Table 5.3. The influence of Zn(II) and Cu(II) on spectrophotometric characteristics  
of 2.24b (DMSO 83%) and 2.25a (DMSO 70%) in solution DMSO-H2O. 
Entry Compound 
λmax of absorption 
of reagent, 
nm 
The influence of metal ion 
Zn(II) Cu(II) 
λmax, 
nm 
Δλ, nm 
λmax, 
nm 
Δλ, nm 
1 2.24b 530 600 70 605 75 
2 2.25a 515 590 75 590 75 
 
 
 Figure 5.8. а) The absorption spectra of 
2.24b with and without Zn(II). 
φ(DMSO) = 83 %,  
С2.24b = 38 µmol/l. 
 
Applying the limited 
we have established that the complexes of the simplest composition 1:1 exist in the 
solution. The stability constant of lgK 
2.24bCu(II) = 7.51±0.05, 
2.25аZn(II) = 8.66±0.05, indicates 
the formation of complex of average 
stability. The reagents are sensitive 
showing limit of ions detection (LD) 
calculated by 3S
below 1 µmol/l (Table 5.4
Complex formation occurs slowly with other 3d metals under conditions of 
interaction with Zn(II) and Cu(II), as in the case of Co(I
case of Ni(II). For the selective determination of Zn(II), the Cu(II) ions can be 
masked by thiosulphate ions. 
Thus at the pH of biological fluids, the spectrophotometric determination of the 
microquantities of Zn(II) and Cu(II
oxoindoline-2-ylidene)acetonitriles as chromophore reagents, as they has a low limit 
of detection of metal ions (0.4
 
 
b) The absorption spectra of 
and without Zn(II).  
φ(DMSO) = 70 %,  
С2.25a = 10 µmol/l. 
logarithmic method for the investigation of complexes
2.24bZn(II)
-criterion 
).  
I) or does not occur in the 
 
) can be carried out using 2
-1 µmol/l) with large λmax shift (Δλ ≥
Table 5.4. Limit of detection of 
Cu(II) by 
Entry Compound Ion
1 
2.24b 
Zn(II)
2 Cu(II)
3 
2.25a 
Zn(II)
4 Cu(II)
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2.25a with 
142
 
 = 7.88±0.02, lgK 
-azahetaryl-2-(5-R-3-
  70 nm).  
Zn(II) and  
2.24b and  2.25a.  
 ∆Aλmax 
LD (3S),  
(µmol/l) 
 ∆A600 0.54 
 ∆A605 0.97 
 ∆A590 0.94 
 ∆A590 0.40 
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Compared with the method of determining Zn(II) and Cu(II) with the use of 
porphyrin derivatives143 (prototype), while maintaining the sensitivity our method is 
less laborious and energy saving (no need to heat up to 100 ° C). Moreover, the 
optimal pH corresponds to the acidity of biological fluids as opposed to the 
prototype, where the determination is carried out in an acid or alkaline medium. 
These facts indicate the promising use of the developed chromophore reagents for the 
analysis of biological fluids. 
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GENERAL CONCLUSIONS 
The work carried out within this PhD project has allowed the development of 
preparative methods of 2-azahetaryl-2-(1-R-pyrrolidine-2-ylidene)acetonitriles 
featuring azaheterocyclic substituents of neutral and cationic nature and 2-
azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles. The method to access 2-
azahetaryl-2-(1H-pyrrolidine-2-ylidene)acetonitriles has been optimized, 
allowing a significant broadening of the scope of the reaction to numerous 
azaheterocyclic substituents (up to 12, starting from 2).  
We have established that 2-azahetaryl-2-(1H-pyrrolidine-2-ylidene)acetonitriles exist 
both in the solution and the solid state as Z isomers in contrast to 2-azahetaryl-2-
(1-alkylpyrrolidin-2-ylidene)acetonitriles that exists as Z isomers in the solid state 
and as a mixture of Z/E diastereomers in the solution. The free activation energy 
of rotation at C=C double bond has been calculated: ΔG≠ E→Z = 14.4 kcal/mol, 
ΔG≠ Z→E = 13.3 kcal/mol, a value that is characteristic of low-energy processes. 
In our investigation on the reaction of 2-azahetaryl-2-(1-R-pyrrolidine-2-
ylidene)acetonitriles with binucleophilic moieties, such as hydrazines and 
hydroxylamine we obseved a complete regioselectivity. Indeed it was established 
that the first nucleophilic attack is directed at C-2 atom of pyrrolidine. The 
orientation of the following attack is determined by the nature of azaheterocylic 
substituent:  
- in the case of neutral azaheterocyclic substituents (beside benzoxazole) the 
attack is directed at the carbon of nitrile group leading to 3-(ω-aminopropyl)-4-
azahetaryl-5-aminopyrazoles;  
- in the case of benzoxazole derivatives the attack occurs both at nitrile group and 
with the same probability at the C-2 atom of azaheterocycle leading to the 
structural isomers: 4-benzo[d]oxazol-2-yl-3-(ω-aminopropyl)-1H-azol-5-amines 
and 5-((2-hydroxyphenyl)amino)-3-(3-(R-amino)propyl)-1H-pyrazol-4-
carbonitriles (4-carboxydiimide in the case of hydroxylamine); 
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- in the case of quaternized benzoxazole and benzimidazole the attack is directed 
at С-2 atom of azaheterocycle leading to  protonated 3-(4-cyano-5-((2-R-
phenyl)methyamino)-1-R1-1H-pyrazol-3-yl)-N-methylpropan-1-amines. With 
quaternized benzothiazole the first attack is directed at carbon of nitrile group 
followed by next nitrogen of ω-aminopropyl chain attack at C-2 atom of N-
methylbenzothiazole leading to an original azepine derivative. 
Starting from 3-(ω-aminopropyl)-4-azahetaryl-5-aminopyrazoles, we investigated 
methods for regioselective functionalization of their amino groups, condensation 
in tetracyclic compounds, namely, benzo[4,5]imidazo[1,2-c]pyrazolo[4,3-
e]pyrimidine and [1,2,3]triazine derivatives with up to 87% overall yield; and 
deamination via diazotization step followed by Suzuki-Miyaura arylation and C–
H activation leading to 5-aryl(styryl, indol-2-yl)-substituted pyrazoles with up to 
92% overall yield were developed.  
We also explored the properties of 2-azahetaryl-2-(1-R-pyrrolidine-2-
ylidene)acetonitriles in reaction with DMF DMA. It was established that the 
presence of easily accessible NH group is essential in “formylation” of the C-3 
centre of pyrrolidine. The method of the synthesis of pyrrolo[3,2-c]pyridine-6-
imine (PP) with 59% over 3 steps was developed. The prospect use of PP for 
water content determination in aprotic organic solvents by fluorometric assay was 
developed for DMSO presenting a limit of detection of 0.068%.   
Finally, we studied the structure and photophysical properties of complexes of 2-
azahetaryl-2-(pyrrolidin/3-oxoindolin-2-ylidene)acetonitriles with 3d-metals and 
boron.  
This allowed us to establish their potent usefulness since:  
- The key characteristics of BF2 complexes based on 2-azahetaryl-2-(pyrrolidin-2-
ylidene)acetonitriles are the big Stokes shifts (up to 9000 cm-1), high brightness 
(up to 86400 l•mol-1•cm-1), positive solvatofluorochromy, fluorescence in the solid 
state and water stability.  
- Films of polymeric composites with additions of metal complexes of 2-
azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles with Сo(II), Cu(II), Ni(II) (ML2) 
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exhibite photovoltaic effect. Electric potential of the surface attain the biggest 
value of 180 mV in the case of СоL2. 
 - 2-Azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles have demonstrated 
the high visibility when chelating Zn(II) and Cu(II): Δλ ≥ 70 nm, λligandmax = 
515–530 nm (red-purple), λcomplexmax = 590–605 nm (blue), at the рH of 
biological fluids. Limit of ions detection is 0.4-1.0 µmol/l. 
 
Therefore this work illustrates the wide potential developments that can be achieved 
based on an efficienty synthetic approach of polyfunctionnal heterocycles. We 
have shown that synthetic efforts are not only allowing new accesses to densely 
functionnalized compounds, but also providing straightforward molecular tools 
for photophysical studies that allow new development in a wide array of fields. 
As such this work contributes to the establish the molecule as the centre of any 
scientific development in chemical sciences. 
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EXPERIMENTAL PART 
Instrumentation. For monitoring reaction progress, analytical thin layer 
chromatography (TLC) was performed using precoated Merck glass or alumina 
backed silica gel plates (Silica gel 60 F254).  
Preparative chromatography was performed either manually with silica gel (63−
200 μm) or with an automated flash chromatography Interchim Puriflash medium-
pressure liquid chromatography system using Interchim high-purity grade silica gel 
(30 or 50 μm) prepacked columns.  
1H NMR and 13C NMR spectra were recorded on a Varian Mercury 400 (400 and 
101 MHz respectively) in DMSO-d6–ССl4, internal standard TMS; a Bruker Avance 
300 (300 and 75 MHz respectively) or a Bruker Avance III 400 (400 and 101 MHz 
respectively) spectrometer, the internal standard is the residual peaks of deuterated 
solvents CDCl3: 7.28 for 1H and 77.0 ppm for 13C; DMSO-d6: 2.50 for 1H and 
40.0 ppm for 13C; CD3OD: 3.31 for 1H and 47.6 ppm for 13C, (CD3)2CO: 2.06 ppm 
for 1H; СD3CN: 1.97 ppm for 1H and 117.3 ppm for 13C. The degree of carbon atom 
substitution was determined by NMR spectra acquired according to the DEPT-135 or 
JMOD methods. Two-dimensional (2D) (COSY, HMQC, HMBC) spectra were 
recorded on a Bruker Avance III 400 (400 MHz) spectrometer and Bruker Avance 
500 (500 MHz). VTP experiment was run on Bruker Avance 500 (500 MHz). All 
spectra were recorded at ambient temperature (298 K) unless otherwise stated. 
Coupling constants (J), are reported in Hz, chemical shift (δ) in ppm. The multiplicity 
of signals is indicated using the following abbreviations: s = singlet, bs = broad 
singlet, d = doublet, t = triplet, q = quartet, quint = quintet, dd = doublet of doublets, 
ddd = doublet of doublets of doublets, dt = doublet of triplets, and m = multiplet. 
IR spectra recorded on FT-IR spectrometries Perkin Elmer in KBr plates and 
neat films.  
High resolution mass spectra (HRМS) were recorded on GCT Premier 
spectrometer upon electron spray ionization (ESI) or chemical ionization (DCI, CH4). 
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Elemental analysis was performed on “CHNOS elementar vario MICRO Cube” 
analizator. 
The melting points  Melting points were determined on a Boetius micro hot 
stage apparatus with VEB Analytik 1399RNMK 05 observation lens or on Stuart 
melting point apparatus SMP10. 
X-Ray diffraction was performed on on single crystal diffractometers: Agilent 
Gemini, Bruker Nonius, Bruker Kappa Apex II, and Xcalibur 3. All crystals were 
grown by the gas diffusion method or slow crystallization from solution.  
The absorption spectra recorded on UV-Vis spectrometer UV-240IPC 
(Shimadzu). The excitation and emission spectra recorded on fluorescent 
spectrometer Perkin Elmer ls55. Weighing of samples was carried out on analytical 
scales VPK, VLR-200. 
Fluorescence quantum yield (Ф) for BF2-rigidified complexes was measured in 
diluted solution in DMSO with absorption maxima of А = 0.05 and calculated using 
the equation 1.   
Ф =  Ф ×  
 !
 "
×
#$#%&"(()!)
#$#%&!(()!)
×
+!
,
+"
,      (1) 
F – the integral of the emission spectrum; A – absorption at maximum of excitation 
wavelenghth; n – refractive index. “r” – standard, “x” – test sample. The standard for 
complexes is  the solution of  7-(diethylamino)-4-methyl-2H-chromen-2-oneу (λabsmax 
= 330 nm, Фr = 0.73) in ethanol.144 Measurements were made on the UV-3100 
spectrophotometer and the SM-3500 spectrofluorometer.  
Quantum-chemical calculations were performed using DFT at B3LYP/6-31G* 
level of theory. Conformations of Z and E isomers in stationary points corresponded 
to the minima on the potential energy surfaces that was confirmed by vibrational 
analyses performed at the same level of theory - no negative vibration frequency was 
found. 
General Consideration. Reactions were performed in oven-dried, round-
bottom flasks equipped with a reflux condenser and protected from humidity by a 
CaCl2 tube unless otherwise noted.  
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The ratio between compounds in a reaction mixture and the ratio between Z and 
E stereoisomers were found by comparing the integration sum under the peaks in the 
1H NMR spectrum of the reaction mixture. 
The distance between layers in the crystal lattice of BF2-complexes was 
calculated as the distance between the molecule plain from the layer n and centroid of 
the molecule from the layer n+1.   
 
General procedure for 2-azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles 2.1a-f 
synthesis. 
Route 1 (for 2.1a-f). 5-Methoxy-3,4-dihydro-2H-pyrrole (0.15 г, 1.5 mmol) was 
added to a hot stirred solution of hetarylacetonitrile 2.2 (1 mmol) and triethylamine 
(0.21 ml, d = 0.726 g/ml, 1.5 mmol) in toluene. The reaction mixture was refluxed for 
3-20 h (TLC control, elution system: CH2Cl2-CH3OH 95:5) and after the reaction 
ceased was cooled down to room temperature and concentrated under reduced 
pressure.Compounds were purified by column chromatography (for enaminionitriles 
2.1а,і), or recrystallization from ethanol (for enaminonitriles 2.1b,d,е,h) or mixture i-
PrOH–dioxane (for enaminonitriles 2.1с,f,j), or СHCl3 (2.1g) in the presence of 
activated charcoal.  
Route 2  (for 2.1a-d). A vigorously stirred solution of hetarylacetonitrile 2 (2 mmol) 
and pyrrolidinone 4 (3 mmol) in dioxane (8 ml) was treated by dropwise addition of 
POCl3 (0.28 ml, d=1.64 g/mlл, 3 mmol) and then refluxed for 1 h. The mixture was 
then cooled, treated with H2O, and stirred for 30 min at 10° C. The obtained 
precipitate was filtered off and recrystallized from EtOH (in the case of pyrrolidines 
2.1а,b,d) or from i-PrOH–dioxane mixture (for pyrrolidine 2.1c) in the presence of 
activated charcoal. 
Synthesis of 2-(cyano(1-methylpyrrolidin-2-ylidene)methyl)-1,3-dimethyl-1H-
benzo[d]imidazol-3-ium iodide (2.8). 
A suspension of 2-(benzoimidazol-2-yl)-2-(pyrrolidin-2-ylidene)acetonitrile 2.1f  
449 mg, 2 mmol) or або 2-benzoimidazolyl-2-(1-methylpyrrolidin-2-
ylidene)acetonitrile 2.13а (450 mg, 2 mmol), iodomethane (0.3 ml, d = 2.28 g/cm3, 5 
156 
 
mmol) and potassium carbonate (690 mg, 5mmol) in anhydrous DMF (5 ml) was 
heated to 80 °C over a 1 h period (TLC elution system: CHCl3–CH3OH, 95:5) The 
reaction mixture was then concentrated under reduced pressure ant triturated with 
CH2Cl2. The solid was filtered off and the filtrate was concentrated. Purification was 
made by triturating of solid residual with a minimal quantity of CH3CN and further 
filtration. Yield 630 mg (1.6 mmol, 79 %) in the case of 2.1f; Yield 654 mg (1.66 
mmol, 83 %) in the case of 2.13а. Light brown powder (mp 197 °C).  
 
Synthesis of (Z)-2-(4-methoxyquinazolin-2-yl)- 2-(pyrrolidin-2-
ylidene)acetonitrile (2.9) and (Z)-2-(3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)-
2-(pyrrolidin-2-ylidene)acetonitrile (2.10). 
A suspension of (Z)-2-(4-oxo-3,4-dihydroquinazolin-2-yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 1g (505 mg, 2 mmol), iodomethane (0.3 ml, d = 2.28 g/cm3,5 
mmol) and potassium carbonate (690 mg, 5mmol) in anhydrous DMF (5 ml) was 
heated to 80 °C over a 1 h period (TLC elution system: EtOAc–CH2Cl2, 1:10. The 
reaction mixture was then concentrated under reduced pressure ant triturated with 
CH2Cl2. The solid was filtered off and the filtrate was concentrated. Products were 
separated by manual column chromatography (elution system: EtOAc-CH2Cl2,1:10, 
Rf 2.9 = 0.58, Rf 2.10 = 0.18). 
 
General procedure for 1-R-pyrrolidin-2-ones 2.12 synthesis. 
New 1-R-pyrrolidin-2-ones 2.12b,c,d,e,g were obtained according to a reported 
procedure.102 Their characteristics are listed below. 
1-benzylpyrrolidin-2-one (2.12b). Yield 89%, colorless viscous liquid. 1H NMR (300 
MHz, CDCl3), δ, ppm (J, Hz): 1.93−2.10 (m, 2H, 4-СН2), 2.44 (t, J = 8.1, 2H, 3-
СН2), 3.26 (t, J = 7.1, 2H, 5-СН2), 4.45 (s, 2H, Bn–СН2), 7.21−7.38 (m, 5H, Ar-H).  
1-cyclopropylpyrrolidin-2-one (2.12с). Yield 53%, colorless viscous liquid.  1H 
NMR (300 MHz, CDCl3), δ, ppm (J, Hz): 0.61−0.69 (m, 2H, NCHCH2), 0.69−0.78 
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(m, 2H, NCHCH2), 1.88−2.00 (m, 2H, 4-CH2), 2.35 (t, J = 8.1, 2H, 3-CH2), 2.56−2.70 
(m, 1H, CH), 3.28 (t, J = 7.0, 2H, 5-CH2). 
(R)-1-phenylethylpyrrolidin-2-one (2.12d). Yield 81%, colorless viscous liquid. 
1H NMR (400 MHz, CDCl3), δ, ppm (J, Hz): 1.54 (d, J = 7.1, 3H, СH3), 1.89–2.04 
(m, 2H, 4-СН2), 2.35–2.51 (m, 2H), 3.00 (ddd, J = 9.6, 8.4, 5.3, 1H, 3-СH2), 3.34 
(ddd, J = 9.6, 8.2, 6.2, 1H, 3-СH2), 5.52 (q, J = 7.2, 1H, СН), 7.25 – 7.39 (m, 5H, Ar–
H). 
1-(furan-2-ylmethyl)pyrrolidin-2-one (2.12e). Yield 83%, colorless viscous liquid. 
1H NMR (300 MHz, CDCl3), δ, ppm (J, Hz): 1.95–2.08 (m, 2H, 4-СН2), 2.43 (t, J = 
8.1, 2H, 5-СН2), 3.34–3.41 (t, J = 7.1, 2H, 3-СН2), 4.47 (s, 2H, СН2), 6.25–6.27 (m, 
1H, 3-Н), 6.32–6.36 (m, 1H, 4-Н), 7.36–7.40 (m, 1H, 5-Н). 
1-phenylpyrrolidin-2-ylidene (2.12g). Yield 70%, yellowish powder. 1H NMR (300 
MHz, CDCl3), δ, ppm (J, Hz): 2.10–2.26 (m, 2H, 4-СН2), 2.55–2.70 (m, 2H, 3-СН2), 
3.81–3.95 (m, 2H, 5-СН2), 7.12–7.21 (m, 1H, 4-Н), 7.34–7.43 (m, 2H, 3,6-Н), 7.59–
7.66 (m, 2H, 2,6-Н). 
 
General procedure for 5-methoxy-1-R-3,4-dihydro-2H-pyrrol-1-ium 
methylsulfate salt synthesis (2.11). 
1-Alkyl-pyrrolidin-2-one (50 mmol) and dimethyl sulfate (4.74 ml, 55 mmol) were 
stirred for 2 h at 80 °C to give the desired pyrrolium salt as a viscous oil, which was 
used directly in the next step without further purification. Reaction progress was 
controlled by 1H NMR spectroscopy through the disappearance of 1-R-pyrrolidin-2-
one in the crude reaction mixture. 
Alternatively, such pyrrolium salts could be obtained as solids upon treatment with 
KPF6 in water. 
 
5-Methoxy-1-methyl-3,4-dihydro-2H-pyrrol-1-ium hexafluorophospate salt 
2.11΄а. 
5-Methoxy-1-R-3,4-dihydro-2H-pyrrol-1-ium methylsulfate salt 2.11a (1g, 4.4 
mmol) was added dropwise to a strongly stirred solution of KPF6 (1.47 g, 8 mmol) in 
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water (25 ml) at rt. The suspension was allowed to stir for 30 min. The white 
precipitate was filtrated off to yield 0.65 g of the title compound (2.5 mmol, 56%) as 
a white solid. 
1H NMR  (300 MHz, acetone-d6), δ, ppm (J, Hz): 2.33−2.55 (m, 2H, 4-СН2), 3.24 (s, 
3H, NCH3), 3.35−3.44 (m, 2H, 3-CH2), 4.02−4.10 (m, 2H, 5-CH2), 4.43 (s, 3H, 
OCH3). 31P NMR (121 MHz, acetone-d6), δ, ppm (J, Hz): −144.37 (sept, J = 707.5). 
 
General procedure for 2-hetaryl-N-R-pyrrolidin-2-ylideneacetonitrile synthesis 
2.7, 2.13–2.18. 
Route 1. A solution of hetarylacetonitrile (4 mmol) in DMF (10 ml) was added 
dropwise to a strongly stirred suspension of NaH (107 mg, 4 mmol) in DMF (5 mL), 
and the reaction mixture was stirred for 10 min until complete evolution of gas had 
occurred. A solution of 5-methoxy-1-R-3,4-dihydro-2H-pyrrol-1-ium salt (6 mmol) 
in DMF (3 mL) was subsequently added to the reaction mixture, and stirring was 
pursued until complete conversion of the starting material had occurred (TLC 
control). Water was then added to the mixture, promoting precipitation. The 
suspension was additionally stirred for 30 min, and the precipitate was then filtered 
and washed with cyclohexane. Further precipitation was achieved by concentration of 
the initial mother liquid (water, DMF) and trituration of the residues at 0 °C with 
water, filtration, and subsequent washing with cyclohexane. Substances do not 
require additional purification (2.7с, 2.18а) or purified by column chromatography 
(2.7b, 2.14b, 2.16b, 2.17а) or by recrystallization from EtOH (2.7a, 2.15а), і-PrOH 
(2.13a,b), EtOH-dioxane (2.18b). The products are obtained as a mixture of Z and E 
stereoisomers. 
Note: 1) the aliquot for TLC was taken from the crude reaction mixture followed by 
addition of water and extraction with EtOAc. 2) for 2.13а-с, 2.15а NaH (2.1 equiv, 
0.336 g, 8.4 mmol) were used to deprotonate the methylene group in the presence of 
the benzimidazole or 4-oxodihydroquinazolone substituent.  
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Route 2. General procedure for 2-azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles 
2.1a-f synthesis, route 2 was used to access 2-benzothiazole-2-(1-methyl-2-
pyrrolidin-2-ylidene)acetonitrile 2.7а. Yield 900 mg (88%), white powder, mp 
186 °С. 
 
General procedure for the synthesis of 2-(cyano(1-methylpyrrolidin-2-
ylidene)methyl)-3-methylbenzo[d]oxazol/thiazol-3-ium hexafluorophosphate 
(2.21, 2.22). 
A mixture of appropriate hetarylacetonitrile (1.5 mmol) and dimethyl sulfate 
(1.71 ml, d = 1.33g/cm3, 18 mmol) was stirred for 40 min at 70°C. Then the reaction 
mixture was poured into water (10 ml) and a solution of NaOH (5% solution in 
water) was added with stirring. a) The solution was neutralized with 2M HCl to pH = 
7 and extracted with EtOAc (3 times). The combined extracts were evaporated under 
reduced pressure and the solid residual was purified by column chromatography 
(elution system: CHA–EtOAc, 3:1) to give 2.21 as a yellow solid (MS (ESI) m/z: [M 
+ H]+ Found for C10H9N2O 173.11); b) The precipitate formed was filtered off, 
washed with cold water and recrystallized from ethanol to give 2.22 as a yellow solid. 
(1H NMR (400 MHz, CDCl3), δ, ppm (J, Hz): 3.36 (br.s, 3H, СН3), 6.95 (d, J = 8.1, 
1H, Н-4), 7.07–7.13 (m, 1H, Н-6), 7.28–7.33 (m, 1H, Н-5), 7.42 (d, J = 7.8, 1H, Н-
7). 
The obtained compounds were used in the next step without any further 
characterization. A solution of 2-(3-methylbenzo[d]oxazol/thiazol-2(3H)-
ylidene)acetonitrile 2.21 or 2.22 and N-methylpyrrolidin-2-one 2.12а (1.2 equiv) in 
dioxane (5 ml) was heated up to reflux and POCl3 (1.2 equiv) was added to the 
reaction mixture dropwise. In 5 min the stirring was ceased and emulsion of the 
formed salts in dioxane separated into 2 layers. The viscous oil of the bottom layer 
was gathered with Pasteur pipette and dropped into solution of KPF6 (2 equiv) in 
water (5 ml) with stirring. The formed precipitate was filtrated off, dried and 
characterized.   
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Table 6.1. Physico-chemical characteristics of 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acetonitriles 2.1a-f, 2.7-2.10, 2.13-2.18, 
2.21, 2.22 
Com
poun
d 
ІUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
2.1а (E)-2-(pyrrolidin-2-
ylidene)-2-(quinolin-
2-yl)acetonitrile 
 
KBr 
3468 (NH), 2182 
(C≡N), 1588 
(С=N, C=C). 
 (400 MHz, DMSO-d6–ССl4), δ, ppm 
(J, Hz): 2.08– 2.22 (м, 2H, 4-СН2); 
3.03 (t, J = 7.8, 2H, 3-СН2); 3.84 (t, J 
= 7.1, 2H, 5-СН2); 7.34–7.40 (м, 1H, 
Н-6); 7.42 (d, J = 8.8, 1H, Н-3); 7.57–
7.63 (м, 1H, Н-7); 7.75 (d, J = 8.0, 
1H, Н-8); 7.97 (d, J = 8.4, 1H, Н-5); 
8.12 (d, J = 8.8, 1H, Н-4); 11.14 (c, 
1H, NH). 
(101 MHz, DMSO-d6–ССl4), δ, ppm: 
21.2 (CH2); 33.9 (CH2); 49.4 (CH2); 
72.5 (С); 118.0 (CH); 121.4 (CN); 
124.4 (CH); 124.7 (С); 127.4 (CH); 
127.6 (CH); 129.4 (CH); 136.3 (CH); 
146.8 (С); 156.3 (С); 168.1 (С). 
Found, %: С 
76.59; Н 5.68; N 
17.88. C15H13N3. 
Calculated, %: 
С 76.57; Н 5.57; 
N 17.86. 
Route 1: yield 136 mg (0.58 mmol, 58%), yellow powder (elution system for column chromatography: gradient CHCl3 100% to CHCl3–CH3OH, 49:1).  
Route  2: yield 315 mg (1.34 mmol, 67%),  yellow powder (mp 207–208 °С, 207 °С9). 
2.1b (Z)-2-
(benzo[d]thiazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
3450 (NH), 2189 
(C≡N), 1595 
(С=N, C=C). 
 (400 MHz, CDCl3), δ, ppm (J, Hz): 
2.18– 2.30 (м, 2H, 4-СН2); 3.08 (t, J = 
7.9, 2H, 3-СН2); 3.85 (t, J = 7.1, 2H, 
5-СН2); 7.28 (ddd, J = 7.9, 7.3, 1.3, 
1H, Н-6); 7.41 (ddd, J = 8.0, 7.3, 1.2, 
1H, Н-5); 7.78 (ddd, J = 8.0, 1.3, 0.5, 
1H, Н-7); 7.81 (ddd, J = 7.9, 1.2, 0.5, 
1H, Н-4); 10.27 (s, 1H, NH).  
 (101 MHz, CDCl3), δ, ppm: 21.7 
(CH2); 33.0 (CH2); 49.1 (CH2); 70.6 
(C); 120.3 (CN); 120.4 (CH); 121.4 
(CH); 123.6 (CH); 125.9 (CH); 132.7 
(C); 153.4 (С); 166.4 (С); 167.9 (С).  
Found, %: С 
64.98; Н 4.87; N 
17.23; S 13.73. 
C13H11N3S. 
Calculated, %: 
С 64.71; Н 4.59; 
N 17.41; S 
13.29. 
Route 1: yield 205 mg (0.85 mmol, 85 %), white powder. Route 2: yield 415 mg (1.72 mmol, 86%), white powder (mp 226 °С, 223–224 °С10). 
2.1с (Z)-2-
(benzo[d]oxazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
3437 (NH), 2203 
(C≡N), 1602, 
1547 (С=N, 
C=C). 
 (400 MHz, DMSO-d6–ССl4), δ, ppm 
(J, Hz): 2.19 (quint, J = 7.3, 2H, 4-
CH2); 3.06 (t, J = 7.5, 2H, 3-CH2); 
3.83 (t, J = 7.1, 2H, 5-CH2); 7.16–7.30 
(м, 2H, Н-5,6); 7.50 (d, J = 7.6, 1H, 
H-7); 7.54 (d, J = 7.5, 1H, H-4); 9.60 
(s,1H, NH). 
(101 MHz, DMSO-d6–ССl4), δ, ppm: 
21.4 (CH2); 33.5 (CH2); 49.8 (CH2); 
61.9 (C); 110.0 (СН); 117.5 (CH); 
118.0 (CN); 123.3 (СН); 124.2 (СН); 
141.8 (С); 148.7 (С); 162.6 (С); 169.7 
(С). 
Found, %: С 
69.33; Н 4.25; N 
18.53. 
C13H11N3О. 
Calculated, %: 
С 69.32; Н 4.92; 
N 18.66. 
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Route 1: yield 167 mg (0.74 mmol, 74 %),  white powder. Route 2: yield 225 mg (1 mmol, 50%), white powder (mp 230 °С).  
2.1d (Z)-2-(4-
methylthiazol-2-yl)-
2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
3475 (NH), 2179 
(C≡N), 1603 
(С=N, C=C). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.08–2.25 (м, 2H, 4-СН2); 2.37 (d, J = 
1.0, 3H, СН3); 2.99 (t, J = 7.8, 2H, 3-
СН2); 3.70–3.81 (м, 2H, 5-СН2); 6.56 
(q, J = 1.0, 1H, Н-5); 9.83 (s, 1H, 
NH). 
(101 MHz, CDCl3), δ, ppm: 17.2 
(СН3); 21.9 (CH2); 32.6 (CH2); 48.7 
(CH2); 70.3 (C); 108.4 (CH); 120.7 
(CN); 151.4 (С); 165.8 (2С). 
Found, %: С 
58.33; Н 5.33; N 
20.12; S 15.15. 
C10H11N3S. 
Calculated, %: 
С 58.51; Н 5.40; 
N 20.47; S 
15.62. 
Route 1: yield 138 mg (0.67 mmol, 67 %), white powder. Route 2: yield 316 mg (1.54 mmol, 77%),  white powder (mp 150–151 °С).  
2.1e (Z)-2-(6-
methylbenzo[d]oxaz
ol-2-yl)-2-
(pyrrolidin-2-
ylidene)acetonitrile
 
Neat film 
 3224 (NH), 2210 
(C≡N), 1613, 
1559 (C=N, 
C=C,), 1255 (C–
O). 
(400 MHz, CDCl3), δ, ppm (J, Hz):  δ 
2.25 (quint, J = 7.6, 2H, 4-CH2), 2.48 
(s, 3H, CH3) 3.10 (t, J = 7.9, 2H, 3-
CH2), 3.84 (t, J = 7.1, 2H, 5-CH2), 
7.07 – 7.11 (м, 2H, 4-H), 7.31 (d d, J 
= 1.5, 0.7, 1H, 7-H), 7.39 (d, J = 8.0, 
1H, 5-H), 9.60 (s, 1H, NH). 
(101 MHz, CDCl3), δ, ppm:  21.7 
(СH3), 21.8 (СH2), 32.9 (СH2), 49.1 
(СH2), 63.3 (C), 110.6 (CH), 116.8 
(CH), 118.4 (C), 125.2 (CH), 133.8 
(C), 139.4 (C), 149.3 (C), 162.2 (C), 
169.5 (C). 
HRMS (ESI) 
Calculated for 
C14H14N3O (M + 
H+) 240.1137, 
Found 240.1143. 
Yield 134 mg (0.56 mmol, 56 %), white powder.  
2.1f (Z)-2-
(benzo[d]imidazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile  
 
K Br 
3226 (NH), 2197 
(C≡N), 1608 
(С=N, C=C). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.08 (p, J = 7.6, 2H, 4-CH2), 2.96 (t, J 
= 7.8, 1H, 3-CH2), 3.73 (t, J = 7.1, 1H, 
5-CH2), 7.05–7.12 (м, 2H, 5,6-H), 
7.33–7.39 (м, 1H, Ar H), 7.43–7.49 
(м, 1H, Ar H), 10.10 (s, 1H, NH), 
12.00 (s, 1H, NHHet). 
(101 MHz, DMSO-d6), δ, ppm: δ 21.7 
(CH2), 33.2 (CH2), 49.4 (CH2), 62.6 
(C), 111.1 (CH), 117.0 (CH), 120.6 
(C), 121.5 (2CH), 134.1 (C), 143.6 
(C), 151.7 (C), 168.5 (C). 
Found, %:  C, 
69.85; H, 6.08; 
N, 25.08. 
C13H12N4. 
Calculated, %: 
C, 69.62; H, 
5.39; N, 24.98. 
Yield 200 mg (0.89 mmol, 89 %), white powder (mp 292–293 °C).  
2.1g (Z)-2-(1-methyl-1H-
benzo[d]imidazol-2-
yl)-2-(pyrrolidin-2-
ylidene) 
KBr 
3448 (NH), 2187 
(C≡N), 1609 
(С=N, C=C). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
2.13–2.30 (м, 2H, 4-CH2), 3.10 (t, J = 
7.9, 2H, 3-CH2), 3.76 – 3.88 (t, J = 
7.9, 2H, 5-CH2), 4.02 (s, 3H, CH3), 
7.34–7.15 (м, 3H, Ar H), 7.64–7.51 
(75 MHz, CDCl3), δ, ppm: CH2: 21.9 
(CH2), 31.1 (CH3), 33.3 (CH2), 49.0 
(CH2), 62.4 (C), 108.7 (CH), 117.2 
(CH), 121.4 (C), 121.6 (CH), 121.8 
(CH), 135.3 (C), 141.8 (C), 150.8 (C), 
MS (ESI) m/z: 
[M + H]+ Found 
for C14H15N4: 
239.1. 
Calculated, %: 
162 
 
 
(m, 1H, Ar H), 10.64 (s, 1H, NH). 170.3 (C). C, 70.57; H, 
5.92; N, 23.51. 
C14H14N4. 
Found, %:  C, 
70.76; H, 6.14; 
N, 24.06. 
Yield 207 mg (0.87 mmol, 87 %), white powder (mp 184–185 °C). 
2.1h  (E)-2-(2-
methylthiazol-4-yl)-
2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
 3449 (NH), 2180 
(C≡N), 1602, 
1511 (C=C, 
C=N). 
(400 MHz, DMSO-d6–CCl4), δ, ppm 
(J, Hz): 2.10 (quint, J = 7.2, 2H, 4-
CH2), 2.72 (s, 3H, CH3), 2.89 (t, J = 
7.7, 2H, 3-CH2), 3.66 (t, J = 6.8, 2H, 
5-CH2), 6.71 (s, 1H, 5-H), 8.70 (s, 1H, 
NH). 
(101 MHz, DMSO-d6–CCl4), δ, ppm: 
19.3 (CH3), 22.1 (CH2), 32.7 (CH2), 
48.4 (CH2), 68.3 (C), 105.8 (CH), 
121.2 (C), 151.8 (C), 162.7 (C), 165.0 
(C). 
Calculated, %: 
C, 58.51; H, 
5.40; N, 20.47. 
C10H11N3S. 
Found, %: C, 
58.33; H, 5.33; 
N, 20.12. 
Yield 135 mg (0.66 mmol, 66 %), white powder (mp 124 °C). 
2.1і (E)-2-(pyridin-2-yl)-
2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
 3439 (NH), 2189 
(C≡N), 1578 
(С=N, C=C). 
(400 MHz, СDCl3), δ, ppm (J, Hz):  
2.13 (quint, J = 7.5, 2H, 4-СН2), 3.05 
(t, J = 7.9, 2H, 3-СН2), 3.75 (t, J = 7.0, 
2H, 5-СН2), 6.92 (ddd, J = 7.5, 7.3, 
1.1, 1H, 5-Н), 7.41 (d, J = 8.2, 1H, 3-
Н), 7.61 (ddd, J = 8.2, 7.3, 1.8, 1H, 4-
Н), 8.32–8.40 (м, 1H, 6-H), 10.46 (s, 
1H, NH). 
(101 MHz, CDCl3), δ, ppm: 21.5 
(CH2), 33.5 (CH2), 48.7 (CH2), 72.5 
(C), 117.7 (CH), 118.7 (CH), 122.0 
(C), 136.4 (CH), 147.0 (CH), 156.6 
(C), 167.1 (C). 
Calculated, %: 
С 71.33, Н 5.99, 
N 22.69. 
C11H11N3.  
Found, %:  С 
71.65, Н 6.34, N 
23.13. 
Eluent for automatic column chromatography: CH2Cl2-СНА, 7:3. Yield 130 mg (0.7 mmol, 70%), white powder (mp 97 °C, 97 °C9 ).  
2.1j (Z)-2-(4-oxo-3,4-
dihydroquinazolin-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 
 
KBr 
 3462, 3339 
(NH), 2192 
(C≡N), 1669 
(C=O), 1617, 
1561, 1546 
(C=N, C=C). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.98 – 2.13 (м, 2H, 4-CH2), 2.97 (t, J 
= 7.7, 2H, 3-CH2), 3.77 (t, J = 7.1, 2H, 
5-CH2), 7.33 (t, J = 7.1, 1H, 6-H), 7. 
60–7.86 (м, 2H, 7, 8-H), 7.99 (d, J = 
8.0, 1H, 5-H), 10.69 (s, 1H, NH), 
10.74 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 20.9 
(CH2), 34.8 (CH2), 50.5 (CH2), 66.1 
(C), 119.5 (C), 119.6 (C), 125.0 (CH), 
126.1 (CH), 126.4 (CH), 134.8 (CH), 
149.1 (C), 152.4 (C), 161.7 (C), 171.2 
(C). 
MS (ESI) m/z: 
[M + H]+ Found 
for C14H13N4O: 
253.1. 
Calculated, %: 
C, 66.66; H, 
4.79; N, 22.21. 
C14H12N4O. 
Found, %: C, 
163 
 
66.95; H, 5.14; 
N, 22.72. 
 Yield 222 mg (0.88 mmol, 88%), white powder (mp 286–287 °C). 
2.8 2-(cyano(1-
methylpyrrolidin-2-
ylidene)methyl)-1,3-
dimethyl-1H-
benzo[d]imidazol-3-
ium iodide  
 
Neat film 2188 
(C≡N), 1598, 
1531 (С=N, 
C=C). 
CDCl3: ratio E:Z = 1:0.75 HRMS (ESI) 
Calculated for 
C16H19N4 (M + 
H+): 267.1610, 
Found: 
267.1613. 
(300 MHz, CDCl3), δ, ppm (J, Hz):   
E isomer:
 
2.23–2.14 (м, 2H, 4-CH2), 
2.95 (t, J = 7.8, 1H, 3-CH2), 3.60 (s, 
3H, NCH3), 3.94 (t, J = 7.3, 2H, 5-
CH2), 4.20 (s, 6H, 2NCH3), 7.64–7.72 
(м, 2H, 5,6-H), 7.72–7.79 (м, 2H, 4,7-
H);  
Z isomer: 2.23–2.34 (м, 2H, 4-CH2), 
2.76 (s, 3H, NCH3), 3.36 (t, J = 7.9, 
2H, 3-CH2), 4.07 (t, J = 7.3, 2H, 5-
CH2), 4.15 (s, 6H, 2NCH3), 7.72–7.64 
(м, 2H, 5,6-H), 7.86–7.79 (м, 2H, 4,7-
H). 
 (75 MHz, CDCl3), δ, ppm:  
 E isomer:
 
20.0 (CH2), 34.6 (2CН3), 
36.3 (СН3), 36.5 (CH2), 49.1 (C), 59.7 
(CH2), 113.0 (2CН), 116.8 (C), 127.5 
(2CН), 131.7 (2C), 148.3 (C), 168.5 
(C).   
Z isomer: 20.2 (CH2), 34.6 (2CH3), 
37.2 (CH2), 37.4 (CH3), 50.5 (C), 60.8 
(CH2), 113.1 (СН), 117.6 (C), 127.6 
(СН), 131.5 (2C), 146.7 (C), 170.7 
(C). 
Yield 630 mg (1.6 mmol, 79 %) for 2.1f; Yield 654 mg (1.66 mmol, 83 %) for 2.13а, light brown powder (mp 197 °C). 
2.9 (Z)-2-(4-
methoxyquinazolin-
2-yl)-2-(pyrrolidin-
2-
ylidene)acetonitrile 
 
KBr 
 3436 (NH), 2196 
(C≡N), 1628, 
1573 (C=N, 
C=C). 
 (400 MHz, CDCl3), δ, ppm (J, Hz): 
2.20 (quint, J = 7.3, 2H, 4-CH2), 3.13 
(t, J = 8.0, 2H, 3-CH2), 3.85 (t, J = 7.0, 
2H, 5-CH2), 4.23 (s, 3H, OCH3), 7.38 
(ddd, J = 8.1, 6.7, 1.4, 1H, 6-H), 7.67 
(d, J = 7.9, 1H, 8-H), 7.72 (ddd, J = 
8.2, 6.7. 1.5, 1H, 7-H), 8.06 (d d, J = 
8.0, 1.4, 1H, 5-H), 10.77 (s, 1H, NH). 
(101 MHz, CDCl3), δ, ppm:  21.6 
(CH2), 33.7 (CH2), 49.1 (CH2), 54.3 
(CH3), 75.1 (C), 113.6 (C), 121.3 (C), 
123.7 (CH), 124.7 (CH), 125.5 (CH), 
133.4  (CH), 150.8 (C), 161.5 (C), 
166.2 (C), 169.8 (C). 
HRMS (ESI) 
Calculated for 
C15H15N4O (M + 
H+): 267.1246, 
Found: 
267.1249. 
Yield 282 mg (1.06 mmol, 53%), white powder (mp 185–186 °C).  
2.10 (Z)-2-(3-methyl-4-
oxo-3,4-
dihydroquinazolin-2-
yl)-2-(pyrrolidin-2-
KBr 
 3432 (NH), 2184 
(C≡N), 1664 
(C=O), 1612, 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.23 (quint, J = 7.5, 2H, 4-CH2), 3.13 
(t, J = 7.9, 2H, 3-CH2), 3.86 (t, J = 7.2, 
2H, 5-CH2), 3.86 (s, 3H, NCH3), 7.36 
(101 MHz, CDCl3), δ, ppm: 21.2 
(CH2), 33.9 (CH3), 34.5 (CH2), 49.4 
(CH2), 67.8 (C), 119.1 (C), 120.7 (C), 
125.1 (CH), 125.4 (CH), 127.1 (CH), 
HRMS (ESI) 
Calculated for 
C15H15N4O (M + 
H+): 267.1246, 
164 
 
ylidene)acetonitrile  
 
1523 (C=N, 
C=C). 
(ddd, J = 8.3, 7.5, 1.0, 1H, 6-H), 7.47 
(d, J = 7.5, 1H, 8-H), 7.68 (ddd, J = 
8.4, 7.6. 1.7, 1H, 7-H), 8.25 (d d, J = 
7.9, 1.3, 1H, 5-H), 10.49 (s, 1H, NH). 
134.1 (CH), 146.6 (C), 153.6 (C), 
162.8 (C), 172.6 (C). 
Found: 
267.1249. 
Yield 85 mg (0.32 mmol, 16%), white powder (mp 244–245 °C).  
2.7а 2-(Benzo[d]thiazol-
2-yl)-2-(1-
methylpyrrolidin-2- 
ylidene)acetonitrile  
 
KBr 
2178 (C≡N), 
1573 (C=N, 
C=C). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.99 (quint, J = 7.5, 2H, 4-CH2), 3.38 
(s, 3H, СН3), 3.43 (t, J =7.5, 2H, 3-
CH2), 3.68 (t, J = 7.3, 2H, 5-CH2), 
7.25 (t, J = 7.7, 1H, Н-6), 7.39 (t, J = 
7.7, 1H, Н-5), 7.72 (d, J = 7.7, 1H, Н-
7), 7.93 (d, J = 7.7, 1H, Н-4). 
(75 MHz, DMSO-d6), δ, ppm: 20.0 
(CH2), 36.2 (CH3), 37.2 (CH2), 
58.1(CH2), 68.4 (C), 120.9 (CH), 
121.4 (C), 121.7 (CH), 123.6 (CH), 
126.4 (CH) 133.1 (C), 154.6 (C), 
167.3 (C), 167.6 (C) 
HRMS (ESI) 
Calculated for 
C14H13N3S (M + 
H+): 256.0908, 
Found: 256.0909 
Route 1: yield 900 mg (3.52 mmol, 88%), white powder.  The reaction was directly scaled up to 10.45 g of starting material affording 13.94 g (91% 
yield) of the desired product. Route 2: yield 450 mg (1.76 mmol, 88%), white powder (mp186 °C). 
  
2.7b 2-(Benzo[d]thiazol-
2-yl)-2-(1-
benzylpyrrolidin-2- 
ylidene)acetonitrile 
 
Neat film 
 2183 (C≡N), 
1588, 1559 
(C=N, C=C).  
DMSO-d6: E isomer, Z isomer traces HRMS (ESI) 
Calculated for 
C20H18N3S (M + 
H+): 332.1221, 
Found: 
332.1212. 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.02 (quint, J = 7.4, 2H, 4-CH2), 3.56 
(t, J = 7.6, 2H, 3-CH2), 3.63 (t, J = 7.2, 
2H, 5-CH2), 5.13 (s, 2H, СН2), 7.26 (t, 
J = 7.6, 1H, H-6), 7.36−7.49 (м, 6H, 
Н-5,Ar), 7.74 (d, J = 8.1, 1H, H-7), 
7.93 (d, J = 7.8, 1H, H-4). 
(101 MHz, DMSO-d6), δ, ppm: 20.1 
(CH2), 37.6 (CH2), 51.0 (CH2), 56.2 
(CH2), 68.6 (C), 120.9 (C), 121.2 
(CH), 121.8 (CH), 123.9 (CH), 126.5 
(CH), 127.5 (2CH), 128.0 (CH), 129.3 
(2CH), 133.2 (C), 136.2 (C), 154.5 
(C), 167.2 (C), 167.4 (C). 
Yield 1.06 g (3.6 mmol, 80%), white powder (mp 134−135 °C), elution system for automatic column chromatography: СНА–EtOAc, 7:3.  
2.7с 2-(Benzo[d]thiazol-
2-yl)-2-(1-
cyclopropylpyrrolidi
n-2- 
ylidene)acetonitrile 
Neat film 2182 
(C≡N), 1548 
(C=N, C=C). 
CDCl3: ratio E:Z = 9:1 HRMS (ESI) 
Calculated for 
C16H16N3S (M + 
H+): 282.1065, 
Found: 
282.1071. 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
0.95−1.03 (м, NCHCH2), 1.08−1.18 
(м, 2H, NCHCH2), 2.04 (quint, J = 
7.6, 2H, 4-CH2), 3.08−3.21 (м, 1H, 
NCH), 3.51 (t, J = 7.8, 2H, 3-CH2), 
3.60 (t, J = 7.3, 2H, 5-CH2), 7.26 (ddd, 
(75 MHz, CDCl3), δ, ppm:  10.6 
(CH2), 20.6 (CH2), 30.1 (CH), 36.4 
(CH2), 54.3 (CH2), 71.8 (C), 120.9 
(C), 121.0 (CH), 121.2 (CH), 123.4 
(CH), 125.7 (CH), 134.0 (C), 154.4 
(C), 167.1 (C), 167.5 (C). 
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J = 8.3, 7.4, 1.3, 1H, H-6), 7.39 (ddd, 
J= 8.5, 7.7, 1.3, 1H, H-5), 7.79 (d d, J 
= 5.6, 0.8, 1H, H-7), 7.82 (d d, J = 5.6, 
0.9, 1H, H-4). 
Yield 832 mg (2.96 mmol, 74%), white powder (mp144 °C). 
2.13а 2-(1H-
Benzo[d]imidazol-2-
yl)-2-(1-
methylpyrrolidin- 
2-
ylidene)acetonitrile 
 
KBr 
3297 (NH), 2184 
(C≡N), 1575, 
1528 (C=N, 
C=C). 
DMSO-d6: ratio  E:Z = 5:1 HRMS (ESI) 
Calculated for 
C14H15N4 (M + 
H+): 239.1297, 
Found: 
239.1299. 
(400 MHz, DMSO-d6), δ, ppm (J, Hz):   
E isomer: 1.93 (quint, 7.6, 2H, 4-CH2), 
3.33 (t, J = 7.6, 2H, 3-CH2), 3.37 (s, 
3H, СН3), 3.62 (t, J = 7.2, 2H, 5-CH2), 
7.32−7.46 (м, 2H, Н Ar), 7.00−7.08 
(м, 2H, H Ar), 11.75 (s, 1H, NH); 
Z isomer: 2.01 (quint, 7.6, 2H, 4-CH2), 
2.78 (s, 3H, CH3), 3.00 (t, J = 7.8, 2H, 
3-CH2), 3.65 (t, J = 7.2, 2H, 5-CH2), 
7.08−7.16 (м, 2H, H Ar), 7.32−7.46 
(м, 1H, H Ar), 7.51 (d, J = 8.4, 1H, H-
4), 12.25 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm:  
E isomer: 20.3 (CH2), 36.0 (CH3), 
36.3 (CH2), 57.8 (CH2), 62.3 (C), 
111.0 (CH), 117.5 (CH), 121.1 (CH), 
121.2 (CH), 122.7 (C), 134.7 (C), 
144.5 (C), 151.6 (C), 167.0 (C); 
Z isomer:20.5 (CH2), 36.3 (CH3), 37.3 
(CH2), 59.0 (CH2), 62.3 (C), 111.2 
(CH), 118.3 (CH), 121.2 (C), 121.5 
(CH), 122.0 (CH), 134.6 (C), 144.0 
(C), 147.8 (C), 164.9 (C). 
Yield 760 mg (3.2 mmol, 80%),  white powder (mp 262 °C).  
2.13b 2-(1H-
Benzo[d]imidazol-2-
yl)-2-(1-
benzylpyrrolidin- 
2-
ylidene)acetonitrile  
 
KBr 
3289 (NH), 2188 
(C≡N), 1588, 
1576, 1524 
(C=N, C=C) 
 
DMSO-d6: ratio  E:Z = 5:1 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
E isomer: 1.97 (quint, J = 7.4, 2H, 4-
CH2), 3.43 (t, J = 7.7, 2H, 3-CH2), 
3.58 (t, J = 7.2, 2H, 5-CH2), 5.11 (s, 
2H,  
NBnCH2), 7.00−7.55 (м, 9H, H Ar), 
11.83 (s, 1H, NH). 
Z isomer: 2.03 (quint, J = 7.4, 2H, 4-
CH2), 3.09 (t, J = 7.7, 2H, 3-CH2), 
3.65 (t, J = 7.1, 2H, 5-CH2), 4.92 (s, 
2H, NCH2), 6.87−6.93 (м, 2H, H Ar), 
7.02−7.52 (м, 7H, H Ar), 12.14 (s, 1H, 
NH). 
 
(101 MHz, DMSO-d6), δ, ppm: 
E isomer: 20.4 (CH2), 36.6 (CH2), 
50.7 (CH2), 55.8 (CH2), 62.8 (C), 
111.1 (CH), 117.6 (CH), 120.5 (C), 
121.3 (CH), 121.4 (CH), 127.5 (CH), 
127.9 (CH), 129.2 (CH), 134.7 (C), 
136.7 (C), 144.4 (C), 151.2 (C), 166.5 
(C); 
Z isomer: 20.7 (CH2), 37.4 (CH2), 
51.8 (CH2), 57.6 (CH2), 63.8 (C), 
111.3 (CH), 118.2 (CH), 121.5 (CH), 
122.2 (CH), 122.6 (C), 127.55 (2CH), 
127.63 (CH), 128.8 (2CH), 134.6 (C), 
136.6 (C), 143.8 (C), 147.5 (C), 163.6 
HRMS (ESI) 
розраховано for 
C20H19N4 (M + 
H+): 315.1610, 
Found: 
315.1608. 
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(C). 
Yield 970 mg (3.08 mmol, 77%), white powder (mp 264−265 °C). 
2.13c 2-(1H-
Benzo[d]imidazol-2-
yl)-2-(1-
cyclopropylpyrrolidi
n- 
2-
ylidene)acetonitrile 
 
Neat film 3296 
(NH), 2184 
(C≡N), 1559, 
1515 (C=N, 
C=C). 
CDCl3: E isomer 100% HRMS (ESI) 
Calculated for 
C16H17N4 (M + 
H+): 265.1453, 
Found: 
265.1459. 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
0.96–1.04 (м, 2H, NCHCH2), 1.05–
1.15 (м, 2H, NCHCH2), 2.02 (quint, J 
= 7.6, 2H, 4-CH2), 3.05–3.16 (м, 1H, 
СН), 3.55 (t, J = 7.6, 2H, 3-CH2), 3.57 
(t, J = 7.1, 2H, 5-CH2) 7.12–7.26 (м, 
2H, Н Ar), 7.35–7.68 (s, 2H, H Ar), 
9.22 (s, 1H, NH) 
(101MHz, DMSO-d6), δ, ppm: 10.7 
(CH2), 20.7 (CH2), 29.8 (CH), 36.0 
(CH2), 54.2 (CH2), 65.4 (C), 121.1 
(2CH), 121.7 (2CH), 122.2 (C), 150.7 
(C), 167.5 (C). 
Yield 634 mg (2.4 mmol, 60 %), white powder (mp 259 °C). 
2.14b 2-(1-
Benzylpyrrolidin-2-
ylidene)-2-(quinolin-
2-yl)- 
acetonitrile 
 
Neat film 2179 
(C≡N), 1561, 
1533, 1498 
(C=N, C=C). 
DMSO-d6: ratio E:Z = 1:3.3. Z isomer HRMS (ESI) 
Calculated for 
C22H20N3 (M + 
H+): 326.1657, 
Found: 
326.1663. 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
Z isomer: 1.96 (quint, J = 7.5, 2H, 4-
CH2), 3.47 (t, J = 7.7, 2H, 3-CH2), 
3.56 (t, J = 7.1, 2H, 5-CH2), 5.15 (s, 
2H, NBnCH2), 7.29−7.47 (м, 5H, H 
Ph), 7.46 (ddd, J = 8.5, 7.0, 1.4, 1H, 
H-6), 7.55 (d, J = 8.8, 1H, H-3), 7.68 
(ddd, J = 8.5, 7.0, 1.4, 1H, H-7), 7.83 
(d, J = 6.7, 1H, H-8), 7.86 (d, J = 6.8, 
1H, H-5), 8.21 (d, J = 8.7, 1H, H-4).  
E isomer: 2.08 (quint, J = 7.5, 2H, 4-
CH2), 3.15 (t, J = 7.8, 2H, 3-CH2), 
3.70 (t, J = 7.1, 2H, 5-CH2), 4.78 (s, 
2H, NCH2), 6.79−6.93 (м, 2H, HPh-
2,6), 7.11−7.24 (м, 3H, HPh-3,4,5), 
7.29 (d, J = 8.6, 1H, H-3), 7.29−7.47 
(м, 1H, H-6), 7.60−7.64 (м, 2H, H-7), 
7.80−7.88 (м, 1H, H-8), 8.10 (d, J = 
8.6, 1H, H-4). 
(101 MHz, DMSO-d6), δ, ppm:    
Z isomer: 20.85 (CH2), 36.5 (CH2), 
51.2 (CH2), 55.2 (CH2), 72.5 (C), 
120.0 (CH), 122.1 (C), 125.3 (C), 
125.4 (CH), 127.6 (2CH), 127.9 (CH), 
128.0 (CH), 128.3 (CH), 129.2 (2CH), 
130.0 (CH), 136.5 (CH), 136.9 (C), 
147.5 (C), 156.7 (C), 167.4 (C).  
E isomer: 20.81 (CH2), 37.9 (CH2), 
53.2 (CH2), 57.9 (CH2), 74.6 (C), 
121.4 (CH), 122.1(C), 124.2(C), 125.9 
(CH), 127.2 (2CH), 127.5 (CH), 128.0 
(CH), 128.1 (CH), 128.7 (2CH), 130.1 
(CH), 136.4 (CH), 136.6 (C), 147.1 
(C), 154.5 (C), 163.9 (C). 
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Yield 872 mg (2.68 mmol, 67%), white powder (mp 141 °C), elution system for column chromatography: first column: CH2Cl2 (100%), second: СНА–
EtOAc 5:1.   
2.15a 2-(1-
Methylpyrrolidin-2-
ylidene)-2-(4-oxo-
3,4-
dihydroquinazolin- 
2-yl)acetonitrile   
 
Neat film 3200, 
3143 (NH), 2187 
(C≡N), 1661 
(C=O), 1561 
(C=N, C=C). 
Е isomer 100%, Z isomer traces HRMS (ESI) 
Calculated for 
C15H15N4O (M + 
H+): 267.1246, 
Found: 
267.1252. 
 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.10 (quint, J = 7.4, 2H, 4-CH2), 3.48 
(s, 3H, СН3), 3.58 (t, J = 7.9, 2H, 3-
CH2), 3.69 (t, J = 7.3 Hz, 2H, 5-CH2), 
7.34 (t, J = 7.5, 1H, H-6), 7.51 (d, J = 
8.1, 1H, H-8), 7.67 (t, J = 7.3, 1H, H-
7), 8.22 (d, J = 7.8, 1H, H-5), 9.10 (s, 
1H, NH). 
(101MHz, CDCl3), δ, ppm: 20.3 
(CH2), 36.7 (CH3), 36.9 (CH2), 57.9 
(CH2), 66.6 (C), 119.4 (C), 119.8 (C), 
125.0 (CH), 126.4 (CH), 126.5 (CH), 
134.5 (CH), 149.4 (C), 150.4 (C), 
161.9 (C), 170.2 (C). 
Yield 800 mg (3.2 mmol, 75%), light brown powder (mp 203−204 °C). 
2.16b 2-(1-
Benzylpyrrolidin-2-
ylidene)-2-(4-
methylthiazol-2-
yl)acetonitrile 
 
Neat film  
2185 (C≡N), 
1560, 1525 
(С=N, C=C). 
СDCl3: ratio E:Z = 3:1 HRMS (ESI) 
Calculated for 
C17H18N3S (M + 
H+): 296.1221, 
Found: 
296.1223. 
(300 MHz, СDCl3), δ, ppm (J, Hz): 
E isomer: 1.99 (quint,  J = 7.5, 2H, 4-
CH2), 2.40 (d, J = 1.0, 3H, СН3), 3.42 
(t, J = 7.8, 2H, 3-CH2), 3.49 (t, J = 7.2, 
2H, 5-CH2), 6.66 (q, J = 1.0, 1H, Н-5), 
5.09 (s, 2H, NCH2Ph), 7.23–7.43 (м, 
5H, Ar H);  
Z isomer: 2.09 (quint,  J = 7.4, 2H, 4-
CH2), 2.36 (d, J = 1.0, 3H, CH3), 3.17 
(t, J = 7.8, 2H, 3-CH2), 3.65 (t, J = 7.1, 
2H, 5-CH2), 4.74 (s, 2H, NCH2Ph), 
6.69 (q, J = 1, 1H, H-5), 7.00–6.94 (м, 
1H, H-4), 7.43–7.23 (м, 4H, Ar H). 
(75 MHz, CDCl3), δ, ppm:  
E isomer: 17.4 (CH2), 20.5 (CH2), 
36.3 (CH2), 51.5 (CH2), 54.8 (CH3), 
69.4 (С), 110.2 (CH), 120.8 (С), 127.8 
(CH), 127.9 (CH), 128.9 (CH), 135.6 
(С), 152.2 (С), 164.3 (С);   
Z isomer: 17.2 (CH3), 20.6 (CH2), 
37.2 (CH2), 57.3 (CH2), 52.9 (CH2), 
69.5 (С), 112.9 (CH), 122.9 (С), 127.2 
(CH), 127.5 (CH), 128.6 (CH), 135.7 
(С), 151.8 (С), 166.0 (С). 
Elution system for column chromatography: hexane–EtOAc, 5:1. The second purification: recrystallization from ethanol in the presence of activated 
charcoal. Yield 850 mg (2.88 mmol, 72 %), white powder (mp 120–121 °C).  
2.17a 2-(1-Methyl-1H- Neat film  DMSO-d6: ratio E:Z = 1.5:1. HRMS (ESI) 
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benzo[d]imidazol-2-
yl)-2-(1-
methylpyrrolidin-2-
ylidene)acetonitrile 
 
2179 (C≡N), 
1591 (С=N, 
C=C). 
 (400 MHz, DMSO-d6), δ, ppm (J, 
Hz):  
Е isomer: 2.01 (quint, J = 7.4, 2H, 4-
CH2), 2.42 (s, 3H, NCH3), 3.03 (t, J = 
7.8, 2H,  3-CH2), 3.60 (t, J = 6.8, 2H, 
5-CH2), 3.73 (s, 3H, NHetCH3), 7.14–
7.28 (м, 2H,  Н-5,6), 7.45–7.63 (м, 
2H,  Н-4,7-H).  
Z isomer: 1.84 (quint, J = 7.5, 2H, 4-
CH2), 2.80 (t, J = 7.8, 2H,  3-CH2), 
3.39 (s, 3H, NCH3), 3.62 (t, J = 6.7, 
2H,  5-CH2), 3.76 (s, 3H,  NHetCH3), 
7.14–7.28 (м, 2H, Н-5,6), 7.45–7.63 
(м, 2H,  Н-4,7).  
(101 MHz, DMSO-d6), δ, ppm:  
Е isomer: 20.5 (CH2), 30.9 (CH3), 
35.7 (CH2),35.8 (CH3), 58.6 (CH2), 
59.3 (C), 110.7 (CH), 119.1 (CH), 
122.0 (C), 122.1 (CH), 122.5 (CH), 
135.7 (C), 142.7 (C), 148.1 (C), 165.9 
(C).   
Z isomer: 20.1 (CH2), 31.2 (CH3), 
35.1 (CH2), 35.5 (CH3), 58.0 (CH2), 
58.1 (C), 110.4 (CH), 118.7 (CH), 
120.8 (C), 121.9 (CH), 122.1 (CH), 
135.9 (C), 142.9 (C), 150.8 (C), 167.1 
(C). 
Calculated for 
C15H17N4 (M + 
H+): 253.1453, 
Found: 
253.1458. 
Elution system for column chromatography: gradient СНА–EtOAc, 3:7 to СНА–EtOAc–CH2Cl2, 3:14:3. The 2-(1-methyl-1H-benzo[d]imidazol-2-
yl)acetonitrile was partly isolated from the column. 5-Metoxy-1-methyl-3,4-dihydro-2H-pyrrolinium hexafluorophosphate was used for the reaction 
2.19а. Yield 575 mg (2.28 mmol, 57 %), yellow viscous liquid  
2.18a 2-(Benzo[d]oxazol-
2-yl)-2-(1-
methylpyrrolidin-2-
ylidene)acetonitrile 
 
Neat film  
2193 (C≡N), 
1580, 1547 
(С=N, C=C), 
1042 (C–O). 
CDCl3: E isomer 100% HRMS (ESI) 
Calculated for  
C14H14N3O (M + 
H+): 240.1137, 
Found: 
240.1140. 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.11 (quint, J = 7.6, 2H, 4-CH2), 3.50 
(t, J = 8.3, 2H, 3-CH2), 3.52 (s, 3H, 
СН3), 3.69 (t, J = 7.2, 2H, 5-CH2), 
7.20 (t, J = 7.4, 1H, Н-6), 7.26 (t, J = 
7.0, 1H, Н-5), 7.47 (d, J = 7.8, 1H, Н-
7), 7.57 (d, J = 7.6, 1H, Н-4).  
(101 MHz, CDCl3), δ, ppm:  20.0 
(CH2), 36.2 (CH3), 36.5 (CH2), 58.4 
(CH2), 63.1 (C), 109.9 (CH), 118.1 
(CH), 119.0 (C), 123.11 (CH), 123.9 
(CH), 142.6 (C), 149.7 (C), 163.0 (C), 
167.9 (C). 
Yield 760 mg (3.16 mmol, 79 %), white powder (mp 223 °C).  
2.18b 2-(Benzo[d]oxazol-
2-yl)-2-(1-
benzylpyrrolidin-2-
ylidene)acetonitrile 
 
Neat film  
2198 (C≡N), 
1564, 1537 
(С=N, C=C), 
1060 (С–О). 
CDCl3: E isomer 100% HRMS (ESI) 
Calculated for  
C20H18N3O (M + 
H+): 316.1450, 
Found: 316.1451 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.06 (quint, J = 7.6, 2H, 4-CH2), 3.59 
(t, J = 7.0, 4H, 3,5-CH2), 5.18 (s, 3H, 
NBnСН2), 7.15–7.27 (м, 2H, H-5,6), 
7.42–7.28 (м, 5H, HPh), 7.46 (d, J = 
7.7, 1H, H-7), 7.56 (d, J = 7.6, 1H, H-
4).  
(101 MHz, CDCl3), δ, ppm: 20.0 
(CH2), 37.0 ( CH2), 51.7 ( CH2), 55.6 
(CH2), 63.6 (C), 110.0 (CH), 118.2 
(CH), 118.5 (C), 123.3 (CH), 124.0 
(CH), 127.8 (CH), 128.1 (CH), 129.0 
(CH), 135.1 (C), 142. 5 (C), 149.7 
(C), 163.1 (C), 167.3 (C). 
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Yield 1.11 г (3.52 mmol, 88 %), white powder (mp 189–190 °C). 
2.21 2-(Cyano(1-
methylpyrrolidin-2-
ylidene)methyl)-3-
methylbenzo[d]oxaz
ol-3-ium 
hexafluorophosphate 
 
Neat film 2206 
(C≡N), 1551, 
1413 (C=C, 
C=N), 833 (P–F). 
(400 MHz, СD3CN), δ, ppm (J, Hz): 
2.15–2.25 (м, 2H, 4-CH2), 3.30–3.43 
(м, 2H, 3-CH2), 3.50 (s, 3H, NCH3), 
3.98 (t, J = 7.4, 2H, 5-CH2), 4.02 (s, 
3H, NHetCH3), 7.57 (t. d, J = 7.8, 1.6, 
1H, Ar H), 7.62 (td, J = 7.7, 1.3, 1H, 
Ar H), 7.65–7.68 (м, 1H, Ar H), 7.73 
(d d, J = 7.6, 1.0, 1H, Ar H).  
19F NMR (376 MHz, СD3CN), δ, ppm 
(J, Hz): -72.97 (d, 1JF-P = 706.5). 
31P NMR  (162 MHz, СD3CN), δ, 
ppm (J, Hz): -144.64 (sept, 1JP-F = 
706.5). 
 (101 MHz, CD3CN), δ, ppm (J, Hz): 
19.1 (CH2), 33.5 (CH3), 37.6 (CH2), 
37.7 (CH3), 58.0 (C), 60.8 (CH2), 
111.5 (CH), 112.3 (CH), 115.2 (CN), 
126.8 (CH), 127.0 (CH), 131.7 (C), 
146.5 (C), 163.4 (C), 173.9 (C). 
HRMS (ESI) 
Calculated for: 
C15H16N3O+ 
254.1293, 
Found: 
254.1296; 
Calculated for 
PF6- : 144.9642, 
Found 144.9645. 
Yield (over two steps) 0.18 g (0.45 mmol, 30 %), white powder (mp 169–170 °C). 
2.22 2-(Cyano(1-
methylpyrrolidin-2-
ylidene)methyl)-3-
methylbenzo[d]thiaz
ol-3-ium 
hexafluorophosphate 
 
Neat film  
2193 (C≡N), 
1503, 1495, 1456 
(C=C, C=N), 839 
(P–F). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.07 (quint, J = 7.7, 2H, 4-CH2), 3.21 
(t, J = 7.7, 2H, 3-CH2), 3.27 (s, 3H, 
NCH3), 3.91 (t, J = 7.3, 2H, 5-CH2), 
4.03 (c, 3H, NHetCH3), 7.69 (t, J = 7.5, 
1H, Н-6), 7.80 (ddd, J = 8.3, 7.7, 1.2, 
1H, Н-5), 8.06 (d, J = 8.4, 1H, Н-4), 
8.26 (d, J = 8.0, 1H, Н-7). 31P  NMR 
(162 MHz, Acetone-d6), δ, ppm (J, 
Hz):  -144.28 (sept, J = 707.6). 
(75 MHz, DMSO-d6), δ, ppm (J, Hz): 
20.1 (СН2), 37.3 (СН2), 38.2 (СН3), 
38.7 (СН3), 60.4 (СН2), 61.8 (С), 
116.8 (СН), 117.8 (С), 124.0 (СН), 
127.8 (СН), 128.2 (С), 129.4 (СН), 
142.0 (С), 170.7 (С), 171.9 (С). 
HRMS (ESI) 
Calculated for 
C15H16N3S+: 
270.1065, 
Found: 
270.1070; 
Calculated for 
PF6-: 144.9642, 
Found: 
144.9645. 
Yield (over two steps) 0.4 g (0.96 mmol, 64 %), white powder (mp 188–189 °C). 
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General method of 2-hetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles 
synthesis (2.23а-с, 2.25, 2.26). 
Phosphorus pentachloride (1.3 mmol) was added to the strongly stirred 
suspension/solution of 5-R-isatine (1 mmol) in hot benzene (10 ml – 15ml) and the 
resulting mixture was refluxed over 1 hour. At this point, solution of 
hetarylacetonitrile in benzene was added portionwise (the characteristic changing of 
color observed in each case) and the mixture was allowed to cool to room 
temperature upon stirring. The precipitate was then filtrated and washed with ethanol, 
water and again with ethanol. Dry precipitate was purified by filtration through the 
plug of silica gel (eluent: CH2Cl2) 
  
2-(3-methylbenzo[d]thiazol-2(3Н)-ylidene)-2-(3-oxo-3Н-indol-2-yl)acetonitrile 
(2.27a) have been synthesiszed according to the procedure described for the synthesis 
of 2-hetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles (2.23а-с, 2.25, 2.26).  
 
2-(Benzo[d]thiazol-2-yl)-2-(1,5-dimethyl-3-oxoindolin-2-ylidene)acetonitrile 
(2.28b). 
The mixture of 2-benzo[d]thiazol-2-yl-2-(5-R-3-oxoindolin-2-ylidene)acetonitrile 
2.23b (159 mg, 0.5 mmol) and К2СО3 (83 mg, 0.75 mmol) in a minimal quantity of 
dry DMF was strirred at room temperature over 10 min. In the presence of К2СО3 the 
color of solution changes from initial purple to dark-blue.  СH3I (47 µl, d = 2.28 
g/cm3, 0.75 mmol) was added to reaction mixture and stirring was continued over 1h. 
The precipitate was filtrated off and purified by automatic column chromatography 
(elution system: CHA–CH2Cl2, 1:1). Yield 141 mg (0.43 mmol, 85%), dark violet 
powder. 
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Table 6.2.  Physico-chemical characteristics of 2-azahetaryl-2-(5-R-3-oxoindolin-2-ylidene)acetonitriles 2.23, 2.25, 2.26-2.28 
 
Com
poun
d 
ІUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
2.24а (Z)-2-
(Benzo[d]thiazol-2-
yl)-2-(3-oxoindolin-
2-
ylidene)acetonitrile 
 
KBr 
3408 (NH), 2205 
(C≡N), 
1712(C=O), 1589 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
7.16 (td, J = 7.5, 0.8, 1H, HIs-5), 7.50–
7.56 (m, 2H, HBt-5, HIs-7), 7.66 (ddd, 
J = 8.2, 7.8, 1.1, 1H, HBt-6), 7.66–7.71 
(m, 1H, HIs-6), 7.73 (d, J = 7.6, 1H, 4-
HIs), 8.20 (d, J = 8.1, 1.0, 0.6, 1H, H-
7), 8.21 (d, J = 8.0, 1.3, 0.6, 1H, H-4), 
11.55 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm:  80.2 
(C), 114.5 (CH), 116.9 (C), 119.9 (C), 
123.0 (CH), 123.2 (CH), 123.6 (CH), 
125.7 (CH), 126.4 (CH), 127.6 (CH), 
134.3 (C), 138.2 (CH), 143.7 (C), 
151.9 (C), 154.0 (C), 163.4 (C), 185.1 
(C). 
HRMS (ESI) 
Calculated for 
C17H10N3OS (M 
+ H+): 304.0545, 
Found: 
304.0545. 
Yield 236 mg (0.78 mmol, 78%), dark red powder (mp > 300 °С).  
2.24b (Z)-2-
(Benzo[d]thiazol-2-
yl)-2-(5-methyl-3-
oxoindolin-2-
ylidene)acetonitrile 
 
KBr 
3433 (NH), 2204 
(C≡N), 1718 
(C=O). 1596 
(C=C, C=N).  
(400 MHz, DMSO-d6), δ, ppm (J, Hz):  
2.33 (s, 3H, CH3), 7.40 (d, J = 8.2, 1H, 
HIs-7), 7.47–7.53 (m, 2H, HIs-6,, HBt-
5), 7.54 (s, 1H, HIs-4), 7.65 (ddd, J = 
8.2, 7.6, 1.1, 1H, HBt-6), 8.18 (d, J = 
7.8, 1H, HBt-4), 8.20 (d, J = 7.7, 1H, 
HBt-7),  11.48 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm (J, 
Hz):   20.6 (СH3), 79.7 (C), 114.3 
(CH), 116.9 (C), 120.0 (C), 122.9 
(CH), 123.1 (CH), 125.6 (CH), 126.3 
(CH), 127.6 (CH), 133.1 (C), 
134.3(C), 138.8 (CH), 143.9 (C), 
150.0 (C), 154.0 (C), 163.5 (C), 185.1 
(C). 
HRMS (ESI) 
Calculated for 
C18H12N3OS (M 
+ H+): 318.0701, 
Found: 
318.0704. 
Yield 222 mg (0.7 mmol, 70%), dark red powder (mp 300–301 °С).  
2.24с (Z)-2-
(Benzo[d]thiazol-2-
yl)-2-(5-methoxy-3-
oxoindolin-2-
ylidene)acetonitrile 
KBr  
3428 (NH), 2201 
(C≡N), 1702 
(C=O), 1591 
(C=C, C=N), 
1213 (C–O). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
3.81 (s, 1H, OCH3), 7.25 (d, J = 2.2, 
1H, HIs-4), 7.28 (d d, J = 8.6, 2.5, 1H, 
HIs-6), 7.44 (d, J = 8.6, 1H,  HIs-7), 
7.52 (t, J = 7.5, 1H, HBt-6), 7.65 (t, J = 
7.7, 1H, HBt-5), 8.20 (d, J = 8.0, 1H, 
HBt-4), 8.18 (d, J = 8.2, 1H, HBt-7), 
(101 MHz, DMSO-d6), δ, ppm (J, 
Hz): 56.3 (CH3), 79.6 (C), 108.9 
(CH), 115.5 (C), 117.0 (C), 120.4 (C), 
122.9 (CH), 123.1 (CH), 125.2 (CH), 
126.2 (CH), 127.6 (CH), 134.2 (CH), 
144.1 (C), 146.2 (C), 154.1 (C), 156.2 
(C), 163.5 (C), 185.1 (C). 
HRMS (ESI) 
Calculated for 
C18H12N3O2S (M 
+ H+): 334.0650, 
Found: 
334.0647. 
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11.42 (s, 1H, NH). 
Yield 290 mg (0.87 mmol, 87%), dark violet powder (mp 297–298 °С).  
2.25а (Z)-2-
(Benzo[d]oxazol-2-
yl)-2-(3-oxoindolin-
2-
ylidene)acetonitrile 
 
KBr 
3435 (NH), 2214 
(C≡N), 1719 
(C=O). 1596 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
7.16 (td, J = 7.4, 0.8, 1H, HIs-5), 7.47–
7.51 (m, 2H, HBzo-5,6), 7.52–7.55 (m, 
1H), 7.67 (td, J = 7.8, 1.3, 1H, HIs-6), 
7.72 (d, J = 7.5, 1H, HIs-4), 7.83–7.90 
(m, 2H, HBzo-4,7), 11.37 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm:  74.0 
(C), 111.6 (CH), 114.5 (C), 114.6 
(CH), 119.97 (C), 120.01 (CH), 123.8 
(CH), 125.7 (CH), 126.0 (CH), 126.6 
(CH), 138.3 (CH), 141.7 (C), 145.9 
(C), 149.9 (C), 151.7 (C), 159.5 (C), 
184.6 (C). 
HRMS (ESI) 
Calculated for 
C17H10N3O2 (M 
+ H+): 288.0773, 
Found: 
288.0773. 
Yield 221 mg (0.77 mmol, 77%), dark red powder (mp > 300 °С).  
2.26а (E)-2-(3-Oxoindolin-
2-ylidene)-2-
(quinolin-2-
yl)acetonitrile 
 
KBr 
3423 (NH), 2203 
(C≡N), 1712 
(C=O), 1586 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
7.14 (td, J = 7.4, 0.7, 1H, HIs-5), 7.57 
(d, J = 8.0 Hz, 1H, HQ-8), 7.66 – 7.72 
(m, 2H, HIs-6-, HQ-7 ), 7.73 (d, J = 7.5, 
1H, 4-HIs), 7.90 (ddd, J = 8.3, 6.9, 1.4, 
1H, HQ-6), 7.96 (d, J = 8.7, 1H, HQ-3), 
8.04 (d, J = 8.3, 1H, HIs-7), 8.56 (d, J 
= 8.8, 1H, HQ-3), 8.59 (d, J = 8.5, 1H, 
HQ-5), 11.98 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 85.2 
(C), 114.3 (CH), 117.3 (C), 119.7 (C), 
120.3 (CH), 123.1 (CH), 125.5 (CH), 
126.6 (C), 127.9 (CH), 128.3 (CH), 
129.5 (CH), 130.9 (CH), 138.0 (CH), 
138.4 (CH), 144.5 (C), 147.4 (C), 
152.0 (C), 153.2 (C), 185.6 (C). 
HRMS (ESI) 
Calculated for 
C19H12N3O (M + 
H+): 298.0980, 
Found: 
298.0984. 
Yield 250 mg (0.84 mmol, 84%), bright red powder (mp > 300 °С). 
2.27a 2-(3-
methylbenzo[d]thiaz
ol-2(3Н)-ylidene)-2-
(3-oxo-3Н-indol-2-
yl)acetonitrile 
Neat film 
 2197 (C≡N), 
1725 (C=O), 
1511, 1478 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
4.26 (s, 3H, СH3), 7.07–7.14 (m, 1H, 
HIs-5), 7.23 (d, J = 7.7 Hz, 1H, HIs-7), 
7.44–7.49 (m, 1H, HIs-6), 7.49– 7.52 
(m, 1H, HIs-4), 7.55 (td, J = 7.5, 1.2, 
 HRMS (ESI) 
Calculated for 
C18H12N3OS (M 
+ H+): 318.0701, 
Found: 
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1H, HBt-5), 7.64 (ddd, J = 8.5, 7.5, 1.2, 
1H, HBt-6), 7.83 (d, J = 8.4, 1H, HBt-
7), 8.14 (d d, J = 8.0, 0.6, 1H, HBt-4). 
318.0699. 
Yield 225 mg (0.84 mmol, 71%), dark violet powder (mp 270–271 °С). 
2.28b 2-(Benzo[d]thiazol-
2-yl)-2-(1,5-
dimethyl-3-
oxoindolin-2-
ylidene)acetonitrile 
 
Neat film 
 2204 (C≡N), 
1713 (C=O), 
1574 (C=C, 
C=N). 
(400 MHz, CD2Cl2), δ, ppm (J, Hz): 
2.42 (s, 3H, CH3), 3.34 (s, 3H, CH3), 
7.01 (d, J = 8.2, 1H, HIs-7), 7.47–7.53 
(m, 1H, HIs-6, HBt-6), 7.56–7.62 (m, 
1H, HIs-7,), 8.01 (ddd, J = 8.0, 1.2, 
0.6, 1H, HBt-7), 8.11 (ddd, J = 8.2, 1.2, 
0.6, 1H, НBt-4). 
(101 MHz, CD2Cl2), δ, ppm: 20.3 
(СН3), 35.3 (СН3), 82.0 (С), 110.4 
(СН), 117.6 (С), 119.9 (С), 121.7 
(СН), 123.4 (СН), 125.5 (СН), 126.0 
(СН), 126.7 (СН), 133.5 (С), 136.0 
(С), 138.2 (СН), 146.1 (С), 151.9 (С), 
153.4 (С), 160.8 (С), 184.4 (С). 
HRMS (ESI) 
Calculated for 
C19H14N3OS (M 
+ H+): 332.0858, 
Found: 
332.0858. 
Elution system for column chromatography: CHA–CH2Cl2, 1:1. Yield 141 mg (0.43 mmol, 85%), dark violet powder.  
174 
 
General procedure for the synthesis of 3-(ω-aminopropyl)-4-hetaryl-5-
aminopyrazole (or isoxazole) 3.1-3.7. 
10-20 equiv of binucleophile (NH2NH2•Н2О or NH2OH (50% water solution) or 
NH2NHMe) were added to a strongly stirred solution of 2-hetaryl-(N-R-pyrrolidin-2-
ylidene)acetonitrile (1 mmol) in dioxane (10 ml). The reaction mixture was then 
heated to reflux for 3−8 h (TLC control, elution system: CHCl3−CH3OH, 20:1 unless 
otherwise noted), cooled down, and concentrated under reduced pressure. Purification 
by column chromatography (for 3.4b, 3.5b) or by trituration with a minimal quantity 
of acetone (for 3.1а, 3.1b, 3.2а, 3.7а) or acetonitrile (for 3.1с, 3.2с) or water–acetone 
(for 3.6а) yielded the desired product. 
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Table 6.3.  Physico-chemical characteristics of 3-(ω-aminopropyl)-4-hetaryl-5-aminopyrazole (or isoxazole) 3.1-3.7.   
 
Com
poun
d 
ІUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
3.1a 4-(Benzo[d]thiazol-
2-yl ) - 1-methyl -3-
(3- 
(methylamino)propyl
)-1H-pyrazol-5-
amine 
 
Neat film  
3376, 3292 (NH, 
NH2ν), 1623 
(NH2δ), 1564, 
1536 (C=C, 
C=N). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.98 (quint, J = 7.4 Hz, 2H, 2-СН2), 
2.48 (s, 3H, NHCH3), 2.76 (t, J = 7.1 
Hz, 2H, 1-СН2), 2.85−2.97 (m, 2H, 3-
СН2), 3.66 (s, 3H, NCH3), 5.77 (s, 2H, 
NH2), 7.28 (dd, J = 7.1, 1.3, 1H, Н-6), 
7.43 (dd, J = 7.2, 1.3, H-5), 7.84 (d, J 
= 7.7, 1H, Н-7), 7.88 (d, J = 8.0, 1H, 
Н-4). 
(101 MHz, CDCl3), δ, ppm:  26.2 
(CH2), 28.8 (CH2), 33.8 (CH3), 36.5 
(CH3), 51.9 (CH2), 97.9 (C), 121.08 
(CH), 121.09 (CH), 123.5 (CH), 125.9 
(CH), 132.4 (C), 147.1 (C), 149.5 (C), 
152.7 (C), 162.2 (C). 
HRMS (ESI) 
Calculated for 
C15H20N5S (M + 
H+): 302.1451, 
Found: 
302.1446. 
Yield 187 mg (0.62 mmol, 62%), white powder (mp 158−159 °C). The reaction was directly scaled up to 12.61 g of starting material affording 10.3 g 
(85% yield) of the desired product. 
3.1b 4-(Benzo[d]thiazol-
2-yl)-3-(3-
(benzylamino)propyl
)- 
1-methyl-1H-
pyrazol-5-amine 
 
Neat film 
3391, 3298 (NH, 
NH2ν), 1622 
(NH2δ), 1539 
(C=C, C=N). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.05 (quint, 7.4, 2H, 2-СН2), 2.82 (t, J 
= 7.4, 2H, 1-СН2), 2.95 (t, 7.8, 2H, 3-
СН2), 3.58 (s, 3H, СН3), 4.04 (s, 2H, 
NCH2), 6.86 (s, 2H, NH2), 7.31 (ddd, J 
= 8.4, 7.5, 0.9, 1H, Ar H), 7.52−7.35 
(m, 6H, Ar H), 7. 89 (d, J = 7.9, 1H, 
Н-7), 8.00 (d, J = 7.5, 1H, Н-4). 
(75 MHz, CD3OD), δ, ppm: 25.4 
(CH2), 26.1 (CH2), 33.9 (CH3), 47.9 
(CH2), 52.1 (CH2), 97.8 (C), 121.9 
(2CH), 124.6 (CH), 127.0 (CH), 130.0 
(2CH), 130.3 (CH), 130.6 (2CH), 
132.7 (C), 133.2 (C), 148.7 (C), 149.6 
(C), 153.8 (C), 162.6 (C). 
HRMS (ESI) 
Calculated for 
C21H24N5S (M + 
H+): 378.1752, 
Found: 
378.1747. 
Yield 264 mg (0.70 mmol, 70%), white powder (mp 192−193 °C).  
3.1c 4-(Benzo[d]thiazol- Neat film  (300 MHz, CDCl3), δ, ppm (J, Hz): (101 MHz, CDCl3), δ, ppm: 6.3 HRMS (ESI) 
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2-yl)-3-(3-
(cyclopropylamino)- 
propyl)-1-methyl-
1H-pyrazol-5-amine 
 
3396, 3376, 3292 
(NH, NH2ν), 
1623 (NH2δ), 
1563, 1540 
(C=C, C=N). 
0.33−0.41 (m, 2H, NCHCH2), 
0.41−0.48 (m, 2H, NCHCH2), 1.99 
(quint, J = 7.6, 2H, 2-СН2), 2.13−2.23 
(m, 1H, NCHCH2), 2.87 (t, J = 7.2, 
2H, 1-СН2), 2.91 (t, J = 7.7, 2H, 3-
СН2), 3.68 (s, 3H, СН3), 5.76 (s, 2H, 
NH2), 7.29 (ddd, J = 8.2, 7.6, 1.2, 1H, 
Н-6), 7.44 (ddd, J = 8.2, 7.3, 1.3, 1H, 
Н-5), 7.85 (dd, J = 8.0, 1.3, 1H, Н-7), 
7.89 (dd, J = 8.2, 1.2, 1H, Н-4) 
(2CH2), 26.2 (CH2), 28.9 (CH2), 30.2 
(CH3), 33.8 (CH), 49.3 (CH2), 97.9 
(C), 121.07 (CH), 121.10 (CH), 123.5 
(CH), 125.9 (CH), 132.4 (C), 147.1 
(C), 149.5 (C), 152.7 (C), 162.2 (C). 
Calculated for 
C17H22N5S (M + 
H+): 328.1596, 
Found: 
328.1592. 
Yield 203 mg (0.62 mmol, 62%), white powder (mp 171 °C).  
3.2a 4-(Benzo[d]thiazol-
2-yl)-3-(3-
(methylamino)propyl
)- 
1H-pyrazol-5-amine 
 
Neat film 
3311 (NH, 
NH2ν), 1624 
(NH2δ), 1580, 
1543 (C=C, 
C=N). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.74−1.91 (m, 2H, 2-СН2), 2.29 (s, 
3H, NCH3), 2.57 (t, J = 6.9, 2H, 1-
СН2), 2.76−2.91 (m, 2H, 3-СН2), 6.23 
(s, 2H, NH2), 7.30 (ddd, J = 7.6, 7.3, 
1.1, 1H, Н-6), 7.44 (ddd, J = 8.0, 7.7, 
1.3, 1H, Н-5), 7.87 (d, J = 8.0, 1H, Н-
7), 8.01 (d, J = 7.8, 1H, Н-4). 
(75 MHz, DMSO-d6) δ 25.2 (CH2), 
28.5 (CH2), 36.6 (CH3), 51.7 (CH2), 
97.4 (C), 121.3 (CH), 122.0 (CH), 
124.0 (CH), 126.6 (CH), 132.4 (C), 
146.4 (C), 153.0 (2C), 162.6 (C). 
HRMS (ESI) 
Calculated for 
C14H18N5S (M + 
H+): 288.1283, 
Found: 
288.1281. 
Yield 161 mg (0.56 mmol, 56% ), light orange powder (mp 205 °C). 
3.2c 4-(Benzo[d]thiazol-
2-yl)-3-(3-
(cyclopropylamino)- 
propyl)-1H-pyrazol-
5-amine 
Neat film  
3411, 3291, 3197 
(NH, NH2ν), 
1602 (NH2δ), 
1539, 1540, 1496 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
0.20−0.32 (m, 2H, NCHCH2), 
0.34−0.47 (m, 2H, NCHCH2), 1.85 
(quint, J = 7.3, 2H, 2-СН2), 2.08−2.18 
(m, 1H, NCHCH2), 2.72 (t, J = 7.0, 
2H, 1-СН2), 2.83 (t, J = 7.4, 2H, 3-
СН2), 6.25 (s, 2H, NH2), 7.31 (t, J = 
7.5, 1H, Н-6), 7.45 (t, J = 7.6, 1H, Н-
5), 7.87 (d, J = 8.0, 1H, Н-7), 8.02 (d, 
(101 MHz, DMSO-d6), δ, ppm:  6.1 
(2CH2), 25.2 (CH2), 28.2 (CH), 30.5 
(CH2), 49.0 (CH2), 97.8 (C), 121.2 
(CH), 122.0 (CH), 124.0 (CH), 126.6 
(CH), 132.3 (C), 146.9 (C), 152.9 
(2C), 162.3 (C). 
HRMS (ESI) 
Calculated for 
C16H20N5S (M + 
H+): 314.1439, 
Found: 
314.1438. 
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J = 7.8, 1H, Н-4). 
Yield 134 mg (0.43 mmol, 43%), whitish powder (mp 121−123 °C).  
3.3a 4-(1H-
Benzo[d]imidazol-2-
yl)-1-methyl-3-(3- 
(methylamino)propyl
)-1H-pyrazol-5-
amine 
 
Neat film 
3306, 3206 (NH, 
NH2ν), 1622 
(NH2δ), 1580 
(C=C, C=N). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.95 (quint, J = 6.9, 1H, 2-СН2), 2.45 
(s, 3H, NHСН3), 2.79 (t, J = 6.7, 2H, 
1-СН2), 2.92 (t, J = 7.2, 2H, 3-СН2), 
3.58 (s, 3H, NСН3), 6.54 (s, 2H, NH2), 
7.04−7.16 (m, 2H, Ar H), 7.46−7.57 
(m, 2H, Ar H). 
(75 MHz, DMSO-d6), δ, ppm (J, Hz): 
25.0 (CH2), 26.2 (CH2), 33.8 (CH3), 
34.5 (CH3), 48.7 (CH2), 92.4 (C), 
114.5 (2CH), 121.3 (2CH), 146.5 
(2C), 148.6 (2C), 149.3 (C). 
HRMS (ESI) 
Calculated for 
C15H21N6 (M + 
H+): 285.1828, 
Found: 
285.1825. 
Elution system for column chromatography (and TLC): CHCl3−CH3OH, 10:3. Further trituration of the obtained yellowish oil with acetone induces its 
consolidation. Yield 186 mg (0.65 mmol, 65%), whitish powder (mp 181−183 °C).  
3.3b 4-(1H-
Benzo[d]imidazol-2-
yl)-3-(3-
(benzylamino)- 
propyl)-1-methyl-
1H-pyrazol-5-amine 
Neat film  
3301 (NH, 
NH2ν), 1623 
(NH2δ), 1579 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.84 (quint, J = 6.7, 2H, 2-СН2), 2.55 
(t, J = 6.4, 2H, 1-СН2), 2.84 (t, J = 7.0, 
2H, 3-СН2), 3.56 (s, 3H, СН3), 3.74 (s, 
2H, NCH2), 6.49 (s, 2H, NH2), 
7.01−7.08 (m, 2H, Ar H), 7.22−7.29 
(m, 1H, Ar H), 7.29−7.40 (m, 6H, Ar 
H).   
(101 MHz, DMSO-d6), δ, ppm: 24.8 
(CH2), 28.8 (CH2), 34.4 (CH3), 46.8 
(CH2), 52.7 (CH2), 92.6 (C), 121.2 
(2CH), 127.2 (CH), 128.7 (6CH), 
140.3 (3C), 147.2 (C), 148.6 (C), 
149.7 (C). 
HRMS (ESI) 
Calculated for 
C21H25N6 (M + 
H+): 361.2141, 
Found: 
361.2140. 
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Elution system for column chromatography (and TLC): CHCl3−CH3OH, 10:3.  Further trituration of the obtained oil with acetone induces its 
consolidation. Yield 234 mg (0.65 mmol, 65%), whitish powder (mp 135 °C). 
3.4b 3-(3-
(Benzylamino)propyl
)-1-methyl-4-
(quinolin-2- 
yl)-1H-pyrazol-5-
amine 
 
Neat film 
3261 (NHν, 
NH2ν), 1619 
(NH2δ), 1599, 
1547, 1518 
(C=C, C=N). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
2.01 (quint, J = 7.0, 2H, 2-СН2), 2.82 
(t, J = 6.8, 2H, 1-СН2), 2.98 (t, J = 7.5, 
2H, 3-СН2), 3.57 (s, 3H, СН3), 3.84 (s, 
2H, NCH2Рh), 6.04 (s, 2H, NH2), 
7.23−7.38 (m, 5H, H Ph), 7.41 (ddd, J 
= 8.1, 7.0, 1.2, 1H, H-6), 7.56 (d, J = 
8.8, 1H, H-3), 7.64 (ddd, J = 8.4, 6.9, 
1.5, 1H, H-7), 7.71 (dd, J = 8.1, 1.2, 
1H, H-8), 7.91 (d, J = 8.4, 1H, Н-5), 
8.01 (d, J = 8.8, 1H, Н-4). 
(101 MHz, CDCl3), δ, ppm: 27.5 
(CH2), 28.1 (CH2), 33.6 (CH3), 48.8 
(CH2), 53.4 (CH2), 100.8 (C), 118.9 
(CH), 124.8 (CH), 125.3 (C), 127.2 
(CH), 127.4 (CH), 127.8 (CH), 128.3 
(2CH), 128.4 (2CH), 129.5 (CH), 
136.1 (CH), 139.2 (C), 147.4 (C), 
147.8 (C), 148.9 (C), 154.8 (C). 
HRMS (ESI) 
Calculated for 
C23H26N5 (M + 
H+): 372.2188, 
Found: 
372.2181. 
Elution system for column chromatography: CHCl3−CH3OH, 20:1.  Further trituration of the obtained oil with acetone induces its consolidation. Yield 
204 mg (0.55 mmol, 55%), yellow powder (mp 170–171°C). 
3.5b 3-(3-
(Benzylamino)propyl
)-4-(quinolin-2-
yl)isoxazol- 
5-amine 
Neat film  
3327 (NHν, 
NH2ν), 1631 
(NH2δ), 1598, 
1541 (C=C, 
C=N), 1294 
(C−O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.06 (quint, J = 7.0, 2H, 2-СН2), 2.85 
(t, J = 6.9 Hz, 2H, 1-СН2), 3.06 (t, J = 
7.5, 2H, 3-СН2), 3.86 (s, 2H, , 
NCH2Рh), 7.03 (s, 2H, NH2), 
7.24−7.31 (m, 1H, HPh-4), 7.32−7.42 
(m, 4H, H Ph), 7.46 (ddd, J = 8.1, 7.0, 
1.1, 1H, Н-6), 7.55 (d, J = 8.8, 1H, Н-
3), 7.68 (ddd, J = 8.4, 6.9, 1.5, 1H, Н-
7), 7.75 (dd, J = 8.2, 1.0, 1H, Н-8), 
(75 MHz, CDCl3), δ, ppm: 25.4 
(CH2), 27.0 (CH2), 48.4 (CH2), 53.6 
(CH2), 91.7 (C), 117.9 (CH), 125.2 
(CH), 125.5 (C), 127.2 (CH), 127.5 
(CH), 127.8 (CH), 128.3 (2CH), 128.5 
(2CH), 129.8 (CH), 136.5 (CH), 139.4 
(C), 147.3 (C), 152.5 (C), 161.3 (C), 
169.2 (C). 
HRMS (ESI) 
Calculated for 
C22H23N4O (M + 
H+): 359.1872, 
Found: 
359.1862. 
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7.93 (d, J = 8.4, 1H, Н-5), 8.08 (d, J = 
8.7, 1H, Н-4). 
Elution system for column chromatography: CHCl3−CH3OH, 20:1. Yield 204 mg (0.5 mmol, 50%), light orange powder (mp 125–126°C).  
3.6a 2-(5-Amino-1-
methyl-3-(3-
(methylamino)propyl
)- 
1H-pyrazol-4-
yl)quinazolin-4(3H)-
one 
 
Neat film  
3358, 3284 
(NHν, NH2ν), 
1668 (C=O), 
1575, 1557, 
(NH2δ, C=C, 
C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz):  
1.93 (quint, J = 6.8, 2H, 2-СН2), 2.38 
(s, 3H, NHСН3), 2.55 (t, J = 5.7, 2H, 
1-СН2), 2.83 (t, J = 6.3, 2H, 3-СН2), 
3.55 (s, 3H, NСН3), 6.65 (s, 2H, NH2), 
7.22 (dd, J = 8.3, 7.4, 1H, H-6), 7.48 
(d, J = 8.0, 1H, H-8),7.59 (ddd, J = 
8.4, 7.6, 1.4, 1H, 7-H), 7.99 (dd, 1.2, 
1H, 5-H), 9.53 (br. s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 23.4 
(CH2), 27.6 (CH2), 33.4 (CH3), 34.4 
(CH3), 46.9 (CH2), 98.5 (C), 120.5 
(C), 123.5 (CH), 125.8 (CH), 126.0 
(CH), 133.1 (CH), 146.9 (C), 149.0 
(C), 150.7 (C), 156.2 (C), 167.2 (C). 
HRMS (ESI) 
Calculated for 
C15H21N6 (M + 
H+): 313.1777, 
Found: 
313.1772. 
Yield 194 mg (0.62 mmol, 62%), white powder (mp 173 °C).  
3.7a 2-(5-Amino-3-(3-
(methylamino)propyl
)isoxazol-4- 
yl)quinazolin-4(3H)-
one  
Neat film 3347, 
3284 (NHν, 
NH2ν), 1633 
(C=O), 1607, 
1571 (NH2δ, 
C=C, C=N), 
1243 (C−O).   
(400 MHz, DMSO-d6), δ, ppm (J, Hz):  
1.92−2.07 (m, 2H, 2-СН2), 2.51 (s, 
3H, CH3), 2.75−2.83 (m, 2H, 1-СН2), 
2.92−3.03 (m, 2H, 3-СН2), 7.18 (t, J = 
7.2, 1H, Н-6), 7.51 (d, J = 7.6, 1H, Н-
8), 7.54 (t, J = 7.2, 1H, Н-7), 7.96 (d, J 
= 7.0, 1H, Н-5), 8.04 (s, 2H, NH2). 
(101 MHz, DMSO-d6), δ, ppm: 21.7 
(CH2), 26.6 (CH2), 33.0 (CH3), 47.0 
(CH2), 90.3 (C), 120.8 (C), 123.2 
(CH), 125.7 (CH), 126.0 (CH), 132.4 
(CH), 151.1 (C), 157.0 (C), 160.8 (C), 
169.5 (C), 170.5 (C). 
HRMS (ESI) 
Calculated for 
C15H18N5O2 (M 
+ H+): 300.1460, 
Found: 
300.1462. 
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Yield 224 mg (0.75 mmol, 75%), light orange powder (mp 171–172 °C).  
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3-(5-Amino-4-(benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)-N,N,N-
trimethylpropan-1-aminium iodide (3.8). 
MeI (0.137 ml, d = 2.28 g/ml, 2.2 mmol) was added dropwise to a stirred solution of 
4-(benzo[d]thiazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-pyrazol-5-amine 
3.1a (301 mg, 1 mmol) and MeONa (54 mg, 1 mmol) in MeOH (6 ml). Stirring was 
pursued for 3 h. The resulting white precipitate (mp 249−250 °C) was filtered off and 
analyzed without additional purification steps. We observed complete conversion of 
the starting material to the desired product but we suspected the presence of NaI.  
 
tert-Butyl (3-(4-(benzo[d]thiazol-2-yl)-5-(benzylamino)-1-methyl-1H-pyrazol-3-
yl)propyl)(methyl)carbamate (3.10). 
Di-tert-butyl dicarbonate (120 mg, 0.55 mmol) was added to a stirred solution of 4-
(benzo[d]thiazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-pyrazol-5-amine 
3.1a (151 mg, 0.5 mmol) in trifluoroethanol (TFE) (3 ml) at rt. The reaction was 
completed in 10 min. After evaporation of volatiles under reduced pressure, the crude 
product was purified by automated flash chromatography (elution system: gradient of 
CH2Cl2−acetone, 9:1 to CH2Cl2−acetone, 2:3) to yield 187 mg (0.47 mmol, 93%) of 
white solid (mp 129−130 °C).  
A suspension of tert-butyl (3-(5-amino-4-(benzo[d]thiazol-2-yl)-1-methyl-1H-
pyrazol-3-yl)propyl)(methyl)carbamate (187 mg, 0.47 mmol), AcOH (0.05 ml, 0.94 
mmol), benzaldehyde (0.06 ml, 0.56 mmol), and activated molecular sieves in 
toluene (5 ml) was stirred in a sealed vessel overnight at 120 °C. At this point, two 
spots were detected by TLC (CH2Cl2−acetone, 9:1) corresponding to the reactant (Rf 
= 0.27) and the desired imine (Rf = 0.67 (bright yellow spot)). The reaction was 
broken off at that point, filtrated through a plug of celite, and the liquid was 
concentrated under reduced pressure. The obtained solid was redissolved in dry 
ethanol (5 ml) and 3 equiv of NaBH4 (53 mg, 1.4 mmol) was subsequently added. 
The reaction was stirred for 30 min at rt (during this time, the color of the reaction 
mixture changed from yellow to white due to reduction of the imine to amine) under 
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Ar. Dilution of the reaction mixture with ethanol, filtration through a plug of Celite, 
and concentration under reduced pressure gave a mixture of 3.1a and 3.10 in 100% 
yield. After compound separation by automated flash chromatography (elution 
system:gradient of CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 9:1), secondary amine 
3.10 was obtained as a colorless oil (108 mg, 0.22 mmol, 47%).  
 
N-(3-(3,5-Dimethyl-3H-benzo[4,5]imidazo[1,2-c]-pyrazolo[4,3-e]pyrimidin-1-
yl)propyl)-N-methylacetamide (3.11).  
A solution of 4-(1H-benzo[d]imidazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-
1H-pyrazol-5-amine 3.3a (142 mg, 0.5 mmol) in 1,1,1-triethoxyethane (10 ml) was 
refluxed for 20 min, and Ac2O (0.47 ml, d= 1.087 g/ml, 5 mmol) was added to the 
reaction mixture at this point. After another 5 min of stirring, the reaction ceased 
(TLC elution system: CHCl3−acetone, 2:1) and the mixture was concentrated under 
reduced pressure. The crude product was purified by automated flash 
chromatography (elution system: gradient of CHCl3−acetone, 2:1) to yield 152 mg 
(0.43 mmol, 87%) of white solid (mp 97−98 °C). 
 
N-Methyl-N-(3-(3-methyl-3H-benzo[4,5]imidazo- 
[1,2-c]pyrazolo[4,3-e][1,2,3]triazin-1-yl)propyl)nitrous amide (3.12) 
t-BuONO (0.12 ml, d = 0.867 g/ml, 1 mmol) was added dropwise to a strongly 
stirred solution of 4-(1H-benzo[d]-imidazol-2-yl)-1-methyl-3-(3-
(methylamino)propyl)-1H-pyrazol-5-amine 3.3a (142 mg, 0.5 mmol) in DMF (5 ml, 
65 °C), and the gas evolution was observed by bubble counter. After 10 min of 
stirring, TLC control (CH2Cl2−acetone, 9:1) indicated the presence of two spots 
corresponding to the starting material and new product. The pH of the reaction 
mixture was slightly basic. Another portion of t-BuONO (0.24 ml, 2 mmol) was 
added dropwise, and the pH of the reaction mixture turned to acidic (pH ∼ 3). After 
10 min of stirring, another TLC control was made to ensure the conversion of starting 
material and formation of one main product. The reaction mixture was allowed to 
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cool to rt, and pH was brought to neutral−slightly basic by addition of saturated aq. 
NaHCO3. This aqueous phase was extracted with EtOAc (three times), and collected 
organic extracts were washed with brine and dried over MgSO4. The solution was 
concentrated under reduced pressure and the residue was purified by automated flash 
chromatography (elution system: CH2Cl2−acetone, 19:1) to yield 137 mg (0.42 mmol, 
85%) of 3.12 as a bright yellow solid (mp 163−164 °C).  
Note: 1) the aliquot for TLC was taken from the reaction mixture followed by 
addition of saturated aq. NaHCO3 to make pH neutral−slightly basic and extraction 
with EtOAc. 2) The solution of t-BuONO is acidic when purchased from commercial 
sources. Its acidity is enough to generate the nitrosonium ion and bring the reaction to 
completion.  
 
 N-(3-(4-(Benzo[d]thiazol-2-yl)-5-iodo-1-methyl-1H-pyrazol-3-yl)propyl)-N-
methylnitrous amide (3.13). 
 t-BuONO (0.6 ml, d = 0.876 g/ml, 5 mmol) was added dropwise to a stirring 
suspension of 3.1a (301 mg, 1 mmol) and I2 (1.1 g, 4.3 mmol) in acetonitrile (10 ml) 
at 65 °C. After stirring for 20 min, the mixture was cooled to room temperature, and 
saturated aq. Na2S2O3 was added. The mixture was extracted three times with ethyl 
acetate, and the combined organic extracts were washed with saturated aq. NaCl and 
dried over MgSO4. Evaporation of volatiles under reduced pressure and further 
purification by automated flash chromatography (elution system: CH2Cl2−acetone, 
19:1) yielded 168 mg of 3.13 (0.38 mmol, 38%) as a light orange solid (mp 104−105 
°C). The reaction was directly scaled up to 1.8 g (6 mmol) of starting material, 
affording 0.83 g (32% yield) of the desired product. 
 
3-(4-(Benzo[d]thiazol-2-yl)-5-iodo-1-methyl-1H-pyrazol-3-yl)-N-methylpropan-
1-amine (3.14a). 
p-TsOH monohydrate (1.52 g, 8 mmol) was added portionwise to a strongly stirred 
solution of 4-(benzo[d]thiazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-
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pyrazol-5-amine 3.1a (0.602 g, 2 mmol) in MeCN 10 (ml), and the reaction mixture 
was stirred over a 5 min period. The flask was then cooled to 0 °C in an ice-water 
bath and KI (0.83 g, 5 mmol), CuI (1 mg, 0.005 mmol), and t-BuONO (0.302 ml, d = 
1.368 g/ml, 4 mmol) were added subsequently to the reaction mixture. The  solution 
was stirred at 0 °C for 20 min then allowed to warm to rt, and stirring was continued 
for a further 2 h. Then, the reaction mixture was quenched with water (30 ml), 5% aq. 
Na2S2O3 solution (30 ml), and saturated aq. NaHCO3 solution to reach pH 8−9. This 
mixture was transferred to a separatory funnel, and the aqueous phase was extracted 
with EtOAc (3 × 50 ml). The combined organic extracts were dried over anhydrous 
MgSO4, filtered, and then concentrated under reduced pressure. The crude mixture 
was purified by automated flash chromatography (elution system: gradient of 
CHCl3−Et3N,10:1 to CHCl3−Et3N−CH3OH, 10:1:0.2) to give 0.247 g (0.6 mmol, 
30%) of 3.14a as a white solid (mp 189 °C) after trituration of the residues with 
MeCN. The reaction was directly scaled up to 1.8 g (6 mmol) of starting material, 
affording 0.74 g (30% yield) of the desired product. 
 
tert-Butyl (3-(4-(Benzo[d]thiazol-2-yl)-5-iodo-1-methyl-1H-pyrazol-3-
yl)propyl)(methyl)carbamate (3.15). 
 Ditert-butyl dicarbonate (120 mg, 0.55 mmol) was added to a stirred solution of 22 
(206 mg, 0.5 mmol) in TFE (3 ml) at rt followed by the addition of NaOMe (30 mg, 
0.55 mmol). The reaction was completed in 30 min. After evaporation of volatiles 
under reduced pressure, the crude product was purified by automated flash 
chromatography (elution system: gradient of CH2Cl2−acetone, 19:1 to 
CH2Cl2−acetone, 9:1) to yield 179 mg (0.35 mmol, 70%) of 3.15 as a white solid (mp 
122 °C).  
 
General Procedure for the Synthesis of R-(3-(4-(Benzo[d]thiazol-2-yl)-5-
aryl/hetaryl/styryl-1-methyl-1Hpyrazol-3-yl))propyl-1-amine (3.16−3.20).  
N-(3-(4-(Benzo[d]-thiazol-2-yl)-5-iodo-1-methyl-1H-pyrazol-3-yl)propyl)-N-
methylpropan-1-amine 3.14a/ N-methylnitrous amide 3.13/ tert-butyl-
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(methyl)carbamate 3.15 (0.15 mmol), boronic acid (3.16a-c, 3.17)/ its diethanolamine 
ester (3.18, 3.19)/ trifluoroborate salt (3.20) (0.17 mmol), Cs2CO3 (64 mg, 0.18 
mmol), and Pd(PPh3)4 (9 mg, 0.0075 mmol) were placed in a two-necked flask fitted 
with a water condenser and rubber septum. The system was evacuated and back-filled 
with argon. This sequence was repeated three times. Dioxane−H2O, 5:1 mixture 
(8 ml) was degassed beforehand by the Freeze−Pump−Thaw method and transferred 
to the reaction vessel under a positive pressure of argon. The resulting mixture was 
stirred under argon at 110 °C overnight. After cooling to room temperature, the 
reaction mixture was diluted with H2O, transferred to the separatory funnel, and 
extracted three times with EtOAc. The filtrate was concentrated under reduced 
pressure, and the residue was purified by automated flash chromatography. Reaction 
conditions for 3.20: teflon reactor, 140 °C, 24 h. Note: indole was implemented into 
the reaction in the form of trifluoroboronate salt with nitrogen protected with tert-
butyloxycarbonyl. 
  
N-(3-(4-(Benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)propyl)-N-
methylnitrous Amide (3.21).  
t-BuONO (0.24 ml, d = 0.867 g/ml, 2 mmol) was added dropwise to a strongly stirred 
solution of 4-(benzo[d]thiazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-
pyrazol-5-amine 3.1a (0.301 g, 1 mmol) in DMF (5 ml, 65 °C), and the gas evolution 
was observed by bubble counter. After 10 min of stirring, the TLC control (CH2Cl2−
acetone, 9:1) indicated the presence of two spots corresponding to the starting 
material and new product. The pH of the reaction mixture was slightly basic. Another 
portion of t-BuONO (0.48 ml, 4 mmol) was added dropwise, and the pH of the 
reaction mixture turned to acidic (pH ∼ 3). After 10 min of stirring, another TLC 
control was made to ensure the conversion of starting material and formation of one 
main product. The reaction mixture was allowed to cool to rt, and pH was brought to 
neutral−slightly basic by addition of saturated aq. NaHCO3. This aqueous phase was 
extracted with EtOAc (three times), and collected organic extracts were washed with 
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brine and dried over MgSO4. The solution was concentrated under reduced pressure, 
and the residue was purified by automated flash chromatography (system: gradient 
of EtOAc−CHA, 7:3 to EtOAc, 100%) to yield 290 mg (0.92 mmol, 92%) of white 
solid (mp 72−73 °C). 
 
3-(4-(Benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)-N-methylpropan-1-
aminium chloride (3.22). 
HCl gas (generated by dropwise addition of H2SO4 on solid NaCl) was bubbled 
vigorously through an ice-cold solution of N-(3-(4-(benzo[d]thiazol-2-yl)-1-methyl-
1H-pyrazol-3-yl)propyl)-N-methylnitrous amide 3.21 (158 mg, 0.5 mmol) in dry 
methanol (8 ml) for 20 min. The resultant precipitate was filtered off and washed 
with ether to yield 157 mg (0.485 mmol, 97%) of white solid (mp 152−153 °C). 
 
N-(3-(4-(Benzo[d]thiazol-2-yl)-5-(4-methoxyphenyl)-1-methyl-1H-pyrazol-3-
yl)propyl)-N-methylnitrous Amide (3.16c). 
N-(3-(4-(Benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)propyl)-N-methylnitrous 
amide 3.21 (95 mg, 0.3 mmol), Pd(OAc)2 (3.4 mg, 0.015 mmol), and Bu4NOAc 
(181 mg, 0.6 mmol) were placed in a flame-dried two-necked flask fitted with a water 
condenser and rubber septum. The system was evacuated and back-filled with argon. 
This sequence was repeated three times. DMA (3 ml) and 4-bromoanisole (0.06 ml, d 
= 1.494 g/ml, 0.45 mmol) were sequentially added under a stream of argon at room 
temperature. The resulting mixture was stirred at 70 °C for 24 h. After cooling to 
room temperature, the reaction mixture was diluted with EtOAc, filtered through a 
plug of Celite, and eluted with additional EtOAc. The filtrate was concentrated under 
reduced pressure, and the residue was purified using automated flash chromatography 
(system: gradient of CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 9:1) to yield 126 mg 
(0.3 mmol, 100%) of 3.16c as a light orange solid (mp 140 °C). 
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Pyrazoles 3.23-3.28, 3.30 and amide 3.31a were obtained according to the general 
procedure described for 3-(ω-aminopropyl)-4-hetaryl-5-aminopyrazoles (isoxazoles) 
3.1-3.7. Note: for pyrazoles 3.27, 3.28, 3.30 that were synthesized from 
pyrrolidinacetonitriles substituted with quaternized azaheterocycles the solvent for 
reaction is EtOH. The reaction continues during 2-3 h.  
 
General procedure for the synthesis of 5-(2-amino-1-(1,3-dimethyl-1H-
benzo[d]imidazol-2(3H)-ylidene)-2-oxoethyl)-1-methyl-3,4-dihydro-2H-pyrrol-1-
ium iodide chloride (3.31b). 
The strongly stirred mixture of 2-(cyano(1-methylpyrrolidin-2-ylidene)methyl)-1,3-
dimethyl-1H-benzo[d]imidazol-3-ium iodide 2.8 (0.3 mmol, 118 mg) and 20 equiv of 
2.5 M NaOH in ethanol (3 ml) was refluxed over 3 h period. At this point the reaction 
was cooled down and treated with 1M HCl to slightly acidic pH (pH around 6). The 
reaction mixture was concentrated under reduced pressure and the solid precipitate 
was triturated with dry ethanol. The precipitate was filtered off and the mother liquid 
was collected, concentrated under reduced presure and triturated with minimal 
quantity of ethanol.  After another filtration–mother liquid collection–concentration 
3.31b was obtained as a beige solid (71 mg, 0.22 mmol,73%). 
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Table 6.4.  Physico-chemical characteristics of 3-(ω-aminopropyl)-4-hetaryl-5-aminopyrazole derivatives 3.8-3.30 and amide 
3.31. 
Com
poun
d 
IUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
3.8 3-(5-Amino-4-
(benzo[d]thiazol-2-
yl)-1-methyl-
1Hpyrazol- 
3-yl)-N,N,N-
trimethylpropan-1-
aminium iodide  
S
N N
N
H2N
N I
 
Neat film  
3393 (NH2ν), 
1614 (NH2δ), 
1563, 1535 
(C=C, C=N). 
(400 MHz, methanol-d4), δ, ppm (J, 
Hz): 2.21−2.36 (m, 2H, 2-СН2), 2.96 
(t, J = 7.3, 2H, 3-СН2), 3.17 (s, 9H, 3-
СН3), 3.48−3.59 (m, 2H, 1-СН2), 3.65 
(s, 3H, NCH3), 7.30 (ddd, J = 8.2, 7.6, 
1.2, 1H, H-6), 7.45 (ddd, J = 8.2, 7.3, 
1.3, 1H, H-5), 7.86−7.93 (m, 2H, H-
4,7). 
(101 MHz, methahol-d4), δ, ppm (J, 
Hz):  21.3 (CH2), 24.3 (CH2), 32.8 
(CH3), 52.2 (t, 1JС-N = 4.0, 3CH3), 65.9 
(t, 1JС-N = 3.0, 2-CH2), 96.7 (C), 
120.79 (CH), 120.84 (CH), 123.5 
(CH), 125.9 (CH), 132.0 (C), 147.0 
(C), 148.5 (C), 152.8 (C), 161.4 (C).  
HRMS (ESI) 
Calculated for 
C17H24N5S (M + 
H+): 330.1752, 
Found: 
330.1758. 
Yield 100%, white powder (mp 249−250 °C). 
3.10 tert-Butyl (3-(4-
(benzo[d]thiazol-2-
yl)-5-(benzylamino)-
1-methyl-1H-
pyrazol-3-
yl)propyl)(methyl)ca
rbamate 
 
Neat film  
3271 (NH), 1690 
(C=O), 1560 
(C=C, C=N), 
1249 (C−O), 
1164 (C−N). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.47 (s, 9H, 3СH3), 1.95−2.07 (m, 2H, 
2-СН2), 2.82−2.94 (m, 5H, 3-СН2, 
NBocCH3), 3.28−3.50 (m, 2H, 1-
СН2), 3.81 (s, 3H, NPyrCH3), 4.55 (s, 
2H, NCH2Ph), 7.28−7.38 (m, 4H, HPh-
2,4,6, HBt-6), 7.39−7.47 (m, 3H, HBt-
5), 7.80−7.88 (m, 2H, HBt-4,7), 7.79 
(br. s, NH). 
(101 MHz, CDCl3), δ, ppm: 25.8 
(CH2), 27.1 (CH2), 28.5 (3CH3), 34.3 
(CH3), 36.8 (CH3), 48.9 (CH2), 50.3 
(CH2), 79.2 (C), 100.6 (C), 121.0 
(CH), 121.2 (CH), 123.7 (CH), 126.0 
(CH), 127.1 (2CH), 127.5 (CH), 128.7 
(2CH), 132.5 (C), 138.9 (C), 149.3 
(C), 149.5 (C), 152.5 (C), 155.8 (C), 
162.0 (C). 
HRMS (ESI) 
Calculated for 
C27H34N5O2S (M 
+ H+): 492.2433, 
Found: 
492.2433. 
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Yield 108 mg (0.22 mmol, 47%). Colorless oil.  
3.11 N-(3-(3,5-Dimethyl-
3H-
benzo[4,5]imidazo[1
,2-c]- 
pyrazolo[4,3-
e]pyrimidin-1-
yl)propyl)-N-
methylacetamide  
N
N
N
N
N
NO
 
Neat film  
1656 (C=O), 
1623, 1601, 
1544, 1525 
(C=C, C=N). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
(mixture of rotamers) 2.09 (s, 1.2H, 
СО(СН3)), 2.14 (s, 1.8H, СО(СН3)), 
2.22−2.39 (m, 2H, 2-СН2), 2.98 (s, 
1.8H, NAcCH3), 3.07 (s, 1.2H, 
NAcCH3), 3.18−3.29 (m, 5H, 3-CH2, 
С(СН3)), 3.45−3.53 (m, 1.2H, 1-СН2), 
3.55−3.63 (m, 0.8H, 1-СН2), 4.10 (s, 
1.2H, NPyrCH3), 4.11 (s, 1.8H, 
NPyrCH3), 7.37−7.47 (m, 1H, H-6), 
7.51−7.60 (m, 1H, Н-5), 7.92−8.00 
(m, 1H, Н-4), 8.00−8.08 (m, 1H, Н-7). 
(101 MHz, CDCl3), δ, ppm: (mixture 
of rotamers) 21.2 (CH3), 22.0 (CH3), 
24.4 (CH3), 24.5 (CH3), 25.7 (CH2), 
25.9 (CH2), 26.0 (CH2), 26.9 (CH2), 
33.3 (CH3), 34.1 (CH3), 34.2 (CH3), 
36.2 (CH3), 47.1 (CH2), 50.5 (CH2), 
99.3 (C), 113.9 (CH), 114.0 (CH), 
119.8 (CH), 122.1 (CH), 122.2 (CH), 
125.5 (CH), 125.7 (CH), 128.8 (C), 
145.2 (C), 145.2 (C), 145.7 (C), 145.8 
(C), 146.5 (C), 146.9 (C), 147.0 (C), 
149.8 (C), 150.0 (C), 170.5 (С), 170.6 
(C). 
HRMS (ESI) 
Calculated for 
C19H22N6O (M + 
H+): 351.1929, 
Found: 
351.1928. 
Yield 87% (152 mg, 0.43 mmol), white powder (mp 97−98 °C). 
3.12 N-Methyl-N-(3-(3-
methyl-3H-
benzo[4,5]imidazo- 
[1,2-c]pyrazolo[4,3-
e][1,2,3]triazin-1-
yl)propyl)nitrous 
amide 
 
Neat film 
1652, 1527, 1447 
(C=N, C=C, 
N=O), 1280 
(N=O), 1333 (N-
=O), 1038 
(N−N), 1129 
(C−N). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
(mixture of rotamers) 2.22−2.35 (m, 
0.4H, 2-СН2), 2.45−2.63 (m, 1.6H, 2-
СН2), 3.14 (s, 2.4H, NNO(CH3)), 
3.20−3.26 (m, 0.4H, 3-СН2), 
3.28−3.38 (m, 1.6H, 3-СН2), 
3.75−3.83 (m, 0.4H, 1-СН2), 3.85 (s, 
0.6H, NNO(CH3)), 4.32−4.41 (m, 
1.6H, 1-СН2), 4.38 (s, 3H, NPyrCH3), 
7.52−7.60 (m, 1H, Н-6), 7.60−7.69 
(m, 1H, Н-5), 7.94−8.00 (m, 1H, Н-4), 
8.33−8.40 (m, 1H, Н-7). 
(75 MHz, CDCl3), δ, ppm: (mixture of 
rotamers) 24.2 (CH2), 25.3 (CH2), 
25.8 (CH2), 26.5 (CH2), 31.4 (CH3), 
35.5 (CH3), 38.9 (CH3), 44.0 (CH2), 
53.1 (CH2), 101.2 (C), 111.9 (CH), 
120.0 (CH), 123.7 (CH), 127.2 (CH), 
128.8 (C), 136.7 (C), 142.6 (C), 144.2 
(C), 145.1 (C),145.3 (C). 
HRMS (ESI) 
Calculated for 
C15H17N8O (M + 
H+): 325.1525, 
Found: 325.1529 
Yield 137 mg (0.42 mmol, 85%), bright yellow powder (mp 163−164 °C). 
3.13 N-(3-(4-
(Benzo[d]thiazol-2-
Neat film  
1538 (C=N, 
(400 MHz, CDCl3), δ, ppm (J, Hz):  
(mixture of rotamers) 1.93−2.04 (m, 
(101 MHz, CDCl3), δ, ppm: (mixture 
of rotamers) 24.8 (CH2), 25.3 (CH2), 
MS (ESI) m/z: 
[M+ H]+ Found 
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yl)-5-iodo-1-methyl-
1Hpyrazol- 
3-yl)propyl)-N-
methylnitrous amide 
 
C=C), 1450, 
1435 
(N=O),1332 
(N=O), 1040 
(N−N), 1144 
(C−N). 
0.4H, 2-СН2), 2.15−2.28 (m, 1.6H, 2-
СН2), 3.01−3.06 (m, 0.4Н, 3-СН2), 
3.08 (s, 2.4H, NNO(CH3)), 3.11−3.17 
(m, 1.6H, 3-СН2), 3.70−3.76 (m, 
0.4H, 1-СН2), 3.78 (s, 0.6H, 
NNO(CH3)), 4.00 (s, 0.6H, NPyrCH3), 
4.01 (s, 2.4H, NPyrCH3), 4.25−4.31 (m, 
1.6H, 1-СН2), 7.41 (ddd, J = 8.3, 7.3, 
1.2, 1H, H-6), 7.51 (ddd, J = 8.3, 7.2, 
1.3, 1H, Н-5), 7.93 (ddd, J = 7.9, 1.1, 
0.6, 1H, Н-7), 8.04 (ddd, J = 8.2, 1.1, 
0.6 Hz, 0.8H, Н-4), 8.08 (ddd, J = 8.2, 
1.1, 0.6, 0.2H,Н-4). 
25.7 (CH2), 27.2 (CH2), 31.4 (CH3), 
39.1 (CH3), 40.51 (CH3), 40.53 (CH3), 
44.5 (CH2), 53.5 (CH2), 86.7 (C), 
120.2 (C), 121.3 (CH), 122.8 (CH), 
125.0 (CH), 126.2 (CH), 134.3 (C), 
152.3 (C), 153.0 (C), 159.0 (C). 
for 
C15H17IN5OS: 
442.55. Found, 
%: С 40.95; Н 
3.29; N 15.87. 
C15H16ІN5ОS. 
Calculated, %: 
С 40.83; Н 3.65; 
N 15.87. 
 
Yield 168 mg (0.38 mmol, 38%), light orange powder (mp 104−105 °C). 
3.14a 3-(4-
(Benzo[d]thiazol-2-
yl)-5-iodo-1-methyl-
1H-pyrazol- 
3-yl)-N-
methylpropan-1-
amine  
 
Neat film 
3394 (NHν), 
1537 (C=C, 
C=N). 
(400 MHz, CDCl3), δ, ppm (J, Hz):  
1.95 (quint, J = 7.3, 2H, 2-CH2), 2.44 
(s, 3H, NHCH3), 2.69 (t, J = 6.9, 2H, 
1-CH2), 3.11 (t, J = 7.5, 2H, 3-CH2), 
4.01 (s, 3H, NPyrCH3), 7.35−7.46 (m, 
1H, H-6), 7.48−7.55 (m, 1H, H-5), 
7.93 (d, J = 7.9, 1H, Н-7), 8.07 (d, J = 
8.0, 1H, Н-4) 
(101 MHz, CDCl3), δ, ppm: 25.4 
(CH2), 28.8 (CH2), 36.1 (CH3), 40.5 
(CH3), 51.2 (CH2), 86.5 (C, C-I), 
120.1 (C), 121.3 (CH), 122.8 (CH), 
124.9 (CH), 126.1 (CH), 134.5 (C), 
153.0 (C), 153.3 (C), 159.5 (C). 
HRMS (ESI) 
Calculated for 
C15H18N4SI (M 
+ H+): 413.0297, 
Found: 
413.0297. 
Yield 247 mg (0.6 mmol, 30%), white powder (mp 104−105 °C).  
3.15 tert-Butyl (3-(4-
(Benzo[d]thiazol-2-
yl)-5-iodo-1- 
methyl-1H-pyrazol-
3-
yl)propyl)(methyl)ca
Neat film  
1690 (C=O), 
1519 (C=C, 
C=N), 1030, 
1250 (C−O). 
1H NMR  (400 MHz, CDCl3), δ, ppm 
(J, Hz): 1.42 (s, 9H, 3СН3), 1.86−2.04 
(m, 2H, 2-СН2), 2.86 (s, 3H, NPrCH3), 
2.98−3.11 (m, 2H, 3-СН2), 3.23−3.41 
(m, 2H, 1-СН2), 4.01 (s, 3H, 
NPyrCH3), 7.40 (t, J = 7.5, 1H, Н-6), 
(101 MHz, CDCl3), δ, ppm: 25.5 
(CH2), 27.2 (CH2), 28.4 (3CH3), 34.1 
(CH3), 40.4 (CH3), 48.7 (CH2), 79.1 
(C), 86.6 (C), 120.0 (C), 121.2 (CH), 
122.9 (CH), 124.9 (CH), 126.1 (CH), 
134.5 (C), 153.0 (C), 153.4 (C), 155.8 
HRMS (ESI) 
Calculated for 
C20H26IN4O2S 
(M + H+): 
513.0821, 
Found: 
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rbamate 
 
7.51(t, J = 7.6, 1H, Н-5), 7.93 (d, J = 
7.9, 1H, Н-7), 8.08 (d, J = 8.1, 1H, Н-
4). 
(C), 159.3 (C). 513.0817. 
Yield 179 mg (0.35 mmol, 70%), white powder (mp 122 °C).  
3.16a 3-(4-
(Benzo[d]thiazol-2-
yl)-5-(4-
methoxyphenyl)-1- 
methyl-1H-pyrazol-
3-yl)-N-
methylpropan-1-
amine 
 
Neat film 
3303 (NHν), 
1519 (C=C, 
C=N), 1249 
(C−O) 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.81 (s, 1H, NH), 2.01 (quint, J = 7.0, 
2H, 2-СН2), 2.44 (s, 3H, NPrCH3), 
2.73 (t, J = 6.9, 2H, 1-СН2), 3.11−3.26 
(m, 2H, 3-СН2), 3.69 (s, 3H, 
NPyrCH3), 3.90 (s, 3H, OCH3), 
7.01−7.08 (m, 2H, НAr-3,5), 7.24 (ddd, 
J = 8.3, 7.3, 1.1, 1H, Н-6), 7.29−7.35 
(m, 2H, НAr-2,6), 7.39 (ddd, J = 8.3, 
7.2, 1.2, 1H, Н-5), 7.66 (ddd, J = 7.9, 
1.1, 0.6, 1H, Н-7), 7.92−7.98 (m, 1H, 
ddd, J = 8.0, 1.1, 0.6, 1H, Н-4). 
(101 MHz, CDCl3), δ, ppm: 25.5 
(CH2), 29.1 (CH2), 36.3 (CH3), 36.8 
(CH3), 51.6 (CH2), 55.4 (CH3), 113.7 
(C), 114.6 (CH), 121.0 (CH), 121.1 
(C), 122.3 (CH), 124.2 (CH), 125.7 
(CH), 131.9 (2CH), 134.4 (C), 143.8 
(C), 151.4 (C), 153.2 (C), 160.9 (C), 
161.1 (C). 
HRMS (ESI) 
Calculated for 
C22H25N4OS (M 
+ H+): 393.1749, 
Found: 
393.1743. 
Elution system for column chromatography: CH2Cl2−CH3OH–Et3N,  8:1:1. Yield 41 mg (0.11 mmol, 70%), yellowish powder (mp 96−97 °C).  
3.16b tert-Butyl (3-(4-
(Benzo[d]thiazol-2-
yl)-5-(4-
methoxyphenyl)- 
1-methyl-1H-
pyrazol-3-
yl)propyl)(methyl)-
Neat film  
1691 (C=O), 
1519 (C=C, 
C=N), 1251 
(C−O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.45 (s, 9H, 3CH3), 1.95−2.13 (m, 2H, 
2-СН2), 2.92 (s, 3H, NPrCH3), 
3.09−3.21 (m, 2H, 3-СН2), 3.34−3.47 
(m, 2H, 1-СН2), 3.70 (s, 3H, 
NPyrCH3), 3.93 (s, 3H, OCH3), 
7.04−7.10 (m, 2H, НAr-3,5), 7.27 (ddd, 
(101 MHz, CDCl3), δ, ppm: 25.5 
(CH2), 27.4 (CH2), 28.5 (3CH3), 34.0 
(CH3), 36.8 (CH3), 48.9 (CH2), 55.4 
(CH3), 79.0 (C), 113.5 (C), 114.6 
(2CH), 120.96 (CH), 121.04 (C), 
122.5 (CH), 124.3 (CH), 125.7 (CH), 
131.9 (2CH), 134.4 (C), 143.9 (C), 
HRMS (ESI) 
Calculated for 
C27H33N4O3S (M 
+ H+): 493.2273, 
Found: 
493.2273. 
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carbamate 
 
J = 8.3, 7.2, 1.2, 1H, H-6), 7.31−7.36 
(m, 2H, НAr-2,6), 7.41 (ddd, J = 8.3, 
7.2, 1.2, 1H, Н-5), 7.69 (ddd, J = 8.0, 
1.2, 0.6, 1H, Н-7), 7.97 (d, J = 8.0, 
1H, Н-4). 
151.3 (C), 153.2 (C), 155.9 (C), 160.9 
(C), 161.0 (C). 
Elution system for column chromatography: CHA−EtOAc, 6:4. Yield 72 mg (0.15 mmol, 98%), yellowish powder (mp 116 °C).  
3.16c N-(3-(4-
(Benzo[d]thiazol-2-
yl)-5-(4-
methoxyphenyl)- 
1-methyl-1H-
pyrazol-3-yl)propyl)-
N-methylnitrous 
amide 
 
Neat film 
1519 (C=N, 
C=C), 1451 
(N=O), 
1333(N=O), 
1029, 1249 
(C−O), 1175 
(C−N). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
(mixture of rotamers) 2.03−2.13 (m, 
0.4H, 2-СН2), 2.24−2.35 (m,1.6H, 2-
СН2), 3.09−3.17 (m, 0.4H, 3-СН2), 
3.13 (s, 2.4H, NPrCH3), 3.19−3.30 
(m,1.6H, 3-СН2), 3.69 (s, 0.6H, 
NPyrCH3), 3.70 (s, 2.4H, NPyrCH3), 
3.78−3.86 (m, 0.4H, 1-СН2), 3.83 (s, 
0.6H, NPrCH3), 3.93 (s, 0.6H, OCH3), 
3.94 (s, 2.4H, OCH3), 4.36 (t, J = 7.2, 
1.6H, 1-СН2), 7.06−7.11 (m, 2H, НAr-
3,5), 7.27 (ddd, J = 8.0, 7.6, 1.1, 1H, 
Н-6), 7.31−7.37 (m, 2H, НAr-2,6), 
7.42 (ddd, J = 8.3, 7.3, 1.2, 1H, Н-5), 
7.68 (ddd, J = 8.0, 1.4, 0.6, 1H, Н-7), 
7.95 (ddd, J = 8.2, 1.3, 0.6, 0.8H, Н-
4), 7.98 (ddd, J = 8.2, 1.3, 0.6, 0.2H, 
Н-4). 
(101 MHz, CDCl3), δ, ppm: (the 
signals of  dominating rotamer are 
only mentioned) 25.3 (CH2), 27.4 
(CH2), 31.4 (CH3), 36.8 (CH3), 53.8 
(CH3), 55.4 (CH2), 113.7 (C), 114.7 
(2CH), 120.8 (C), 121.0 (CH), 122.4 
(CH), 124.4 (CH), 125.8 (CH), 131.9 
(2CH), 134.3 (C), 144.1 (C), 150.2 
(C), 153.1 (C), 160.9 (C), 161.0 (C). 
HRMS (ESI) 
Calculated for 
C22H24N5O2S (M 
+ H+): 422.1651, 
Found: 
422.1652. 
Elution system for column chromatography: gradient CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 9:1. Yield 62 mg (0.15 mmol, 98%), light orange 
powder (mp 140 °C).  
3.17 tert-Butyl (3-(5-
([1,1΄-Biphenyl]-4-
yl)-4-(benzo[d]- 
Neat film  
1688 (C=O), 
1522 (C=C, 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.46 (s, 9H, 3CH3), 2.00−2.12 (m, 2H, 
2-СН2), 2.93 (s, 3H, NPrCH3), 
(101 MHz, CDCl3), δ, ppm: 25.4 
(CH2), 27.4 (CH2), 28.5 (3CH3), 34.0 
(CH3), 37.0 (CH3), 48.9 (CH2), 79.0 
HRMS (ESI) 
Calculated for 
C32H35N4O2S (M 
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thiazol-2-yl)-1-
methyl-1H-pyrazol-
3-yl)propyl)(methyl)-
carbamate 
 
C=N), 1245 
(C−O). 
3.07−3.23 (m, 2H, 3-СН2), 3.34−3.50 
(m, 2H, 2-СН2), 3.77 (s, 3H, 
NPyrCH3), 7.27 (ddd, J = 8.0, 7.6, 1.1, 
1H, НHet-6), 7.39 – 7.47 (m, 1H, HAr- 
4´), 7.42 (ddd, J = 8.3, 7.2, 1.2, 1H, 
HHet-5), 7.47–7.55 (m, 4H, HAr-
2´,3´,5´,6´), 7.69 (ddd, J = 8.0, 1.3, 
0.6, 1H, HHet-7), 7.68–7.76 (m, 2H, 
HAr-3,5), 7.75–7.82 (m, 2H, HAr-2,6), 
8.00 (d, J = 8.1, 1H, HHet-4). 
(C), 113.6 (C), 121.0 (CH), 122.6 
(CH), 124.4 (CH), 125.8 (CH), 127.1 
(2CH), 127.7 (2CH), 127.9 (C), 128.0 
(CH), 129.0 (2CH), 130.9 (2CH), 
134.5 (C), 140.0 (C), 142.7 (C), 143.7 
(C), 151.4 (C), 153.2 (C), 155.9 (C), 
160.7 (C). 
+ H+): 539.2481, 
Found: 
539.2485. 
Elution system for column chromatography: gradient CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 23:2.  Yield 78 mg (0.15 mmol, 97%), yellowish 
powder (mp 124−125 °C).  
3.18 tert-Butyl (3-(4-
(Benzo[d]thiazol-2-
yl)-5-(3,5-bis- 
(trifluoromethyl)phe
nyl)-1-methyl-1H-
pyrazol-3-yl)propyl)- 
(methyl)carbamate 
 
Neat film 
1689 (C=O), 
1522 (C=C, 
C=N), 1248 
(C−O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.46 (s, 9H, 3СН3), 1.97−2.12 (m, 2H, 
2-СН2), 2.91 (s, 3H, NPrCH3), 
3.01−3.16 (m, 2H, 3-СН2), 3.34−3.49 
(m, 2H, 3-СН2), 3.78 (s, 3H, 
NPyrCH3), 7.33 (ddd, J = 8.3, 7.3, 1.2, 
1H, HHet-6), 7.45 (ddd, J = 8.3, 7.3, 
1.2, 1H, HHet-5), 7.77 (ddd, J = 8.1, 
1.2, 0.6, 1H, HHet-7), 7.93 (ddd, J = 
8.2, 1.3, 0.5, 1H, HHet-4), 8.01 (s, 2H, 
HAr-2,6), 8.06 (s, 1H, HAr-4). 19F 
NMR (376 MHz, CDCl3) ), δ, ppm:  
−62.88. 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
25.3 (CH2), 27.3 (CH2), 28.5 (3CH3), 
34.1 (CH3), 37.3 (CH3), 48.8 (CH2), 
79.1 (C), 114.3 (C), 122.9 (q, J = 
272.8, 2CF3), 121.1 (CH), 122.8 (CH), 
123.5 (CH), 124.9 (CH), 126.2 (CH), 
127.0 (C), 131.1 (2CH), 131.5 (C), 
132.2 (q, J = 33.7, 2CCF3), 134.3 (C), 
140.3 (C), 151.5 (C), 153.0 (C), 155.8 
(C), 159.0 (C). 
MS (ESI) m/z: 
[M + H+] Found 
for 
C28H29F6N4O2S: 
599.13. 
Found, %: С 
56.12; Н 4.35; N 
9.19. 
C28H28F6N4O2S. 
Calculated, %: 
С 56.18; Н 4.71; 
N 9.36. 
Elution system for column chromatography: gradient CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 23:2.Yield 81 mg  (0.14 mmol, 90%), white powder 
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(mp 126 °C).  
3.19 (E)-tert-Butyl (3-(4-
(Benzo[d]thiazol-2-
yl)-1-methyl- 
5-styryl-1H-pyrazol-
3-
yl)propyl)(methyl)ca
rbamate 
 
Neat film 
1684 (C=O), 
1542 (C=C, 
C=N), 1244 
(C−O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
1.44 (s, 9H, 3-СН3), 1.88−2.07 (m, 
2H, 2-СН2), 2.88 (s, 3H, NPrCH3), 
2.97−3.13 (m, 2H, 3-СН2), 3.30−3.44 
(m, 2H, 1-СН2), 4.01 (s, 3H, 
NPyrCH3), 7.04 (d, J = 16.7, 1H, CH-
1), 7.34 (d, J = 16.6, 1H, CH-2), 
7.33−7.40 (m, 2H, HHet-6, HAr –4), 
7.40−7.46 (m, 2H, HAr-3,5), 7.49 (ddd, 
J = 8.3, 7.2, 1.2, 1H, HHet-5), 
7.53−7.57 (m, 2H, HAr-2,6), 7.87 (ddd, 
J = 7.9, 1.3, 0.7, 1H, HHet-7), 
7.98−8.11 (m, 1H, HHet-4). 
13C (101 MHz, CDCl3), δ, ppm: 25.1 
(CH2), 27.0 (CH2), 28.5 (3CH3), 34.1 
(CH3), 37.9 (CH3), 48.8 (CH2), 79.1 
(C), 113.2 (C), 115.2 (CH), 121.2 
(CH), 122.8 (CH), 124.6 (CH), 126.0 
(CH), 126.9 (2CH), 128.9 (2CH), 
134.7 (C), 136.2 (C), 137.0 (CH), 
140.5 (C), 150.9 (C), 153.4 (C), 155.8 
(C), 160.5 (C). 
HRMS (ESI) 
Calculated for 
C28H33N4O2S (M 
+ H+): 489.2324, 
Found: 
489.2322. 
Elution system for column chromatography: gradient CH2Cl2−acetone, 19:1 to CH2Cl2−acetone, 23:2. Yield 53 mg (0.11 mmol, 72%), orange powder 
(mp 105−106 °C).  
3.20 N-(3-(4-
(Benzo[d]thiazol-2-
yl)-5-(1H-indol-2-
yl)-1- 
methyl-1H-pyrazol-
3-yl)propyl)-N-
methylnitrous amide 
Neat film  
3185 (NHν), 
1532 (C=N, 
C=C), 1454, 
1427 (N=O, 
C−H), 1333 
(N=O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
(mixture of rotamers) 2.05 (quint, J = 
7.6, 0.4H, 2-СН2), 2.28 (quint, J = 7.3, 
1.6H, 2-СН2), 2.99−3.05 (m, 0.4H, 3-
СН2), 3.09 (s, 2.4H, NPrCH3), 
3.10−3.15 (m, 1.6H, 3-СН2), 
3.74−3.79 (m, 0.4H, 1-СН2), 3.80 (s, 
0.6H, NPrCH3), 4.10 (s, 2.4H, 
NPyrCH3), 4.11 (s, 0.6H, NPyrCH3), 
4.32 (t, J = 7.1, 1.6H, 1-СН2), 6.81 – 
6.86 (m, 1H, HInd-3), 7.19 (ddd, J = 
7.8, 7.5, 0.9, 1H, HInd-7),  7.30 (ddd, J 
= 8.1, 7.6, 1.0, 1H, HInd-5), 7.40 (ddd, 
J = 8.2, 7.6, 1.0, 1H, HHet-6), 7.53 
(ddd, J = 8.2, 7.6, 1.1, 1H, HHet-5), 
(101 MHz, CDCl3), δ, ppm: (the 
signals of  dominating rotamer are 
only mentioned) 25.0 (CH2), 27.2 
(CH2), 31.5 (CH3), 39.0 (CH3), 53.5 
(CH2), 104.9 (CH), 
111.7 (CH), 113.0 (C), 120.4 (CH), 
120.9 (CH), 121.4 (CH), 122.2 (CH), 
123.3 (CH), 125.2 (CH), 125.6 (C), 
126.5 (CH), 128.0 (C), 134.6 (C), 
136.2 (C), 136.3 (C), 149.6 (C), 152.2 
(C), 161.0 (C). 
HRMS (ESI) 
Calculated for 
C23H23N6OS (M 
+ H+): 431.1648, 
Found: 
431.1650. 
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7.55 (d, 8.3, 1H, HInd-4), 7.72 (d, J = 
7.8, 1H, HInd-7), 7.85 (d, J = 7.8, 1H, 
HHet-7), 8.10 (d, J = 8.0, 1H, HHet-4), 
11.67 (s, 0.8H, NH), 11.84 (s, 0.2H, 
NH). 
Yield 15 mg (0.4 mmol, 24%), light yellow powder (mp 178 °C).  Elution system for column chromatography: gradient CH2Cl2, 100% to 
CH2Cl2−acetone, 93:7. 
3.21 N-(3-(4-
(Benzo[d]thiazol-2-
yl)-1-methyl-1H-
pyrazol- 
3-yl)propyl)-N-
methylnitrous amide 
N
S
N
N
N
ON
 
Neat film  
1566, 1556 
(O=N, C=C, 
C=N), 1425 
(N=O), 1331 
(N=O), 1038 
(N−N), 1140 
(C−N). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
(mixture of rotamers) 2.03 (quint, J = 
7.6, 0.4H, 2-СН2), 2.25 (quint, J = 7.5, 
1.6 H, 2-СН2), 3.03 (t, J = 7.5, 0.4 H, 
3-СН2), 3.11 (s, 2.4 H, NPrCH3), 3.13 
(t, J = 7.5, 1.6 H, 3-СН2), 3.76 (t, J = 
7.4, 0.4 H, 1-СН2), 3.79 (s, 0.6 H, 
NPrCH3), 3.90 (s, 0.6 H, NPyrCH3), 
3.91 (s, 2.4 H, NPyrCH3), 4.31 (t, J = 
7.2, 1.6 H, 1-СН2), 7.31−7.37 (m, 1H, 
Н-6), 7.43−7.50 (m, 1H, Н-5), 7.84 (d, 
J = 8.0, 1H, Н-7), 7.88 (s, 1H, НPyr-5), 
7.93−8.00 (m, 1H, Н-4). 
(101 MHz, CDCl3), δ, ppm: (mixture 
of rotamers) 24.88 (CH2), 24.92 
(CH2), 25.4 (CH2), 27.3 (CH2), 30.3 
(CH3), 31.5 (CH3), 39.1 (CH3), 44.5 
(CH2), 53.6 (CH2), 115.1 (C), 121.3 
(CH), 121.48 (CH), 121.5 (CH), 
124.64 (CH), 124.67 (CH), 126.2 
(CH), 131.64 (CH), 131.71 (CH), 
134.01 (C), 134.06 (C), 150.25 (C), 
150.32 (C), 153.79 (C), 153.82 (C), 
160.04 (C), 160.08 (C). 
HRMS (ESI) 
Calculated for 
C15H18N5OS (M 
+ H+): 316.1232, 
Found: 
316.1231. 
Yield 290 mg (0.92 mmol, 92%), white powder (mp 72−73 °C). 
3.22 3-(4-
(Benzo[d]thiazol-2-
yl)-1-methyl-1H-
pyrazol-3- 
yl)-N-methylpropan-
1-aminium chloride  
Neat film   
3431 (NH2ν), 
1603, 1559, 1529 
(C=C, C=N, 
NH2δ). 
(400 MHz, CD3OD), δ, ppm (J, Hz): 
2.23 (quint, J = 7.3, 2H, 2-СН2), 2.73 
(s, 3H, NPrCH3), 3.10−3.21 (m, 4H, 
1,3-СН2), 3.98 (s, 3H, NPyrCH3), 7.52 
(t, J = 7.7, 1H, Het H), 7.62 (t, J = 7.7, 
1H, Het H), 8.00 (d, J = 8.2, 1H, Het 
H), 8.07 (d, J = 8.1, 1H, Het H), 8.44 
(s, 1H, НPyr-5). 
(101 MHz, CD3OD), δ, ppm: 24.0 
(CH2), 24.4 (CH2), 32.2 (CH3), 38.1 
(CH3), 48.4 (CH2), 112.3 (C), 119.8 
(CH), 122.1 (CH), 125.8 (CH), 127.4 
(CH), 132.0 (C), 133.5 (CH), 148.5 
(C), 150.1 (C), 162.8 (C). 
HRMS (ESI) 
Calculated for 
C15H19N4S (M + 
H+): 287.1330, 
Found: 
287.1337. 
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Yield 157 mg (0.485 mmol, 97%), white powder (mp 152−153 °C). 
3.23a 4-(Benzo[d]oxazol-
2-yl)-1-methyl-3-(3-
(methylamino)propyl
)-1H-pyrazol-5-
amine 
 
Neat film  
3310 (NHν, 
NH2ν), 1625 
(NH2δ), 1580 
(NHδ, C=C, 
C=N), 1065 (C-
O). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.90 (quint, J = 7.2, 2H, 2-СН2), 2.40 
(s, 3H, NPrCH3), 2.74 (t, J = 7.4, 1-
СН2), 2.86 (t, J = 7.5, 2H, 3-СН2), 
3.59 (s, 3H, NPyrCH3), 6.55 (s, 2H, 
NH2), 7.26 (dd, J = 7.7, 1.4, 1H, Het 
H), 7.30 (dd, J = 7.6, 1.4, 1H, Het H), 
7.61 (dd, J = 7.6, 1.4, 1H, Het H), 7.64 
(dd, J = 7.6, 1.4, 1H, Het H). 
(101 MHz, DMSO-d6), δ, ppm: 22.2 
(CH2), 25.9 (CH2), 26.6 (CH3), 34.6 
(CH3), 50.1 (CH2), 88.9 (C), 110.5 
(CH), 118.2 (CH), 123.5 (CH), 124.7 
(CH), 141.8 (C), 148.9 (C), 149.0 (C), 
149.7 (C), 160.9 (C). 
HRMS (ESI) 
Calculated for 
C15H20N5O  (M 
+ H+) 286.1668, 
Found  
286.1661. 
Isomers 3.23а and 3.24а were separated by column chromatography (еlution system: CHCl3–CH3OH–Et3N (20:2:1), Rf  2.23а = 0.43, Rf  2.24а = 
0.29). Yield 80 mg (0.28 mmol, 28%), white powder (mp 143–144 °C).  
3.24a 5-((2-
Hydroxyphenyl)amin
o)-1-methyl-3-(3-
(methylamino)propyl
)-1H-pyrazole-4-
carbonitrile  
OH
H
N
N
N
NC
HN
 
Neat film  
3352 (NHν, 
OHν), 2218 
(C≡N), 1564 
(NHδ, C=C, 
C=N), 1280 (C–
O). 
(300 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.90 (quint, J = 7.5, 2H, 2-СН2), 2.44 
(s, 3H, NPrCH3), 2.57 (t, J = 7.6, 2H, 
1-СН2), 2.79 (t, J = 7.6, 2H, 3-СН2), 
3.62 (s, 3H, NPyrCH3), 6.70 (ddd, J = 
7.0, 7.3, 2.0, 1H, H-5), 6.79 (d, J = 
7.9, 1H, H-6), 6.84 (ddd, J = 6.8, 6.8, 
1.4, 1H, H-4), 6.89 (dd, J = 7.8, 1.7, 
1H, H-3), 8.09 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 24.8 
(CH2), 25.5 (CH2), 33.7 (CH3), 35.8 
(CH3), 49.0 (CH2), 79.2 (C), 114.4 
(C), 116.1 (CH), 119.6 (CH), 120.4 
(CH), 123.8 (CH), 129.3 (C), 148.2 
(C), 149.1 (C), 152.6 (C). 
HRMS (ESI) 
Calculated for 
C15H20N5O (M + 
H+) 286.1668, 
Found 286.1667. 
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Yield 57 mg (0.20 mmol, 20 %), white powder (mp 140-141 °C). 
3.23b 4-(benzo[d]oxazol-2-
yl)-3-(3-
(benzylamino)propyl
)-1-methyl-1H-
pyrazol-5-amine 
 
Neat film 
3300 (NHν, 
NH2ν), 1623 
(NH2δ), 1578 
(C=C, C=N), 
1064 (C–O). 
(300 MHz,CDCl3), δ, ppm (J, Hz): 
2.03 (quint, J = 7.2, 2H, 2-CH2), 2.83 
(t, J = 7.0, 2H, 1-CH2), 3.03 (t, J = 7.5, 
2H, 3-CH2), 3.64 (s, 3H, NCH3), 3.85 
(s, 2H, NBnCH2), 5.42 (s, 2H, NH2), 
7.19–7.25 (m, 1H, H-6), 7.25–7.36 (m, 
6H, Ph H, H-5), 7.43 (d, J = 7.5, 1H, 
Н-7), 7.60 (d, J = 7.9, 1H, Н-4). 
13C (75 MHz, CDCl3), δ, ppm: 26.0 
(CH2), 28.8 (CH2), 33.9 (CH2), 48.9 
(CH2), 53.6 (CH2), 91.0 (C), 109.9 
(CH), 118.1 (CH), 123.1 (CH), 124.1 
(CH), 126.9 (CH), 128.2 (2CH), 128.4 
(2CH), 140.1 (C), 141.6 (C), 148.2 
(C), 149.2 (C), 150.2 (C), 160.6 (C). 
HRMS (ESI) 
Calculated for 
C21H24N5O  (M 
+ H+) 362.1981, 
Found:  
362.1974. 
Isomers 3.23b and 3.24b were separated by column chromatography (elution system: gradient acetone–CHCl3, 5:1) to acetone 100%, Rf  3.23b = 0.3, 
Rf 3.24b = 0.2. Further trituration of the obtained oil with minimal quantity of acetone induces its consolidation. Yield 127 mg (0.35 mmol, 35 %), 
white powder (mp 129–131 °C).  
3.24b 3-(3-
(Benzylamino)propyl
)-5-((2-
hydroxyphenyl)amin
o)-1-methyl-1H-
pyrazole-4-
carbonitrile 
 
Neat film 3286 
(NHν, OHν), 
2216 (C≡N), 
1559 (NHδ, 
C=C, C=N), 
1255, 1279 (C-
O). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.76 (quint, J = 7.1, 2H, 2-СН2), 2.53 
(t, J = 7.1, 2H,1-СН2), 2.55 (t, J = 7.5, 
2H, 3-СН2), 3.59 (s, 3H, NPyrCH3), 
3.68 (s, 2H, NBnCH2), 6.67–6.76 (m, 
2H, Н-3,4), 6.81–6.88 (m, 2H, Н-5,6), 
7.18–7.24 (m, 1H, НBn-4), 7.26-7.36 
(m, 4H, НBn-2,3,5,6), 7.89 (s, 1H, 
NH), 9.66 (s, 1H, OH). Signals of δH 
7.89 and 9.66 ppm disappear upon 
D2O addition. 
(101 MHz, DMSO-d6), δ, ppm: 25.5 
(CH2), 28.6 (CH2), 35.7 (CH3), 48.5 
(CH2), 53.3 (CH2), 79.7 (C), 114.6 
(C), 115.9 (CH), 119.7 (СН), 119.8 
(CH), 123.5 (CH), 126.9 (CH), 128.3 
(2CH), 128.5 (2CH), 129.5 (C), 141.4 
(C), 147.9 (C), 148.7 (C), 153.6 (C). 
HRMS (ESI) 
Calculated for 
C21H24N5O (M + 
H+) 362.1981, 
Found: 
362.1973. 
Yield 116 mg (0.32 mmol, 32 %), white powder (mp 131–132 °C). 
3.25b 4-(benzo[d]oxazol-2-
yl)-3-(3-
Neat film  
3388, 3289 
1H NMR  (400 MHz,CDCl3), δ, ppm 
(J, Hz): 2.07 (quint, J  = 7.2, 2H, 2-
101 MHz, CDCl3), δ, ppm: 24.1 
(CH2), 27.4 (CH2), 48.5 (CH2), 53.7 
HRMS (ESI) 
Calculated for 
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(benzylamino)propyl
)isoxazol-5-amine 
 
(NHν, NH2ν), 
1623 (NH2δ) 
1582 (NHδ, 
C=C, C=N), 
1063, 1041 (C-
O). 
СН2), 2.84 (t, J = 7.1, 2H, 2-СН2), 
3.06 (t, J = 7.5, 2H, 2-СН2), 3.86 (s, 
2H, NBnCH2), 6.48 (s, 2H, NH2), 7.23–
7.38 (m, 7H, Ar H), 7.45 (d, J = 7.8, 
1H, H-7), 7.61 (d, J = 7.9, 1H, H-4). 
(CH2), 83.3 (C), 110.1 (CH), 118.5 
(CH), 123.7 (CH), 124.5 (CH), 127.0 
(CH), 128.2 (2CH), 128.4 (2CH), 
139.8 (C), 141.2 (C), 149.3 (C), 158.4 
(C), 161.8 (C), 169.6 (C). 
C20H21N4O2 (M 
+ H+) 349.1665, 
Found: 
349.1655. 
The mixture of products 3.25b and 3.26b were separated by column chromatography (elution system: gradient acetone–CHCl3, 5:2 to acetone 100%). 
After complete coming out of 3.25b from the column the polarity of elution system was increased (elution system: acetone–Et3N–MeOH 20:1:0.2).  
Yield 94 mg (0.27 mmol, 27 %), white powder (mp 97–99 °C). 
3.26b (Z)-3-(3-
(benzylamino)propyl
)-N'-hydroxy-5-((2-
hydroxyphenyl)amin
o)isoxazole-4-
carboximidamide 
 
Neat film  
3282 (OH, NHν, 
NH2 ν), 1638 
(NH2δ), 1536 
(NHδ, C=C, 
C=N), 1250 (C–
O). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.80 (quint, J = 7.4, 2H, 2-СН2), 2.55 
(m, 2.40–2.60, 2H, 1-СН2), 2.83 (t, J = 
7.5, 2H, 3-СН2), 3.69 (s, 2H, NBnCH2), 
5.75 (s, 2H, NH2), 6.82 (td, J = 7.4, 
1.4, 1H, Н-5), 6.86 (td, J = 7.4, 1.4, 
1H, Н-4), 7.56 (dd, J = 7.9, 1.7, 1H, 
Н-6), 6.91 (dd, J = 7.8, 1.5, 1H, Н-3), 
7.21 (t, J = 6.7, 1H, HBn-4), 7.26–7.37 
(m, 4H, HBn-2,3,5,6), 9.34 (s, 1H), 
9.52 (s, 1H), 10.10 (br.s, 1H). Note: 
the integral intensity of signals at δH 
5.75, 9.34, 9.52 and 10.10 ppm 
diminish upon addition of D2O. 
(101 MHz, DMSO-d6), δ, ppm: 23.5  
(СH2), 27.2 (СH2), 47.9 (СH2), 52.9 
(СH2), 88.1 (C), 115.2 (CH), 116.8 
(CH), 120.0 (CH), 123.1 (CH), 127.2 
(CH), 127.3 (C), 128.6 (2CH), 128.6 
(2CH), 140.1 (C), 145.9 (C), 147.7 
(C), 161.4 (C), 163.6 (C). 
HRMS (ESI) 
Calculated for 
C20H24N5O3 (M 
+ H+) 382.1879, 
Found: 
382.1873. 
Yield 88 mg (0.23 mmol, 23 %), white powder (mp 90 °C). 
3.27 4-cyano-N-methyl-N-
(2-
(methylamino)phenyl
)-3-(3-
(methylamino)propyl
)-1H-pyrazol-5-
aminium iodide  
Neat film  
3362, 3166 
(NHν, NH2ν), 
2214 (CN), 
1591(NH2δ), 
1513 (NHδ, 
C=C, C=N). 
(400 MHz, CD3CN), δ, ppm (J, Hz): 
2.07 (quint, J = 7.2, 2H, 2-CH2), 2.62 
(s, 3H, NH2+CH3), 2.74 (t, J = 7.2, 2H, 
3-CH2), 2.81 (s, 3H, NHCH3), 3.03 (t, 
J = 7.1, 2H, 1-CH2), 3.22 (s, 3H, 
NPhCH3), 4.74 (s, 1H, NH), 6.66 (ddd, 
J = 7.5, 1.3, 1H, H-5), 6.72 (dd, J = 
(101 MHz, CD3CN), δ, ppm: 24.6 
(CH2), 24.5 (CH2), 30.2 (CH3), 33.7 
(CH3), 39.7 (CH3), 49.5 (CH2), 76.2 
(С), 111.6 (CH), 115.1 (С), 117.2 
(CH), 128.2 (CH), 130.0 (CH), 131.7 
(С), 147.5 (С), 153.1 (С), 156.6 (С). 
HRMS (ESI) 
Calculated for 
C16H23IN6+ 
299.1984, 
Found: 
299.1987. 
199 
 
 
8.1, 1.3, 1H, H-3), 7.08 (dd, J = 7.5, 
1.5, 1H, H-6), 7.23 (ddd, J = 8.1, 7.5, 
1.5, 1H, H-4). 
Product was purified by recrystallization from acetonitrile. Yield 362 mg (0.85 mmol, 85%), light brown powder (mp 187–188 °C). 
3.28 3-(4-cyano-5-((2-
hydroxyphenyl)(meth
yl)amino)-1-methyl-
1H-pyrazol-3-yl)-N-
methylpropan-1-
amonium  
hexafluorophosphate 
 
Neat film  
3632, 3259 (OH, 
NH2), 2220 
(CN), 
1596(NH2+δ), 
1553, 1511 
(NHδ, C=C, 
C=N), 1281 (C–
O), 839 (P–F). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.88–1.97 (m, 2H, 2-CH2), 2.58 (s, 
3H, NH2+CH3), 2.60–2.65 (m, 2H, 3-
CH2), 2.92 – 3.01 (m, 2H, 1-CH2), 
3.24 (s, 3H, NPyrCH3), 3.31 (s, 3H, 
NPhCH3), 6.82 (ddd, J = 8.2, 7.6, 1.4, 
1H, H-5), 6.88 (dd, J = 8.1, 1.4, 1H, 
H-3), 6.97 (dd, J = 7.9, 1.6, 1H, H-6), 
7.03 (ddd, J = 8.0, 7.3, 1.6, 1H, H-4), 
8.31 (s, 2H, NH2+), 9.71 (s, 1H, OH). 
31P NMR (162 MHz, DMSO-d6), δ, 
ppm (J, Hz): 
 
δ -144.20 (sept, J = 
711.2). 19F NMR (376 MHz, DMSO-
d6), δ, ppm (J, Hz):  -70.15 (d, J = 
711.2). 
(101 MHz, DMSO-d6), δ, ppm: 24.4 
(CH2), 24.5 (CH2), 33.0 (CH3), 36.4 
(CH3), 41.2 (CH3), 48.3 (CH2), 80.7 
(С), 115.1 (С), 117.0 (CH), 120.2 
(CH), 124.4 (CH), 126.7 (CH), 133.6 
(С), 151.6 (С), 152.1 (С), 152.9 (С). 
HRMS (ESI) 
Calculated for 
C16H22N5O+ 
300.1824, 
Found: 
300.1826; 
Calculated for 
PF6 -144.9642, 
Found: 
144.9646. 
Products were purified by automatic column chromatography (elution system: gradient CH3OH–CH2Cl2, 1:19 to CH3OH–CH2Cl2, 1:9). Yield 392 mg 
(0.88 mmol, 88%), white powder (mp 165–166 °C). 
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3.30 3-imino-2,5-
dimethyl-4-((2-
(methylamino)phenyl
)thio)-2,3,5,6,7,8-
hexahydropyrazolo[
4,3-c]azepin-5-ium 
hexafluorophosphat 
 
Neat film  
3424, 3374, 3154 
(NHν), 1654, 
1610, 1592 
(C=N, C=C, 
NHδ), 832 (P–F). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.09–2.19 (m, 2H, 7-CH2), 2.74 (d, J = 
5.0, 3H, NPhCH3), 2.75–2.80 (m, 2H, 
8-CH2), 3.26 (s, 3H, NAzepineCH3), 
3.31–3.38 (m, 2H, 6-CH2), 3.76 (s, 
3H, NPyrCH3), 5.31 (q, J = 5.1, 1H, 
NPhH), 6.60 (ddd, J = 8.1, 7.5, 1.2, 1H, 
H-4), 6.65 (dd, J = 8.2, 1.1, 1H, H-6), 
7.15 (dd, J = 7.7, 1.5, 1H, H-3), 7.24 
(ddd, 1H, J = 8.5, 7.8, 1.5, 1H, H-5), 
8.80 (s, 1H, NH), 9.00 (s, 1H, NH). 
31P NMR (162 MHz, DMSO-d6), δ, 
ppm (J, Hz): -144.20 (sept, J = 711.2). 
19F NMR (376 MHz, DMSO-d6), δ, 
ppm (J, Hz): -70.16 (d, J = 711.4). 
(101 MHz, DMSO-d6), δ, ppm: 22.2 
(CH2), 27.6 (CH2), 30.6 (CH3), 37.5 
(CH3), 38.2 (CH3), 52.6 (CH2), 111.2 
(CH), 113.3 (C), 114.2 (C), 117.4 
(CH), 131.2 (CH), 134.2 (CH), 135.5 
(C), 149.5 (C), 151.5 (C), 159.1 (C). 
HRMS (ESI) 
Calculated for 
C16H22N5S+ 
316.1596,           
Found: 
316.1591; 
Calculated for 
PF6-144.9642, 
Found: 
144.9649. 
Products were purified by automatic column chromatography (elution system: gradient CH3CN–CH2Cl2, 19:1 to CH3CN–CH2Cl2, 22:3). Yield 360 mg 
(0.78 mmol, 78%), white powder (mp 177–178 °C). 
3.31a 5-(2-amino-1-(1,3-
dimethyl-1H-
benzo[d]imidazol-
2(3H)-ylidene)-2-
oxoethyl)-1-methyl-
3,4-dihydro-2H-
pyrrol-1-ium iodide
 
Neat film  
3432 (NH2ν), 
1639 (C=O) 
1599, 1560 
(NH2δ, C=C) 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
(mixture of rotamers,  the signals of  
dominating rotamer are only 
mentioned) δ 1.90–2.08 (m, 2H, 4-
CH2), 2.20 (s, 3H, NCH3), 3.28 (t, J = 
7.3, 2H, 3-CH2), 3.59 (t, J = 7.0, 2H, 
5-CH2), 3.77 (s, 6H, 2NCH3), 6.67 (s, 
2H, NH2), 7.60–7.71 (m, 2H, H-5,6), 
7.91–8.02 (m, 2H, H-4,7). 
(75 MHz, DMSO-d6), δ, ppm:  20.6 
(CH2), 32.0 (2CH3), 35.0 (CH2), 35.3 
(CH3), 56.4 (CH2), 76.4 (C), 112.9 
(2CH), 125.7 (2CH), 131.7 (2C), 
151.0 (C), 167.0 (C), 169.0 (C, CO). 
HRMS (ESI) 
Calculated for 
C16H21N4O (M + 
H+) 285.1715, 
Found: 
285.1718. 
Product was purified by recrystalliaztion from propan-2-ol. Yield 312 mg (0.8 mmol, 79%), light brown powder. 
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General procedure for the synthesis of (Z)-2-(benzo[d]thiazol-2-yl)-2-((E)-3-
((dimethylamino)methylen)pyrrolidin-2-yledene)acetonitrile (4.2a). 
DМF DМА (1.07 ml, d = 0.897 g/cm3, 8 mmol) was added to a solution of 2-
benzo[d]thiazol-2-yl-2-(pyrrolidin-2-ylidene)acetonitrile 2.1b (0.965 g, 4 mmol) in 
anhydrouys toluene (15 ml) and the resultant  mixture was left to reflux over 3 h 
(TLC control, CHCl3-CH3OH, 95:5). At this point another portion of DMF DMA 
(1.07 ml, 8 mmol) was added to the reaction mixture. Reaction was left to reflux until 
complete convertion of starting material. If necessary another portion of DMF DMA 
should be added. After the reaction was completed the precipitate was filtered off and 
purified by recrystallization from ethanol-dioxane mixture. Yield 0.84 g (2.84 mmol, 
71%), yllow-green powder (mp 194–195 °С).   
 
1-Methyl-2,3-dihydro-1Н-benzo[4,5]imidazo[1,2-a]pyrrolo 
[2,3-d]pyridine-11-carbonitrile (4.4) 
DМF DМА (0.16 ml, 0.6 mmol) was added to a solution of  2-
benzo[d]imidazol-2-yl-2-(1-methylpyrrolidin-2-ylidene)acetonitrile 2.13а  (119 mg, 
0.5  mmol) in anhydrouys toluene (8 ml) and the resultant mixture was left to reflux 
until complete convertion of starting material, approimately 30 min (TLC control, 
CHCl3-CH3OH, 9:1). Product was purified by tritutation with hot propan-2-ol. Yield 
111 mg (0.45 mmol, 90%), white powder (mp > 300 °С). 
  
General procedure for the synthesis of 2-(benzo[d]thiazol-2-yl)-2-((E)-3-((R-
amino)methylene)purrolidin-2-ylidene)acetonitrile 4.6-4.8 
1-R-amine (1.5 mmol) was added to a solution of (Z)-2-(benzo[d]thiazol-2-yl)-
2-((E)-3-((dimethylamino)methylene)pyrrolidin-2-ylidene)acetonitrile 4.2a (592 mg, 
2 mmol) in dioxane-ethanol mixture (16 ml, 1:1) and the resultant mixture was left to 
reflux over 3 h. At this point another portion of 1-R-amine (1.5 mmol) was added and 
the refluxing was continued until complete convertion of starting material (TLC 
control, CHCl3-CH3OH, 19:1). The raction mixture was cooled down; the precipitate 
was filtered off and recrystallized from ethanol.   
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7-(Benzo[d]thiazol-2-yl)-5-benzyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-6(5H)-
imine (4.9). 
NaOEt (75 mg, 1.1 mmol) was added to a solution of (Z)-2-(benzo[d]thiazol-2-
yl)-2-((E)-3-((benzylamino)methylene)pyrrolidin-2-ylidene)acetonitrile 4.6 (358 mg, 
1 mmol) in dioxane-ethanol mixture (10 ml, 4:1) and the resultant mixture was left to 
reflux over 15 min. The blue fluorescence appears and the bright yellow precipitate 
forms. The reaction mixture was cooled down; the precipitate was filtered off and 
recrystallized from ethanol. Yield 323 mg (0.9 mmol, 90%), yellow powder, (mp 225 
°С). 
 
6-Amino-7-(benzo[d]thiazol-2-yl)-5-benzyl-2,3-dihydro-1H-pyrrolo[3,2-
c]pyridin-5-ium hydrogensulafate (4.10a). 
Pyrrolo[3,2-с]pyridin-6-imine 4.9 (179 mg, 0.5 mmol) was stirred upon reflux in 
30% Н2SO4 water-dioxane mixture over 36 h. During this time the hydrolysis of 
imino group did not occur (TLC control). When the mixture was cooling down the 
precipitate of the salt 4.10a was formed. Yield is 228 mg (0.49 mmol, 98%).  
 
6-Amino-7-(benzo[d]thiazol-2-yl)-5-benzyl-2,3-dihydro-1H-pyrrolo[3,2-
c]pyridin-5-ium chloride (4.10b). 
HCl gas was bubbled vigorously through an ice-cold solution of pyrrolo[3,2-
с]pyridin-6-imine 4.9 (179 mg, 0.5 mmol) in anhydrous dioxane for 30 min. The 
resultant precipitate was filtered off and washed with ether to yield 198 mg (0.49 
mmol, 98%), white powder. 
 
7-(Benzo[d]thiazol-2-yl)-5-benzyl-6-(dimethylamino)-1-methyl-2,3-dihydro-1H-
pyrrolo[3,2-c]pyridin-5-ium iodide (4.11). 
The mixture of pyrrolo[3,2-с]pyridin-6-imine 4.9 (107mg, 0.3 mmol) in 
СН3СN-DMF (10 ml, 5:1) and K2CO3 (207 mg, 1.5 mmol) was stirred at 80 °С over 
5 min. At this point МеI (0.1 ml, d = 2.279 g/cm3, 1.5 mmol) was added to reaction 
mixture and the stirring was pursued for another 30 min. After the reaction was 
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ceased (TLC control, CH2Cl2–CH3OH–Et3N, 9:1:0.1) the realultant precipitate was 
filtrated off; filtrate was condensed under reduced pressure and the residue was 
triturated with CH2Cl2. Yield 80%, (118 mg, 0.22 mmol), yellowish powder.   
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Table 6.5.  Physico-chemical characteristics of 2-azahetaryl-2-(pyrrolidin-2-ylidene)acetonitrile derivatives functionalized at С-3 
centre of pyrrolidine fragment 4.2a, 4.4, 4.6-4.11 
Com
poun
d 
IUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
4.2a (Z)-2-
(benzo[d]thiazol-2-
yl)-2-((E)-3-
((dimethylamino)met
hylen)pyrrolidin-2-
yledene)acetonitrile 
 
Neat film  
3201 (NH), 2172 
(C≡N), 1636, 
1553 (C=C, 
C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz):  
3.02–3.11 (m, 2H, 2СН3, 4-СН2), 3.67 
(t, J = 7.9, 2H, 5-СН2), 7.16–7.22 (m, 
1H, Н-6), 7.33–7.39 (m, 1H, Н-5), 
7.68 (d, J = 7.8, 1H, Ar H), 7.76 (s, 
1H, CHN(CH3)2), 7.85–7.90 (m, 1H, 
Ar H), 10.24 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 26.8 
(СН2), 42.6 (2СН3), 46.3 (СН2), 61.8 
(С), 99.0 (С), 119.8 (СН), 121.7 
(СН), 123.1 (СН), 123.7 (С), 126.4 
(СН), 131.7 (С), 144.5 (СН), 154.0 
(С), 164.7 (С), 168.8 (С). 
HRMS (ESI) 
Calculated for 
C16H17N4S (M + 
H+): 297.1174, 
Found: 
297.1173. 
Yield 840 mg (2.84 mmol, 71%), yellow-green powder (mp 194–195 °С).   
4.4 1-Methyl-2,3-
dihydro-1Н-
benzo[4,5]imidazo[1
,2-a]pyrrolo 
[2,3-d]pyridine-11-
carbonitrile  
 
KBr 
2198 (C≡N), 
1674, 1590, 1514 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
3.03 (t, J = 7.9, 2H, 3-СН2), 3.32 (s, 
3H, СН3), 3.80 (t, J = 7.8, 2H, 2-СН2), 
7.18 (t, J = 7.3, 1H, Ar H), 7.30 (t, J = 
7.7, 1H, Ar H), 7.58 (d, J = 7.9, 1H, 
Н-7), 7.89 (d, J = 7.6, 1H, Н-4). 
(101 MHz, DMSO-d6), δ, ppm: 23.2 
(CH2), 34.2 (CH3), 56.4 (CH2), 67.1 
(C), 110.8 (CH), 116.8 (C), 117.6 
(CH), 120.9 (CH), 121.5 (C), 123.1 
(CH), 124.8 (CH), 130.1 (C), 143.5 
(C), 149.3 (C), 156.1 (C). 
Calculated, %: 
C, 72.56; H, 
4.87; N, 22.57. 
C15H12N4. 
Found, %: C, 
72.58; H, 4.43; 
N, 21.60. 
Yield 111 mg (0.45 mmol, 90%), white powder (mp > 300 °С). 
4.6 (Z)-2-
(benzo[d]thiazol-2-
yl)-2-((E)-3-
((benzylamino)methy
lene)pyrrolidin-2-
ylidene)acetonitrile 
KBr 
 3289, 3258 
(NH), 2186 
(C≡N), 1645, 
1557 (C=C, 
C=N). 
(400 MHz, DMSO-d6-CCl4), δ, ppm 
(J, Hz):  2.75 (t, J = 7.4, 2H, 4-СН2), 
3.78 (t, J = 7.7, 2H, 5-СН2), 4.38 (d, J 
= 5.5, 2H, CHNHCH2), 7.04 (d.t, J = 
12.3, 5.6, 2H, CHNHCH2), 7.14 (t, J = 
7.1, 1H, H-6), 7.24–7.40 (m, 6H, Ph 
H, H-5), 7.61 (d, J = 8.0, 1H, Ar H), 
7.76 (d, J = 7.8, 1H, Ar H), 7.95 (d, J 
(101 MHz, DMSO-d6), δ, ppm: 26.0 
(СН2), 45.8 (СН2), 51.8 (СН2), 61.9 
(С), 101.2 (С), 120.0 (СН), 121.8 
(СН), 123.2 (СН), 123.4 (С), 126.5 
(СН), 127.7 (2СН), 127.8 (CH), 129.1 
(2СН), 131.8 (С), 140.3 (С), 142.4 
(СН), 154.1 (С), 162.5 (С), 168.6 (С). 
Calculated, %: 
C, 70.36; H, 
5.06; N, 15.63. 
C21H18N4S. 
Found, %: C, 
70.40; H, 5.26; 
N, 15.87. 
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= 12.9, 1H, CHNHCH2), 10.22 (s, 1H, 
NH). 
Yield 660 mg (1.84 mmol, 92%), yellow powder (mp 190 °C).  
4.7 (Z)-2-
(benzo[d]thiazol-2-
yl)-2-((E)-3-(((3,4-
dimethoxyphenethyl)
amino)methylene)pyr
rolidin-2-
ylidene)acetonitrile 
 
KBr 
3319 (NH), 2176 
(C≡N), 1654, 
1648, 1561 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz):  
2.58–2.67 (m, 2H, CH2), 2.76 (t, J = 
7.1, 2H, CH2), 3.27–3.43 (m, 2H, 
CH2), 3.65–3.80 (m, 8H, 2СН3, CH2), 
6.69–6.80 (m, 1H, H-63,4-(OMe)2Ar, 
CHNHCH2), 6.84 (d, J = 1.9, 1H, Н-
23,4-(OMe)2Ar), 6.87 (d, J = 8.2, 1H, Н-
53,4-(OMe)2Ar), 7.15–7.22 (m, 1H, Н-6), 
7.32–7.40 (m, 1H, Н-5), 7.64–7.69 (m, 
1H, Ar H), 7.80 (dt, J = 13.2, 1.6, 1H, 
CHNHCH2), 7.84–7.89 (m, 1H, Ar H), 
10.08 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 26.0 
(СН2), 37.0 (СН2), 45.6 (СН2), 50.1 
(СН2), 55.8 (СН3), 56.0 (СН3), 61.7, 
100.1 (С), 112.5 (СН), 113.1 (СН), 
119.8 (СН), 121.1 (СН), 121.7 (СН), 
123.1 (СН), 123.3 (С), 126.3 (СН), 
131.6 (С), 131.7 (С), 142.3 (С), 147.8 
(С), 149.1 (С), 154.0 (С), 162.4 (С), 
168.6 (С). 
Calculated, %: 
C, 66.64; H, 
5.29; N, 12.95. 
C24H24N4O2S. 
Found, %: C, 
64.76; H, 5.20; 
N, 12.61. 
Yield 744 mg  (1.72 mmol, 86%), yellow powder (mp 170 °С). 
4.8 (Z)-2-
(benzo[d]thiazol-2-
yl)-2-((E)-3-
(pyrrolidin-1-
ylmethylene)pyrrolid
in-2-
ylidene)acetonitrile 
 
Neat film 3206 
(NH), 2171 
(C≡N), 1629, 
1555 (C=N, 
C=C). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
1.83–1.89 (m, 4H, 
CHN(CH2)2(CH2)2), 3.10 (t, J = 7.7, 
2H, 4-CH2), 3.49–3.60 (m, 4H, 
CHN(CH2)2(CH2)2), 3.66 (t, J = 7.9, 
2H, 5-CH2), 7.19 (t, J = 7.6, 1H, Н-6), 
7.36 (t, J = 7.8, 1H, H-5), 7.68 (d, J = 
7.9, 1H, H-7), 7.87 (d, J = 7.8, 1H, H-
4), 8.01 (s, 1H, CHN(CH2)2(CH2)2), 
10.25 (s, 1H, NH). 
(101 MHz, DMSO-d6), δ, ppm: 25.4 
(2CH2), 26.6 (CH2), 46.1 (CH2), 51.1 
(2CH2), 61.7 (C), 99.8 (C), 119.8 
(CH), 121.7 (CH), 123.1 (CH), 123.7 
(C), 126.4 (CH), 131.7 (C), 140.9 
(CH), 154.0 (C), 164.0 (C), 168.8 (C).  
HRMS (ESI) 
Calculated for 
C18H19N4S  (M + 
H+) 323.1330, 
Found 323.1331. 
Yield 548 mg (1.7 mmol, 85%), yellow powder (mp 221–222 oC).  
4.9 7-(Benzo[d]thiazol-
2-yl)-5-benzyl-2,3-
dihydro-1H-
pyrrolo[3,2-
c]pyridin-6(5H)-
imine  
KBr 
3315 (NH), 1678, 
1579, 1563 
(C=C, C=N). 
(400 MHz, CDCl3), δ, ppm (J, Hz):  
2.98 (td, J = 7.8, 1.6, 2H, 3-СН2), 3.96 
(t, J = 7.9, 2H, 2-СН2), 4.93 (s, 2H, 
СНNCH2), 6.83 (t, J = 1.6, 1Н, 
СНNCH2), 7.24–7.34 (m, 6H, Н-6, 
HPh-2,4,6), 7.35 – 7.39 (m, 2H, HPh-
(101 MHz, CDCl3), δ, ppm (J, Hz): 
24.7 (CH2), 47.5 (CH2), 54.3 (CH2), 
94.4 (C), 112.6 (C), 120.3 (CH), 121.1 
(CH), 122.8 (CH), 125.2 (CH), 126.6 
(2CH), 127.9 (CH), 129.1 (2CH), 
130.9 (CH), 134.2 (C), 135.7 (C), 
Calculated, %: 
C, 70.36; H, 
5.06; N, 15.63. 
C24H24N4O2S. 
Found, %: C, 
70.56; H, 5.11; 
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3,5), 7.42 (ddd, J = 8.4, 7.3, 1.2, 1H, 
H-5), 7.87–7.89 (m, 1H, Н-4), 7.89–
7.91 (m, 1H, Н-7).  
DMSO-d6 : ratio imine:enamine 1.6:1. 
(400 MHz, DMSO-d6), δ, ppm (J, 
Hz): Imine: 2.95 (t, J = 7.2, 2H, 3-
СН2), 3.87 (t, J = 7.2, 2H, 2-СН2), 
5.03 (s, 2H, СHNCH2), 6.32 (s, 1H, 
NHCNBn), 7.12–7.54 (m, 8H), 7.86 
(d, J = 8.3, 1H, Ar H), 7.90 (d, J = 7.7, 
1H, Ar H), 9.28 (s, 1Н, NH). 
Enamine: 2.74 (t, J = 7.1, 2H, 3-СН2), 
3.99 (t, 6.9, 2H, 2-СН2), 5.07 (s, 2H, 
СHNCH2), 6.83 (s, 1H, СHNCH2), 
7.12–7.54 (m, 7H), 7.75 (d, J = 7.8, 
1H, Ar H), 7.94 (d, J = 8.0, 1H, Ar H), 
9.13 (br.s, 2Н, NH2). The signals of 
NH proton disappear upon D2O 
addition; the signal of CH proton 
broadening. 
151.6 (C), 154.5 (C), 157.1 (C), 165.3 
(C). 
N, 15.46. 
Yield 323 mg (0.9 mmol, 90%), yellow powder (mp 225 °С). 
4.10a 6-Amino-7-
(benzo[d]thiazol-2-
yl)-5-benzyl-2,3-
dihydro-1H-
pyrrolo[3,2-
c]pyridin-5-ium 
hydrogensulafate  
 
 (400 MHz, DMSO-d6), δ, ppm (J, Hz): 
3.13 (t, J = 7.9, 2H, 3-СН2), 3.89 (t, J 
= 8.2, 2H, 2-СН2), 5.42 (s, 2H, 
СHNCH2), 7.32–7.37 (m, 2H, НPh -
2,6), 7.38–7.41 (m, 1H, НPh -4), 7.43–
7.48 (m, 2H, НPh -3,5), 7.55 (t, J = 7.6, 
1H, Н-6), 7.63 (t, J = 7.6, 1H, Н-5), 
7.82 (s, 1H, СHNCH2), 8.13 (d, J = 
8.0, 1H, Н-4), 8.21 (d, J = 7.7, 1H, Н-
7), 8.57 (s, 1H, NH), 8.68 (s, 2H, 
NH2). The signals of NH proton 
disappear upon D2O addition. 
(101 MHz, DMSO-d6), δ, ppm: 24.3 
(CH2), 48.3 (CH2), 54.8 (CH2), 91.7 
(C), 120.8 (C), 122.4 (CH), 122.9 
(CH), 126.2 (CH), 127.2 (CH), 127.4 
(2CH), 128.5 (CH), 129.3 (2CH), 
133.3 (C), 134.1 (CH), 135.0 (C), 
151.6 (C), 152.2 (C), 158.7 (C), 161.4 
(C). 
 
Yield 228 mg (0.49 mmol, 98%), white powder. 
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4.10b 6-Amino-7-
(benzo[d]thiazol-2-
yl)-5-benzyl-2,3-
dihydro-1H-
pyrrolo[3,2-
c]pyridin-5-ium 
chloride 
 
KBr 
3400, 3283 (NH), 
1677, 1655, 
1617, 1596, 1578 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
3.07–3.13 (m, 2H, 3-СН2), 3.85 (t, J = 
8.3, 2H, 2-СН2), 5.45 (s, 2H, 
СHNCH2), 7.30–7.34 (m, 2H, НPh -
2,6), 7.34–7.38 (m, 1H, НPh -4), 7.39–
7.45 (m, 2H, НPh -3,5), 7.52 (ddd, J = 
8.2, 7.6, 1.2, 1H, Н-6), 7.60 (ddd, J = 
8.3, 7.8, 1.3, 1H, Н-5), 7.83 (br.s, 1H, 
СHNCH2), 8.08 – 8.13 (m, 1H, Н-4), 
8.18–8.21 (m, 1H, Н-7), 8.61 (s, 1H, 
NH), 8.76 (c, 2H, NH2). The integral 
intensity of the signals corresponds to 
NH protons dimish upon D2O 
addition. 
(101 MHz, DMSO-d6), δ, ppm: 24.3 
(CH2), 48.3 (CH2), 54.8 (CH2), 91.6 
(C), 120.8 (C), 122.4 (CH), 122.9 
(CH), 126.2 (CH), 127.2 (CH), 127.5 
(2CH), 128.5 (CH), 129.3 (2CH), 
133.4 (C), 134.1 (CH), 135.2 (C), 
151.6 (C), 152.2 (C), 158.8 (C), 161.4 
(C). 
HRMS (ESI) 
Calculated for 
C21H19N4S+ 
359.1329, Found  
359.1328. 
Yield 198 mg (0.49 mmol, 98%), white powder. 
4.11 7-(Benzo[d]thiazol-
2-yl)-5-benzyl-6-
(dimethylamino)-1-
methyl-2,3-dihydro-
1H-pyrrolo[3,2-
c]pyridin-5-ium 
iodide 
 
Neat film 1660, 
1576, 1527 
(C=C, C=N). 
(400 MHz, DMSO-d6), δ, ppm (J, Hz): 
2.34 (c, 6H, NCH), 3.01–3.10 (m, 2H, 
3-СН2), 3.91 (t, J = 8.8, 2H, 2-СН2), 
5.27 (s, 2H, СHNCH2), 7.22–7.26 (m, 
2H, НPh -2,6), 7.32–7.37 (m, 1H, НPh -
4), 7.39–7.44 (m, 2H, НPh -3,5), 7.57 
(td, J = 7.6, 1.4, 1H, Н-6), 7.62 (td, J = 
7.7, 1.5, 1H, Н-5), 8.00–8.07 (m, 1H, 
СHNCH2), 8.1 –8.15 (m, 1H, Н-4), 
8.22–8.26 (m, 1H, Н-7). 
(101 MHz, DMSO-d6), δ, ppm: 23.5 
(CH2), 35.4 (CH3), 42.4 (CH3), 57.4 
(CH2), 57.6 (CH2), 104.8 (C), 123.2 
(CH), 123.9 (CH), 126.9 (CH), 127.1 
(C), 127.2 (2CH), 127.4 (CH), 128.6 
(CH), 129.4 (2CH), 135.9 (CH), 136.4 
(C), 136.6 (C), 152.5 (C), 158.1 (C), 
159.1 (C), 159.6 (C). 
HRMS (ESI) 
Calculated for 
C25H25N4S+ 
401.1800, Found  
401.1800. 
Calculated for І- 
126.9045, Found 
126.9047. 
Yield 118 mg (0.22 mmol, 80%), yellowish powder.   
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General procedure for the synthesis of BF2-rigidified complexes 5.1а-h. 
(Z)-2-hetaryl-2-(pyrrolidin-2-ylidene)acetonitriles 2.1а-d, g, i, 2.9, 2.10 (0.5 mmol) 
and N,N-diisopropylethylamine (0.25 ml, d = 0.782 g/ml, 1.5 mmol) were heated to 
reflux in dichloromethane (8 ml) for 15 min. BF3•OEt2 (0.5 ml, d = 1.130 g/ml, 4 
mmol) was added and the mixture was refluxed another 30 min. After the reaction 
was cooled down, it was diluted with additional amount of dichloromethane and 
washed with water 3 times and brine 1 time. The organic fraction was dried over 
Na2SO4, filtrated off and evaporated under reduced pressure. The crude products 
were purified by automated flash chromatography.  
 
Preparation of the samples of Films of polymeric composites (FPC). 
The samples for the investigation were prepared with a free FPC surface, (glass 
substrate)/ITO/FPC, where ITO is an electroconducting layer of SnO2: In2O3. To 
prepare the samples filtered solutions of CuL2, NiL2, CoL2 complexes, and SOM in 
methylene chloride were deposited on a glass substrate with a layer of ITO and dried 
at room temperature for 24 h and then in a drying cabinet at 80 °C for 48 h. The 
content of HL and metal complexes in the SOM amounted to between 1 and 50 wt.%. 
Increase of the concentration of the additives in the SOM to more than 50 wt.% leads 
to nonuniformity in the morphology of the films, which cannot be permitted for use 
in photoelectric converters. The thickness of the FPC was ~1.5 µm  
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Table 6.6. Physico-chemical characteristics of BF2-complexes 5.1а-h 
Com
poun
d 
IUPAC name IR, ν, cm−1 1H NMR  13C NMR  HRMS/MS, 
elemental 
analysis 
5.1а BF2-rigidified (Z)-2-
(benzo[d]thiazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile   
 
Neat film 
2204 (C≡N), 
1598, 1584 
(C=N, C=C). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
2.24–2.36 (m, 2H, 4-СH2), 3.19 (t, J = 
8.0, 2H, 3-CH2), 4.04–4.10 (m, 2H, 5-
CH2), 7.41 (ddd, J = 8.4, 7.4, 1.1, 1H, 
H-6), 7.54 (ddd, J = 8.4, 7.4, 1.3, 1H, 
H-5), 7.75 (ddd, J = 8.0, 1.2, 0.5, 1H, 
H-7), 8.02 – 8.07 (m, 1H, H-4). 19F 
NMR (282 MHz, CDCl3), δ, ppm (J, 
Hz): -139.07 (q, J = 29.0). 11B NMR 
(96 MHz, CDCl3), δ, ppm (J, Hz): 
1.48 (t, J = 29.3). 
(75 MHz, CDCl3), δ, ppm (J, Hz): 
21.3 (CH2), 34.3 (CH2), 51.6 (CH2), 
70.3 (С), 116.6 (C), 118.1 (t, 2JCN = 
3.2, 4-CH), 121.9 (CH), 125.4 (CH), 
127.4 (C), 127.8 (CH), 142.9 (C), 
166.9 (C), 170.1 (C). 
HRMS (DCI-
CH4) Calculated 
for 
C13H11BF2N3S 
(M + H+) 
290.0735, Found  
290.0741. 
Elution system for column chromatography: CH2Cl2–CHA, 7:3. Yield 133 mg (0.46 mmol, 92%), white powder (mp 233 °C)  
5.1b BF2-rigidified (Z)-2-
(benzo[d]oxazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile   
 
Neat film 
2214 (C≡N), 
1636, 1616, 1532 
(C=N, C=C). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
2.24–2.39 (m, 2H, 4-CH2), 3.22 (t, J = 
8.0, 2H, 3-CH2),  4.03–4.10 (m, 2H, 5-
CH2), 7.40 (ddd, J = 7.9, 7.6, 1.6, 1H, 
Het H), 7.46 (ddd, J = 7.9, 7.7, 1.5, 
1H, Het H), 7.53–7.61 (m, 1H, 7-H, 
Het H), 7.67–7.75 (m, 1H, 5-H). 19F 
NMR (282 MHz, CDCl3), δ, ppm (J, 
Hz): -140.41 (q, J = 26.0). 11B NMR 
(96 MHz, CDCl3), δ, ppm (J, Hz): 
1.17 (t, J = 26.2). 
(75 MHz, CDCl3), δ, ppm (J, Hz): 
21.4 (CH2), 34.8 (CH2), 51.7 (CH2), 
61.2 (C), 111.2 (CH), 114.2 (C), 114.9 
(CH), 125.6 (CH), 126.4 (CH), 130.9 
(C), 148.1 (C), 162.7 (C), 173.1 (C). 
HRMS (DCI-
CH4) Calculated 
for 
C13H11BF2N3O 
(M + H+) 
274.0963, 
Found: 
274.0969. 
Elution system for column chromatography: CH2Cl2–CHA, 7:3. Yield 123 mg (0.45 mmol, 89%), white powder (mp 226–227 °C).  
5.1с BF2-rigidified (Z)-2-
(4-methylthiazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile 
Neat film 
2202 (C≡N), 
1592, 1567 
(C=N, C=C). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.20–2.29 (m, 2H, 4-CH2), 2.51 (td, 
3JHN = 1.6, 3J HH = 1.2, 3H, CH3), 3.12 
(t, J = 8.0, 2H, 3-CH2), 3.95–4.01 (m, 
2H, 5-CH2), 6.60 (d, J = 1.2, 1H, H-5). 
19F NMR (282 MHz, CDCl3), δ, ppm 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
14.63 (t, 2JCN = 4.0, CH3), 21.7 (CH2), 
34.0 (CH2), 51.2 (CH2), 69.2 (C), 
107.9 (CH), 117.2 (C), 145.1 (C), 
167.1 (C), 168.5 (C). 
HRMS (DCI-
CH4) Calculated 
for: 
C10H11BF2N3S 
(M + H+) 
254.0735, 
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(J, Hz): -133.57 (q, J = 29.5). 11B 
NMR (96 MHz, CDCl3), δ, ppm (J, 
Hz): 1.15 (t, J = 29.8). 
Found: 
290.0732. 
Elution system for column chromatography: CH2Cl2–CHA, 3:2. Yield 118 mg (0.47 mmol, 93%), white powder (mp 156–157 °C).  
5.1d BF2-rigidified (Z)-2-
(1-methyl-1H-
benzo[d]imidazol-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile   
 
Neat film 2206 
(C≡N), 1584, 
1542 (C=N, 
C=C). 
(300 MHz, CDCl3), δ, ppm (J, Hz): 
2.20–2.31 (m, 2H, 4-CH2), 3.18 (t, J = 
8.0, 2H, 3-CH2), 3.99–4.06 (m, 2H, 5-
CH2), 4.07 (s, 3H, NCH3), 7.30–7.43 
(m, 3H, Het H), 7.77–7.86 (m, 1H, H-
4). 19F NMR (282 MHz, CDCl3), δ, 
ppm (J, Hz): -143.18 (q, J = 27.7). 11B 
NMR (96 MHz, CDCl3), δ, ppm (J, 
Hz): 1.15 (t, J = 28.0). 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
21.5 (CH2), 30.8 (CH3), 34.9 (CH2), 
51.2 (CH2), 59.3 (C), 109.2 (CH), 
114.9 (CH), 118.2 (C), 124.1 (CH), 
124.4 (CH), 131.9 (C), 133.5 (C), 
147.8 (C), 172.1 (C).   
HRMS (DCI-
CH4) Calculated 
for C14H14BF2N4 
(M + H+) 
287.1280, 
Found: 
287.1278. 
Elution system for column chromatography: CH2Cl2–CHA, 7:3. Yield 106 mg (0.37 mmol, 73%), white powder (mp 280 °C).  
5.1e BF2-rigidified (E)-2-
(pyrrolidin-2-
ylidene)-2-(quinolin-
2-yl)acetonitrile 
 
Neat film 
2201 (C≡N), 
1632, 1596, 1553 
(C=N, C=C). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.22–2.33 (m, 2H, 4-CH2), 3.22 (t, J = 
8.0, 2H, 3-CH2), 4.06–4.13 (m, 2H, 5-
CH2), 7.50 (t, J = 7.4, 1H, H-6), 7.58 
(d, J = 9.1, 1H, H-3), 7.72 (d, J = 8.2, 
1H, H-5) 7.74 (ddd, J = 8.5, 8.1, 1.5, 
1H, H-7), 8.07 (d, J = 9.1, 1H, H-4), 
8.61 (d.t, 2JHH = 8.4 Hz, 3JHN = 2.5, 
1H, H-8). 19F NMR (376 MHz, 
CDCl3), δ, ppm (J, Hz):  -131.79 (q, J 
= 32.9). 11B NMR (128 MHz, CDCl3), 
δ, ppm (J, Hz): 2.33 (t, J = 33.0). 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
21.1 (CH2), 34.9 (CH2), 52.0 (CH2), 
72.75 (t, 2JCN = 2.5, HetCCN), 118.5 
(C), 118.6 (CH), 122.45 (t, 2JCN = 8.6, 
8-CH), 125.3 (C), 125.9 (CH), 128.6 
(CH), 131.9 (CH), 139.58 (t, 1JCN = 
2.8 Hz, (CH)4CN), 140.4 (CH), 152.7 
(C), 169.7 (C). 
HRMS (DCI-
CH4) Calculated 
for C15H13BF2N3 
(M + H+) 
284.1171, 
Found: 
284.1165. 
Elution system for column chromatography: CH2Cl2–CHA, 3:2. Yield 118 mg (0.45 mmol, 89%), bright yellow powder (mp 224 °C).  
5.1f BF2-rigidified (E)-2-
(pyridin-2-yl)-2-
(pyrrolidin-2-
ylidene)acetonitrile 
Neat film 2202 
(C≡N), 1631, 
1596 (C=N, 
C=C). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.17–2.27 (m, 2H, 4-СH2), 3.17 (t, J = 
8.0 Hz, 2H, 3-CH2), 3.95–4.00 (m, 2H, 
5-CH2), 7.13 (ddd, J = 7.6, 6.1, 1.3, 
1H, H-5), 7.55 (d, J = 8.6, 1H, H-3), 
7.85 (ddd, J = 8.7, 7.1, 1.6, 1H, H-4), 
(101 MHz, CDCl3), δ, ppm: 21.4 
(CH2), 34.6 (CH2), 51.4 (CH2), 70.4 
(C), 117.5 (CH), 118.2 (C), 119.8 
(CH), 139.5 (CH), 140.2 (CH), 150.9 
(C), 169.4 (C). 
HRMS (DCI-
CH4) Calculated 
for C11H11BF2N3 
(M + H+) 
234.1014, 
Found: 
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8.31 (d, J = 6.2, 1H, H-6). 19F NMR 
(376 MHz, CDCl3), δ, ppm (J, Hz): -
137.84 (q, J = 29.3). 11B NMR (128 
MHz, CDCl3), δ, ppm (J, Hz): 1.24 (t, 
J = 29.7). 
234.1012. 
Elution system for column chromatography: CH2Cl2–CHA, 3:2. Yield 105 mg (0.45 mmol, 90%), yellowish powder (mp 158–159 °C).  
5.1g BF2-rigidified (Z)-2-
(4-
methoxyquinazolin-
2-yl)-2-(pyrrolidin-
2-
ylidene)acetonitrile 
 
Neat film 2209 
(C≡N), 1626, 
1594 (C=N, 
C=C), 1212 (C–
O). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.18–2.33 (m, 2H, 4-СH2), 3.21 (t, J = 
8.0, 2H, 3-СH2), 4.02–4.07 (m, 2H, 5-
СH2), 4.31 (s, 3H, CH3, ОСН3) 7.49 
(ddd, J = 8.3, 7.1, 0.8, 1H, H-6), 7.83 
(ddd, J = 8.8, 7.1, 1.6, 1H, H-7), 8.10 
(dd, J = 8.1, 1.4, 1H, H-5), 8.38 (d.t, 
2JHH = 8.9, 3JHN = 2.6, 1H, H-8). 19F 
NMR (376 MHz, CDCl3), δ, ppm (J, 
Hz): -134.37 (q, J = 32.1). 11B NMR 
(128 MHz, CDCl3), δ, ppm (J, Hz): 
2.21 (t, J = 32.6). 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
21.0 (CH2), 34.8 (CH2), 51.8 (CH2), 
55.7 (CH3), 73.7 (C), 113.4 (C), 117.9 
(C), 121.5 (t, 2JCN = 7.6, 8-CH), 124.4 
(CH), 126.0 (CH), 135.4 (CH), 143.0 
(t, 1JCN = 2.7, (CH)4CN), 158.4 (C), 
166.7 (C), 171.4 (C). 
HRMS (DCI-
CH4) Calculated 
for 
C15H14BF2N4O 
(M + H+) 
315.1229, 
Found: 
315.1236. 
Elution system for column chromatography: CH2Cl2–CHA, 7:3. Yield 127 mg (0.41 mmol, 81%), greenish powder (mp 232–233 °C).  
5.1h BF2-rigidified (Z)-2-
(3-methyl-4-oxo-3,4-
dihydroquinazolin-2-
yl)-2-(pyrrolidin-2-
ylidene)acetonitrile . 
 
Neat film 
2204 (C≡N), 
1685 (C=O), 
1623 (C=N, 
C=C). 
(400 MHz, CDCl3), δ, ppm (J, Hz): 
2.22–2.34 (m, 2H, 4-CH2), 3.26 (t, J = 
8.0, 1H, 3-CH2), 3.98 (s, 3H, NCH3), 
4.07–4.13 (m, 2H, 5-CH2), 7.42–7.48 
(m, 1H, H-6), 7.76 (ddd, J = 8.9, 7.2, 
1.8, 1H, H-7), 8.27 (dd, J = 7.9, 1.7, 
1H, H-5), 8.28 (dt, 2JHH = 8.9, 2JHN = 
3.0, 1H, 8-H). 19F NMR (376 MHz, 
CDCl3), δ, ppm (J, Hz): -134.82 (q, J 
= 30.8). 11B NMR (128 MHz, CDCl3), 
δ, ppm (J, Hz): 1.60 (t, J = 31.4). 
(101 MHz, CDCl3), δ, ppm (J, Hz): 
20.4 (CH2), 36.38 (CH2), 36.44 (CH3), 
52.7 (CH2), 66.3 (C), 117.7 (C), 118.0 
(C), 121.8 (t, 2JCN = 9.3, 8-CH), 126.4 
(CH), 127.7 (CH), 135.4 (CH), 139.8 
(t, 1JCN = 2.4, (CH)4CN), 154.7 (C), 
160.1 (C), 173.5 (C). 
HRMS (DCI-
CH4) Calculated 
for 
C15H14BF2N4O 
(M + H+) 
315.1229, 
Found: 
315.1224. 
Elution system for column chromatography: CH2Cl2–CHA, 7:3. Yield 118 mg (0.38 mmol, 75%), white powder (mp degradate when heating).  
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SUPPLEMENTARY INFORMATION 
(Z)-2-(Benzo[d]thiazol-2-yl)-2-(pyrrolidin-2-ylidene)acetonitrile (2.1b). 
 
2-(Benzo[d]thiazol-2-yl)-2-(1-methylpyrrolidin-2-ylidene)acetonitrile (2.7b).  
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2-(Cyano(1-methylpyrrolidin-2-ylidene)methyl)-3-methylbenzo[d]oxazol-3-ium 
hexafluorophosphate (2.21). 
 
(Z)-2-(benzo[d]thiazol-2-yl)-2-(5-methyl-3-oxoindolin-2-ylidene)acetonitrile (2.23b). 
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4-(Benzo[d]thiazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-pyrazol-5-amine 
(3.1а). 
 
4-(1H-Benzo[d]imidazol-2-yl)-1-methyl-3-(3-(methylamino)propyl)-1H-pyrazol-5-
amine (3.3a). 
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3-(3-(Benzylamino)propyl)-4-(quinolin-2-yl)isoxazol-5-amine (3.5b). 
 
 
3-(5-Amino-4-(benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)-N,N,N-
trimethylpropan-1-aminium iodide (3.8). 
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Tert-butyl (3-(4-(benzo[d]thiazol-2-yl)-5-(benzylamino)-1-methyl-1H-pyrazol-3-
yl)propyl)(methyl)carbamate (3.10). 
 
 
N-(3-(3,5-dimethyl-3H-benzo[4,5]imidazo[1,2-c]pyrazolo[4,3-e]pyrimidin-1-
yl)propyl)-N-methylacetamide (3.11). Суміш ротамерів. 
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N-methyl-N-(3-(3-methyl-3H-benzo[4,5]imidazo[1,2-c]pyrazolo[4,3-e][1,2,3]triazin-
1-yl)propyl)nitrous amide (3.12). 
 
 
3-(4-(benzo[d]thiazol-2-yl)-5-(4-methoxyphenyl)-1-methyl-1H-pyrazol-3-yl)-N-
methylpropan-1-amine (3.16a). 
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N-(3-(4-(benzo[d]thiazol-2-yl)-5-(4-methoxyphenyl)-1-methyl-1H-pyrazol-3-
yl)propyl)-N-methylnitrous amide (3.16с). 
(E)-Tert-butyl (3-(4-(benzo[d]thiazol-2-yl)-1-methyl-5-styryl-1H-pyrazol-3-
yl)propyl)(methyl)carbamate (3.19).  
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N-(3-(4-(benzo[d]thiazol-2-yl)-5-(1H-indol-2-yl)-1-methyl-1H-pyrazol-3-yl)propyl)-
N-methylnitrous amide (3.20). 
3-(4-(benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-3-yl)-N-methylpropan-1-aminium 
chloride (3.22). 
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Сomparison 3.23a and 3.24a
 
 
(Z)-3-(3-(benzylamino)propyl)-N'-hydroxy-5-((2-hydroxyphenyl)amino)isoxazole-4-
carboximidamide (3.26b). 
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3-(4-cyano-5-((2-hydroxyphenyl)(methyl)amino)-1-methyl-1H-pyrazol-3-yl)-N-
methylpropan-1-aminium hexafluorophosphate (3.28).  
 
3-Imino-2,5-dimethyl-4-((2-(methylamino)phenyl)thio)-2,3,5,6,7,8-
hexahydropyrazolo[4,3-c]azepin-1-ium hexafluorophosphate (3.30). 
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(Z)-2-(benzo[d]thiazol-2-yl)-2-3-((dimethylamino)methylene)pyrrolidin-2-
ylidene)acetonitrile (4.2). 
 
1-methyl-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]pyrrolo[2,3-d]pyridine-11-
carbonitrile (4.4). 
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7-(benzo[d]thiazol-2-yl)-5-benzyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-6(5H)-imine 
(4.9). 
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Comparison 4.10a and 4.10b. 
 
 
7-(Benzo[d]thiazol-2-yl)-5-benzyl-6-(dimethylamino)-1-methyl-2,3-dihydro-1H-
pyrrolo[3,2-c]pyridin-5-ium iodide (4.11).
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12-Cyano-5,5-difluoro-1,2,3,5-tetrahydrobenzo[4,5]oxazolo[3,2-c]pyrrolo[2,1-
f][1,3,2]diazaborinin-6-ium-5-uide (5.1b). 
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Thesis summary 
 
The research carried out in the course of this PhD work is centered on cyclic 2-
azahetaryl-3-enaminonitrile derivatives which represent an attractive scaffold due to 
its high number of potential reactive sites. Regioselective functionalization of each 
site may give access to various structurally different Nitrogen-containing moieties 
featuring an azaheterocycle substituent.  
One first application in heterocyclic synthesis of 2-azahetaryl-2-(1-R-pyrrolidin-
2-ylidene)acetonitriles, readily accessed from available and cheap starting materials, 
is their involvement in Knorr-type synthesis of pyrazoles (isoxazoles) where they 
play the role of the 1,3-dielectrophiles. Thus 4-azahetaryl-3-(ω-aminopropyl)-1H-
pyrazole(isoxazole)-5-amines are formed with complete regioselectivity in good 
yields 50-85%. This establishes an efficient and easily reproducible two-step 
approach to heterocycle-substituted amino-pyrazoles from heterocyclic acetonitriles. 
Unprecedented subsequent transformations were carried out providing an access 
to regioselectively derivatized polyamino azoles, tetracyclic compounds in up to 45% 
overall yield and arylated pyrazoles in up to 71% yield through diazotization, 
followed by arylation through Suzuki−Miyaura cross-coupling or C−H activation. 
We illustrated the unprecedented but efficient nitrogen protection as a nitrosamine 
during the Pd-catalyzed cross-coupling. Also the possibility of pyrazoles C–H 
activation in order to get densely substituted pyrazoles was shown for the first time.  
We also performed the quaternarization of the nitrogen of the heterocycle to 
investigate the effect of a cationic moiety on the regioselectivity of the reaction of 
such azahetaryl-3-enaminonitrile derivatives with 1,2-binucleophiles. The increased 
electron demand on the heterocycle induced a reaction path shift that produced the 
azole ring-opened product. Derivatives of benzoxazole and benzimidazole form 
second way products straight away, while the one of benzothiazole undergoes the 
“classical” transformation pathway and subsequent nucleophilic substitution at C-2 
center of benzothiazole leading to azepine cycle formation. In the case of 
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benzoxazolyl substituted enaminonitriles under the same conditions both 
regioisomers are formed.  
Formylation reaction of 2-(benzo[d]thiazol-2-yl)-2-(pyrrolidin-2-ylidene) 
acetonitrile with N,N-dimethylformamide dimethyl acetal (DMF DMA), followed by 
further reamination and cyclization under basic conditions gave rise to pyrrolo[3,2-
c]pyridine-6-imine, a compound that exhibits a high fluorescent quantum yield (Ф = 
61%) and proved to be very sensitive to protonation. Both characteristics are 
expected to be useful to develop an unprecedented water detection test for aprotic 
solvents. We have demonstrated that such a fluorometric method for determining 
water content in DMSO presents a limit of detection of 0.068%. From other 
enaminonitriles reactions with DMF DMA provided either a mixture of methylated 
and formylated products, or only methylated products (few adducts also shown non 
reactivity). These observations prompted us to assume that the presence of easily 
accessible NH group is essential in formylation of the C-3 center of pyrrolidine 
allowing to propose a mechanism for this uncommon reaction. 
2-Azahetaryl-2-(pyrrolidin-2-ylidene)acetonitriles and their 3-oxo-benzo- 
analogues were also used to create: a) visible spectrophotometric probes for Zn(II) b) 
water stable BF2-rigidified complexes that overcome the limitations of BODIPY-dyes 
and have Stokes shifts up to 9000 cm-1, emission at violet-blue range, fluorescence 
both in solution (Ф up to 90%) and crystalline state; c) films of polymeric composites 
exhibiting photovoltaic effect. 
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Résumé de thése 
 
Les recherches effectuées au cours de ce travail de thèse sont centrées sur les 
dérivés cycliques de type 2-azahetaryl-3-énaminonitrile qui représentent une structure 
d’intérêt du fait de son nombre élevé de sites réactifs potentiels. La fonctionnalisation 
régiosélective de chaque site donne en effet accès à des une grande diversité 
structurelle de composés azoté et substitué par un azahétérocycle. 
Un atout majeur des 2-azahetaryl-2-(1-R-pyrrolidin-2-ylidene)acétonitriles est 
leur grande accessibilité à partir de matières premières simples et bon marché. Nous 
avons pu étudier leur emploi dans la synthèse des pyrazoles (isoxazoles). Ils jouent 
alors le rôle de diélectrophiles 1,3. L’action d’hydrazine (hydroxylamine) conduit à 
des 5-amino-4-azahetaryl-3-(ω-aminopropyl)-1H-pyrazole (isoxazole) formés avec 
une régiosélectivité complète et de bons rendements 50-85%. Ceci établit une 
approche en deux étapes efficace et facilement reproductible à des amino-pyrazoles 
substitués par des hétérocycles à partir d'acétonitriles hétérocycliques. 
Des transformations subséquentes ont été réalisées donnant accès à des 
polyamino-azoles dérivatisés régiosélectivement, à des composés tétracycliques 
jusqu'à un rendement global de 45% et à des pyrazoles arylés jusqu'à 71% de 
rendement par diazotation suivie d'une arylation par couplage croisé Suzuki-Miyaura 
ou C–H activation. Nous avons illustré une protection de l'azote efficace sous forme 
de nitrosamine pendant le couplage croisé catalysé par Pd.  
Nous avons également effectué la quaternarisation de l'azote de l'hétérocycle 
pour étudier l'effet d'une moitié cationique sur la régiosélectivité de la réaction de tels 
dérivés 2-azahetaryl-3-énaminonitrile avec des 1,2-binucléophiles. L'augmentation de 
la demande en électrons sur l'hétérocycle a induit un changement de chemin 
réactionnel qui a conduit à un produit issu de l’ouverture du cycle azole. Une 
différence de réactivité entre les dérivés du benzoxazole et du benzimidazole d’une 
part et du benzothiazole d’autre part a été observée. Alors que les premiers suivent la 
voie d’ouverture de cycle, le second suit une transformation «classique» puis une 
substitution nucléophile au centre C-2 du benzothiazole conduisant à la formation du 
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cycle de l'azépine. Dans le cas des énaminonitriles substitués par un benzoxazolyle 
dans les mêmes conditions, les deux régioisomères sont formés. 
La réaction de formylation du 2-(benzo[d]thiazol-2-yl)-2-(pyrrolidin-2-ylidène) 
acétonitrile avec le N,N-diméthylformamide diméthylacétal (DMF DMA), suivie 
d'une amination et d'une cyclisation dans des conditions basiques a engendré à la 
pyrrolo[3,2-c]pyridine-6-imine, un composé qui présente un rendement quantique 
fluorescent élevé (Ф = 61%) et s'est révélé très sensible à la protonation. Les deux 
caractéristiques devraient être utiles pour développer un test de détection d'eau 
originaux pour les solvants aprotiques. Nous avons démontré qu'une telle méthode 
fluorométrique pour déterminer la teneur en eau dans le DMSO présente une limite 
de détection de 0,068%. A partir d'autres réactions d'énaminonitriles avec du DMF 
DMA un mélange de produits méthylés et formylés est obtenu, soit seulement des 
produits méthylés (peu d'adduits ont également montré une non-réactivité). Ces 
observations nous ont amenés à supposer que la présence de groupe NH facilement 
accessible est essentielle dans la formylation du centre C-3 de la pyrrolidine 
permettant de proposer un mécanisme pour cette réaction peu commune. 
Les 2-azahetaryl-2-(pyrrolidin-2-ylidène)acétonitriles et leurs 3-oxo-benzo-
analogues ont également été utilisés pour créer: a) des sondes spectrophotométriques 
pour Zn(II); b) des complexes BF2-rigidifiés stables à l'eau qui dépassent les 
limitations des BODIPY et ont des décalages de Stokes jusqu'à 9000 cm-1, émission 
en bleu violet, fluorescence à la fois en solution (Ф jusqu'à 90%) et à l'état cristallin; 
c) des films de composites polymériques présentant un effet photovoltaïque. 
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CONTENU PRINCIPAL (en français) 
 
Dans l'introduction le cadre général et les objectifs de l'étude de 2-
azahetaryl-3-énaminonitriles A (Figure 1) sont présentés. 
 
Figure 1. Structure générale des 2-azahéaryl-3-énaminonitriles cycliques 
étudiés dans cette thèse. 
 
Dans un premier chapitre, une étude générale de la littérature concernant les 
2-(1-R-pyrrolidin-2-ylidène)acétonitriles et leurs analogues benzo-fusionnés А est 
presenté. Des détails sont fournis sur les différentes approches de synthèse de ces 
composés. Leurs différentes réactivités en fonction de leur nature cyclique ou 
acyclique et de leurs substitutions sont alors recouvertes d'une gamme de 
nucléophiles et d'acétals de diméthylformamide. Une dernière partie de ce chapitre 
 
 
 
 
Figure 2.  Représentation graphique de la revue de littérature. 
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décrit la complexation du bore et des métaux par le 2-(pyrrolidin-2-
ylidène)acétonitrile et les applications des complexes isolés sont caractérisées 
(Figure 2). 
 
Un deuxième chapitre décrit en détail la synthèse et la caractérisation des 2-
azahétaryl-2-(1-R-pyrrolidin-2-ylidène)acétonitrile et du 2-azahétaryl-2-(3-
oxoindolin-2-ylidène)acétonitrile A (R1 = Het) obtenu au cours de nos études. Une 
étude approfondie de la configuration par différentes méthodes analytiques, telles 
que la diffraction des rayons X, la RMN incluant des expériences à température 
variable ainsi que le calcul, est ensuite décrite. 
2-Azahétaryl-2-(pyrrolidin-2-ylidène)acétonitriles 
On peut accéder au 2-azahétaryl-2-(1-R-pyrrolidin-2-ylidène)acétonitriles par 
deux voies représentées sur le Schéma 1.  
 
Schéma 1. Voies d'accès à la synthèse des 2-azahétaryl-2-(pyrrolidin-2-ylidène) 
acétonitriles 1. 
 
La première voie comprend la synthèse d'éther lactimique 3 qui se condense 
après avec l'hétarylacétonitrile 2. L'ajustement de ce schéma de synthèse nous a 
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permis d'augmenter le nombre de substituants hétérocycliques dans les 2-
(pyrrolidin-2-ylidène)acétonitriles et d'obtenir 8 nouveaux composés 1b-h, j.  
Nous avons également mis au point une nouvelle méthode pour la synthèse 
des énaminonitriles 1 en utilisant une condensation à trois composants impliquant 
l’hétarylacétonitrile 2, l’oxychlorure de phosphore et la pyrrolidin-2-one 4. 
Contrairement à la méthode décrite précédemment (Schéma 1, voie 1) qui nécessite 
la préparation initiale de 5-méthoxy-3,4-dihydro-2H-pyrroles 3 la méthode 
proposée est simplifiée permettant la génération in situ de cation 5-chloro-3,4-
dihydro-2H-pyrrolinium 5 et préparation du 2-hétaryl-2-(pyrrolidin-2-
ylidène)acétonitrile souhaité en 1 heure (Schéma 1, voie 2). 
Étant donné la structure de 1, on peut supposer qu'il peut exister sous forme 
de mélange d'isomères Z et E (isomérisation autour de la liaison énamine C=C). 
Cependant, un seul jeu de signaux dans les spectres RMN, dans lesquels le proton 
NH déplacé vers le champ faible (8,7-11,3 ppm), ainsi que des données XRD, 
indiquent que seule la forme Z est observée. Selon les calculs de chimie quantique, 
la quantité théorique d'isomère E ne dépasse pas 0,1%. 
 
2-Azahétaryl-2-(1-alkylpyrrolidin-2-ylidène)acétonitriles 
Nous avons montré que le schéma de synthèse permettant d'accéder aux 2-
azahetaryl-2-(1-alkylpyrrolidin-2-ylidène)acétonitriles par alkylation de leurs 
analogues non substitués en N ne fonctionne pas correctement. Ainsi, nous avons 
développé une stratégie alternative pour leur synthèse, représentée sur le Schéma 2, 
voie 1. La condensation entre les 2-azahetarylacétonitriles anion 2 (obtenu par 
déprotonation par NaH) et 5-méthoxy-1-R-3,4-dihydro-2H-pyrrol-1-ium 14 ou 15 
se déroule à température ambiante en donnant 57-91% de énamine désiré 6-12. Le 
procédé alternatif pour la synthèse est illustré dans le Schéma 2, la voie 2 est 
analogue à la méthode qui a été développée pour la synthèse d'énaminonitriles 1 
non substitués (Schéma 1, voie 2). 
Compte tenu de la structure des énaminonitriles N substitués 6-12, on pourrait 
également supposer qu'ils existent sous la forme d'un mélange d'isomères Z et E. 
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Cependant, les données d'analyse DRX ont révélé quà l’état solide le 
diastéréoisomère présentant un encombrement stérique inférieure (N-alkyle et CN 
en position cis) est isolé préférentiellement. 
 
 
Schéma 2. Synthèse de 2-azahétaryl-2-(1-alkylpyrrolidin-2-ylidène)acétonitriles 6-
12. 
 
L'état cristallin a révélé une conformation presque plane du cycle pyrrolidine 
(déviation du plan à 0,16 Å), qui est quasi-coplanaire avec le substituant 
hétérocyclique (angle dièdre inférieur à 9 °). 
Néanmoins l’étude RMN démontre que la solution contient un mélange de 
diastéréoisomères. Deux singulets larges de 3-CH2 et N-CH3 adjacents à la liaison 
С=С sont divisés en quatre pics indépendants lors du refroidissement. Sur la base 
des données spectrales, l'énergie d'activation libre (ΔG≠) pour l'échange entre les 
espèces diastéréoisomères 7a E et 7a Z a été calculée. Les valeurs de ΔG≠ trouvées 
ΔG≠ E → Z = 14,4 kcal/mol, ΔG≠ Z → E = 13,3 kcal/mol sont en accord avec les 
précédentes indiquées pour ces énamines conjuguées et caractérisent le procédé 
d'isomérisation comme étant à basse énergie. 
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2-(Pyrrolidin-2-ylidène)acétonitriles substitués par des benzazoles quaternisés 
La position C-2 du fragment énaminonitrile a été activée par quaternisation de 
l'azote du benzazole, ce qui a favorisé la séparation des charges dans la molécule. 
La quaternisation a été réalisée par alkylation directe du pyrrolidinacétonitrile 
7a, substitué par un benzimidazolyle, ou de l'hétérolacétonitrile dans le cas des 
dérivés benzoxazolyl 2b et benzothiazolyl 2c; les précurseurs accédés 17 et 18 
réagissent encore avec le chlorure d'imidoyl 5a généré in situ (Schéma 3). 
 
Schéma 3. 2-(Pyrrolidin-2-ylidène)acétonitriles substitués par des benzazoles 
quaternisés 16, 19, 20. 
 
Le composé 16 existe sous forme de mélange de diastéréoisomères à la fois 
en solution (selon les données RMN dans CDCl3, il y a 58% d'isomère) et à l'état 
solide (liaison C=C torsadée selon DRX, angle dièdre égal à 53°). 
Dans les spectres RMN 13С de 16, 19 et 20, le pic de l'atome С-2 du fragment 
d'énaminonitrile déplacé vers le champ faible (δ = 170,7–173,9 ppm) par rapport 
aux analogues neutres (δ = 167,0–168,1 ppm). Ceci indique le déblindage 
supplémentaire lié au déplacement de la densité électronique vers l'azote déficient 
en electrons. 
 
2-Azahétaryl-2-(5-R-3-oxoindolin-2-ylidène)acétonitriles 
L'indolin-2,3-dione 21 a été choisie comme matière de départ appropriée pour 
la synthèse de 2-azahétaryl-2-(5-R-3-oxoindolin-2-ylidène)acétonitriles 22-24. On 
sait que sa fonctionnalisation par nucléophiles est possible en position 2 via la 
formation d'imidochlorure intermédiaire. Habituellement, ce dernier est isolé et 
dissous dans un solvant plus polaire pour effectuer une réaction de condensation. 
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En raison de la faible stabilité de l’imidochlorure, le rendement de la réaction est 
toujours faible. Nous avons ainsi développé une nouvelle approche en un pot qui 
comprend la formation in situ d’imidochlorure (~ 1 h, ébullition dans le benzène) 
et sa condensation ultérieure avec l’hététylacétonitrile (Schéma 4). La durée totale 
de réaction est d'environ 1 heure, l'étape limitante étant la formation 
d'imidochlorure. Les produits sont formés avec des rendements élevés; il existe des 
composés de couleurs vives variant du rouge au violet et exibit une longue bande 
d'absorption de longueur d'onde dans la gamme 515-550 nm. Selon la RMN et la 
DRX, les composés de données 22-24 existent sous forme de Z à la fois en solution 
et à l'état solide. Cette configuration est probablement stabilisée par une liaison 
hydrogène intramoléculaire (N···H–N). 
 Schéma 4. Synthesis of 2-azahétaryl-2-(5-R-3-oxoindolin-2-ylidène)acétonitriles 
 22-24. 
 
La particularité des 3-oxindoles functionalizé 22-24 est leur comportement 
lors du changement de l'acidité du milieu. Tout en augmentant la basicité du 
milieu, le déplacement batochrome d'absorption λmax se produit, 150 nm pour 22b 
(λabsmax = 680 nm) et 130 nm pour 23a (λabsmax = 665 nm). Visuellement, c'est le 
passage du violet au bleu. Les constantes de dissociation conditionnelles (pKa) ont 
été calculées pour 22b et 23a sur la base des données obtenues: pKa22b = 10,09 ± 
0,05; pKa23a = 10,96 ± 0,25. 
 
Dans le troisième chapitre, nous décrivons la réactivité du 2-azahétaryl-2-(1-
R-pyrrolidin-2-ylidène)acétonitrile en tant que 1,3-diélectrophiles envers les 
composés binucléophiles et la synthèse de pyrazoles et d'isoxazoles substitués 
254 
 
différemment. Les transformations en aval sur les pyrazoles sont décrites en détail 
et ont montré une excellente région et chimiosélectivité. 
 
Réactions de 2-azahétaryl-2-(1-R-pyrrolidin-2-ylidène)acétonitriles avec 
des 1,2-binucléophiles faisant intervenir l'atome С-2 de pyrrolidine et le 
carbone du groupe nitrile 
La délocalisation de la densité d'électrons d'un fragment d'énamine dans le 2-
azahéaryl-2-(pyrrolidin-2-ylidène)acétonitriles 1, 6-12 (selon les données RMN et 
DRX) favorise un déplacement de l'équilibre énamine-imminium, augmentant le 
caractère électrophile de l'atome C-2 du fragment d'énaminonitrile et diminuant 
simultanément celui du groupe nitrile. Ces observations suggèrent que les 1,3-
diélectrophiles peuvent réagir avec les binucléophiles de manière régiosélective. 
La réaction se déroule en douceur avec des pyrrolidinacétonitriles à 
substitution N-alkyle dans le dioxane au reflux avec un excès de 10-20 équivalents 
du réactif binucléophile et fournit les pyrazoles et les isoxazoles avec des 
rendements modérés à bons (50-85%) (Schéma 5). Une conversion de cycle de 
pyrrolidine en pyrazole (ou isoxazole) devrait se produire par attaque nucléophile 
sur le carbone insaturé de la pyrrolidine, donnant A; les intermédiaires spiro B se 
formeraient alors par attaque du deuxième atome du binucléophile sur le groupe 
nitrile en une forme favorisée de 5 exo-dig. Enfin, l'ouverture du cycle pyrrolidine 
est favorisé par l'aromatisation du cycle azole et fournit la chaîne aliphatique 
substituée par l'azote 25-31.  Cette ouverture du cycle conclut le mécanisme 
d’addition nucléophile- annulation spirannique et ouverture de cycle (ANSARO) 
qui explique le déroulement de cette transformation (Schéma 5). 
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Schéma 5. Réactions de 2-azahétaryl-2-(1-R-pyrrolidin-2-ylidène)acétonitriles 
avec des 1,2-binucléophiles. 
 
 
La nature des substituants alkyl et hétaryl s'est avérée n'affecter que 
modérément l'efficacité de la réaction, bien que la substitution benzothiazole 
fournisse systématiquement de meilleurs rendements. L'implication du groupe 
nitrile est mise en évidence par la disparition de ses signaux caractéristiques de 
l'étirement des vibrations dans l'intervalle 2198−2178 cm-1 des spectres IR. Les 
spectres de RMN 1H révèlent la présence du groupe NH2 à 6,25-6,94 ppm pour les 
pyrazoles et de 8,04 à 8,20 ppm pour les isoxazoles. La structure des composés a 
également été confirmée par DRX. 
 
Fonctionnalisation régiosélective de 3-(ω-aminopropyl)-4-azahetaryl-5-
aminopyrazoles 
L'alkylamine secondaire est significativement plus nucléophile que 
l'aromatique primaire et la réaction d'alkylation du rendement en 25a est le sel 
d'ammonium 32. Lors de la protection d'une amine secondaire avec un groupe tert-
butyloxycarbonyle, l'alkylation réductive régiosélective du groupe amino primaire 
est soumise à un composé 33 (Schéma 6). 
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Schéma 6. Alkylation régiosélective des groupes amino de 25a. 
 
Le groupe aminé pendant du pyrazole et à proximité de NH du benzimidazole 
permet la condensation de 27a avec des électrophiles tels que des orthoesters 
(Schéma 7 , voie 1). Cette approche pourrait délivrer des échafaudages de 
pyrazolopyrimidine intéressants à des fins de chimie médicinale, comme cela a été 
illustré dans le développement d'inhibiteurs de la glycogène synthase kinase 3, une 
enzyme impliquée dans de nombreuses maladies telles que le diabète de type II, la 
maladie d'Alzheimer, le cancer, le trouble bipolaire et l'inflammation. On a 
également eu accès à un composé aromatique tétracyclique en quelque sorte 
similaire par un simple traitement de 27a avec un excès de nitrite de tert-butyle 
dans le DMF (Schéma 7, voie 2).  
 
Schéma 7. Accès direct aux structures tétracycliques fusionnées 34, 35. 
 
 Dans ces conditions, l'intermédiaire diazonium pourrait en effet être piégé 
par l'azote de l'imidazole pour générer le triazène 35 correspondant, avec une 
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protection concomitante de l'amine secondaire en tant que nitrosamine. Il présente 
une structure tétracyclique unique qui n'a jamais été décrite auparavant et, en tant 
que telle, élargit l'espace chimique de la chimie hétérocyclique.  
Le groupe amino a également été utilisé pour introduire les substituants 
aromatiques, stéryliques ou hétéroaromatiques à la 5ème position du pyrazole 
(Schéma 8).  La première étape d'halogénation est soumise à la procédure classique 
de Sandmeyer ou à une méthode modifiée impliquant l'utilisation de nitrite de tert-
butyl et d'iode cristallin. Le 5-iodopyrazole 36 est le produit de réaction 
majoritaire. Dans le second cas, nous introduisons un halogène et une protection 
sur le groupe amino secondaire par un procédé en un one pot. La réaction de 
couplage croisé de Suzuki-Miyaura subit un rendement quantitatif pour les 
substitutions aromatiques et stéryliques et un rendement modéré de 24% pour 
l'indolyl. 
  
 
Schéma 8. La réaction de l'iodation du 5-aminopyrazole 25a par Zandmeier. 
Couplage croisé de Suzuki-Miyaura pour 5-iodopyrazole 36. 
 
Une approche différente pour introduire le substituant aryle à la 5ème 
position du pyrazole est la désamination réductrice par la formation de pyrazole 38 
suivie d'une étape d'activation C–H. Les conditions opératoires de la première 
étape sont similaires à celles appliquées pour l'introduction de l'halogène mais le 
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donneur de radicaux hydrogène est le DMF. La réaction de couplage suivante 
conduit à 37a avec un rendement quantitatif (Schéma 9).  
 
 Schéma 9. Reductive deamination and futher C–H functionalization of pyrazole 
25a. 
 
Ainsi, en optimisant la technique, nous avons pu augmenter le rendement en 
5-arylpyrazoles de 21% à 92%. 
 
Réactions de 2-azahétaryl-2-(1-R-pyrrolidin-2-ylidène)acétonitriles avec 
des 1,2-binucléophiles impliquant l'atome С-2 de pyrrolidine et l'atome С-2 
d'azahétérocycle 
En procédant à la réaction de 2-benzoxazol-2-yl-2-(1-R-pyrrolidin-2-
ylidène)acétonitriles avec de la méthylhydrazine, on a pu récupérer deux composés 
38 et 39 après la séparation du mélange réactionnel. Une caractéristique du produit 
cyclique d'isoxazole ouvert 39 est le déplacement des protons aromatiques vers le 
champ fort dans le spectre RMN 1H et la présence d'une vibration caractéristique 
du groupe nitrile dans les spectres IR (2216-2218 cm-1). 
Le mécanisme comprend l’attaque NH à l’atome C-2 du noyau pyrrolidine 
menant à l’intermédiaire A dans lequel YH se situe identiquement à proximité du 
groupe nitrile et de l’atome C-2 du benzoxazole et attaque l’une ou l’autre avec 
une probabilité qui dépend directement de leur électrophilie (Schéma 10). 
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Schéma 10. La réaction des 2-benzoxazol-2-yl-2-(1-R-pyrrolidin-2-
ylidène)acétonitriles 12 avec de la méthylhydrazine. 
 
En introduisant les énaminonitriles cycliques substitués par des azoles 
quaternisés 16, 19 dans la réaction avec les 1,2-binucléophiles, on observe la 
formation de produits à cycle ouvert 40, 41 (Schéma 11). Lorsque le dérivé de 
benzothiazole 20 réagit avec la méthylhydrazine, la transformation subit selon la 
1ère voie; l'ouverture du cycle thiazole procède à la deuxième étape avec formation 
simultanée d'azépine 42 (Schéma 11). Les structures des produits ont été 
confirmées par RMN 2D et DRX. 
 
 
Schéma 11. Réaction des énaminonitriles cycliques substitués par des azoles 
quaternisés  avec des hydrazines. 
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Après avoir développé le caractère électrophile du 2-azahétaryl-2-(1-R-
pyrrolidin-2-ylidène)acétonitriles, nous démontrons au chapitre 4 que ces adduits 
peuvent également se comporter comme nucléophiles en présence d'électrophiles 
tels que les acétals de diméthylformamide. 
Les données expérimentales ainsi que les précédents de la littérature nous 
ont amenés à supposer que la présence du groupe NH facilement accessible est 
essentielle à la formylation du centre C-3 de la pyrrolidine, ce qui permet de 
proposer un mécanisme pour cette réaction peu commune (Schéma 12). 
 
Schéma 12. Mécanisme proposé pour la réaction de 2-azahétaryl-2-(1-R-
pyrrolidin-2-ylidène)acétonitriles 1 avec DMF DMA. 
 
L'incorporation de la fraction diméthylméthylidène se fait de manière 
réversible par attaque nucléophile de l'ion aza-oxo-stabilisé A par l'azote de la 
pyrrolidine, ce qui donne l'intermédiaire intermédiaire B; la position C-3 de la 
pyrrolidine dans B activée par effet inductif (-I) du groupe amidine et amélioration 
de la stabilité mésomérique de l'anion par la fraction acrylonitrile. En conséquence, 
une déprotonation par un anion méthoxy et une réaction avec une autre molécule 
de DMF DMA peuvent se produire, produisant C; celle-ci se transforme en 2-
azahéaryl-2-(3- (diméthylamino)méthylène)pyrrolidin-2-ylidène)acétonitrile 43 par 
inversion de la première étape (Schéma 12). 
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Synthèse de pyrrolo [3,2-c]pyridin-6-imine, étude physico-chimique et 
perspectives d'utilisation 
Un modèle de produit de formylation 43a été incorporé à une réaction de 
transamination avec de la benzylamine, suivie d'une cyclisation en pyrrolo[3,2-
c]pyridine-6-imine 45 en présence d'une base (Schéma 13). 
 Schéma 13. Synthèse de pyrrolo[3,2-c]pyridine-6-imine 45. 
 
Le pyrrolo[3,2-c]pyridin-6-imine 45 existe sous la forme d'un mélange 
d'équilibre d'énamine et d'imine en solution et d'énamine à l'état solide. En raison 
du fragment de vinamidine, le composé est très sensible à la présence de donneurs 
de protons. Il y a une large bande dans les spectres d'absorption en solvant 
aprotique (toluène, dioxane, acétonitrile, DMSO) dans la région de 320-340 nm,  
qui devient étroite entre 320-370 nm en présence de donneurs de protons, à savoir 
HCl, H2O, MeOH, EtOH. 
Une telle sensibilité de la pyrrolo[3,2-c]pyridin-6-imine 45 à la protonation 
avec un rendement quantique de fluorescence élevé (Ф = 61 %, standard – sulfate 
de quinine) a été utilisée pour développer un test fluorométrique de l'eau sans 
précédent pour les solvants aprotiques. Nous avons montré qu'une telle méthode 
fluorimétrique pour déterminer la teneur en eau du DMSO présentait une limite de 
détection de 0,068%. 
Le cinquième chapitre est consacré à la formation de (i) complexes de bore 
et de difluorure de 2-azahétaryl-2-(1H-pyrrolidin-2-ylidène)acétonitrile et 
propriétés photophysiques d'une gamme d'adduits isolés; (ii) les complexes d-métal 
(Cu, Zn, Co, Ni), leur isolement et leur caractérisation complète ainsi que leur mise 
en œuvre dans des dispositifs permettant d'étudier leurs puissantes applications 
dans les cellules solaires et de détecter le Zn et Cu dans les fluides biologiques. 
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Complexes rigidifiés par le BF2 sur la base du 2-azahétaryl-2-(pyrrolidin-
2-ylidène)acétonitriles 
Les complexes BF2 du 2-azéhetaryl-2-(pyrrolidin-2-ylidène)acétonitrile 46 
ont des analogues structuraux avec les colorants BODIPY, à savoir le 
boroazacycle. Les colorants BODIPY présentent des propriétés uniques, à savoir 
les rendements quantiques élevés, une bonne stabilité dans les conditions 
physiologiques, les bandes d’absorption et d’émission étroites. Malgré la 
fluorescence intense des colorants BODIPY en solution, ils ont un faible décalage 
de Stokes qui interrompt l’analyse du signal des objets biologiques et ils ne sont 
presque pas fluorescents à l’état solide. La désymétrisation du ligand bidente dans 
le complexe de bore est l’une des solutions pour vaincre les colorants BODIPY. 
Nous avons procédé à la désymétrisation en introduisant des hétérocyles ayant des 
propriétés fondamentalement différentes. Les huit complexes 46a-h ont été 
obtenus par la procédure illustrée dans le schéma 14. 
 
Schéma 14. Synthèse de BF2 complexes 46. 
 
Tous les complexes sont stables à l'eau, ont des décalages de Stokes allant 
jusqu'à 9000 cm-1, une émission dans la gamme bleu-violet, une fluorescence à la 
fois en solution (Ф jusqu'à 90%) et à l'état cristallin. Une caractéristique importante 
de la biovizualisation est la neutralité de telles sondes permettant de traverser la 
membrane cellulaire. La brillance de ces colorants est suffisante pour les études in 
vitro, mais leur émission (400 - 460 nm) est hors de la fenêtre optique (650 - 900 
nm) nécessaire aux études in vivo. Néanmoins, la présence du groupe BF2 pourrait 
être utilisée pour incorporer le marqueur radioactif [18F] et donnerait à ces sondes 
le caractère bimodal. 
263 
 
Complexes de 2-azahetaryl-2-(pyrrolidin/5-R-3-oxoindolin-2-ylidène) 
acétonitriles avec des métaux 3d: synthèse, structure et perspectives 
d'utilisation 
Le metal 3d central dans le complexe 47 
comportant les ligands enaminonitrile 1 prend une 
géométrie tétraédrique avec une coordination par 
quatre atomes d'azote (Figure 3). Les propriétés 
photovoltaïques et photoconductrices des 
composites de film d'un copolymère de styrène 
avec le méthacrylate d'octyle (COM) et les 
additions des complexes de 47 avec Co (II), Cu 
(II), Ni (II) ont été étudiées. Le plus grand effet photovoltaïque comporte des films 
contenant du CoL2. La valeur du potentiel électrique de la surface (VPHmax) 
augmente dans une rangée de CuL2 (80 mV), NiL2 (120 mV), CoL2 (180mV). 
Compte tenu de la position λmax dans le domaine visible du spectre, ainsi que 
de la tendance des composés à former des complexes chélatés, nous avons étudié 
les propriétés photophysiques du 2-azahetaryl-2-(5-R-3-oxoindolin-2-
ylidène)acétonitriles 22-24 en présence d’ions métalliques (3d). La formation de 
complexe à partir du composé modèle 2.24b avec Cu(II) et Zn(II) est caractérisée 
par un décalage bathochrome significatif des maxima d'absorption (Δλ ≥ 70 nm); 
changement de la couleur du violet (λmax = 530 nm) au bleu (λmax = 600 nm). En 
appliquant la méthode logarithmique limitée à la recherche de complexes, nous 
avons trouvé que des complexes de stabilité moyenne se sont formés. Les réactifs 
sont sensibles et indiquent la détection de la limite des ions (LD) calculée selon le 
critère 3S en dessous de 1 µmol/l. La formation complexe se produit lentement 
avec d'autres métaux 3d dans des conditions d'interaction avec Zn(II) et Cu(II), 
comme dans le cas de Co(II) ou ne se produit pas dans le cas de Ni(II). Pour la 
détermination sélective de Zn(II), les ions Cu(II) peuvent être masqués par les ions 
thiosulfate. 
 
Figure 3.   Structure 
moléculaire du composé 47b 
avec Co (ІІ). 
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La sixième chapitre de la thèse est une partie expérimentale, qui décrit les 
méthodes de synthèse des composés décrits dans le travail, et une description de 
leurs caractéristiques spectrales et physiques. 
 
Conclusions général 
Les travaux menés dans le cadre de cette thèse ont permis de mettre au point des 
méthodes de préparation des 2-azahétaryl-2-(1-R-pyrrolidine-2-
ylidène)acétonitriles comportant des substituants azahétéro-cycliques de nature 
neutre et cationique et du 2-azahétaryl-2-(5-R-3-oxoindolin-2-
ylidène)acétonitriles. La méthode pour accéder aux 2-azahétaryl-2-(1H-
pyrrolidine-2-ylidène)acétonitriles a été optimisée, permettant un élargissement 
significatif de la portée de la réaction à de nombreux substituants 
azahétérocycliques (jusqu'à 12, à partir de 2). 
Nous avons établi que les 2-azahétqryl-2-(1H-pyrrolidine-2-ylidène)acétonitriles 
existent à la fois dans la solution et à l'état solide en tant qu'isomères Z, 
contrairement au 2-azahétaryl-2-(1-alkylpyrrolidine 2-ylidène) les acétonitriles 
qui existent sous forme d'isomères Z à l'état solide et sous forme d'un mélange 
de diastéréoisomères Z/E dans la solution. L'énergie d'activation libre de rotation 
à la double liaison C=C a été calculée: ΔG≠ E→Z = 14,4 kcal/mol, ΔG≠ Z→E = 
13,3 kcal/mol, valeur caractéristique des processus à basse énergie. 
Dans notre étude sur la réaction des 2-azahétaryl-2-(1-R-pyrrolidine-2-ylidène) 
acétonitriles avec des fragments binucléophiles, tels que les hydrazines et 
l'hydroxylamine, nous avons observé une régiosélectivité complète. En effet, il a 
été établi que la première attaque nucléophile est dirigée contre un atome de C-2 
de pyrrolidine. L'orientation de l'attaque suivante est déterminée par la nature du 
substituant azahétérocylique: 
- dans le cas de substituants azahétérocycliques neutres (à côté du benzoxazole), 
l'attaque est dirigée contre le carbone du groupe nitrile conduisant aux 3-(ω-
aminopropyl)-4-azahétaryl-5-aminopyrazoles; 
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- dans le cas des dérivés du benzoxazole, l'attaque se produit à la fois sur le 
groupe nitrile et avec la même probabilité sur l'atome C-2 de l'azahétérocycle 
conduisant aux isomères structuraux: le 4-benzo[d]oxazol-2-yl-3-aminopropyl)-
1H-azol-5-amines et 5-((2-hydroxyphényl)amino)-3-(3-(R-amino)propyl)-1H-
pyrazol-4-carbonitriles (4-carboxydiimide dans le cas de hydroxylamine); 
- dans le cas du benzoxazole et du benzimidazole quaternisés, l’attaque est 
dirigée contre l’atome C 2 de l’azahétérocycle conduisant au 3-(4-cyano-5-((2-
R-phényl)méthylamino)-1-R1-1H-pyrazol-3-yl)-N-méthylpropan-1-amines. 
Avec le benzothiazole quaternisé, la première attaque est dirigée contre le 
carbone du groupe nitrile suivi de l'attaque suivante de la chaîne ω-
aminopropyle par l'atome C-2 du N-méthylbenzothiazole conduisant à un dérivé 
azépine original. 
En partant de 3-(ω-aminopropyl)-4-azahetaryl-5-aminopyrazoles, nous avons 
étudié des méthodes de fonctionnalisation régiosélective de leurs groupes amino, 
la condensation dans des composés tétracycliques, à savoir le 
benzo[4,5]imidazo[1,2-c]pyrazolo[4,3-e]pyrimidine et [1,2,3]triazine avec un 
rendement global allant jusqu'à 87%; et la désamination via une étape de 
diazotation suivie par une arylation de Suzuki-Miyaura et une activation de C–H 
conduisant à des pyrazoles substitués par 5-aryl(styryl, indol-2-yl) avec un 
rendement global allant jusqu'à 92%. 
Nous avons également exploré les propriétés du 2-azahétaryl-2-(1-R-pyrrolidine-2-
ylidène) acétonitriles en réaction avec le DMF DMA. Il a été établi que la 
présence de groupes NH facilement accessibles est essentielle dans la 
«formylation» du centre C-3 de la pyrrolidine. La méthode de synthèse de 
pyrrolo[3,2-c]pyridine-6-imine (PP) avec 59% en 3 étapes a été développée. 
L'utilisation envisagée de PP pour la détermination de la teneur en eau dans des 
solvants organiques aprotiques par dosage fluorométrique a été développée pour 
le DMSO présentant une limite de détection de 0,068%. 
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Enfin, nous avons étudié la structure et les propriétés photophysiques de 
complexes de 2-azahétaryl-2-(pyrrolidine/3-oxoindolin-2-ylidène) acétonitriles 
avec des métaux 3d et du bore. 
Cela nous a permis d’établir leur utilité puisque: 
- Les principales caractéristiques des complexes BF2 à base de 2-azahétaryl-2 
(pyrrolidin-2-ylidène)acétonitriles sont les grands déplacements de Stokes 
(jusqu'à 9000 cm-1), haute luminosité (jusqu'à 86400 l•mol-1•cm-1), 
solvatofluorochromie positive, fluorescence à l'état solide et stabilité de l'eau. 
- Les films de composites polymériques avec ajouts de complexes métalliques 
de 2-azahétaryl-2-(pyrrolidin-2-ylidène)acétonitriles avec du Co(II), du Cu(II), 
du Ni(II) (ML2) ont un effet photovoltaïque. Le potentiel électrique de la surface 
atteint la plus grande valeur de 180 mV dans le cas de СоL2. 
- Le 2-azahétaryl-2-(5-R-3-oxoindolin-2-ylidène)acétonitriles a démontré une 
grande visibilité lors de la chélation du Zn(II) et du Cu(II): Δλ ≥ 70 nm, λligandmax 
= 515-530 nm (rouge-violet), λcomplexmax = 590–605 nm (bleu), au рH des 
fluides biologiques. La limite de détection des ions est de 0,4 à 1,0 µmol/l. 
 
Ce travail illustre donc les grands développements potentiels pouvant être 
réalisés sur la base d’une approche synthétique efficace des hétérocycles 
polyfonctionnels. Nous avons montré que les efforts de synthèse permettent non 
seulement de nouveaux accès à des composés densément fonctionnalisés, mais 
fournissent également des outils moléculaires simples pour les études 
photophysiques permettant de nouveaux développements dans un large éventail 
de domaines. À ce titre, ces travaux contribuent à faire de la molécule le centre 
de tout développement scientifique en sciences chimiques. 
 
